DECOR Information for Project: epSOS (epsos-)

Issues already assigned

Currently assigned to: Giorgio Cangioli (id 5)

 (epsos-issue-2) Add laparoscopic colectomy
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.2)
Last assignment to Giorgio Cangioli

Issue Add laparoscopic colectomy
Id epsos-issue-2
Type Change Request
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-10 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSProcedures 1.3.6.1.4.1.12559.11.10.1.3.1.42.10 July 2009 - 2013‑06‑03 Draft
notice There are open issues with this item:
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 19063003 Arthroplasty of knee SNOMED-CT Hospital Data Project WHO
0-L 84877006 Arthroscopy of knee with meniscus repair SNOMED-CT TOP 20 Germany
0-L 119922005 Biliary tract endoscopy SNOMED-CT TOP 20 Germany
0-L 86273004 Biopsy SNOMED-CT
0-L 10847001 Bronchoscopy SNOMED-CT Hospital Data Project WHO
0-L 112802009 Cardiovascular surgical procedure SNOMED-CT
0-L 250980009 Cardioversion SNOMED-CT
0-L 66951008 Carotid endarterectomy SNOMED-CT Hospital Data Project WHO
0-L 38102005 Cholecystectomy SNOMED-CT Hospital Data Project WHO Excision of all or part of the gallbladder
0-L 3418002 Chondrectomy of spine SNOMED-CT Hospital Data Project WHO
0-L 23968004 Colectomy SNOMED-CT Hospital Data Project WHO
0-L 73761001 Colonoscopy SNOMED-CT Hospital Data Project WHO
0-L 4770005 Colporrhaphy for repair of urethrocele SNOMED-CT TOP 20 Germany
0-L 63016009 Complete cystectomy SNOMED-CT TOP 20 Germany
0-L 232717009 Coronary artery bypass graft SNOMED-CT Hospital Data Project WHO
0-L 312775003 Debridement of ulcer SNOMED-CT TOP 20 Germany
0-L 47534009 Decompression of median nerve SNOMED-CT Hospital Data Project WHO The surgical relief of compression of the median nerve at the wrist
0-L 76810006 Diagnostic dilation and curettage of uterus SNOMED-CT Hospital Data Project WHO A form carried out to examine the removed uterine contents for disease characteristics
0-L 423827005 Endoscopy SNOMED-CT
0-L 85548006 Episiotomy SNOMED-CT TOP 20 Germany
0-L 9888007 Excision of intracranial lesion SNOMED-CT Hospital Data Project WHO
0-L 370611004 Excision of malignant neoplasm SNOMED-CT
0-L 56361007 Excision of soft tissue SNOMED-CT
0-L 257822003 Extracapsular extraction SNOMED-CT Hospital Data Project WHO
0-L 54885007 Extraction of cataract SNOMED-CT Hospital Data Project WHO
0-L 112828007 Femoral-popliteal artery bypass graft SNOMED-CT Hospital Data Project WHO
0-L 236886002 Hysterectomy SNOMED-CT TOP 20 Germany
0-L 359612003 Implantation of cochlear prosthetic device SNOMED-CT Hospital Data Project WHO
0-L 64253000 Implantation of heart assist system SNOMED-CT
0-L 118955007 Implantation to cardiovascular system SNOMED-CT
0-L 426153007 Insertion of artificial airway SNOMED-CT
0-L 302343007 Insertion of prosthesis for breast SNOMED-CT
0-L 265703000 Jaw and temporomandibular joint operations SNOMED-CT
0-L 45595009 Laparoscopic cholecystectomy SNOMED-CT Hospital Data Project WHO
0-L 236887006 Laparoscopic hysterectomy SNOMED-CT TOP 20 Germany
0-L 15018006 Laparoscopic repair of inguinal hernia SNOMED-CT Hospital Data Project WHO
0-L 363187007 Limb operation SNOMED-CT Czech EDS
0-L 133864008 Lithotripsy SNOMED-CT
0-L 173171007 Lobectomy of lung SNOMED-CT Hospital Data Project WHO
0-L 386638009 Obstetric operation SNOMED-CT
0-L 21371007 Operation on abdominal region SNOMED-CT Czech EDS
0-L 57168000 Operation on bone SNOMED-CT Czech EDS
0-L 392090004 Operation on breast SNOMED-CT
0-L 26476002 Operation on bronchus SNOMED-CT
0-L 53266006 Operation on diaphragm SNOMED-CT
0-L 12658000 Operation on female genital organs SNOMED-CT Czech EDS
0-L 78418002 Operation on heart and pericardium SNOMED-CT
0-L 112698002 Operation on joint SNOMED-CT Czech EDS
0-L 387714009 Operation on lung SNOMED-CT
0-L 49509003 Operation on lymphatic structure SNOMED-CT
0-L 386765006 Operation on mediastinum SNOMED-CT
0-L 37508003 Operation on neck SNOMED-CT Czech EDS
0-L 16545005 Operation on nervous system SNOMED-CT Czech EDS
0-L 34969007 Operation on retroperitoneum SNOMED-CT
0-L 392011001 Operation on skin SNOMED-CT
0-L 59300005 Operation on spleen SNOMED-CT
0-L 86800006 Operation on trachea SNOMED-CT
0-L 392048005 Operation on urinary system SNOMED-CT Czech EDS
0-L 107907001 Operative procedure on digestive system SNOMED-CT
0-L 108021004 Operative procedure on male genitourinary system SNOMED-CT
0-L 392236004 Operative procedure on spinal structure SNOMED-CT Czech EDS
0-L 36228007 Ophthalmic examination and evaluation SNOMED-CT
0-L 64368001 Partial mastectomy SNOMED-CT Hospital Data Project WHO
0-L 429639007 Percutaneous transluminal balloon angioplasty with insertion of stent into coronary artery SNOMED-CT Hospital Data Project WHO
0-L 118804001 Procedure on blood vessel SNOMED-CT TOP 20 Germany
0-L 118683007 Procedure on ear and related structures SNOMED-CT
0-L 118949002 Procedure on extremity SNOMED-CT
0-L 118675001 Procedure on female genital system SNOMED-CT
0-L 118716003 Procedure on foot SNOMED-CT TOP 20 Germany
0-L 118950002 Procedure on head AND/OR neck SNOMED-CT
0-L 118831003 Procedure on intestine SNOMED-CT TOP 20 Germany
0-L 118795000 Procedure on pleura SNOMED-CT
0-L 90470006 Prostatectomy SNOMED-CT Hospital Data Project WHO
0-L 397956004 Prosthetic arthroplasty of the hip SNOMED-CT Hospital Data Project WHO
0-L 85921004 Puncture procedure SNOMED-CT
0-L 384723003 Radical mastectomy SNOMED-CT Hospital Data Project WHO
0-L 122470005 Reduction of closed fracture SNOMED-CT TOP 20 Germany
0-L 122471009 Reduction of open fracture SNOMED-CT TOP 20 Germany
0-L 405525004 Repair of aneurysm of abdominal aorta SNOMED-CT Hospital Data Project WHO
0-L 441612006 Repair of infrarenal abdominal aortic aneurysm with insertion of endovascular stent SNOMED-CT Hospital Data Project WHO
0-L 44558001 Repair of inguinal hernia SNOMED-CT Hospital Data Project WHO
0-L 112727005 Revision of hip replacement SNOMED-CT Hospital Data Project WHO
0-L 86749008 Stripping and ligation SNOMED-CT TOP 20 Germany
0-L 70183006 Subcutaneous mastectomy SNOMED-CT Hospital Data Project WHO
0-L 385488000 Surgical procedure on chest wall SNOMED-CT
0-L 373353005 Surgical procedure on eye proper SNOMED-CT Czech EDS
0-L 385487005 Surgical procedure on thorax SNOMED-CT Czech EDS
0-L 13619001 Thyroidectomy SNOMED-CT
0-L 173422009 Tonsillectomy SNOMED-CT Hospital Data Project WHO
0-L 359623004 Total lobectomy of lung SNOMED-CT Hospital Data Project WHO
0-L 70536003 Transplant of kidney SNOMED-CT Hospital Data Project WHO
0-L 90199006 Transurethral prostatectomy SNOMED-CT Hospital Data Project WHO
0-L 30904006 Vascular surgery procedure SNOMED-CT Czech EDS
0-L 232632009 Wedge excision of lung SNOMED-CT Hospital Data Project WHO
0-L 80146002 Appendicectomy SNOMED-CT Hospital Data Project WHO
0-L 11466000 Caesarean section SNOMED-CT Hospital Data Project WHO
0-L 10458001 Evacuation of intracerebral haematoma SNOMED-CT Hospital Data Project WHO
0-L 59712006 Evacuation of subdural haematoma SNOMED-CT Hospital Data Project WHO
0-L 46116005 Excision of malignant tumour of breast SNOMED-CT
0-L 234336002 Haemopoietic stem cell transplant SNOMED-CT Hospital Data Project WHO
0-L 6025007 Laparoscopic appendicectomy SNOMED-CT Hospital Data Project WHO
0-L 287310004 Lung tumour excision SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:31:51
  Author assigned by Alexander Henket (id#4)
  Description Is obtaining this code still relevant
tracking Tracking 2013‑06‑09 - status: Open
  Author Alexander Henket
Description Issue:

Should add laparoscopic colectomy. Currently no good code was identified

Additional info:

Hospital Data Project WHO

 (epsos-issue-24) Value set epSOSCodeProb without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.24)
Last assignment to Giorgio Cangioli

Issue Value set epSOSCodeProb without dataset binding
Id epsos-issue-24
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-23 (2013‑06‑03)
Description
The Value Set is used as an optional description of a problem in the patient Summary. It gives an information on the circumstances under which the problem was defined/discovered.
Value Set Name Value Set Id Version / effective date Status
epSOSCodeProb 1.3.6.1.4.1.12559.11.10.1.3.1.42.23 July 2009 - 2013‑06‑03 Draft
notice There is an open issue with this item:
  • epsos-issue-24: Value set epSOSCodeProb without dataset binding (Open)
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 404684003 Clinical finding SNOMED-CT
0-L 409586006 Complaint SNOMED-CT
0-L 282291009 Diagnosis interpretation SNOMED-CT
0-L 64572001 Disease SNOMED-CT
0-L 248536006 Finding of functional performance and activity SNOMED-CT
0-L 418799008 Finding reported by subject or history provider SNOMED-CT
0-L 55607006 Problem SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:07:01
  Author assigned by Alexander Henket (id#4)
  Description It does not map to the Problem Code, this is already bound to epSOSIllnessesAndDisorders, but it still appears to be the most likely candidate
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-37) Value set epSOSDisplayLabel without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.37)
Last assignment to Giorgio Cangioli

Issue Value set epSOSDisplayLabel without dataset binding
Id epsos-issue-37
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-46 (2013‑06‑03)
Description
The Value Set is used to denominate all the labels and messages adopted for the epSOS CDA display
Value Set Name Value Set Id Version / effective date Status
epSOSDisplayLabel 1.3.6.1.4.1.12559.11.10.1.3.1.42.46 2013‑06‑03 Draft
notice There is an open issue with this item:
  • epsos-issue-37: Value set epSOSDisplayLabel without dataset binding (Open)
Source Code System:
  • 1.3.6.1.4.1.12559.11.10.1.3.1.44.4 epSOSDisplayLabel
Level/ Type Code Display Name Code System Description
0-L 1 Active Ingredient epSOSDisplayLabel
0-L 10 Clinical Manifestation epSOSDisplayLabel
0-L 107 I confirm that the patient –data subject has consented to the following statement: ‘I agree that my Patient Summary may be transferred to a registered Health Professional in [COUNTRY B] for the purposes of providing me with medical care and/or medication’ epSOSDisplayLabel
0-L 11 Closed/Inactive Problem epSOSDisplayLabel
0-L 12 Contact Information epSOSDisplayLabel
0-L 13 Country epSOSDisplayLabel
0-L 14 Country A Medicinal Product Code epSOSDisplayLabel
0-L 15 Creation Date epSOSDisplayLabel
0-L 16 Custodian epSOSDisplayLabel
0-L 17 Date epSOSDisplayLabel
0-L 18 Date To epSOSDisplayLabel
0-L 19 Date of Birth epSOSDisplayLabel
0-L 2 Active Problem epSOSDisplayLabel
0-L 20 Date of Prescription epSOSDisplayLabel
0-L 21 Device/Implant epSOSDisplayLabel
0-L 22 Dispense epSOSDisplayLabel
0-L 23 Dispensed Package Size epSOSDisplayLabel
0-L 24 Dispensed Product epSOSDisplayLabel
0-L 25 Dose Form epSOSDisplayLabel
0-L 26 End Date epSOSDisplayLabel
0-L 27 Every epSOSDisplayLabel
0-L 28 Facility ID epSOSDisplayLabel
0-L 29 Facility Name epSOSDisplayLabel
0-L 3 Address epSOSDisplayLabel
0-L 30 Family Name epSOSDisplayLabel
0-L 31 for epSOSDisplayLabel
0-L 32 Frequency of Intakes epSOSDisplayLabel
0-L 33 Gender epSOSDisplayLabel
0-L 34 Given Name epSOSDisplayLabel
0-L 35 Guardian epSOSDisplayLabel
0-L 36 Implant Date epSOSDisplayLabel
0-L 37 Instructions to patient epSOSDisplayLabel
0-L 38 Is substitution of brand name allowed? epSOSDisplayLabel
0-L 39 Last Update epSOSDisplayLabel
0-L 4 Advise to the dispenser epSOSDisplayLabel
0-L 40 Legal Authenticator epSOSDisplayLabel
0-L 41 National Insurance Number epSOSDisplayLabel
0-L 42 No epSOSDisplayLabel
0-L 43 Number of packages epSOSDisplayLabel
0-L 44 Observation Type epSOSDisplayLabel
0-L 45 Onset Date epSOSDisplayLabel
0-L 46 Organisation Identifier epSOSDisplayLabel
0-L 47 Organisation Name epSOSDisplayLabel
0-L 48 Other Active Ingredients epSOSDisplayLabel
0-L 49 Other Contacts epSOSDisplayLabel
0-L 5 Agent epSOSDisplayLabel
0-L 50 Package Size epSOSDisplayLabel
0-L 51 Patient epSOSDisplayLabel
0-L 52 Patient IDs epSOSDisplayLabel
0-L 53 per unit epSOSDisplayLabel
0-L 54 Preferred HP/Legal organization to contact epSOSDisplayLabel
0-L 55 Prefix epSOSDisplayLabel
0-L 56 Prescriber epSOSDisplayLabel
0-L 57 Prescriber details epSOSDisplayLabel
0-L 58 Prescription ID epSOSDisplayLabel
0-L 59 Prescription Item Details epSOSDisplayLabel
0-L 6 at epSOSDisplayLabel
0-L 60 Prescription Item ID epSOSDisplayLabel
0-L 61 Prescription Items List epSOSDisplayLabel
0-L 62 Procedure epSOSDisplayLabel
0-L 63 Procedure Date epSOSDisplayLabel
0-L 64 Profession epSOSDisplayLabel
0-L 65 Reaction Type epSOSDisplayLabel
0-L 66 Regional/National Health ID epSOSDisplayLabel
0-L 67 Route of Administration epSOSDisplayLabel
0-L 68 See details epSOSDisplayLabel
0-L 69 Specialty epSOSDisplayLabel
0-L 7 Author (HP) epSOSDisplayLabel
0-L 70 Strength epSOSDisplayLabel
0-L 71 Substitute epSOSDisplayLabel
0-L 72 The Active Problem section is missing ! epSOSDisplayLabel
0-L 73 The Allergies, adverse reactions, alerts section is missing ! epSOSDisplayLabel
0-L 74 The Medical Devices and implants section is missing ! epSOSDisplayLabel
0-L 75 The Medication Summary section is missing ! epSOSDisplayLabel
0-L 76 The History of Procedures section is missing ! epSOSDisplayLabel
0-L 77 unit(s) epSOSDisplayLabel
0-L 78 Units per intake epSOSDisplayLabel
0-L 79 Vaccination epSOSDisplayLabel
0-L 8 Authoring Device epSOSDisplayLabel
0-L 80 Vaccination Date epSOSDisplayLabel
0-L 81 Yes epSOSDisplayLabel
0-L 82 I have identified the patient-data subject epSOSDisplayLabel
0-L 83 I confirm that the patient –data subject has consented to the following statement: ‘I agree that my ePrescription may be transferred to a registered Health Professional in [COUNTRY B] for the purposes of providing me with medical care and/or medication’ epSOSDisplayLabel
0-L 84 Observation Value epSOSDisplayLabel
0-L 85 Date From epSOSDisplayLabel
0-L 9 Brand Name epSOSDisplayLabel
0-L 99 Physical Findings epSOSDisplayLabel
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:43:45
  Author assigned by Alexander Henket (id#4)
  Description This means we do not use in our specification at all and can remove it from ART-DECOR?
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:40:12
  Author assigned by Giorgio Cangioli (id#5)
  Description this value set is used for the display system. There are no bindings with the CDA elements
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-31) Value set epSOSPersonalRelationship without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.31)
Last assignment to Giorgio Cangioli

Issue Value set epSOSPersonalRelationship without dataset binding
Id epsos-issue-31
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-38 (2013‑06‑03)
Description
The Value Set is used (optionally) to code the type of contact relationship between a person and the patient.
Value Set Name Value Set Id Version / effective date Status
epSOSPersonalRelationship 1.3.6.1.4.1.12559.11.10.1.3.1.42.38 913-20091020 - 2013‑06‑03 Draft
notice There is an open issue with this item:
  • epsos-issue-31: Value set epSOSPersonalRelationship without dataset binding (Open)
Source Code System:
  • 2.16.840.1.113883.5.111 RoleCode
Level/ Type Code Display Name Code System Description
0-L AUNT aunt RoleCode
0-L CHILD child RoleCode
0-L CHLDADOPT adopted child RoleCode
0-L CHLDFOST foster child RoleCode
0-L CHLDINLAW child in-law RoleCode
0-L COUSN cousin RoleCode
0-L DAU natural daughter RoleCode
0-L DAUADOPT adopted daughter RoleCode
0-L DAUC daughter RoleCode
0-L DAUFOST foster daughter RoleCode
0-L DAUINLAW daughter in-law RoleCode
0-L DOMPART domestic partner RoleCode
0-L FAMMEMB family member RoleCode
0-L FRND unrelated friend RoleCode
0-L FTH father RoleCode
0-L FTHINLAW father-in-law RoleCode
0-L GGRPRN great grandparent RoleCode
0-L GRNDCHILD grandchild RoleCode
0-L GRPRN grandparent RoleCode
0-L MTH mother RoleCode
0-L MTHINLAW mother-in-law RoleCode
0-L NBOR neighbor RoleCode
0-L NCHILD natural child RoleCode
0-L NIENEPH niece/nephew RoleCode
0-L PRN parent RoleCode
0-L PRNINLAW parent in-law RoleCode
0-L ROOM roomate RoleCode
0-L SIB sibling RoleCode
0-L SIGOTHR significant other RoleCode
0-L SON natural son RoleCode
0-L SONADOPT adopted son RoleCode
0-L SONC son RoleCode
0-L SONFOST foster son RoleCode
0-L SONINLAW son in-law RoleCode
0-L SPS spouse RoleCode
0-L STPCHLD step child RoleCode
0-L STPDAU stepdaughter RoleCode
0-L STPSON stepson RoleCode
0-L UNCLE uncle RoleCode
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:20:28
  Author assigned by Alexander Henket (id#4)
  Description The only element that comes close is "The role of the person: contact person or legal guardian", but as it says in the description that needs two concepts that are not intrinsically part of this PersonalRelationship value set. My fear is that we're somehow missing something in the dataset
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-32) Value set epSOSRoleClass without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.32)
Last assignment to Giorgio Cangioli

Issue Value set epSOSRoleClass without dataset binding
Id epsos-issue-32
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-39 (2013‑06‑03)
Description
The Value Set is used to make the distinction between an emergency contact and the next of kin for a patient.
Value Set Name Value Set Id Version / effective date Status
epSOSRoleClass 1.3.6.1.4.1.12559.11.10.1.3.1.42.39 913-20091020 - 2013‑06‑03 Draft
notice There are open issues with this item:
  • epsos-issue-32: Value set epSOSRoleClass without dataset binding (Open)
  • epsos-issue-38: Two different descriptions in the documentation (Open)
Source Code System:
  • 2.16.840.1.113883.5.110 RoleClass
Level/ Type Code Display Name Code System Description
0-L ECON emergency contact RoleClass
0-L NOK next of kin RoleClass
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
Issue epsos-issue-38
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:27:44
  Author assigned by Alexander Henket (id#4)
  Description Comparable to issue#31 this appears to come close to "The role of the person: contact person or legal guardian", but misses Legal Guardian. It is just meant to support the CDA.participant.AssociatedEntity.classCode? If so then this is just conveyed at template level See also:

Issue#38 that deals with the same valueSet
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping. May be HL7 Template only?

 (epsos-issue-33) Value set epSOSTimingAddress without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.33)
Last assignment to Giorgio Cangioli

Issue Value set epSOSTimingAddress without dataset binding
Id epsos-issue-33
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-40 (2013‑06‑03)
Description
The Value Set is used (optionally) to code the usage of a phone number, email and all telecommunications. Can be used for all phone numbers mentioned in the three CDA-documents.
Value Set Name Value Set Id Version / effective date Status
epSOSTelecomAddress 1.3.6.1.4.1.12559.11.10.1.3.1.42.40 913-20091020 - 2013‑06‑03 Draft
notice There is an open issue with this item:
  • epsos-issue-33: Value set epSOSTimingAddress without dataset binding (Open)
Source Code System:
  • 2.16.840.1.113883.5.1119 AddressUse
Level/ Type Code Display Name Code System Description
0-L AS answering service AddressUse
0-L EC emergency contact AddressUse
0-L H home AddressUse
0-L HP primary home AddressUse
0-L HV vacation home AddressUse
0-L MC mobile contact AddressUse
0-L PG pager AddressUse
0-L WP work place AddressUse
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:29:01
  Author assigned by Alexander Henket (id#4)
  Description The dataset does not have any concept like Telecom type for example. Shouldn't we have that to support this?
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-38) Two different descriptions in the documentation
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.38)
Last assignment to Giorgio Cangioli

Issue Two different descriptions in the documentation
Id epsos-issue-38
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Value set epsos-valueset-39 (2013‑06‑03)
Description
The Value Set is used to make the distinction between an emergency contact and the next of kin for a patient.
Value Set Name Value Set Id Version / effective date Status
epSOSRoleClass 1.3.6.1.4.1.12559.11.10.1.3.1.42.39 913-20091020 - 2013‑06‑03 Draft
notice There are open issues with this item:
  • epsos-issue-32: Value set epSOSRoleClass without dataset binding (Open)
  • epsos-issue-38: Two different descriptions in the documentation (Open)
Source Code System:
  • 2.16.840.1.113883.5.110 RoleClass
Level/ Type Code Display Name Code System Description
0-L ECON emergency contact RoleClass
0-L NOK next of kin RoleClass
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
Issue Value set epSOSRoleClass without dataset binding epsos-issue-32
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑10 19:40:12
  Author assigned by Alexander Henket (id#4)
  Description Please respond in conjunction with issue#32. Thanks in advance
tracking Tracking 2013‑10‑18 15:46:48 - status: Open
  Author Tessa van Stijn
Description Issue:

- According to specifications at page 24 of the document "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf" the value of /ClinicalDocument/participant/[@typeCode=’IND’]/associatedEntity/@classCode should come from valueset epSOSRoleClass 2.16.840.1.113883.5.110

The valueset epSOSRoleClass has the values: "ECON" and "NOK".

At page 84 of the same document there is different information:

"The <associatedEntity> element defines the type of contact. The classCode attribute shall be present, and contains a value from the set AGNT, CAREGIVER, ECON, NOK, or PRS to idenitify contacts that are agents of the patient, care givers, emergency contacts, next of kin, or other relations respectively."

Proposal:

- Please clarify which of these two descriptions is correct.

Should the valueset epSOSRoleClass be corrected to contain also the values AGNT, CAREGIVER and PRS or should the information at the page 84 be corrected (contains only the values ECON and NOK)?

See also:

Issue#32 that deals with the same valueSet

 (epsos-issue-39) Element Indication
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.39)
Last assignment to Giorgio Cangioli

Issue Element Indication
Id epsos-issue-39
Type Change Request
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-143 "Dispense" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication
folder  Dispense
Id epsos-dataelement-143
notice There are open issues with this item:
Description Information about dispensed medication
Used in 3 scenarios, inherited 0 times
target This concept is used in transaction Send eD to country A (0..*) in scenario
target This concept is used in transaction Return MRO (0..*) in scenario
target This concept is used in transaction Send HCER to country A (0..*) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:53:41
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑10‑18 15:50:15 - status: Open
  Author Tessa van Stijn
Description Issue:

- According to specifications at page 96 of the document "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf"

"D1 4 3 Specification of services v1 0 20120911 (2).pdf" the element Indication should be included in Medication.

In the document "D1 4 3 Specification of services v1 0 20120911 (2).pdf" the element Indication is not present.

Proposal:

- Please clarify if the element Indication should be included in Dispensation.

More info:

-

 (epsos-issue-42) Status
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.42)
Last assignment to Giorgio Cangioli

Issue Status
Id epsos-issue-42
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-101 "Medication" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data
folder  Medication
Id epsos-dataelement-101
notice There is an open issue with this item:
Description
Used in 5 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (0..1) in scenario
target This concept is used in transaction Send eD to country A (0..1) in scenario
target This concept is used in transaction Return MRO (0..1) in scenario
target This concept is used in transaction Send HCER to country A (0..1) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 18:07:58
  Author assigned by Alexander Henket (id#4)
  Description The appendix recognizes a prescription status, but describes it as
(12.1.2.4.5.6. Substance Administration Status Code) "The status code of "active" indicates that the medication has not been yet administrated .", but also:
(12.1.1.2.4.4. Substance Administration Status Code) "The status of all <substanceAdministration> elements must be either "active" or "completed". Status of "active" indicates a currently valid prescription, status of completed indicates a previously taken medication."

However the dataset does not recognize a notion of Status on a prescription, so should it be added? Only on Prescription or also on Dispense?
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:37:13
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑11‑10 19:36:53 - status: Open
  Author Giorgio Cangioli
Description Not sure about the question...

In any case conceptually is requried to otionally provide patient instructiona and advice to the ispenser.

The template used for implementing this concept require to provide also the statusCode elemente with value completed....
tracking Tracking 2013‑10‑18 15:56:05 - status: Open
  Author Tessa van Stijn
Description Issue:

- According to the specifications at page 120 of the document

 "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf" the Medication (element should include an element Status Code (if the related statement is made about the medication).

In the document "D1 4 3 Specification of services v1 0 20120911 (2).pdf" the element Status Code is not present.

Proposal:

-Please clarify if the element Status Code should be included.

More info:

-

 (epsos-issue-43) Name of the concept
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.43)
Last assignment to Giorgio Cangioli

Issue Name of the concept
Id epsos-issue-43
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-98 "Disability or function" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medical Problems
folder  Disability or function
Id epsos-dataelement-98
notice There is an open issue with this item:
Description
Used in 3 scenarios, inherited 0 times
target This concept is used in transaction Return MRO (0..*) in scenario
target This concept is used in transaction Send HCER to country A (0..*) in scenario
target This concept is used in transaction Return PS of country A (0..*) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 18:09:16
  Author assigned by Alexander Henket (id#4)
  Description Can we close this one without action based on the fact that Invalidity is not actually used in epSOS, but just kept in the dataset for historical reasons? The concept is not in the scenarios anymore.
tracking Tracking 2013‑10‑21 11:53:43 - status: Open
  Author Elze de Groot
Description Name of the concept: Autonomy/invalidity (MRO) vs Disability or function (HCER)

 (epsos-issue-47) Missing value set binding for Health Care Alert code
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.47)
Last assignment to Giorgio Cangioli

Issue Missing value set binding for Health Care Alert code
Id epsos-issue-47
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-216 "Health Care Alert code" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Alerts / Medical Alert Information
Health Care Alert code
Id epsos-dataelement-216
notice There is an open issue with this item:
  • epsos-issue-47: Missing value set binding for Health Care Alert code (Open)
Description The code of the health care alert
Value Domain Type code
Used in one scenario, inherited 0 times
target This concept is used in transaction Return PS of country A (0..1) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:32:12
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑11‑29 10:37:10 - status: Open
  Author Alexander Henket
Description Finding:

The documentation is undecided as to what value set binding is applicable. Also it would appear that "Other alerts" is not part of epSOS-I in which case we would need to detach from the PS it is currently attached to.

 (epsos-issue-48) Missing value set binding for Treatment code
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.48)
Last assignment to Giorgio Cangioli

Issue Missing value set binding for Treatment code
Id epsos-issue-48
Type Clarification needed
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-130 "Treatment code" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medical Problems / Treatments
Treatment code
Id epsos-dataelement-130
notice There is an open issue with this item:
Description normalized identifier, concept code
Value Domain Type code
Used in 2 scenarios, inherited 0 times
target This concept is used in transaction Send HCER to country A (0..1) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:32:28
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑11‑29 10:37:10 - status: Open
  Author Alexander Henket
Description Finding:

The documentation is undecided as to what value set binding is applicable.

 (epsos-issue-49) Missing value set binding for Prescriber Speciality
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.49)
Last assignment to Giorgio Cangioli

Issue Missing value set binding for Prescriber Speciality
Id epsos-issue-49
Type Change Request
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-238 "Prescriber Speciality" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication / Prescription / Prescriber
Prescriber Speciality
Id epsos-dataelement-238
notice There is an open issue with this item:
  • epsos-issue-49: Missing value set binding for Prescriber Speciality (Open)
Description Some countries need the specialty of the prescriber for the epSOS ePrescription to be seen as valid. In the epSOS phase 1 ePrescription data set, this element is not basic (minimum), therefore not always filled in. The proposal is to define the specialty of the prescriber as a basic element, so it should be filled in, if available. As it could be that this information is not available in every country, null values should be allowed.
Value Domain Type code
Used in 4 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (0..*) in scenario
target This concept is used in transaction Return MRO (0..1) in scenario
target This concept is used in transaction Send HCER to country A (0..1) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:32:42
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑11‑29 10:56:53 - status: Open
  Author Alexander Henket
Description Finding:

The documentation is undecided as to what value set binding is applicable.

 (epsos-issue-50) Missing concepts for Dispenser?
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.50)
Last assignment to Giorgio Cangioli

Issue Missing concepts for Dispenser?
Id epsos-issue-50
Type Change Request
Status  Open, assigned
Priority normal
Object(s) Data element epsos-dataelement-247 "Dispenser" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication / Dispense
folder  Dispenser
Id epsos-dataelement-247
notice There is an open issue with this item:
Description
Used in 3 scenarios, inherited 0 times
target This concept is used in transaction Send eD to country A (0..1) in scenario
target This concept is used in transaction Return MRO (0..1) in scenario
target This concept is used in transaction Send HCER to country A (0..1) in scenario
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:32:58
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑11‑29 10:58:36 - status: Open
  Author Alexander Henket
Description Finding:

The dispenser documentation was not consistent with the prescriber. There is no Profession and no Speciality. Should there be?

 (epsos-issue-51) What is template "1.3.6.1.4.1.19376.1.5.3.1.2.4"
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.51)
Last assignment to Giorgio Cangioli

Issue What is template "1.3.6.1.4.1.19376.1.5.3.1.2.4"
Id epsos-issue-51
Type Change Request
Status  Open, assigned
Priority normal
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:33:12
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑12‑02 13:23:23 - status: Open
  Author Alexander Henket
Description

 (epsos-issue-52) Cardinality/nullFlavor for address (parts)
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.52)
Last assignment to Giorgio Cangioli

Issue Cardinality/nullFlavor for address (parts)
Id epsos-issue-52
Type Change Request
Status  Open, assigned
Priority normal
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 13:33:24
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑12‑02 13:31:47 - status: Open
  Author Alexander Henket
Description

In "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf" it would appear that addresses are overstated and suffer from some copy/paste problems. You are currently required to either state no address parts or every single mentioned address part with either a value or a nullFlavor (not stated which nullFlavor). Also every address part may appear 1..* R, including city, state, and country. This leads to fragments like:

         <addr use="H">
            <state nullFlavor="NI"/>
            <city>MILANO</city>
            <country>IT</country>
            <state>ZH</state>
            <city>ROTTERDAM</city>
            <country>NL</country>
            <postalCode nullFlavor="UNK"/>
         </addr>

I.e. multiple types of NULL and multiple colliding address parts. What is the reason behind this? Any addr specification we have encountered in any context has said that unknown address(parts/es) should just be omitted, and with the exception of streetAddressLine no other parts should be use more than once.

 (epsos-issue-53) HP can have only 1 relevant speciality in a given context
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.53)
Last assignment to Giorgio Cangioli

Issue HP can have only 1 relevant speciality in a given context
Id epsos-issue-53
Type Change Request
Status  Open, assigned
Priority normal
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑12‑02 14:05:26
  Author assigned by Alexander Henket (id#4)
tracking Tracking 2013‑12‑02 14:05:10 - status: Open
  Author Alexander Henket
Description Requirement 1.10.7 in "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf" has card 0..*. This is not possible. It must be 0..1. Also the description of that specialty should be something like "the relevant speciality of the HP in relation to this serviceEvent or when authoring the document." Any given HP may have multiple specialities, but only 1 is relevant given the context.

Issues not yet assigned

Issues dealt with

 (epsos-issue-10) Value set epSOSHealthcareProfessionalRoles without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.10)
Not assigned yet.

Issue Value set epSOSHealthcareProfessionalRoles without dataset binding
Id epsos-issue-10
Type Clarification needed
Status  Closed
Priority normal
Object(s) Value set epsos-valueset-1 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSHealthcareProfessionalRoles 1.3.6.1.4.1.12559.11.10.1.3.1.42.1 2008 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.2.9.6.2.7 ISCO
Level/ Type Code Display Name Code System Description
0-L 22 Health professionals ISCO
0-L 221 Medical doctors ISCO
0-L 2211 Generalist medical practitioners ISCO
0-L 2212 Specialist medical practitioners ISCO
0-L 222 Nursing and midwifery professionals ISCO
0-L 2221 Nursing professionals ISCO
0-L 2222 Midwifery professionals ISCO
0-L 223 Traditional and complementary medicine professionals ISCO
0-L 224 Paramedical practitioners ISCO
0-L 225 Veterinarians ISCO
0-L 226 Other health professionals ISCO
0-L 2261 Dentists ISCO
0-L 2262 Pharmacists ISCO
0-L 2263 Environmental and occupational health and hygiene professionals ISCO
0-L 2264 Physiotherapists ISCO
0-L 2265 Dieticians and nutritionists ISCO
0-L 2266 Audiologists and speech therapists ISCO
0-L 2267 Optometrists and ophthalmic opticians ISCO
0-L 2269 Health professionals not elsewhere classified ISCO
0-L 32 Health associate professionals ISCO
0-L 321 Medical and pharmaceutical technicians ISCO
0-L 3211 Medical imaging and therapeutic equipment technicians ISCO
0-L 3212 Medical and pathology laboratory technicians ISCO
0-L 3213 Pharmaceutical technicians and assistants ISCO
0-L 3214 Medical and dental prosthetic technicians ISCO
0-L 322 Nursing and midwifery associate professionals ISCO
0-L 3221 Nursing associate professionals ISCO
0-L 3222 Midwifery associate professionals ISCO
0-L 323 Traditional and complementary medicine associate professionals ISCO
0-L 325 Other health associate professionals ISCO
0-L 3251 Dental assistants and therapists ISCO
0-L 3252 Medical records and health information technicians ISCO
0-L 3253 Community health workers ISCO
0-L 3254 Dispensing opticians ISCO
0-L 3255 Physiotherapy technicians and assistants ISCO
0-L 3256 Medical assistants ISCO
0-L 3257 Environmental and occupational health inspectors and associates ISCO
0-L 3258 Ambulance workers ISCO
0-L 3259 Health associate professionals not elsewhere classified ISCO
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑10‑22 15:28:33 - status: Closed
  Author Elze de Groot
Description Binded to healthcare professional roles in legal entity
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-1) Add Thyroidectomy, Partial and Total
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.1)
Last assignment to Alexander Henket

Issue Add Thyroidectomy, Partial and Total
Id epsos-issue-1
Type Change Request
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-10 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSProcedures 1.3.6.1.4.1.12559.11.10.1.3.1.42.10 July 2009 - 2013‑06‑03 Draft
notice There are open issues with this item:
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 19063003 Arthroplasty of knee SNOMED-CT Hospital Data Project WHO
0-L 84877006 Arthroscopy of knee with meniscus repair SNOMED-CT TOP 20 Germany
0-L 119922005 Biliary tract endoscopy SNOMED-CT TOP 20 Germany
0-L 86273004 Biopsy SNOMED-CT
0-L 10847001 Bronchoscopy SNOMED-CT Hospital Data Project WHO
0-L 112802009 Cardiovascular surgical procedure SNOMED-CT
0-L 250980009 Cardioversion SNOMED-CT
0-L 66951008 Carotid endarterectomy SNOMED-CT Hospital Data Project WHO
0-L 38102005 Cholecystectomy SNOMED-CT Hospital Data Project WHO Excision of all or part of the gallbladder
0-L 3418002 Chondrectomy of spine SNOMED-CT Hospital Data Project WHO
0-L 23968004 Colectomy SNOMED-CT Hospital Data Project WHO
0-L 73761001 Colonoscopy SNOMED-CT Hospital Data Project WHO
0-L 4770005 Colporrhaphy for repair of urethrocele SNOMED-CT TOP 20 Germany
0-L 63016009 Complete cystectomy SNOMED-CT TOP 20 Germany
0-L 232717009 Coronary artery bypass graft SNOMED-CT Hospital Data Project WHO
0-L 312775003 Debridement of ulcer SNOMED-CT TOP 20 Germany
0-L 47534009 Decompression of median nerve SNOMED-CT Hospital Data Project WHO The surgical relief of compression of the median nerve at the wrist
0-L 76810006 Diagnostic dilation and curettage of uterus SNOMED-CT Hospital Data Project WHO A form carried out to examine the removed uterine contents for disease characteristics
0-L 423827005 Endoscopy SNOMED-CT
0-L 85548006 Episiotomy SNOMED-CT TOP 20 Germany
0-L 9888007 Excision of intracranial lesion SNOMED-CT Hospital Data Project WHO
0-L 370611004 Excision of malignant neoplasm SNOMED-CT
0-L 56361007 Excision of soft tissue SNOMED-CT
0-L 257822003 Extracapsular extraction SNOMED-CT Hospital Data Project WHO
0-L 54885007 Extraction of cataract SNOMED-CT Hospital Data Project WHO
0-L 112828007 Femoral-popliteal artery bypass graft SNOMED-CT Hospital Data Project WHO
0-L 236886002 Hysterectomy SNOMED-CT TOP 20 Germany
0-L 359612003 Implantation of cochlear prosthetic device SNOMED-CT Hospital Data Project WHO
0-L 64253000 Implantation of heart assist system SNOMED-CT
0-L 118955007 Implantation to cardiovascular system SNOMED-CT
0-L 426153007 Insertion of artificial airway SNOMED-CT
0-L 302343007 Insertion of prosthesis for breast SNOMED-CT
0-L 265703000 Jaw and temporomandibular joint operations SNOMED-CT
0-L 45595009 Laparoscopic cholecystectomy SNOMED-CT Hospital Data Project WHO
0-L 236887006 Laparoscopic hysterectomy SNOMED-CT TOP 20 Germany
0-L 15018006 Laparoscopic repair of inguinal hernia SNOMED-CT Hospital Data Project WHO
0-L 363187007 Limb operation SNOMED-CT Czech EDS
0-L 133864008 Lithotripsy SNOMED-CT
0-L 173171007 Lobectomy of lung SNOMED-CT Hospital Data Project WHO
0-L 386638009 Obstetric operation SNOMED-CT
0-L 21371007 Operation on abdominal region SNOMED-CT Czech EDS
0-L 57168000 Operation on bone SNOMED-CT Czech EDS
0-L 392090004 Operation on breast SNOMED-CT
0-L 26476002 Operation on bronchus SNOMED-CT
0-L 53266006 Operation on diaphragm SNOMED-CT
0-L 12658000 Operation on female genital organs SNOMED-CT Czech EDS
0-L 78418002 Operation on heart and pericardium SNOMED-CT
0-L 112698002 Operation on joint SNOMED-CT Czech EDS
0-L 387714009 Operation on lung SNOMED-CT
0-L 49509003 Operation on lymphatic structure SNOMED-CT
0-L 386765006 Operation on mediastinum SNOMED-CT
0-L 37508003 Operation on neck SNOMED-CT Czech EDS
0-L 16545005 Operation on nervous system SNOMED-CT Czech EDS
0-L 34969007 Operation on retroperitoneum SNOMED-CT
0-L 392011001 Operation on skin SNOMED-CT
0-L 59300005 Operation on spleen SNOMED-CT
0-L 86800006 Operation on trachea SNOMED-CT
0-L 392048005 Operation on urinary system SNOMED-CT Czech EDS
0-L 107907001 Operative procedure on digestive system SNOMED-CT
0-L 108021004 Operative procedure on male genitourinary system SNOMED-CT
0-L 392236004 Operative procedure on spinal structure SNOMED-CT Czech EDS
0-L 36228007 Ophthalmic examination and evaluation SNOMED-CT
0-L 64368001 Partial mastectomy SNOMED-CT Hospital Data Project WHO
0-L 429639007 Percutaneous transluminal balloon angioplasty with insertion of stent into coronary artery SNOMED-CT Hospital Data Project WHO
0-L 118804001 Procedure on blood vessel SNOMED-CT TOP 20 Germany
0-L 118683007 Procedure on ear and related structures SNOMED-CT
0-L 118949002 Procedure on extremity SNOMED-CT
0-L 118675001 Procedure on female genital system SNOMED-CT
0-L 118716003 Procedure on foot SNOMED-CT TOP 20 Germany
0-L 118950002 Procedure on head AND/OR neck SNOMED-CT
0-L 118831003 Procedure on intestine SNOMED-CT TOP 20 Germany
0-L 118795000 Procedure on pleura SNOMED-CT
0-L 90470006 Prostatectomy SNOMED-CT Hospital Data Project WHO
0-L 397956004 Prosthetic arthroplasty of the hip SNOMED-CT Hospital Data Project WHO
0-L 85921004 Puncture procedure SNOMED-CT
0-L 384723003 Radical mastectomy SNOMED-CT Hospital Data Project WHO
0-L 122470005 Reduction of closed fracture SNOMED-CT TOP 20 Germany
0-L 122471009 Reduction of open fracture SNOMED-CT TOP 20 Germany
0-L 405525004 Repair of aneurysm of abdominal aorta SNOMED-CT Hospital Data Project WHO
0-L 441612006 Repair of infrarenal abdominal aortic aneurysm with insertion of endovascular stent SNOMED-CT Hospital Data Project WHO
0-L 44558001 Repair of inguinal hernia SNOMED-CT Hospital Data Project WHO
0-L 112727005 Revision of hip replacement SNOMED-CT Hospital Data Project WHO
0-L 86749008 Stripping and ligation SNOMED-CT TOP 20 Germany
0-L 70183006 Subcutaneous mastectomy SNOMED-CT Hospital Data Project WHO
0-L 385488000 Surgical procedure on chest wall SNOMED-CT
0-L 373353005 Surgical procedure on eye proper SNOMED-CT Czech EDS
0-L 385487005 Surgical procedure on thorax SNOMED-CT Czech EDS
0-L 13619001 Thyroidectomy SNOMED-CT
0-L 173422009 Tonsillectomy SNOMED-CT Hospital Data Project WHO
0-L 359623004 Total lobectomy of lung SNOMED-CT Hospital Data Project WHO
0-L 70536003 Transplant of kidney SNOMED-CT Hospital Data Project WHO
0-L 90199006 Transurethral prostatectomy SNOMED-CT Hospital Data Project WHO
0-L 30904006 Vascular surgery procedure SNOMED-CT Czech EDS
0-L 232632009 Wedge excision of lung SNOMED-CT Hospital Data Project WHO
0-L 80146002 Appendicectomy SNOMED-CT Hospital Data Project WHO
0-L 11466000 Caesarean section SNOMED-CT Hospital Data Project WHO
0-L 10458001 Evacuation of intracerebral haematoma SNOMED-CT Hospital Data Project WHO
0-L 59712006 Evacuation of subdural haematoma SNOMED-CT Hospital Data Project WHO
0-L 46116005 Excision of malignant tumour of breast SNOMED-CT
0-L 234336002 Haemopoietic stem cell transplant SNOMED-CT Hospital Data Project WHO
0-L 6025007 Laparoscopic appendicectomy SNOMED-CT Hospital Data Project WHO
0-L 287310004 Lung tumour excision SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 14:35:23 - status: Closed
  Author Alexander Henket
Description Thyroidectomy = 13619001
arrowright Assignment to Alexander Henket (id#4) on 2013‑06‑11 14:59:14
  Author assigned by Alexander Henket (id#4)
  Description Find out the right code
tracking Tracking 2013‑06‑09 - status: Open
  Author Alexander Henket
Description Issue:

Should add "Thyroidectomy, Partial and Total". Currently 2 codes 171975009 or 13619001 are under consideration

Additional info:

Hospital Data Info Project WHO

 (epsos-issue-3) Add prefix/suffix to Full Name
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.3)
Not assigned yet.

Issue Add prefix/suffix to Full Name
Id epsos-issue-3
Type Change Request
Status  Closed
Priority normal
Object(s) Data element epsos-dataelement-9 "Full Name" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Patient Data / Personal Information
folder  Full Name
Id epsos-dataelement-9
Description The full name of the patient
Used in 5 scenarios, inherited 0 times
target This concept is used in transaction Request eP from country A (0..*) in scenario
target This concept is used in transaction Return eP from country A (1..1 Required) in scenario
target This concept is used in transaction Send eD to country A (1..1 Required) in scenario
target This concept is used in transaction Request MRO (0..*) in scenario
target This concept is used in transaction Return MRO (1..1 Required) in scenario
target This concept is used in transaction Send HCER to country A (1..1 Mandatory) in scenario
target This concept is used in transaction Request PS of country A (0..*) in scenario
target This concept is used in transaction Return PS of country A (1..1 Mandatory) in scenario
Data element epsos-dataelement-19 "Author Full Name" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Document Data / Author
folder  Author Full Name
Id epsos-dataelement-19
Description The full name of the Health Professional
Used in 5 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (1..1 Mandatory) in scenario
target This concept is used in transaction Send eD to country A (1..1 Mandatory) in scenario
target This concept is used in transaction Return MRO (1..1 Required) in scenario
target This concept is used in transaction Send HCER to country A (1..1 Required) in scenario
target This concept is used in transaction Return PS of country A (1..1 Mandatory) in scenario
Data element epsos-dataelement-46 "Full Name" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Patient Data / Contact Information / Preferred HP to contact
folder  Full Name
Id epsos-dataelement-46
Description Name of the HP/name of the legal organization. If it is an HP, the structure of the name will be the same as described in ‘Full name’ (Given name, family name/surname)
Used in 5 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (1..1 Mandatory) in scenario
target This concept is used in transaction Send eD to country A (1..1 Mandatory) in scenario
target This concept is used in transaction Return MRO (1..1 Mandatory) in scenario
target This concept is used in transaction Send HCER to country A (1..1 Required) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
Data element epsos-dataelement-36 "Full Name" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Patient Data / Contact Information / Contact Person/legal guardian
folder  Full Name
Id epsos-dataelement-36
Description Full name of the contact person or guardian
Used in 2 scenarios, inherited 0 times
target This concept is used in transaction Send HCER to country A (0..1) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
tracking Tracking 2013‑11‑28 14:37:53 - status: Closed
  Author Alexander Henket
Description Prefix/suffix added to every Full Name
tracking Tracking 2013‑06‑09 23:22:32 - status: Open
  Author Alexander Henket
Description Issue:

Where the dataset has Full Name components "given" and "family name/surname", the PS recognizes at least "prefix" for patient, and for HPs also "suffix"

Proposal:

Find alignment. Adjust the dataset so it contains "prefix" for patients full name and "prefix" + "suffix" for HPs

 (epsos-issue-4) epSOS Active Ingredients: enumerate or not
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.4)
Last assignment to Alexander Henket

Issue epSOS Active Ingredients: enumerate or not
Id epsos-issue-4
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-24 (2013‑06‑03)
Description
The Value Set is used as a mandatory code for the Active Ingredient of medications in the Medications Summary as well as the prescription Sections. Also used to code allergy agents in the Allergies and Other Adverse Reactions Section of the patient Summary.
Value Set Name Value Set Id Version / effective date Status
epSOSActiveIngredient 1.3.6.1.4.1.12559.11.10.1.3.1.42.24 January 2010 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.73 WHO ATC
Level/ Type Code Display Name Code System Description
0-L A ALIMENTARY TRACT AND METABOLISM WHO ATC
0-L A01 STOMATOLOGICAL PREPARATIONS WHO ATC
0-L A01A STOMATOLOGICAL PREPARATIONS WHO ATC
0-L A01AA Caries prophylactic agents WHO ATC
0-L A01AA01 sodium fluoride WHO ATC
0-L A01AA02 sodium monofluorophosphate WHO ATC
0-L A01AA03 olaflur WHO ATC
0-L A01AA04 stannous fluoride WHO ATC
0-L A01AA30 combinations WHO ATC
0-L A01AA51 sodium fluoride, combinations WHO ATC
0-L A01AB Antiinfectives and antiseptics for local oral treatment WHO ATC
0-L A01AB02 hydrogen peroxide WHO ATC
0-L A01AB03 chlorhexidine WHO ATC
0-L A01AB04 amphotericin B WHO ATC
0-L A01AB05 polynoxylin WHO ATC
0-L A01AB06 domiphen WHO ATC
0-L A01AB07 oxyquinoline WHO ATC
0-L A01AB08 neomycin WHO ATC
0-L A01AB09 miconazole WHO ATC
0-L A01AB10 natamycin WHO ATC
0-L A01AB11 various WHO ATC
0-L A01AB12 hexetidine WHO ATC
0-L A01AB13 tetracycline WHO ATC
0-L A01AB14 benzoxonium chloride WHO ATC
0-L A01AB15 tibezonium iodide WHO ATC
0-L A01AB16 mepartricin WHO ATC
0-L A01AB17 metronidazole WHO ATC
0-L A01AB18 clotrimazole WHO ATC
0-L A01AB19 sodium perborate WHO ATC
0-L A01AB21 chlortetracycline WHO ATC
0-L A01AB22 doxycycline WHO ATC
0-L A01AB23 minocycline WHO ATC
0-L A01AC Corticosteroids for local oral treatment WHO ATC
0-L A01AC01 triamcinolone WHO ATC
0-L A01AC02 dexamethasone WHO ATC
0-L A01AC03 hydrocortisone WHO ATC
0-L A01AC54 prednisolone, combinations WHO ATC
0-L A01AD Other agents for local oral treatment WHO ATC
0-L A01AD01 epinephrine WHO ATC
0-L A01AD02 benzydamine WHO ATC
0-L A01AD05 acetylsalicylic acid WHO ATC
0-L A01AD06 adrenalone WHO ATC
0-L A01AD07 amlexanox WHO ATC
0-L A01AD08 becaplermin WHO ATC
0-L A01AD11 various WHO ATC
0-L A02 DRUGS FOR ACID RELATED DISORDERS WHO ATC
0-L A02A ANTACIDS WHO ATC
0-L A02AA Magnesium compounds WHO ATC
0-L A02AA01 magnesium carbonate WHO ATC
0-L A02AA02 magnesium oxide WHO ATC
0-L A02AA03 magnesium peroxide WHO ATC
0-L A02AA04 magnesium hydroxide WHO ATC
0-L A02AA05 magnesium silicate WHO ATC
0-L A02AA10 combinations WHO ATC
0-L A02AB Aluminium compounds WHO ATC
0-L A02AB01 aluminium hydroxide WHO ATC
0-L A02AB02 algeldrate WHO ATC
0-L A02AB03 aluminium phosphate WHO ATC
0-L A02AB04 dihydroxialumini sodium carbonate WHO ATC
0-L A02AB05 aluminium acetoacetate WHO ATC
0-L A02AB06 aloglutamol WHO ATC
0-L A02AB07 aluminium glycinate WHO ATC
0-L A02AB10 combinations WHO ATC
0-L A02AC Calcium compounds WHO ATC
0-L A02AC01 calcium carbonate WHO ATC
0-L A02AC02 calcium silicate WHO ATC
0-L A02AC10 combinations WHO ATC
0-L A02AD Combinations and complexes of aluminium, calcium and magnesium compounds WHO ATC
0-L A02AD01 ordinary salt combinations WHO ATC
0-L A02AD02 magaldrate WHO ATC
0-L A02AD03 almagate WHO ATC
0-L A02AD04 hydrotalcite WHO ATC
0-L A02AD05 almasilate WHO ATC
0-L A02AF Antacids with antiflatulents WHO ATC
0-L A02AF01 magaldrate and antiflatulents WHO ATC
0-L A02AF02 ordinary salt combinations and antiflatulents WHO ATC
0-L A02AG Antacids with antispasmodics WHO ATC
0-L A02AH Antacids with sodium bicarbonate WHO ATC
0-L A02AX Antacids, other combinations WHO ATC
0-L A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) WHO ATC
0-L A02BA H2-receptor antagonists WHO ATC
0-L A02BA01 cimetidine WHO ATC
0-L A02BA02 ranitidine WHO ATC
0-L A02BA03 famotidine WHO ATC
0-L A02BA04 nizatidine WHO ATC
0-L A02BA05 niperotidine WHO ATC
0-L A02BA06 roxatidine WHO ATC
0-L A02BA07 ranitidine bismuth citrate WHO ATC
0-L A02BA08 lafutidine WHO ATC
0-L A02BA51 cimetidine, combinations WHO ATC
0-L A02BA53 famotidine, combinations WHO ATC
0-L A02BB Prostaglandins WHO ATC
0-L A02BB01 misoprostol WHO ATC
0-L A02BB02 enprostil WHO ATC
0-L A02BC Proton pump inhibitors WHO ATC
0-L A02BC01 omeprazole WHO ATC
0-L A02BC02 pantoprazole WHO ATC
0-L A02BC03 lansoprazole WHO ATC
0-L A02BC04 rabeprazole WHO ATC
0-L A02BC05 esomeprazole WHO ATC
0-L A02BD Combinations for eradication of Helicobacter pylori WHO ATC
0-L A02BD01 omeprazole, amoxicillin and metronidazole WHO ATC
0-L A02BD02 lansoprazole, tetracycline and metronidazole WHO ATC
0-L A02BD03 lansoprazole, amoxicillin and metronidazole WHO ATC
0-L A02BD04 pantoprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BD05 omeprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BD06 esomeprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BD07 lansoprazole, amoxicillin and clarithromycin WHO ATC
0-L A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) WHO ATC
0-L A02BX01 carbenoxolone WHO ATC
0-L A02BX02 sucralfate WHO ATC
0-L A02BX03 pirenzepine WHO ATC
0-L A02BX04 methiosulfonium chloride WHO ATC
0-L A02BX05 bismuth subcitrate WHO ATC
0-L A02BX06 proglumide WHO ATC
0-L A02BX07 gefarnate WHO ATC
0-L A02BX08 sulglicotide WHO ATC
0-L A02BX09 acetoxolone WHO ATC
0-L A02BX10 zolimidine WHO ATC
0-L A02BX11 troxipide WHO ATC
0-L A02BX12 bismuth subnitrate WHO ATC
0-L A02BX13 alginic acid WHO ATC
0-L A02BX51 carbenoxolone, combinations excl. psycholeptics WHO ATC
0-L A02BX71 carbenoxolone, combinations with psycholeptics WHO ATC
0-L A02BX77 gefarnate, combinations with psycholeptics WHO ATC
0-L A02X OTHER DRUGS FOR ACID RELATED DISORDERS WHO ATC
0-L A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS WHO ATC
0-L A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS WHO ATC
0-L A03AA Synthetic anticholinergics, esters with tertiary amino group WHO ATC
0-L A03AA01 oxyphencyclimine WHO ATC
0-L A03AA03 camylofin WHO ATC
0-L A03AA04 mebeverine WHO ATC
0-L A03AA05 trimebutine WHO ATC
0-L A03AA06 rociverine WHO ATC
0-L A03AA07 dicycloverine WHO ATC
0-L A03AA08 dihexyverine WHO ATC
0-L A03AA09 difemerine WHO ATC
0-L A03AA30 piperidolate WHO ATC
0-L A03AB Synthetic anticholinergics, quaternary ammonium compounds WHO ATC
0-L A03AB01 benzilone WHO ATC
0-L A03AB02 glycopyrronium WHO ATC
0-L A03AB03 oxyphenonium WHO ATC
0-L A03AB04 penthienate WHO ATC
0-L A03AB05 propantheline WHO ATC
0-L A03AB06 otilonium bromide WHO ATC
0-L A03AB07 methantheline WHO ATC
0-L A03AB08 tridihexethyl WHO ATC
0-L A03AB09 isopropamide WHO ATC
0-L A03AB10 hexocyclium WHO ATC
0-L A03AB11 poldine WHO ATC
0-L A03AB12 mepenzolate WHO ATC
0-L A03AB13 bevonium WHO ATC
0-L A03AB14 pipenzolate WHO ATC
0-L A03AB15 diphemanil WHO ATC
0-L A03AB16 (2-benzhydryloxyethyl)diethyl-methylammonium iodide WHO ATC
0-L A03AB17 tiemonium iodide WHO ATC
0-L A03AB18 prifinium bromide WHO ATC
0-L A03AB19 timepidium bromide WHO ATC
0-L A03AB21 fenpiverinium WHO ATC
0-L A03AB53 oxyphenonium, combinations WHO ATC
0-L A03AC Synthetic antispasmodics, amides with tertiary amines WHO ATC
0-L A03AC02 dimethylaminopropionylphenothiazine WHO ATC
0-L A03AC04 nicofetamide WHO ATC
0-L A03AC05 tiropramide WHO ATC
0-L A03AD Papaverine and derivatives WHO ATC
0-L A03AD01 papaverine WHO ATC
0-L A03AD02 drotaverine WHO ATC
0-L A03AD30 moxaverine WHO ATC
0-L A03AE Drugs acting on serotonin receptors WHO ATC
0-L A03AE01 alosetron WHO ATC
0-L A03AE02 tegaserod WHO ATC
0-L A03AE03 cilansetron WHO ATC
0-L A03AE04 prucalopride WHO ATC
0-L A03AX Other drugs for functional bowel disorders WHO ATC
0-L A03AX01 fenpiprane WHO ATC
0-L A03AX02 diisopromine WHO ATC
0-L A03AX03 chlorbenzoxamine WHO ATC
0-L A03AX04 pinaverium WHO ATC
0-L A03AX05 fenoverine WHO ATC
0-L A03AX06 idanpramine WHO ATC
0-L A03AX07 proxazole WHO ATC
0-L A03AX08 alverine WHO ATC
0-L A03AX09 trepibutone WHO ATC
0-L A03AX10 isometheptene WHO ATC
0-L A03AX11 caroverine WHO ATC
0-L A03AX12 phloroglucinol WHO ATC
0-L A03AX13 silicones WHO ATC
0-L A03AX30 trimethyldiphenylpropylamine WHO ATC
0-L A03AX58 alverine, combinations WHO ATC
0-L A03B BELLADONNA AND DERIVATIVES, PLAIN WHO ATC
0-L A03BA Belladonna alkaloids, tertiary amines WHO ATC
0-L A03BA01 atropine WHO ATC
0-L A03BA03 hyoscyamine WHO ATC
0-L A03BA04 belladonna total alkaloids WHO ATC
0-L A03BB Belladonna alkaloids, semisynthetic, quaternary ammonium compounds WHO ATC
0-L A03BB01 butylscopolamine WHO ATC
0-L A03BB02 methylatropine WHO ATC
0-L A03BB03 methylscopolamine WHO ATC
0-L A03BB04 fentonium WHO ATC
0-L A03BB05 cimetropium bromide WHO ATC
0-L A03C ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS WHO ATC
0-L A03CA Synthetic anticholinergic agents in combination with psycholeptics WHO ATC
0-L A03CA01 isopropamide and psycholeptics WHO ATC
0-L A03CA02 clidinium and psycholeptics WHO ATC
0-L A03CA03 oxyphencyclimine and psycholeptics WHO ATC
0-L A03CA04 otilonium bromide and psycholeptics WHO ATC
0-L A03CA05 glycopyrronium and psycholeptics WHO ATC
0-L A03CA06 bevonium and psycholeptics WHO ATC
0-L A03CA07 ambutonium and psycholeptics WHO ATC
0-L A03CA08 diphemanil and psycholeptics WHO ATC
0-L A03CA30 emepronium and psycholeptics WHO ATC
0-L A03CA34 propantheline and psycholeptics WHO ATC
0-L A03CB Belladonna and derivatives in combination with psycholeptics WHO ATC
0-L A03CB01 methylscopolamine and psycholeptics WHO ATC
0-L A03CB02 belladonna total alkaloids and psycholeptics WHO ATC
0-L A03CB03 atropine and psycholeptics WHO ATC
0-L A03CB04 methylhomatropine and psycholeptics WHO ATC
0-L A03CB31 hyoscyamine and psycholeptics WHO ATC
0-L A03CC Other antispasmodics in combination with psycholeptics WHO ATC
0-L A03D ANTISPASMODICS IN COMBINATION WITH ANALGESICS WHO ATC
0-L A03DA Synthetic anticholinergic agents in combination with analgesics WHO ATC
0-L A03DA01 tropenzilone and analgesics WHO ATC
0-L A03DA02 pitofenone and analgesics WHO ATC
0-L A03DA03 bevonium and analgesics WHO ATC
0-L A03DA04 ciclonium and analgesics WHO ATC
0-L A03DA05 camylofin and analgesics WHO ATC
0-L A03DA06 trospium and analgesics WHO ATC
0-L A03DA07 tiemonium iodide and analgesics WHO ATC
0-L A03DB Belladonna and derivatives in combination with analgesics WHO ATC
0-L A03DB04 butylscopolamine and analgesics WHO ATC
0-L A03DC Other antispasmodics in combination with analgesics WHO ATC
0-L A03E ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS WHO ATC
0-L A03EA Antispasmodics, psycholeptics and analgesics in combination WHO ATC
0-L A03ED Antispasmodics in combination with other drugs WHO ATC
0-L A03F PROPULSIVES WHO ATC
0-L A03FA Propulsives WHO ATC
0-L A03FA01 metoclopramide WHO ATC
0-L A03FA02 cisapride WHO ATC
0-L A03FA03 domperidone WHO ATC
0-L A03FA04 bromopride WHO ATC
0-L A03FA05 alizapride WHO ATC
0-L A03FA06 clebopride WHO ATC
0-L A04 ANTIEMETICS AND ANTINAUSEANTS WHO ATC
0-L A04A ANTIEMETICS AND ANTINAUSEANTS WHO ATC
0-L A04AA Serotonin (5HT3) antagonists WHO ATC
0-L A04AA01 ondansetron WHO ATC
0-L A04AA02 granisetron WHO ATC
0-L A04AA03 tropisetron WHO ATC
0-L A04AA04 dolasetron WHO ATC
0-L A04AA05 palonosetron WHO ATC
0-L A04AD Other antiemetics WHO ATC
0-L A04AD01 scopolamine WHO ATC
0-L A04AD02 cerium oxalate WHO ATC
0-L A04AD04 chlorobutanol WHO ATC
0-L A04AD05 metopimazine WHO ATC
0-L A04AD10 dronabinol WHO ATC
0-L A04AD11 nabilone WHO ATC
0-L A04AD12 aprepitant WHO ATC
0-L A04AD13 casopitant WHO ATC
0-L A04AD51 scopolamine, combinations WHO ATC
0-L A04AD54 chlorobutanol, combinations WHO ATC
0-L A05 BILE AND LIVER THERAPY WHO ATC
0-L A05A BILE THERAPY WHO ATC
0-L A05AA Bile acid preparations WHO ATC
0-L A05AA01 chenodeoxycholic acid WHO ATC
0-L A05AA02 ursodeoxycholic acid WHO ATC
0-L A05AA03 cholic acid WHO ATC
0-L A05AB Preparations for biliary tract therapy WHO ATC
0-L A05AB01 nicotinyl methylamide WHO ATC
0-L A05AX Other drugs for bile therapy WHO ATC
0-L A05AX01 piprozolin WHO ATC
0-L A05AX02 hymecromone WHO ATC
0-L A05AX03 cyclobutyrol WHO ATC
0-L A05B LIVER THERAPY, LIPOTROPICS WHO ATC
0-L A05BA Liver therapy WHO ATC
0-L A05BA01 arginine glutamate WHO ATC
0-L A05BA03 silymarin WHO ATC
0-L A05BA04 citiolone WHO ATC
0-L A05BA05 epomediol WHO ATC
0-L A05BA06 ornithine oxoglurate WHO ATC
0-L A05BA07 tidiacic arginine WHO ATC
0-L A05BA08 glycyrrhizic acid WHO ATC
0-L A05C DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION WHO ATC
0-L A06 LAXATIVES WHO ATC
0-L A06A LAXATIVES WHO ATC
0-L A06AA Softeners, emollients WHO ATC
0-L A06AA01 liquid paraffin WHO ATC
0-L A06AA02 docusate sodium WHO ATC
0-L A06AA51 liquid paraffin, combinations WHO ATC
0-L A06AB Contact laxatives WHO ATC
0-L A06AB01 oxyphenisatine WHO ATC
0-L A06AB02 bisacodyl WHO ATC
0-L A06AB03 dantron WHO ATC
0-L A06AB04 phenolphthalein WHO ATC
0-L A06AB05 castor oil WHO ATC
0-L A06AB06 senna glycosides WHO ATC
0-L A06AB07 cascara WHO ATC
0-L A06AB08 sodium picosulfate WHO ATC
0-L A06AB09 bisoxatin WHO ATC
0-L A06AB20 contact laxatives in combination WHO ATC
0-L A06AB30 contact laxatives in combination with belladonna alkaloids WHO ATC
0-L A06AB52 bisacodyl, combinations WHO ATC
0-L A06AB53 dantron, combinations WHO ATC
0-L A06AB56 senna glycosides, combinations WHO ATC
0-L A06AB57 cascara, combinations WHO ATC
0-L A06AB58 sodium picosulfate, combinations WHO ATC
0-L A06AC Bulk producers WHO ATC
0-L A06AC01 ispaghula (psylla seeds) WHO ATC
0-L A06AC02 ethulose WHO ATC
0-L A06AC03 sterculia WHO ATC
0-L A06AC05 linseed WHO ATC
0-L A06AC06 methylcellulose WHO ATC
0-L A06AC07 triticum (wheat fibre) WHO ATC
0-L A06AC08 polycarbophil calcium WHO ATC
0-L A06AC51 ispaghula, combinations WHO ATC
0-L A06AC53 sterculia, combinations WHO ATC
0-L A06AC55 linseed, combinations WHO ATC
0-L A06AD Osmotically acting laxatives WHO ATC
0-L A06AD01 magnesium carbonate WHO ATC
0-L A06AD02 magnesium oxide WHO ATC
0-L A06AD03 magnesium peroxide WHO ATC
0-L A06AD04 magnesium sulfate WHO ATC
0-L A06AD10 mineral salts in combination WHO ATC
0-L A06AD11 lactulose WHO ATC
0-L A06AD12 lactitol WHO ATC
0-L A06AD13 sodium sulfate WHO ATC
0-L A06AD14 pentaerithrityl WHO ATC
0-L A06AD15 macrogol WHO ATC
0-L A06AD16 mannitol WHO ATC
0-L A06AD17 sodium phosphate WHO ATC
0-L A06AD18 sorbitol WHO ATC
0-L A06AD19 magnesium citrate WHO ATC
0-L A06AD21 sodium tartrate WHO ATC
0-L A06AD61 lactulose, combinations WHO ATC
0-L A06AD65 macrogol, combinations WHO ATC
0-L A06AG Enemas WHO ATC
0-L A06AG01 sodium phosphate WHO ATC
0-L A06AG02 bisacodyl WHO ATC
0-L A06AG03 dantron, incl. combinations WHO ATC
0-L A06AG04 glycerol WHO ATC
0-L A06AG06 oil WHO ATC
0-L A06AG07 sorbitol WHO ATC
0-L A06AG10 docusate sodium, incl. combinations WHO ATC
0-L A06AG11 laurilsulfate, incl. combinations WHO ATC
0-L A06AG20 combinations WHO ATC
0-L A06AH Peripheral opioid receptor antagonists WHO ATC
0-L A06AH01 methylnaltrexone bromide WHO ATC
0-L A06AH02 alvimopan WHO ATC
0-L A06AX Other laxatives WHO ATC
0-L A06AX01 glycerol WHO ATC
0-L A06AX02 carbon dioxide producing drugs WHO ATC
0-L A06AX03 lubiprostone WHO ATC
0-L A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVEAGENTS WHO ATC
0-L A07A INTESTINAL ANTIINFECTIVES WHO ATC
0-L A07AA Antibiotics WHO ATC
0-L A07AA01 neomycin WHO ATC
0-L A07AA02 nystatin WHO ATC
0-L A07AA03 natamycin WHO ATC
0-L A07AA04 streptomycin WHO ATC
0-L A07AA05 polymyxin B WHO ATC
0-L A07AA06 paromomycin WHO ATC
0-L A07AA07 amphotericin B WHO ATC
0-L A07AA08 kanamycin WHO ATC
0-L A07AA09 vancomycin WHO ATC
0-L A07AA10 colistin WHO ATC
0-L A07AA11 rifaximin WHO ATC
0-L A07AA51 neomycin, combinations WHO ATC
0-L A07AA54 streptomycin, combinations WHO ATC
0-L A07AB Sulfonamides WHO ATC
0-L A07AB02 phthalylsulfathiazole WHO ATC
0-L A07AB03 sulfaguanidine WHO ATC
0-L A07AB04 succinylsulfathiazole WHO ATC
0-L A07AC Imidazole derivatives WHO ATC
0-L A07AC01 miconazole WHO ATC
0-L A07AX Other intestinal antiinfectives WHO ATC
0-L A07AX01 broxyquinoline WHO ATC
0-L A07AX02 acetarsol WHO ATC
0-L A07AX03 nifuroxazide WHO ATC
0-L A07AX04 nifurzide WHO ATC
0-L A07B INTESTINAL ADSORBENTS WHO ATC
0-L A07BA Charcoal preparations WHO ATC
0-L A07BA01 medicinal charcoal WHO ATC
0-L A07BA51 medicinal charcoal, combinations WHO ATC
0-L A07BB Bismuth preparations WHO ATC
0-L A07BC Other intestinal adsorbents WHO ATC
0-L A07BC01 pectin WHO ATC
0-L A07BC02 kaolin WHO ATC
0-L A07BC03 crospovidone WHO ATC
0-L A07BC04 attapulgite WHO ATC
0-L A07BC05 diosmectite WHO ATC
0-L A07BC30 combinations WHO ATC
0-L A07BC54 attapulgite, combinations WHO ATC
0-L A07C ELECTROLYTES WITH CARBOHYDRATES WHO ATC
0-L A07CA Oral rehydration salt formulations WHO ATC
0-L A07D ANTIPROPULSIVES WHO ATC
0-L A07DA Antipropulsives WHO ATC
0-L A07DA01 diphenoxylate WHO ATC
0-L A07DA02 opium WHO ATC
0-L A07DA03 loperamide WHO ATC
0-L A07DA04 difenoxin WHO ATC
0-L A07DA05 loperamide oxide WHO ATC
0-L A07DA52 morphine, combinations WHO ATC
0-L A07DA53 loperamide, combinations WHO ATC
0-L A07E INTESTINAL ANTIINFLAMMATORY AGENTS WHO ATC
0-L A07EA Corticosteroids acting locally WHO ATC
0-L A07EA01 prednisolone WHO ATC
0-L A07EA02 hydrocortisone WHO ATC
0-L A07EA03 prednisone WHO ATC
0-L A07EA04 betamethasone WHO ATC
0-L A07EA05 tixocortol WHO ATC
0-L A07EA06 budesonide WHO ATC
0-L A07EA07 beclometasone WHO ATC
0-L A07EB Antiallergic agents, excl. corticosteroids WHO ATC
0-L A07EB01 cromoglicic acid WHO ATC
0-L A07EC Aminosalicylic acid and similar agents WHO ATC
0-L A07EC01 sulfasalazine WHO ATC
0-L A07EC02 mesalazine WHO ATC
0-L A07EC03 olsalazine WHO ATC
0-L A07EC04 balsalazide WHO ATC
0-L A07F ANTIDIARRHEAL MICROORGANISMS WHO ATC
0-L A07FA Antidiarrheal microorganisms WHO ATC
0-L A07FA01 lactic acid producing organisms WHO ATC
0-L A07FA02 saccharomyces boulardii WHO ATC
0-L A07FA51 lactic acid producing organisms, combinations WHO ATC
0-L A07X OTHER ANTIDIARRHEALS WHO ATC
0-L A07XA Other antidiarrheals WHO ATC
0-L A07XA01 albumin tannate WHO ATC
0-L A07XA02 ceratonia WHO ATC
0-L A07XA03 calcium compounds WHO ATC
0-L A07XA04 racecadotril WHO ATC
0-L A07XA51 albumin tannate, combinations WHO ATC
0-L A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS WHO ATC
0-L A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS WHO ATC
0-L A08AA Centrally acting antiobesity products WHO ATC
0-L A08AA01 phentermine WHO ATC
0-L A08AA02 fenfluramine WHO ATC
0-L A08AA03 amfepramone WHO ATC
0-L A08AA04 dexfenfluramine WHO ATC
0-L A08AA05 mazindol WHO ATC
0-L A08AA06 etilamfetamine WHO ATC
0-L A08AA07 cathine WHO ATC
0-L A08AA08 clobenzorex WHO ATC
0-L A08AA09 mefenorex WHO ATC
0-L A08AA10 sibutramine WHO ATC
0-L A08AA56 ephedrine, combinations WHO ATC
0-L A08AB Peripherally acting antiobesity products WHO ATC
0-L A08AB01 orlistat WHO ATC
0-L A08AX Other antiobesity drugs WHO ATC
0-L A08AX01 rimonabant WHO ATC
0-L A09 DIGESTIVES, INCL. ENZYMES WHO ATC
0-L A09A DIGESTIVES, INCL. ENZYMES WHO ATC
0-L A09AA Enzyme preparations WHO ATC
0-L A09AA01 diastase WHO ATC
0-L A09AA02 multienzymes (lipase, protease etc.) WHO ATC
0-L A09AA03 pepsin WHO ATC
0-L A09AA04 tilactase WHO ATC
0-L A09AB Acid preparations WHO ATC
0-L A09AB01 glutamic acid hydrochloride WHO ATC
0-L A09AB02 betaine hydrochloride WHO ATC
0-L A09AB03 hydrochloric acid WHO ATC
0-L A09AB04 citric acid WHO ATC
0-L A09AC Enzyme and acid preparations, combinations WHO ATC
0-L A09AC01 pepsin and acid preparations WHO ATC
0-L A09AC02 multienzymes and acid preparations WHO ATC
0-L A10 DRUGS USED IN DIABETES WHO ATC
0-L A10A INSULINS AND ANALOGUES WHO ATC
0-L A10AB Insulins and analogues for injection, fast-acting WHO ATC
0-L A10AB01 insulin (human) WHO ATC
0-L A10AB02 insulin (beef) WHO ATC
0-L A10AB03 insulin (pork) WHO ATC
0-L A10AB04 insulin lispro WHO ATC
0-L A10AB05 insulin aspart WHO ATC
0-L A10AB06 insulin glulisine WHO ATC
0-L A10AB30 combinations WHO ATC
0-L A10AC Insulins and analogues for injection, intermediate-acting WHO ATC
0-L A10AC01 insulin (human) WHO ATC
0-L A10AC02 insulin (beef) WHO ATC
0-L A10AC03 insulin (pork) WHO ATC
0-L A10AC04 insulin lispro WHO ATC
0-L A10AC30 combinations WHO ATC
0-L A10AD Insulins and analogues for injection, intermediate-acting combined with fast-acting WHO ATC
0-L A10AD01 insulin (human) WHO ATC
0-L A10AD02 insulin (beef) WHO ATC
0-L A10AD03 insulin (pork) WHO ATC
0-L A10AD04 Insulin lispro WHO ATC
0-L A10AD05 insulin aspart WHO ATC
0-L A10AD30 combinations WHO ATC
0-L A10AE Insulins and analogues for injection, long-acting WHO ATC
0-L A10AE01 insulin (human) WHO ATC
0-L A10AE02 insulin (beef) WHO ATC
0-L A10AE03 insulin (pork) WHO ATC
0-L A10AE04 insulin glargine WHO ATC
0-L A10AE05 insulin detemir WHO ATC
0-L A10AE30 combinations WHO ATC
0-L A10AF Insulins and analogues for inhalation WHO ATC
0-L A10AF01 insulin (human) WHO ATC
0-L A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS WHO ATC
0-L A10BA Biguanides WHO ATC
0-L A10BA01 phenformin WHO ATC
0-L A10BA02 metformin WHO ATC
0-L A10BA03 buformin WHO ATC
0-L A10BB Sulfonamides, urea derivatives WHO ATC
0-L A10BB01 glibenclamide WHO ATC
0-L A10BB02 chlorpropamide WHO ATC
0-L A10BB03 tolbutamide WHO ATC
0-L A10BB04 glibornuride WHO ATC
0-L A10BB05 tolazamide WHO ATC
0-L A10BB06 carbutamide WHO ATC
0-L A10BB07 glipizide WHO ATC
0-L A10BB08 gliquidone WHO ATC
0-L A10BB09 gliclazide WHO ATC
0-L A10BB10 metahexamide WHO ATC
0-L A10BB11 glisoxepide WHO ATC
0-L A10BB12 glimepiride WHO ATC
0-L A10BB31 acetohexamide WHO ATC
0-L A10BC Sulfonamides (heterocyclic) WHO ATC
0-L A10BC01 glymidine WHO ATC
0-L A10BD Combinations of oral blood glucose lowering drugs WHO ATC
0-L A10BD01 phenformin and sulfonamides WHO ATC
0-L A10BD02 metformin and sulfonamides WHO ATC
0-L A10BD03 metformin and rosiglitazone WHO ATC
0-L A10BD04 glimepiride and rosiglitazone WHO ATC
0-L A10BD05 metformin and pioglitazone WHO ATC
0-L A10BD06 glimepiride and pioglitazone WHO ATC
0-L A10BD07 metformin and sitagliptin WHO ATC
0-L A10BD08 metformin and vildagliptin WHO ATC
0-L A10BD09 pioglitazone and alogliptin WHO ATC
0-L A10BF Alpha glucosidase inhibitors WHO ATC
0-L A10BF01 acarbose WHO ATC
0-L A10BF02 miglitol WHO ATC
0-L A10BF03 voglibose WHO ATC
0-L A10BG Thiazolidinediones WHO ATC
0-L A10BG01 troglitazone WHO ATC
0-L A10BG02 rosiglitazone WHO ATC
0-L A10BG03 pioglitazone WHO ATC
0-L A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors WHO ATC
0-L A10BH01 sitagliptin WHO ATC
0-L A10BH02 vildagliptin WHO ATC
0-L A10BH03 saxagliptin WHO ATC
0-L A10BH04 alogliptin WHO ATC
0-L A10BX Other blood glucose lowering drugs, excl. insulins WHO ATC
0-L A10BX01 guar gum WHO ATC
0-L A10BX02 repaglinide WHO ATC
0-L A10BX03 nateglinide WHO ATC
0-L A10BX04 exenatide WHO ATC
0-L A10BX05 pramlintide WHO ATC
0-L A10BX06 benfluorex WHO ATC
0-L A10BX07 liraglutide WHO ATC
0-L A10BX08 mitiglinide WHO ATC
0-L A10X OTHER DRUGS USED IN DIABETES WHO ATC
0-L A10XA Aldose reductase inhibitors WHO ATC
0-L A10XA01 tolrestat WHO ATC
0-L A11 VITAMINS WHO ATC
0-L A11A MULTIVITAMINS, COMBINATIONS WHO ATC
0-L A11AA Multivitamins with minerals WHO ATC
0-L A11AA01 multivitamins and iron WHO ATC
0-L A11AA02 multivitamins and calcium WHO ATC
0-L A11AA03 multivitamins and other minerals, incl. combinations WHO ATC
0-L A11AA04 multivitamins and trace elements WHO ATC
0-L A11AB Multivitamins, other combinations WHO ATC
0-L A11B MULTIVITAMINS, PLAIN WHO ATC
0-L A11BA Multivitamins, plain WHO ATC
0-L A11C VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO WHO ATC
0-L A11CA Vitamin A, plain WHO ATC
0-L A11CA01 retinol (vit A) WHO ATC
0-L A11CA02 betacarotene WHO ATC
0-L A11CB Vitamin A and D in combination WHO ATC
0-L A11CC Vitamin D and analogues WHO ATC
0-L A11CC01 ergocalciferol WHO ATC
0-L A11CC02 dihydrotachysterol WHO ATC
0-L A11CC03 alfacalcidol WHO ATC
0-L A11CC04 calcitriol WHO ATC
0-L A11CC05 colecalciferol WHO ATC
0-L A11CC06 calcifediol WHO ATC
0-L A11CC20 combinations WHO ATC
0-L A11D VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 WHO ATC
0-L A11DA Vitamin B1, plain WHO ATC
0-L A11DA01 thiamine (vit B1) WHO ATC
0-L A11DA02 sulbutiamine WHO ATC
0-L A11DA03 benfotiamine WHO ATC
0-L A11DB Vitamin B1 in combination with vitamin B6 and/or vitamin B12 WHO ATC
0-L A11E VITAMIN B-COMPLEX, INCL. COMBINATIONS WHO ATC
0-L A11EA Vitamin B-complex, plain WHO ATC
0-L A11EB Vitamin B-complex with vitamin C WHO ATC
0-L A11EC Vitamin B-complex with minerals WHO ATC
0-L A11ED Vitamin B-complex with anabolic steroids WHO ATC
0-L A11EX Vitamin B-complex, other combinations WHO ATC
0-L A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS WHO ATC
0-L A11GA Ascorbic acid (vitamin C), plain WHO ATC
0-L A11GA01 ascorbic acid (vit C) WHO ATC
0-L A11GB Ascorbic acid (vitamin C), combinations WHO ATC
0-L A11GB01 ascorbic acid (vit C) and calcium WHO ATC
0-L A11H OTHER PLAIN VITAMIN PREPARATIONS WHO ATC
0-L A11HA Other plain vitamin preparations WHO ATC
0-L A11HA01 nicotinamide WHO ATC
0-L A11HA02 pyridoxine (vit B6) WHO ATC
0-L A11HA03 tocopherol (vit E) WHO ATC
0-L A11HA04 riboflavin (vit B2) WHO ATC
0-L A11HA05 biotin WHO ATC
0-L A11HA06 pyridoxal phosphate WHO ATC
0-L A11HA07 inositol WHO ATC
0-L A11HA08 tocofersolan WHO ATC
0-L A11HA30 dexpanthenol WHO ATC
0-L A11HA31 calcium pantothenate WHO ATC
0-L A11HA32 pantethine WHO ATC
0-L A11J OTHER VITAMIN PRODUCTS, COMBINATIONS WHO ATC
0-L A11JA Combinations of vitamins WHO ATC
0-L A11JB Vitamins with minerals WHO ATC
0-L A11JC Vitamins, other combinations WHO ATC
0-L A12 MINERAL SUPPLEMENTS WHO ATC
0-L A12A CALCIUM WHO ATC
0-L A12AA Calcium WHO ATC
0-L A12AA01 calcium phosphate WHO ATC
0-L A12AA02 calcium glubionate WHO ATC
0-L A12AA03 calcium gluconate WHO ATC
0-L A12AA04 calcium carbonate WHO ATC
0-L A12AA05 calcium lactate WHO ATC
0-L A12AA06 calcium lactate gluconate WHO ATC
0-L A12AA07 calcium chloride WHO ATC
0-L A12AA08 calcium glycerylphosphate WHO ATC
0-L A12AA09 calcium citrate lysine complex WHO ATC
0-L A12AA10 calcium glucoheptonate WHO ATC
0-L A12AA11 calcium pangamate WHO ATC
0-L A12AA12 calcium acetate anhydrous WHO ATC
0-L A12AA20 calcium (different salts in combination) WHO ATC
0-L A12AA30 calcium laevulate WHO ATC
0-L A12AX Calcium, combinations with other drugs WHO ATC
0-L A12B POTASSIUM WHO ATC
0-L A12BA Potassium WHO ATC
0-L A12BA01 potassium chloride WHO ATC
0-L A12BA02 potassium citrate WHO ATC
0-L A12BA03 potassium hydrogentartrate WHO ATC
0-L A12BA04 potassium hydrogencarbonate WHO ATC
0-L A12BA05 potassium gluconate WHO ATC
0-L A12BA30 combinations WHO ATC
0-L A12BA51 potassium chloride, combinations WHO ATC
0-L A12C OTHER MINERAL SUPPLEMENTS WHO ATC
0-L A12CA Sodium WHO ATC
0-L A12CA01 sodium chloride WHO ATC
0-L A12CA02 sodium sulfate WHO ATC
0-L A12CB Zinc WHO ATC
0-L A12CB01 zinc sulfate WHO ATC
0-L A12CB02 zinc gluconate WHO ATC
0-L A12CB03 zinc protein complex WHO ATC
0-L A12CC Magnesium WHO ATC
0-L A12CC01 magnesium chloride WHO ATC
0-L A12CC02 magnesium sulfate WHO ATC
0-L A12CC03 magnesium gluconate WHO ATC
0-L A12CC04 magnesium citrate WHO ATC
0-L A12CC05 magnesium aspartate WHO ATC
0-L A12CC06 magnesium lactate WHO ATC
0-L A12CC07 magnesium levulinate WHO ATC
0-L A12CC08 magnesium pidolate WHO ATC
0-L A12CC09 magnesium orotate WHO ATC
0-L A12CC10 magnesium oxide WHO ATC
0-L A12CC30 magnesium (different salts in combination) WHO ATC
0-L A12CD Fluoride WHO ATC
0-L A12CD01 sodium fluoride WHO ATC
0-L A12CD02 sodium monofluorophosphate WHO ATC
0-L A12CD51 fluoride, combinations WHO ATC
0-L A12CE Selenium WHO ATC
0-L A12CE01 sodium selenate WHO ATC
0-L A12CE02 sodium selenite WHO ATC
0-L A12CX Other mineral products WHO ATC
0-L A13 TONICS WHO ATC
0-L A13A TONICS WHO ATC
0-L A14 ANABOLIC AGENTS FOR SYSTEMIC USE WHO ATC
0-L A14A ANABOLIC STEROIDS WHO ATC
0-L A14AA Androstan derivatives WHO ATC
0-L A14AA01 androstanolone WHO ATC
0-L A14AA02 stanozolol WHO ATC
0-L A14AA03 metandienone WHO ATC
0-L A14AA04 metenolone WHO ATC
0-L A14AA05 oxymetholone WHO ATC
0-L A14AA06 quinbolone WHO ATC
0-L A14AA07 prasterone WHO ATC
0-L A14AA08 oxandrolone WHO ATC
0-L A14AA09 norethandrolone WHO ATC
0-L A14AB Estren derivatives WHO ATC
0-L A14AB01 nandrolone WHO ATC
0-L A14AB02 ethylestrenol WHO ATC
0-L A14AB03 oxabolone cipionate WHO ATC
0-L A14B OTHER ANABOLIC AGENTS WHO ATC
0-L A15 APPETITE STIMULANTS WHO ATC
0-L A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS WHO ATC
0-L A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS WHO ATC
0-L A16AA Amino acids and derivatives WHO ATC
0-L A16AA01 levocarnitine WHO ATC
0-L A16AA02 ademetionine WHO ATC
0-L A16AA03 glutamine WHO ATC
0-L A16AA04 mercaptamine WHO ATC
0-L A16AA05 carglumic acid WHO ATC
0-L A16AA06 betaine WHO ATC
0-L A16AB Enzymes WHO ATC
0-L A16AB01 alglucerase WHO ATC
0-L A16AB02 imiglucerase WHO ATC
0-L A16AB03 agalsidase alfa WHO ATC
0-L A16AB04 agalsidase beta WHO ATC
0-L A16AB05 laronidase WHO ATC
0-L A16AB06 sacrosidase WHO ATC
0-L A16AB07 alglucosidase alfa WHO ATC
0-L A16AB08 galsulfase WHO ATC
0-L A16AB09 idursulfase WHO ATC
0-L A16AX Various alimentary tract and metabolism products WHO ATC
0-L A16AX01 tioctic acid WHO ATC
0-L A16AX02 anethole trithione WHO ATC
0-L A16AX03 sodium phenylbutyrate WHO ATC
0-L A16AX04 nitisinone WHO ATC
0-L A16AX05 zinc acetate WHO ATC
0-L A16AX06 miglustat WHO ATC
0-L A16AX07 sapropterin WHO ATC
0-L B BLOOD AND BLOOD FORMING ORGANS WHO ATC
0-L B01 ANTITHROMBOTIC AGENTS WHO ATC
0-L B01A ANTITHROMBOTIC AGENTS WHO ATC
0-L B01AA Vitamin K antagonists WHO ATC
0-L B01AA01 dicoumarol WHO ATC
0-L B01AA02 phenindione WHO ATC
0-L B01AA03 warfarin WHO ATC
0-L B01AA04 phenprocoumon WHO ATC
0-L B01AA07 acenocoumarol WHO ATC
0-L B01AA08 ethyl biscoumacetate WHO ATC
0-L B01AA09 clorindione WHO ATC
0-L B01AA10 diphenadione WHO ATC
0-L B01AA11 tioclomarol WHO ATC
0-L B01AB Heparin group WHO ATC
0-L B01AB01 heparin WHO ATC
0-L B01AB02 antithrombin III WHO ATC
0-L B01AB04 dalteparin WHO ATC
0-L B01AB05 enoxaparin WHO ATC
0-L B01AB06 nadroparin WHO ATC
0-L B01AB07 parnaparin WHO ATC
0-L B01AB08 reviparin WHO ATC
0-L B01AB09 danaparoid WHO ATC
0-L B01AB10 tinzaparin WHO ATC
0-L B01AB11 sulodexide WHO ATC
0-L B01AB12 bemiparin WHO ATC
0-L B01AB51 heparin, combinations WHO ATC
0-L B01AC Platelet aggregation inhibitors excl. heparin WHO ATC
0-L B01AC01 ditazole WHO ATC
0-L B01AC02 cloricromen WHO ATC
0-L B01AC03 picotamide WHO ATC
0-L B01AC04 clopidogrel WHO ATC
0-L B01AC05 ticlopidine WHO ATC
0-L B01AC06 acetylsalicylic acid WHO ATC
0-L B01AC07 dipyridamole WHO ATC
0-L B01AC08 carbasalate calcium WHO ATC
0-L B01AC09 epoprostenol WHO ATC
0-L B01AC10 indobufen WHO ATC
0-L B01AC11 iloprost WHO ATC
0-L B01AC13 abciximab WHO ATC
0-L B01AC15 aloxiprin WHO ATC
0-L B01AC16 eptifibatide WHO ATC
0-L B01AC17 tirofiban WHO ATC
0-L B01AC18 triflusal WHO ATC
0-L B01AC19 beraprost WHO ATC
0-L B01AC21 treprostinil WHO ATC
0-L B01AC22 prasugrel WHO ATC
0-L B01AC30 combinations WHO ATC
0-L B01AD Enzymes WHO ATC
0-L B01AD01 streptokinase WHO ATC
0-L B01AD02 alteplase WHO ATC
0-L B01AD03 anistreplase WHO ATC
0-L B01AD04 urokinase WHO ATC
0-L B01AD05 fibrinolysin WHO ATC
0-L B01AD06 brinase WHO ATC
0-L B01AD07 reteplase WHO ATC
0-L B01AD08 saruplase WHO ATC
0-L B01AD09 ancrod WHO ATC
0-L B01AD10 drotrecogin alfa (activated) WHO ATC
0-L B01AD11 tenecteplase WHO ATC
0-L B01AD12 protein C WHO ATC
0-L B01AE Direct thrombin inhibitors WHO ATC
0-L B01AE01 desirudin WHO ATC
0-L B01AE02 lepirudin WHO ATC
0-L B01AE03 argatroban WHO ATC
0-L B01AE04 melagatran WHO ATC
0-L B01AE05 ximelagatran WHO ATC
0-L B01AE06 bivalirudin WHO ATC
0-L B01AE07 dabigatran etexilate WHO ATC
0-L B01AX Other antithrombotic agents WHO ATC
0-L B01AX01 defibrotide WHO ATC
0-L B01AX04 dermatan sulfate WHO ATC
0-L B01AX05 fondaparinux WHO ATC
0-L B01AX06 rivaroxaban WHO ATC
0-L B02 ANTIHEMORRHAGICS WHO ATC
0-L B02A ANTIFIBRINOLYTICS WHO ATC
0-L B02AA Amino acids WHO ATC
0-L B02AA01 aminocaproic acid WHO ATC
0-L B02AA02 tranexamic acid WHO ATC
0-L B02AA03 aminomethylbenzoic acid WHO ATC
0-L B02AB Proteinase inhibitors WHO ATC
0-L B02AB01 aprotinin WHO ATC
0-L B02AB02 alfa1 antitrypsin WHO ATC
0-L B02AB03 c1-inhibitor WHO ATC
0-L B02AB04 camostat WHO ATC
0-L B02B VITAMIN K AND OTHER HEMOSTATICS WHO ATC
0-L B02BA Vitamin K WHO ATC
0-L B02BA01 phytomenadione WHO ATC
0-L B02BA02 menadione WHO ATC
0-L B02BB Fibrinogen WHO ATC
0-L B02BB01 human fibrinogen WHO ATC
0-L B02BC Local hemostatics WHO ATC
0-L B02BC01 absorbable gelatin sponge WHO ATC
0-L B02BC02 oxidized cellulose WHO ATC
0-L B02BC03 tetragalacturonic acid hydroxymethylester WHO ATC
0-L B02BC05 adrenalone WHO ATC
0-L B02BC06 thrombin WHO ATC
0-L B02BC07 collagen WHO ATC
0-L B02BC08 calcium alginate WHO ATC
0-L B02BC09 epinephrine WHO ATC
0-L B02BC10 fibrinogen, human WHO ATC
0-L B02BC30 combinations WHO ATC
0-L B02BD Blood coagulation factors WHO ATC
0-L B02BD01 coagulation factor IX, II, VII and X in combination WHO ATC
0-L B02BD02 coagulation factor VIII WHO ATC
0-L B02BD03 factor VIII inhibitor bypassing activity WHO ATC
0-L B02BD04 coagulation factor IX WHO ATC
0-L B02BD05 coagulation factor VII WHO ATC
0-L B02BD06 von Willebrand factor and coagulation factor VIII in combination WHO ATC
0-L B02BD07 coagulation factor XIII WHO ATC
0-L B02BD08 eptacog alfa (activated) WHO ATC
0-L B02BD09 nonacog alfa WHO ATC
0-L B02BD30 thrombin WHO ATC
0-L B02BX Other systemic hemostatics WHO ATC
0-L B02BX01 etamsylate WHO ATC
0-L B02BX02 carbazochrome WHO ATC
0-L B02BX03 batroxobin WHO ATC
0-L B02BX04 romiplostim WHO ATC
0-L B02BX05 eltrombopag WHO ATC
0-L B03 ANTIANEMIC PREPARATIONS WHO ATC
0-L B03A IRON PREPARATIONS WHO ATC
0-L B03AA Iron bivalent, oral preparations WHO ATC
0-L B03AA01 ferrous glycine sulfate WHO ATC
0-L B03AA02 ferrous fumarate WHO ATC
0-L B03AA03 ferrous gluconate WHO ATC
0-L B03AA04 ferrous carbonate WHO ATC
0-L B03AA05 ferrous chloride WHO ATC
0-L B03AA06 ferrous succinate WHO ATC
0-L B03AA07 ferrous sulfate WHO ATC
0-L B03AA08 ferrous tartrate WHO ATC
0-L B03AA09 ferrous aspartate WHO ATC
0-L B03AA10 ferrous ascorbate WHO ATC
0-L B03AA11 ferrous iodine WHO ATC
0-L B03AB Iron trivalent, oral preparations WHO ATC
0-L B03AB01 ferric sodium citrate WHO ATC
0-L B03AB02 saccharated iron oxide WHO ATC
0-L B03AB03 sodium feredetate WHO ATC
0-L B03AB04 ferric hydroxide WHO ATC
0-L B03AB05 dextriferron WHO ATC
0-L B03AB06 ferric citrate WHO ATC
0-L B03AB07 chondroitin sulfate-iron complex WHO ATC
0-L B03AB08 ferric acetyl transferrin WHO ATC
0-L B03AB09 ferric proteinsuccinylate WHO ATC
0-L B03AC Iron trivalent, parenteral preparations WHO ATC
0-L B03AC01 dextriferron WHO ATC
0-L B03AC02 saccharated iron oxide WHO ATC
0-L B03AC03 iron-sorbitol-citric acid complex WHO ATC
0-L B03AC05 ferric sorbitol gluconic acid complex WHO ATC
0-L B03AC06 ferric oxide dextran complex WHO ATC
0-L B03AC07 ferric sodium gluconate complex WHO ATC
0-L B03AD Iron in combination with folic acid WHO ATC
0-L B03AD01 ferrous amino acid complex WHO ATC
0-L B03AD02 ferrous fumarate WHO ATC
0-L B03AD03 ferrous sulfate WHO ATC
0-L B03AD04 dextriferron WHO ATC
0-L B03AE Iron in other combinations WHO ATC
0-L B03AE01 iron, vitamin B12 and folic acid WHO ATC
0-L B03AE02 iron, multivitamins and folic acid WHO ATC
0-L B03AE03 iron and multivitamins WHO ATC
0-L B03AE04 iron, multivitamins and minerals WHO ATC
0-L B03AE10 various combinations WHO ATC
0-L B03B VITAMIN B12 AND FOLIC ACID WHO ATC
0-L B03BA Vitamin B12 (cyanocobalamin and analogues) WHO ATC
0-L B03BA01 cyanocobalamin WHO ATC
0-L B03BA02 cyanocobalamin tannin complex WHO ATC
0-L B03BA03 hydroxocobalamin WHO ATC
0-L B03BA04 cobamamide WHO ATC
0-L B03BA05 mecobalamin WHO ATC
0-L B03BA51 cyanocobalamin, combinations WHO ATC
0-L B03BA53 hydroxocobalamin, combinations WHO ATC
0-L B03BB Folic acid and derivatives WHO ATC
0-L B03BB01 folic acid WHO ATC
0-L B03BB51 folic acid, combinations WHO ATC
0-L B03X OTHER ANTIANEMIC PREPARATIONS WHO ATC
0-L B03XA Other antianemic preparations WHO ATC
0-L B03XA01 erythropoietin WHO ATC
0-L B03XA02 darbepoetin alfa WHO ATC
0-L B03XA03 methoxy polyethylene glycol-epoetin beta WHO ATC
0-L B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS WHO ATC
0-L B05A BLOOD AND RELATED PRODUCTS WHO ATC
0-L B05AA Blood substitutes and plasma protein fractions WHO ATC
0-L B05AA01 albumin WHO ATC
0-L B05AA02 other plasma protein fractions WHO ATC
0-L B05AA03 fluorocarbon blood substitutes WHO ATC
0-L B05AA05 dextran WHO ATC
0-L B05AA06 gelatin agents WHO ATC
0-L B05AA07 hydroxyethylstarch WHO ATC
0-L B05AA08 hemoglobin crosfumaril WHO ATC
0-L B05AA09 hemoglobin raffimer WHO ATC
0-L B05AA10 hemoglobin glutamer (bovine) WHO ATC
0-L B05AX Other blood products WHO ATC
0-L B05AX01 erythrocytes WHO ATC
0-L B05AX02 thrombocytes WHO ATC
0-L B05AX03 blood plasma WHO ATC
0-L B05AX04 stem cells from umbilical cord blood WHO ATC
0-L B05B I.V. SOLUTIONS WHO ATC
0-L B05BA Solutions for parenteral nutrition WHO ATC
0-L B05BA01 amino acids WHO ATC
0-L B05BA02 fat emulsions WHO ATC
0-L B05BA03 carbohydrates WHO ATC
0-L B05BA04 protein hydrolysates WHO ATC
0-L B05BA10 combinations WHO ATC
0-L B05BB Solutions affecting the electrolyte balance WHO ATC
0-L B05BB01 electrolytes WHO ATC
0-L B05BB02 electrolytes with carbohydrates WHO ATC
0-L B05BB03 trometamol WHO ATC
0-L B05BC Solutions producing osmotic diuresis WHO ATC
0-L B05BC01 mannitol WHO ATC
0-L B05BC02 carbamide WHO ATC
0-L B05C IRRIGATING SOLUTIONS WHO ATC
0-L B05CA Antiinfectives WHO ATC
0-L B05CA01 cetylpyridinium WHO ATC
0-L B05CA02 chlorhexidine WHO ATC
0-L B05CA03 nitrofural WHO ATC
0-L B05CA04 sulfamethizole WHO ATC
0-L B05CA05 taurolidine WHO ATC
0-L B05CA06 mandelic acid WHO ATC
0-L B05CA07 noxytiolin WHO ATC
0-L B05CA08 ethacridine lactate WHO ATC
0-L B05CA09 neomycin WHO ATC
0-L B05CA10 combinations WHO ATC
0-L B05CB Salt solutions WHO ATC
0-L B05CB01 sodium chloride WHO ATC
0-L B05CB02 sodium citrate WHO ATC
0-L B05CB03 magnesium citrate WHO ATC
0-L B05CB04 sodium bicarbonate WHO ATC
0-L B05CB10 combinations WHO ATC
0-L B05CX Other irrigating solutions WHO ATC
0-L B05CX01 glucose WHO ATC
0-L B05CX02 sorbitol WHO ATC
0-L B05CX03 glycine WHO ATC
0-L B05CX04 mannitol WHO ATC
0-L B05CX10 combinations WHO ATC
0-L B05D PERITONEAL DIALYTICS WHO ATC
0-L B05DA Isotonic solutions WHO ATC
0-L B05DB Hypertonic solutions WHO ATC
0-L B05X I.V. SOLUTION ADDITIVES WHO ATC
0-L B05XA Electrolyte solutions WHO ATC
0-L B05XA01 potassium chloride WHO ATC
0-L B05XA02 sodium bicarbonate WHO ATC
0-L B05XA03 sodium chloride WHO ATC
0-L B05XA04 ammonium chloride WHO ATC
0-L B05XA05 magnesium sulfate WHO ATC
0-L B05XA06 potassium phosphate, incl. comb. with other potassium salts WHO ATC
0-L B05XA07 calcium chloride WHO ATC
0-L B05XA08 sodium acetate WHO ATC
0-L B05XA09 sodium phosphate WHO ATC
0-L B05XA10 magnesium phosphate WHO ATC
0-L B05XA11 magnesium chloride WHO ATC
0-L B05XA12 zinc chloride WHO ATC
0-L B05XA13 hydrochloric acid WHO ATC
0-L B05XA14 sodium glycerophosphate WHO ATC
0-L B05XA15 potassium lactate WHO ATC
0-L B05XA16 cardioplegia solutions WHO ATC
0-L B05XA17 potassium acetate WHO ATC
0-L B05XA30 combinations of electrolytes WHO ATC
0-L B05XA31 electrolytes in combination with other drugs WHO ATC
0-L B05XB Amino acids WHO ATC
0-L B05XB01 arginine hydrochloride WHO ATC
0-L B05XB02 alanyl glutamine WHO ATC
0-L B05XB03 lysine WHO ATC
0-L B05XC Vitamins WHO ATC
0-L B05XX Other i.v. solution additives WHO ATC
0-L B05XX02 trometamol WHO ATC
0-L B05Z HEMODIALYTICS AND HEMOFILTRATES WHO ATC
0-L B05ZA Hemodialytics, concentrates WHO ATC
0-L B05ZB Hemofiltrates WHO ATC
0-L B06 OTHER HEMATOLOGICAL AGENTS WHO ATC
0-L B06A OTHER HEMATOLOGICAL AGENTS WHO ATC
0-L B06AA Enzymes WHO ATC
0-L B06AA02 fibrinolysin and desoxyribonuclease WHO ATC
0-L B06AA03 hyaluronidase WHO ATC
0-L B06AA04 chymotrypsin WHO ATC
0-L B06AA07 trypsin WHO ATC
0-L B06AA10 desoxyribonuclease WHO ATC
0-L B06AA11 bromelains WHO ATC
0-L B06AA55 streptokinase, combinations WHO ATC
0-L B06AB Other hem products WHO ATC
0-L B06AB01 hematin WHO ATC
0-L C CARDIOVASCULAR SYSTEM WHO ATC
0-L C01 CARDIAC THERAPY WHO ATC
0-L C01A CARDIAC GLYCOSIDES WHO ATC
0-L C01AA Digitalis glycosides WHO ATC
0-L C01AA01 acetyldigitoxin WHO ATC
0-L C01AA02 acetyldigoxin WHO ATC
0-L C01AA03 digitalis leaves WHO ATC
0-L C01AA04 digitoxin WHO ATC
0-L C01AA05 digoxin WHO ATC
0-L C01AA06 lanatoside C WHO ATC
0-L C01AA07 deslanoside WHO ATC
0-L C01AA08 metildigoxin WHO ATC
0-L C01AA09 gitoformate WHO ATC
0-L C01AA52 acetyldigoxin, combinations WHO ATC
0-L C01AB Scilla glycosides WHO ATC
0-L C01AB01 proscillaridin WHO ATC
0-L C01AB51 proscillaridin, combinations WHO ATC
0-L C01AC Strophantus glycosides WHO ATC
0-L C01AC01 g-strophanthin WHO ATC
0-L C01AC03 cymarin WHO ATC
0-L C01AX Other cardiac glycosides WHO ATC
0-L C01AX02 peruvoside WHO ATC
0-L C01B ANTIARRHYTHMICS, CLASS I AND III WHO ATC
0-L C01BA Antiarrhythmics, class Ia WHO ATC
0-L C01BA01 quinidine WHO ATC
0-L C01BA02 procainamide WHO ATC
0-L C01BA03 disopyramide WHO ATC
0-L C01BA04 sparteine WHO ATC
0-L C01BA05 ajmaline WHO ATC
0-L C01BA08 prajmaline WHO ATC
0-L C01BA12 lorajmine WHO ATC
0-L C01BA51 quinidine, combinations excl. psycholeptics WHO ATC
0-L C01BA71 quinidine, combinations with psycholeptics WHO ATC
0-L C01BB Antiarrhythmics, class Ib WHO ATC
0-L C01BB01 lidocaine WHO ATC
0-L C01BB02 mexiletine WHO ATC
0-L C01BB03 tocainide WHO ATC
0-L C01BB04 aprindine WHO ATC
0-L C01BC Antiarrhythmics, class Ic WHO ATC
0-L C01BC03 propafenone WHO ATC
0-L C01BC04 flecainide WHO ATC
0-L C01BC07 lorcainide WHO ATC
0-L C01BC08 encainide WHO ATC
0-L C01BD Antiarrhythmics, class III WHO ATC
0-L C01BD01 amiodarone WHO ATC
0-L C01BD02 bretylium tosilate WHO ATC
0-L C01BD03 bunaftine WHO ATC
0-L C01BD04 dofetilide WHO ATC
0-L C01BD05 ibutilide WHO ATC
0-L C01BD06 tedisamil WHO ATC
0-L C01BG Other class I antiarrhythmics WHO ATC
0-L C01BG01 moracizine WHO ATC
0-L C01BG07 cibenzoline WHO ATC
0-L C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES WHO ATC
0-L C01CA Adrenergic and dopaminergic agents WHO ATC
0-L C01CA01 etilefrine WHO ATC
0-L C01CA02 isoprenaline WHO ATC
0-L C01CA03 norepinephrine WHO ATC
0-L C01CA04 dopamine WHO ATC
0-L C01CA05 norfenefrine WHO ATC
0-L C01CA06 phenylephrine WHO ATC
0-L C01CA07 dobutamine WHO ATC
0-L C01CA08 oxedrine WHO ATC
0-L C01CA09 metaraminol WHO ATC
0-L C01CA10 methoxamine WHO ATC
0-L C01CA11 mephentermine WHO ATC
0-L C01CA12 dimetofrine WHO ATC
0-L C01CA13 prenalterol WHO ATC
0-L C01CA14 dopexamine WHO ATC
0-L C01CA15 gepefrine WHO ATC
0-L C01CA16 ibopamine WHO ATC
0-L C01CA17 midodrine WHO ATC
0-L C01CA18 octopamine WHO ATC
0-L C01CA19 fenoldopam WHO ATC
0-L C01CA21 cafedrine WHO ATC
0-L C01CA22 arbutamine WHO ATC
0-L C01CA23 theodrenaline WHO ATC
0-L C01CA24 epinephrine WHO ATC
0-L C01CA30 combinations WHO ATC
0-L C01CA51 etilefrine, combinations WHO ATC
0-L C01CE Phosphodiesterase inhibitors WHO ATC
0-L C01CE01 amrinone WHO ATC
0-L C01CE02 milrinone WHO ATC
0-L C01CE03 enoximone WHO ATC
0-L C01CE04 bucladesine WHO ATC
0-L C01CX Other cardiac stimulants WHO ATC
0-L C01CX06 angiotensinamide WHO ATC
0-L C01CX07 xamoterol WHO ATC
0-L C01CX08 levosimendan WHO ATC
0-L C01D VASODILATORS USED IN CARDIAC DISEASES WHO ATC
0-L C01DA Organic nitrates WHO ATC
0-L C01DA02 glyceryl trinitrate WHO ATC
0-L C01DA04 methylpropylpropanediol dinitrate WHO ATC
0-L C01DA05 pentaerithrityl tetranitrate WHO ATC
0-L C01DA07 propatylnitrate WHO ATC
0-L C01DA08 isosorbide dinitrate WHO ATC
0-L C01DA09 trolnitrate WHO ATC
0-L C01DA13 eritrityl tetranitrate WHO ATC
0-L C01DA14 isosorbide mononitrate WHO ATC
0-L C01DA20 organic nitrates in combination WHO ATC
0-L C01DA38 tenitramine WHO ATC
0-L C01DA52 glyceryl trinitrate, combinations WHO ATC
0-L C01DA54 methylpropylpropanediol dinitrate, combinations WHO ATC
0-L C01DA55 pentaerithrityl tetranitrate, combinations WHO ATC
0-L C01DA57 propatylnitrate, combinations WHO ATC
0-L C01DA58 isosorbide dinitrate, combinations WHO ATC
0-L C01DA59 trolnitrate, combinations WHO ATC
0-L C01DA63 eritrityl tetranitrate, combinations WHO ATC
0-L C01DA70 organic nitrates in combination with psycholeptics WHO ATC
0-L C01DB Quinolone vasodilators WHO ATC
0-L C01DB01 flosequinan WHO ATC
0-L C01DX Other vasodilators used in cardiac diseases WHO ATC
0-L C01DX01 itramin tosilate WHO ATC
0-L C01DX02 prenylamine WHO ATC
0-L C01DX03 oxyfedrine WHO ATC
0-L C01DX04 benziodarone WHO ATC
0-L C01DX05 carbocromen WHO ATC
0-L C01DX06 hexobendine WHO ATC
0-L C01DX07 etafenone WHO ATC
0-L C01DX08 heptaminol WHO ATC
0-L C01DX09 imolamine WHO ATC
0-L C01DX10 dilazep WHO ATC
0-L C01DX11 trapidil WHO ATC
0-L C01DX12 molsidomine WHO ATC
0-L C01DX13 efloxate WHO ATC
0-L C01DX14 cinepazet WHO ATC
0-L C01DX15 cloridarol WHO ATC
0-L C01DX16 nicorandil WHO ATC
0-L C01DX18 linsidomine WHO ATC
0-L C01DX19 nesiritide WHO ATC
0-L C01DX51 itramin tosilate, combinations WHO ATC
0-L C01DX52 prenylamine, combinations WHO ATC
0-L C01DX53 oxyfedrine, combinations WHO ATC
0-L C01DX54 benziodarone, combinations WHO ATC
0-L C01E OTHER CARDIAC PREPARATIONS WHO ATC
0-L C01EA Prostaglandins WHO ATC
0-L C01EA01 alprostadil WHO ATC
0-L C01EB Other cardiac preparations WHO ATC
0-L C01EB02 camphora WHO ATC
0-L C01EB03 indometacin WHO ATC
0-L C01EB04 crataegus glycosides WHO ATC
0-L C01EB05 creatinolfosfate WHO ATC
0-L C01EB06 fosfocreatine WHO ATC
0-L C01EB07 fructose 1,6-diphosphate WHO ATC
0-L C01EB09 ubidecarenone WHO ATC
0-L C01EB10 adenosine WHO ATC
0-L C01EB11 tiracizine WHO ATC
0-L C01EB13 acadesine WHO ATC
0-L C01EB15 trimetazidine WHO ATC
0-L C01EB16 ibuprofen WHO ATC
0-L C01EB17 ivabradine WHO ATC
0-L C01EB18 ranolazine WHO ATC
0-L C01EB19 icatibant WHO ATC
0-L C01EB21 regadenoson WHO ATC
0-L C01EX Other cardiac combination products WHO ATC
0-L C02 ANTIHYPERTENSIVES WHO ATC
0-L C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING WHO ATC
0-L C02AA Rauwolfia alkaloids WHO ATC
0-L C02AA01 rescinnamine WHO ATC
0-L C02AA02 reserpine WHO ATC
0-L C02AA03 combinations of rauwolfia alkaloids WHO ATC
0-L C02AA04 rauwolfia alkaloids, whole root WHO ATC
0-L C02AA05 deserpidine WHO ATC
0-L C02AA06 methoserpidine WHO ATC
0-L C02AA07 bietaserpine WHO ATC
0-L C02AA52 reserpine, combinations WHO ATC
0-L C02AA53 combinations of rauwolfia alkoloids, combinations WHO ATC
0-L C02AA57 bietaserpine, combinations WHO ATC
0-L C02AB Methyldopa WHO ATC
0-L C02AB01 methyldopa (levorotatory) WHO ATC
0-L C02AB02 methyldopa (racemic) WHO ATC
0-L C02AC Imidazoline receptor agonists WHO ATC
0-L C02AC01 clonidine WHO ATC
0-L C02AC02 guanfacine WHO ATC
0-L C02AC04 tolonidine WHO ATC
0-L C02AC05 moxonidine WHO ATC
0-L C02AC06 rilmenidine WHO ATC
0-L C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING WHO ATC
0-L C02BA Sulfonium derivatives WHO ATC
0-L C02BA01 trimetaphan WHO ATC
0-L C02BB Secondary and tertiary amines WHO ATC
0-L C02BB01 mecamylamine WHO ATC
0-L C02BC Bisquaternary ammonium compounds WHO ATC
0-L C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING WHO ATC
0-L C02CA Alpha-adrenoreceptor antagonists WHO ATC
0-L C02CA01 prazosin WHO ATC
0-L C02CA02 indoramin WHO ATC
0-L C02CA03 trimazosin WHO ATC
0-L C02CA04 doxazosin WHO ATC
0-L C02CA06 urapidil WHO ATC
0-L C02CC Guanidine derivatives WHO ATC
0-L C02CC01 betanidine WHO ATC
0-L C02CC02 guanethidine WHO ATC
0-L C02CC03 guanoxan WHO ATC
0-L C02CC04 debrisoquine WHO ATC
0-L C02CC05 guanoclor WHO ATC
0-L C02CC06 guanazodine WHO ATC
0-L C02CC07 guanoxabenz WHO ATC
0-L C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON WHO ATC
0-L C02DA Thiazide derivatives WHO ATC
0-L C02DA01 diazoxide WHO ATC
0-L C02DB Hydrazinophthalazine derivatives WHO ATC
0-L C02DB01 dihydralazine WHO ATC
0-L C02DB02 hydralazine WHO ATC
0-L C02DB03 endralazine WHO ATC
0-L C02DB04 cadralazine WHO ATC
0-L C02DC Pyrimidine derivatives WHO ATC
0-L C02DC01 minoxidil WHO ATC
0-L C02DD Nitroferricyanide derivatives WHO ATC
0-L C02DD01 nitroprusside WHO ATC
0-L C02DG Guanidine derivatives WHO ATC
0-L C02DG01 pinacidil WHO ATC
0-L C02K OTHER ANTIHYPERTENSIVES WHO ATC
0-L C02KA Alkaloids, excl. rauwolfia WHO ATC
0-L C02KA01 veratrum WHO ATC
0-L C02KB Tyrosine hydroxylase inhibitors WHO ATC
0-L C02KB01 metirosine WHO ATC
0-L C02KC MAO inhibitors WHO ATC
0-L C02KC01 pargyline WHO ATC
0-L C02KD Serotonin antagonists WHO ATC
0-L C02KD01 ketanserin WHO ATC
0-L C02KX Other antihypertensives WHO ATC
0-L C02KX01 bosentan WHO ATC
0-L C02KX02 ambrisentan WHO ATC
0-L C02KX03 sitaxentan WHO ATC
0-L C02L ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION WHO ATC
0-L C02LA Rauwolfia alkaloids and diuretics in combination WHO ATC
0-L C02LA01 reserpine and diuretics WHO ATC
0-L C02LA02 rescinnamine and diuretics WHO ATC
0-L C02LA03 deserpidine and diuretics WHO ATC
0-L C02LA04 methoserpidine and diuretics WHO ATC
0-L C02LA07 bietaserpine and diuretics WHO ATC
0-L C02LA08 rauwolfia alkaloids, whole root and diuretics WHO ATC
0-L C02LA09 syrosingopine and diuretics WHO ATC
0-L C02LA50 comb. of rauwolfia alkaloids and diuretics incl. other combinations WHO ATC
0-L C02LA51 reserpine and diuretics, combinations with other drugs WHO ATC
0-L C02LA52 rescinnamine and diuretics, combinations with other drugs WHO ATC
0-L C02LA71 reserpine and diuretics, combinations with psycholeptics WHO ATC
0-L C02LB Methyldopa and diuretics in combination WHO ATC
0-L C02LB01 methyldopa (levorotatory) and diuretics WHO ATC
0-L C02LC Imidazoline receptor agonists in combination with diuretics WHO ATC
0-L C02LC01 clonidine and diuretics WHO ATC
0-L C02LC05 moxonidine and diuretics WHO ATC
0-L C02LC51 clonidine and diuretics, combinations with other drugs WHO ATC
0-L C02LE Alpha-adrenoreceptor antagonists and diuretics WHO ATC
0-L C02LE01 prazosin and diuretics WHO ATC
0-L C02LF Guanidine derivatives and diuretics WHO ATC
0-L C02LF01 guanethidine and diuretics WHO ATC
0-L C02LG Hydrazinophthalazine derivatives and diuretics WHO ATC
0-L C02LG01 dihydralazine and diuretics WHO ATC
0-L C02LG02 hydralazine and diuretics WHO ATC
0-L C02LG03 picodralazine and diuretics WHO ATC
0-L C02LG51 dihydralazine and diuretics, combinations with other drugs WHO ATC
0-L C02LG73 picodralazine and diuretics, combinations with psycholeptics WHO ATC
0-L C02LK Alkaloids, excl. rauwolfia, in combination with diuretics WHO ATC
0-L C02LK01 veratrum and diuretics WHO ATC
0-L C02LL MAO inhibitors and diuretics WHO ATC
0-L C02LL01 pargyline and diuretics WHO ATC
0-L C02LN Serotonin antagonists and diuretics WHO ATC
0-L C02LX Other antihypertensives and diuretics WHO ATC
0-L C02LX01 pinacidil and diuretics WHO ATC
0-L C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 WHO ATC
0-L C03 DIURETICS WHO ATC
0-L C03A LOW-CEILING DIURETICS, THIAZIDES WHO ATC
0-L C03AA Thiazides, plain WHO ATC
0-L C03AA01 bendroflumethiazide WHO ATC
0-L C03AA02 hydroflumethiazide WHO ATC
0-L C03AA03 hydrochlorothiazide WHO ATC
0-L C03AA04 chlorothiazide WHO ATC
0-L C03AA05 polythiazide WHO ATC
0-L C03AA06 trichlormethiazide WHO ATC
0-L C03AA07 cyclopenthiazide WHO ATC
0-L C03AA08 methyclothiazide WHO ATC
0-L C03AA09 cyclothiazide WHO ATC
0-L C03AA13 mebutizide WHO ATC
0-L C03AB Thiazides and potassium in combination WHO ATC
0-L C03AB01 bendroflumethiazide and potassium WHO ATC
0-L C03AB02 hydroflumethiazide and potassium WHO ATC
0-L C03AB03 hydrochlorothiazide and potassium WHO ATC
0-L C03AB04 chlorothiazide and potassium WHO ATC
0-L C03AB05 polythiazide and potassium WHO ATC
0-L C03AB06 trichlormethiazide and potassium WHO ATC
0-L C03AB07 cyclopenthiazide and potassium WHO ATC
0-L C03AB08 methyclothiazide and potassium WHO ATC
0-L C03AB09 cyclothiazide and potassium WHO ATC
0-L C03AH Thiazides, combinations with psycholeptics and/or analgesics WHO ATC
0-L C03AH01 chlorothiazide, combinations WHO ATC
0-L C03AH02 hydroflumethiazide, combinations WHO ATC
0-L C03AX Thiazides, combinations with other drugs WHO ATC
0-L C03AX01 hydrochlorothiazide, combinations WHO ATC
0-L C03B LOW-CEILING DIURETICS, EXCL. THIAZIDES WHO ATC
0-L C03BA Sulfonamides, plain WHO ATC
0-L C03BA02 quinethazone WHO ATC
0-L C03BA03 clopamide WHO ATC
0-L C03BA04 chlortalidone WHO ATC
0-L C03BA05 mefruside WHO ATC
0-L C03BA07 clofenamide WHO ATC
0-L C03BA08 metolazone WHO ATC
0-L C03BA09 meticrane WHO ATC
0-L C03BA10 xipamide WHO ATC
0-L C03BA11 indapamide WHO ATC
0-L C03BA12 clorexolone WHO ATC
0-L C03BA13 fenquizone WHO ATC
0-L C03BA82 clorexolone, comb. with psycholeptics WHO ATC
0-L C03BB Sulfonamides and potassium in combination WHO ATC
0-L C03BB02 quinethazone and potassium WHO ATC
0-L C03BB03 clopamide and potassium WHO ATC
0-L C03BB04 chlortalidone and potassium WHO ATC
0-L C03BB05 mefruside and potassium WHO ATC
0-L C03BB07 clofenamide and potassium WHO ATC
0-L C03BC Mercurial diuretics WHO ATC
0-L C03BC01 mersalyl WHO ATC
0-L C03BD Xanthine derivatives WHO ATC
0-L C03BD01 theobromine WHO ATC
0-L C03BK Sulfonamides, combinations with other drugs WHO ATC
0-L C03BX Other low-ceiling diuretics WHO ATC
0-L C03BX03 cicletanine WHO ATC
0-L C03C HIGH-CEILING DIURETICS WHO ATC
0-L C03CA Sulfonamides, plain WHO ATC
0-L C03CA01 furosemide WHO ATC
0-L C03CA02 bumetanide WHO ATC
0-L C03CA03 piretanide WHO ATC
0-L C03CA04 torasemide WHO ATC
0-L C03CB Sulfonamides and potassium in combination WHO ATC
0-L C03CB01 furosemide and potassium WHO ATC
0-L C03CB02 bumetanide and potassium WHO ATC
0-L C03CC Aryloxyacetic acid derivatives WHO ATC
0-L C03CC01 etacrynic acid WHO ATC
0-L C03CC02 tienilic acid WHO ATC
0-L C03CD Pyrazolone derivatives WHO ATC
0-L C03CD01 muzolimine WHO ATC
0-L C03CX Other high-ceiling diuretics WHO ATC
0-L C03CX01 etozolin WHO ATC
0-L C03D POTASSIUM-SPARING AGENTS WHO ATC
0-L C03DA Aldosterone antagonists WHO ATC
0-L C03DA01 spironolactone WHO ATC
0-L C03DA02 potassium canrenoate WHO ATC
0-L C03DA03 canrenone WHO ATC
0-L C03DA04 eplerenone WHO ATC
0-L C03DB Other potassium-sparing agents WHO ATC
0-L C03DB01 amiloride WHO ATC
0-L C03DB02 triamterene WHO ATC
0-L C03E DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION WHO ATC
0-L C03EA Low-ceiling diuretics and potassium-sparing agents WHO ATC
0-L C03EA01 hydrochlorothiazide and potassium-sparing agents WHO ATC
0-L C03EA02 trichlormethiazide and potassium-sparing agents WHO ATC
0-L C03EA03 epitizide and potassium-sparing agents WHO ATC
0-L C03EA04 altizide and potassium-sparing agents WHO ATC
0-L C03EA05 mebutizide and potassium-sparing agents WHO ATC
0-L C03EA06 chlortalidone and potassium-sparing agents WHO ATC
0-L C03EA07 cyclopenthiazide and potassium-sparing agents WHO ATC
0-L C03EA12 metolazone and potassium-sparing agents WHO ATC
0-L C03EA13 bendroflumethiazide and potassium-sparing agents WHO ATC
0-L C03EA14 butizide and potassium-sparing agents WHO ATC
0-L C03EB High-ceiling diuretics and potassium-sparing agents WHO ATC
0-L C03EB01 furosemide and potassium-sparing agents WHO ATC
0-L C03EB02 bumetanide and potassium-sparing agents WHO ATC
0-L C03X OTHER DIURETICS WHO ATC
0-L C03XA Vasopressin antagonists WHO ATC
0-L C03XA01 tolvaptan WHO ATC
0-L C03XA02 conivaptan WHO ATC
0-L C04 PERIPHERAL VASODILATORS WHO ATC
0-L C04A PERIPHERAL VASODILATORS WHO ATC
0-L C04AA 2-amino-1-phenylethanol derivatives WHO ATC
0-L C04AA01 isoxsuprine WHO ATC
0-L C04AA02 buphenine WHO ATC
0-L C04AA31 bamethan WHO ATC
0-L C04AB Imidazoline derivatives WHO ATC
0-L C04AB01 phentolamine WHO ATC
0-L C04AB02 tolazoline WHO ATC
0-L C04AC Nicotinic acid and derivatives WHO ATC
0-L C04AC01 nicotinic acid WHO ATC
0-L C04AC02 nicotinyl alcohol (pyridylcarbinol) WHO ATC
0-L C04AC03 inositol nicotinate WHO ATC
0-L C04AC07 ciclonicate WHO ATC
0-L C04AD Purine derivatives WHO ATC
0-L C04AD01 pentifylline WHO ATC
0-L C04AD02 xantinol nicotinate WHO ATC
0-L C04AD03 pentoxifylline WHO ATC
0-L C04AD04 etofylline nicotinate WHO ATC
0-L C04AE Ergot alkaloids WHO ATC
0-L C04AE01 ergoloid mesylates WHO ATC
0-L C04AE02 nicergoline WHO ATC
0-L C04AE04 dihydroergocristine WHO ATC
0-L C04AE51 ergoloid mesylates, combinations WHO ATC
0-L C04AE54 dihydroergocristine, combinations WHO ATC
0-L C04AF Enzymes WHO ATC
0-L C04AF01 kallidinogenase WHO ATC
0-L C04AX Other peripheral vasodilators WHO ATC
0-L C04AX01 cyclandelate WHO ATC
0-L C04AX02 phenoxybenzamine WHO ATC
0-L C04AX07 vincamine WHO ATC
0-L C04AX10 moxisylyte WHO ATC
0-L C04AX11 bencyclane WHO ATC
0-L C04AX17 vinburnine WHO ATC
0-L C04AX19 suloctidil WHO ATC
0-L C04AX20 buflomedil WHO ATC
0-L C04AX21 naftidrofuryl WHO ATC
0-L C04AX23 butalamine WHO ATC
0-L C04AX24 visnadine WHO ATC
0-L C04AX26 cetiedil WHO ATC
0-L C04AX27 cinepazide WHO ATC
0-L C04AX28 ifenprodil WHO ATC
0-L C04AX30 azapetine WHO ATC
0-L C04AX32 fasudil WHO ATC
0-L C05 VASOPROTECTIVES WHO ATC
0-L C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANALFISSURES FOR TOPICAL USE WHO ATC
0-L C05AA Corticosteroids WHO ATC
0-L C05AA01 hydrocortisone WHO ATC
0-L C05AA04 prednisolone WHO ATC
0-L C05AA05 betamethasone WHO ATC
0-L C05AA06 fluorometholone WHO ATC
0-L C05AA08 fluocortolone WHO ATC
0-L C05AA09 dexamethasone WHO ATC
0-L C05AA10 fluocinolone acetonide WHO ATC
0-L C05AA11 fluocinonide WHO ATC
0-L C05AB Antibiotics WHO ATC
0-L C05AD Local anesthetics WHO ATC
0-L C05AD01 lidocaine WHO ATC
0-L C05AD02 tetracaine WHO ATC
0-L C05AD03 benzocaine WHO ATC
0-L C05AD04 cinchocaine WHO ATC
0-L C05AD05 procaine WHO ATC
0-L C05AD06 oxetacaine WHO ATC
0-L C05AD07 pramocaine WHO ATC
0-L C05AE Muscle relaxants WHO ATC
0-L C05AE01 glyceryl trinitrate WHO ATC
0-L C05AE02 isosorbide dinitrate WHO ATC
0-L C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use WHO ATC
0-L C05AX01 aluminium preparations WHO ATC
0-L C05AX02 bismuth preparations, combinations WHO ATC
0-L C05AX03 other preparations, combinations WHO ATC
0-L C05AX04 zinc preparations WHO ATC
0-L C05AX05 tribenoside WHO ATC
0-L C05B ANTIVARICOSE THERAPY WHO ATC
0-L C05BA Heparins or heparinoids for topical use WHO ATC
0-L C05BA01 organo-heparinoid WHO ATC
0-L C05BA02 sodium apolate WHO ATC
0-L C05BA03 heparin WHO ATC
0-L C05BA04 pentosan polysulfate sodium WHO ATC
0-L C05BA51 heparinoid, combinations WHO ATC
0-L C05BA53 heparin, combinations WHO ATC
0-L C05BB Sclerosing agents for local injection WHO ATC
0-L C05BB01 monoethanolamine oleate WHO ATC
0-L C05BB02 polidocanol WHO ATC
0-L C05BB03 invert sugar WHO ATC
0-L C05BB04 sodium tetradecyl sulfate WHO ATC
0-L C05BB05 phenol WHO ATC
0-L C05BB56 glucose, combinations WHO ATC
0-L C05BX Other sclerosing agents WHO ATC
0-L C05BX01 calcium dobesilate WHO ATC
0-L C05BX51 calcium dobesilate, combinations WHO ATC
0-L C05C CAPILLARY STABILIZING AGENTS WHO ATC
0-L C05CA Bioflavonoids WHO ATC
0-L C05CA01 rutoside WHO ATC
0-L C05CA02 monoxerutin WHO ATC
0-L C05CA03 diosmin WHO ATC
0-L C05CA04 troxerutin WHO ATC
0-L C05CA05 hidrosmin WHO ATC
0-L C05CA51 rutoside, combinations WHO ATC
0-L C05CA53 diosmin, combinations WHO ATC
0-L C05CA54 troxerutin, combinations WHO ATC
0-L C05CX Other capillary stabilizing agents WHO ATC
0-L C05CX01 tribenoside WHO ATC
0-L C07 BETA BLOCKING AGENTS WHO ATC
0-L C07A BETA BLOCKING AGENTS WHO ATC
0-L C07AA Beta blocking agents, non-selective WHO ATC
0-L C07AA01 alprenolol WHO ATC
0-L C07AA02 oxprenolol WHO ATC
0-L C07AA03 pindolol WHO ATC
0-L C07AA05 propranolol WHO ATC
0-L C07AA06 timolol WHO ATC
0-L C07AA07 sotalol WHO ATC
0-L C07AA12 nadolol WHO ATC
0-L C07AA14 mepindolol WHO ATC
0-L C07AA15 carteolol WHO ATC
0-L C07AA16 tertatolol WHO ATC
0-L C07AA17 bopindolol WHO ATC
0-L C07AA19 bupranolol WHO ATC
0-L C07AA23 penbutolol WHO ATC
0-L C07AA27 cloranolol WHO ATC
0-L C07AA57 sotalol, combinations WHO ATC
0-L C07AB Beta blocking agents, selective WHO ATC
0-L C07AB01 practolol WHO ATC
0-L C07AB02 metoprolol WHO ATC
0-L C07AB03 atenolol WHO ATC
0-L C07AB04 acebutolol WHO ATC
0-L C07AB05 betaxolol WHO ATC
0-L C07AB06 bevantolol WHO ATC
0-L C07AB07 bisoprolol WHO ATC
0-L C07AB08 celiprolol WHO ATC
0-L C07AB09 esmolol WHO ATC
0-L C07AB10 epanolol WHO ATC
0-L C07AB11 s-atenolol WHO ATC
0-L C07AB12 nebivolol WHO ATC
0-L C07AB13 talinolol WHO ATC
0-L C07AB52 metoprolol, combinations WHO ATC
0-L C07AB57 bisoprolol, combinations WHO ATC
0-L C07AG Alpha and beta blocking agents WHO ATC
0-L C07AG01 labetalol WHO ATC
0-L C07AG02 carvedilol WHO ATC
0-L C07B BETA BLOCKING AGENTS AND THIAZIDES WHO ATC
0-L C07BA Beta blocking agents, non-selective, and thiazides WHO ATC
0-L C07BA02 oxprenolol and thiazides WHO ATC
0-L C07BA05 propranolol and thiazides WHO ATC
0-L C07BA06 timolol and thiazides WHO ATC
0-L C07BA07 sotalol and thiazides WHO ATC
0-L C07BA12 nadolol and thiazides WHO ATC
0-L C07BA68 metipranolol and thiazides, combinations WHO ATC
0-L C07BB Beta blocking agents, selective, and thiazides WHO ATC
0-L C07BB02 metoprolol and thiazides WHO ATC
0-L C07BB03 atenolol and thiazides WHO ATC
0-L C07BB04 acebutolol and thiazides WHO ATC
0-L C07BB06 bevantolol and thiazides WHO ATC
0-L C07BB07 bisoprolol and thiazides WHO ATC
0-L C07BB52 metoprolol and thiazides, combinations WHO ATC
0-L C07BG Alpha and beta blocking agents and thiazides WHO ATC
0-L C07BG01 labetalol and thiazides WHO ATC
0-L C07C BETA BLOCKING AGENTS AND OTHER DIURETICS WHO ATC
0-L C07CA Beta blocking agents, non-selective, and other diuretics WHO ATC
0-L C07CA02 oxprenolol and other diuretics WHO ATC
0-L C07CA03 pindolol and other diuretics WHO ATC
0-L C07CA17 bopindolol and other diuretics WHO ATC
0-L C07CA23 penbutolol and other diuretics WHO ATC
0-L C07CB Beta blocking agents, selective, and other diuretics WHO ATC
0-L C07CB02 metoprolol and other diuretics WHO ATC
0-L C07CB03 atenolol and other diuretics WHO ATC
0-L C07CB53 atenolol and other diuretics, combinations WHO ATC
0-L C07CG Alpha and beta blocking agents and other diuretics WHO ATC
0-L C07CG01 labetalol and other diuretics WHO ATC
0-L C07D BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS WHO ATC
0-L C07DA Beta blocking agents, non-selective, thiazides and other diuretics WHO ATC
0-L C07DA06 timolol, thiazides and other diuretics WHO ATC
0-L C07DB Beta blocking agents, selective, thiazides and other diuretics WHO ATC
0-L C07DB01 atenolol, thiazides and other diuretics WHO ATC
0-L C07E BETA BLOCKING AGENTS AND VASODILATORS WHO ATC
0-L C07EA Beta blocking agents, non-selective, and vasodilators WHO ATC
0-L C07EB Beta blocking agents, selective, and vasodilators WHO ATC
0-L C07F BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES WHO ATC
0-L C07FA Beta blocking agents, non-selective, and other antihypertensives WHO ATC
0-L C07FA05 propranolol and other antihypertensives WHO ATC
0-L C07FB Beta blocking agents, selective, and other antihypertensives WHO ATC
0-L C07FB02 metoprolol and other antihypertensives WHO ATC
0-L C07FB03 atenolol and other antihypertensives WHO ATC
0-L C08 CALCIUM CHANNEL BLOCKERS WHO ATC
0-L C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS WHO ATC
0-L C08CA Dihydropyridine derivatives WHO ATC
0-L C08CA01 amlodipine WHO ATC
0-L C08CA02 felodipine WHO ATC
0-L C08CA03 isradipine WHO ATC
0-L C08CA04 nicardipine WHO ATC
0-L C08CA05 nifedipine WHO ATC
0-L C08CA06 nimodipine WHO ATC
0-L C08CA07 nisoldipine WHO ATC
0-L C08CA08 nitrendipine WHO ATC
0-L C08CA09 lacidipine WHO ATC
0-L C08CA10 nilvadipine WHO ATC
0-L C08CA11 manidipine WHO ATC
0-L C08CA12 barnidipine WHO ATC
0-L C08CA13 lercanidipine WHO ATC
0-L C08CA14 cilnidipine WHO ATC
0-L C08CA15 benidipine WHO ATC
0-L C08CA55 nifedipine, combinations WHO ATC
0-L C08CX Other selective calcium channel blockers with mainly vascular effects WHO ATC
0-L C08CX01 mibefradil WHO ATC
0-L C08D SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS WHO ATC
0-L C08DA Phenylalkylamine derivatives WHO ATC
0-L C08DA01 verapamil WHO ATC
0-L C08DA02 gallopamil WHO ATC
0-L C08DA51 verapamil, combinations WHO ATC
0-L C08DB Benzothiazepine derivatives WHO ATC
0-L C08DB01 diltiazem WHO ATC
0-L C08E NON-SELECTIVE CALCIUM CHANNEL BLOCKERS WHO ATC
0-L C08EA Phenylalkylamine derivatives WHO ATC
0-L C08EA01 fendiline WHO ATC
0-L C08EA02 bepridil WHO ATC
0-L C08EX Other non-selective calcium channel blockers WHO ATC
0-L C08EX01 lidoflazine WHO ATC
0-L C08EX02 perhexiline WHO ATC
0-L C08G CALCIUM CHANNEL BLOCKERS AND DIURETICS WHO ATC
0-L C08GA Calcium channel blockers and diuretics WHO ATC
0-L C08GA01 nifedipine and diuretics WHO ATC
0-L C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM WHO ATC
0-L C09A ACE INHIBITORS, PLAIN WHO ATC
0-L C09AA ACE inhibitors, plain WHO ATC
0-L C09AA01 captopril WHO ATC
0-L C09AA02 enalapril WHO ATC
0-L C09AA03 lisinopril WHO ATC
0-L C09AA04 perindopril WHO ATC
0-L C09AA05 ramipril WHO ATC
0-L C09AA06 quinapril WHO ATC
0-L C09AA07 benazepril WHO ATC
0-L C09AA08 cilazapril WHO ATC
0-L C09AA09 fosinopril WHO ATC
0-L C09AA10 trandolapril WHO ATC
0-L C09AA11 spirapril WHO ATC
0-L C09AA12 delapril WHO ATC
0-L C09AA13 moexipril WHO ATC
0-L C09AA14 temocapril WHO ATC
0-L C09AA15 zofenopril WHO ATC
0-L C09AA16 imidapril WHO ATC
0-L C09B ACE INHIBITORS, COMBINATIONS WHO ATC
0-L C09BA ACE inhibitors and diuretics WHO ATC
0-L C09BA01 captopril and diuretics WHO ATC
0-L C09BA02 enalapril and diuretics WHO ATC
0-L C09BA03 lisinopril and diuretics WHO ATC
0-L C09BA04 perindopril and diuretics WHO ATC
0-L C09BA05 ramipril and diuretics WHO ATC
0-L C09BA06 quinapril and diuretics WHO ATC
0-L C09BA07 benazepril and diuretics WHO ATC
0-L C09BA08 cilazapril and diuretics WHO ATC
0-L C09BA09 fosinopril and diuretics WHO ATC
0-L C09BA12 delapril and diuretics WHO ATC
0-L C09BA13 moexipril and diuretics WHO ATC
0-L C09BA15 zofenopril and diuretics WHO ATC
0-L C09BB ACE inhibitors and calcium channel blockers WHO ATC
0-L C09BB02 enalapril and lercanidipine WHO ATC
0-L C09BB03 lisinopril and amlodipine WHO ATC
0-L C09BB04 perindopril and amlodipine WHO ATC
0-L C09BB05 ramipril and felodipine WHO ATC
0-L C09BB10 trandolapril and verapamil WHO ATC
0-L C09BB12 delapril and manidipine WHO ATC
0-L C09C ANGIOTENSIN II ANTAGONISTS, PLAIN WHO ATC
0-L C09CA Angiotensin II antagonists, plain WHO ATC
0-L C09CA01 losartan WHO ATC
0-L C09CA02 eprosartan WHO ATC
0-L C09CA03 valsartan WHO ATC
0-L C09CA04 irbesartan WHO ATC
0-L C09CA05 tasosartan WHO ATC
0-L C09CA06 candesartan WHO ATC
0-L C09CA07 telmisartan WHO ATC
0-L C09CA08 olmesartan medoxomil WHO ATC
0-L C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS WHO ATC
0-L C09DA Angiotensin II antagonists and diuretics WHO ATC
0-L C09DA01 losartan and diuretics WHO ATC
0-L C09DA02 eprosartan and diuretics WHO ATC
0-L C09DA03 valsartan and diuretics WHO ATC
0-L C09DA04 irbesartan and diuretics WHO ATC
0-L C09DA06 candesartan and diuretics WHO ATC
0-L C09DA07 telmisartan and diuretics WHO ATC
0-L C09DA08 olmesartan medoxomil and diuretics WHO ATC
0-L C09DB Angiotensin II antagonists and calcium channel blockers WHO ATC
0-L C09DB01 valsartan and amlodipine WHO ATC
0-L C09DB02 olmesartan medoxomil and amlodipine WHO ATC
0-L C09DB04 telmisartan and amlodipine WHO ATC
0-L C09DX Angiotensin II antagonists, other combinations WHO ATC
0-L C09DX01 valsartan, amlodipine and hydrochlorothiazide WHO ATC
0-L C09DX02 valsartan and aliskiren WHO ATC
0-L C09X OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM WHO ATC
0-L C09XA Renin-inhibitors WHO ATC
0-L C09XA01 remikiren WHO ATC
0-L C09XA02 aliskiren WHO ATC
0-L C09XA52 aliskiren and hydrochlorothiazide WHO ATC
0-L C10 LIPID MODIFYING AGENTS WHO ATC
0-L C10A LIPID MODIFYING AGENTS, PLAIN WHO ATC
0-L C10AA HMG CoA reductase inhibitors WHO ATC
0-L C10AA01 simvastatin WHO ATC
0-L C10AA02 lovastatin WHO ATC
0-L C10AA03 pravastatin WHO ATC
0-L C10AA04 fluvastatin WHO ATC
0-L C10AA05 atorvastatin WHO ATC
0-L C10AA06 cerivastatin WHO ATC
0-L C10AA07 rosuvastatin WHO ATC
0-L C10AA08 pitavastatin WHO ATC
0-L C10AB Fibrates WHO ATC
0-L C10AB01 clofibrate WHO ATC
0-L C10AB02 bezafibrate WHO ATC
0-L C10AB03 aluminium clofibrate WHO ATC
0-L C10AB04 gemfibrozil WHO ATC
0-L C10AB05 fenofibrate WHO ATC
0-L C10AB06 simfibrate WHO ATC
0-L C10AB07 ronifibrate WHO ATC
0-L C10AB08 ciprofibrate WHO ATC
0-L C10AB09 etofibrate WHO ATC
0-L C10AB10 clofibride WHO ATC
0-L C10AC Bile acid sequestrants WHO ATC
0-L C10AC01 colestyramine WHO ATC
0-L C10AC02 colestipol WHO ATC
0-L C10AC03 colextran WHO ATC
0-L C10AC04 colesevelam WHO ATC
0-L C10AD Nicotinic acid and derivatives WHO ATC
0-L C10AD01 niceritrol WHO ATC
0-L C10AD02 nicotinic acid WHO ATC
0-L C10AD03 nicofuranose WHO ATC
0-L C10AD04 aluminium nicotinate WHO ATC
0-L C10AD05 nicotinyl alcohol (pyridylcarbinol) WHO ATC
0-L C10AD06 acipimox WHO ATC
0-L C10AD52 nicotinic acid, combinations WHO ATC
0-L C10AX Other lipid modifying agents WHO ATC
0-L C10AX01 dextrothyroxine WHO ATC
0-L C10AX02 probucol WHO ATC
0-L C10AX03 tiadenol WHO ATC
0-L C10AX05 meglutol WHO ATC
0-L C10AX06 omega-3-triglycerides incl. other esters and acids WHO ATC
0-L C10AX07 magnesium pyridoxal 5-phosphate glutamate WHO ATC
0-L C10AX08 policosanol WHO ATC
0-L C10AX09 ezetimibe WHO ATC
0-L C10AX10 alipogene tiparvovec WHO ATC
0-L C10B LIPID MODIFYING AGENTS, COMBINATIONS WHO ATC
0-L C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents WHO ATC
0-L C10BA01 lovastatin and nicotinic acid WHO ATC
0-L C10BA02 simvastatin and ezetimibe WHO ATC
0-L C10BA03 pravastatin and fenofibrate WHO ATC
0-L C10BX HMG CoA reductase inhibitors, other combinations WHO ATC
0-L C10BX01 simvastatin and acetylsalicylic acid WHO ATC
0-L C10BX02 pravastatin and acetylsalicylic acid WHO ATC
0-L C10BX03 atorvastatin and amlodipine WHO ATC
0-L D DERMATOLOGICALS WHO ATC
0-L D01 ANTIFUNGALS FOR DERMATOLOGICAL USE WHO ATC
0-L D01A ANTIFUNGALS FOR TOPICAL USE WHO ATC
0-L D01AA Antibiotics WHO ATC
0-L D01AA01 nystatin WHO ATC
0-L D01AA02 natamycin WHO ATC
0-L D01AA03 hachimycin WHO ATC
0-L D01AA04 pecilocin WHO ATC
0-L D01AA06 mepartricin WHO ATC
0-L D01AA07 pyrrolnitrin WHO ATC
0-L D01AA08 griseofulvin WHO ATC
0-L D01AA20 combinations WHO ATC
0-L D01AC Imidazole and triazole derivatives WHO ATC
0-L D01AC01 clotrimazole WHO ATC
0-L D01AC02 miconazole WHO ATC
0-L D01AC03 econazole WHO ATC
0-L D01AC04 chlormidazole WHO ATC
0-L D01AC05 isoconazole WHO ATC
0-L D01AC06 tiabendazole WHO ATC
0-L D01AC07 tioconazole WHO ATC
0-L D01AC08 ketoconazole WHO ATC
0-L D01AC09 sulconazole WHO ATC
0-L D01AC10 bifonazole WHO ATC
0-L D01AC11 oxiconazole WHO ATC
0-L D01AC12 fenticonazole WHO ATC
0-L D01AC13 omoconazole WHO ATC
0-L D01AC14 sertaconazole WHO ATC
0-L D01AC15 fluconazole WHO ATC
0-L D01AC16 flutrimazole WHO ATC
0-L D01AC20 combinations WHO ATC
0-L D01AC52 miconazole, combinations WHO ATC
0-L D01AC60 bifonazole, combinations WHO ATC
0-L D01AE Other antifungals for topical use WHO ATC
0-L D01AE01 bromochlorosalicylanilide WHO ATC
0-L D01AE02 methylrosaniline WHO ATC
0-L D01AE03 tribromometacresol WHO ATC
0-L D01AE04 undecylenic acid WHO ATC
0-L D01AE05 polynoxylin WHO ATC
0-L D01AE06 2-(4-chlorphenoxy)-ethanol WHO ATC
0-L D01AE07 chlorphenesin WHO ATC
0-L D01AE08 ticlatone WHO ATC
0-L D01AE09 sulbentine WHO ATC
0-L D01AE10 ethyl hydroxybenzoate WHO ATC
0-L D01AE11 haloprogin WHO ATC
0-L D01AE12 salicylic acid WHO ATC
0-L D01AE13 selenium sulfide WHO ATC
0-L D01AE14 ciclopirox WHO ATC
0-L D01AE15 terbinafine WHO ATC
0-L D01AE16 amorolfine WHO ATC
0-L D01AE17 dimazole WHO ATC
0-L D01AE18 tolnaftate WHO ATC
0-L D01AE19 tolciclate WHO ATC
0-L D01AE20 combinations WHO ATC
0-L D01AE21 flucytosine WHO ATC
0-L D01AE22 naftifine WHO ATC
0-L D01AE23 butenafine WHO ATC
0-L D01AE54 undecylenic acid, combinations WHO ATC
0-L D01B ANTIFUNGALS FOR SYSTEMIC USE WHO ATC
0-L D01BA Antifungals for systemic use WHO ATC
0-L D01BA01 griseofulvin WHO ATC
0-L D01BA02 terbinafine WHO ATC
0-L D02 EMOLLIENTS AND PROTECTIVES WHO ATC
0-L D02A EMOLLIENTS AND PROTECTIVES WHO ATC
0-L D02AA Silicone products WHO ATC
0-L D02AB Zinc products WHO ATC
0-L D02AC Soft paraffin and fat products WHO ATC
0-L D02AD Liquid plasters WHO ATC
0-L D02AE Carbamide products WHO ATC
0-L D02AE01 carbamide WHO ATC
0-L D02AE51 carbamide, combinations WHO ATC
0-L D02AF Salicylic acid preparations WHO ATC
0-L D02AX Other emollients and protectives WHO ATC
0-L D02B PROTECTIVES AGAINST UV-RADIATION WHO ATC
0-L D02BA Protectives against UV-radiation for topical use WHO ATC
0-L D02BA01 aminobenzoic acid WHO ATC
0-L D02BA02 octinoxate WHO ATC
0-L D02BB Protectives against UV-radiation for systemic use WHO ATC
0-L D02BB01 betacarotene WHO ATC
0-L D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS WHO ATC
0-L D03A CICATRIZANTS WHO ATC
0-L D03AA Cod-liver oil ointments WHO ATC
0-L D03AX Other cicatrizants WHO ATC
0-L D03AX01 cadexomer iodine WHO ATC
0-L D03AX02 dextranomer WHO ATC
0-L D03AX03 dexpanthenol WHO ATC
0-L D03AX04 calcium pantothenate WHO ATC
0-L D03AX05 hyaluronic acid WHO ATC
0-L D03AX06 becaplermin WHO ATC
0-L D03AX09 crilanomer WHO ATC
0-L D03AX10 enoxolone WHO ATC
0-L D03B ENZYMES WHO ATC
0-L D03BA Proteolytic enzymes WHO ATC
0-L D03BA01 trypsin WHO ATC
0-L D03BA02 collagenase WHO ATC
0-L D03BA52 collagenase, combinations WHO ATC
0-L D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. WHO ATC
0-L D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. WHO ATC
0-L D04AA Antihistamines for topical use WHO ATC
0-L D04AA01 thonzylamine WHO ATC
0-L D04AA02 mepyramine WHO ATC
0-L D04AA03 thenalidine WHO ATC
0-L D04AA04 tripelennamine WHO ATC
0-L D04AA09 chloropyramine WHO ATC
0-L D04AA10 promethazine WHO ATC
0-L D04AA12 tolpropamine WHO ATC
0-L D04AA13 dimetindene WHO ATC
0-L D04AA14 clemastine WHO ATC
0-L D04AA15 bamipine WHO ATC
0-L D04AA22 isothipendyl WHO ATC
0-L D04AA32 diphenhydramine WHO ATC
0-L D04AA33 diphenhydramine methylbromide WHO ATC
0-L D04AA34 chlorphenoxamine WHO ATC
0-L D04AB Anesthetics for topical use WHO ATC
0-L D04AB01 lidocaine WHO ATC
0-L D04AB02 cinchocaine WHO ATC
0-L D04AB03 oxybuprocaine WHO ATC
0-L D04AB04 benzocaine WHO ATC
0-L D04AB05 quinisocaine WHO ATC
0-L D04AB06 tetracaine WHO ATC
0-L D04AB07 pramocaine WHO ATC
0-L D04AX Other antipruritics WHO ATC
0-L D05 ANTIPSORIATICS WHO ATC
0-L D05A ANTIPSORIATICS FOR TOPICAL USE WHO ATC
0-L D05AA Tars WHO ATC
0-L D05AC Antracen derivatives WHO ATC
0-L D05AC01 dithranol WHO ATC
0-L D05AC51 dithranol, combinations WHO ATC
0-L D05AD Psoralens for topical use WHO ATC
0-L D05AD01 trioxysalen WHO ATC
0-L D05AD02 methoxsalen WHO ATC
0-L D05AX Other antipsoriatics for topical use WHO ATC
0-L D05AX01 fumaric acid WHO ATC
0-L D05AX02 calcipotriol WHO ATC
0-L D05AX03 calcitriol WHO ATC
0-L D05AX04 tacalcitol WHO ATC
0-L D05AX05 tazarotene WHO ATC
0-L D05AX52 calcipotriol, combinations WHO ATC
0-L D05B ANTIPSORIATICS FOR SYSTEMIC USE WHO ATC
0-L D05BA Psoralens for systemic use WHO ATC
0-L D05BA01 trioxysalen WHO ATC
0-L D05BA02 methoxsalen WHO ATC
0-L D05BA03 bergapten WHO ATC
0-L D05BB Retinoids for treatment of psoriasis WHO ATC
0-L D05BB01 etretinate WHO ATC
0-L D05BB02 acitretin WHO ATC
0-L D05BX Other antipsoriatics for systemic use WHO ATC
0-L D05BX51 fumaric acid derivatives, combinations WHO ATC
0-L D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE WHO ATC
0-L D06A ANTIBIOTICS FOR TOPICAL USE WHO ATC
0-L D06AA Tetracycline and derivatives WHO ATC
0-L D06AA01 demeclocycline WHO ATC
0-L D06AA02 chlortetracycline WHO ATC
0-L D06AA03 oxytetracycline WHO ATC
0-L D06AA04 tetracycline WHO ATC
0-L D06AX Other antibiotics for topical use WHO ATC
0-L D06AX01 fusidic acid WHO ATC
0-L D06AX02 chloramphenicol WHO ATC
0-L D06AX04 neomycin WHO ATC
0-L D06AX05 bacitracin WHO ATC
0-L D06AX07 gentamicin WHO ATC
0-L D06AX08 tyrothricin WHO ATC
0-L D06AX09 mupirocin WHO ATC
0-L D06AX10 virginiamycin WHO ATC
0-L D06AX11 rifaximin WHO ATC
0-L D06AX12 amikacin WHO ATC
0-L D06AX13 retapamulin WHO ATC
0-L D06B CHEMOTHERAPEUTICS FOR TOPICAL USE WHO ATC
0-L D06BA Sulfonamides WHO ATC
0-L D06BA01 silver sulfadiazine WHO ATC
0-L D06BA02 sulfathiazole WHO ATC
0-L D06BA03 mafenide WHO ATC
0-L D06BA04 sulfamethizole WHO ATC
0-L D06BA05 sulfanilamide WHO ATC
0-L D06BA06 sulfamerazine WHO ATC
0-L D06BA51 silver sulfadiazine, combinations WHO ATC
0-L D06BB Antivirals WHO ATC
0-L D06BB01 idoxuridine WHO ATC
0-L D06BB02 tromantadine WHO ATC
0-L D06BB03 aciclovir WHO ATC
0-L D06BB04 podophyllotoxin WHO ATC
0-L D06BB05 inosine WHO ATC
0-L D06BB06 penciclovir WHO ATC
0-L D06BB07 lysozyme WHO ATC
0-L D06BB08 ibacitabine WHO ATC
0-L D06BB09 edoxudine WHO ATC
0-L D06BB10 imiquimod WHO ATC
0-L D06BB11 docosanol WHO ATC
0-L D06BB53 aciclovir, combinations WHO ATC
0-L D06BX Other chemotherapeutics WHO ATC
0-L D06BX01 metronidazole WHO ATC
0-L D06C ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS WHO ATC
0-L D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS WHO ATC
0-L D07A CORTICOSTEROIDS, PLAIN WHO ATC
0-L D07AA Corticosteroids, weak (group I) WHO ATC
0-L D07AA01 methylprednisolone WHO ATC
0-L D07AA02 hydrocortisone WHO ATC
0-L D07AA03 prednisolone WHO ATC
0-L D07AB Corticosteroids, moderately potent (group II) WHO ATC
0-L D07AB01 clobetasone WHO ATC
0-L D07AB02 hydrocortisone butyrate WHO ATC
0-L D07AB03 flumetasone WHO ATC
0-L D07AB04 fluocortin WHO ATC
0-L D07AB05 fluperolone WHO ATC
0-L D07AB06 fluorometholone WHO ATC
0-L D07AB07 fluprednidene WHO ATC
0-L D07AB08 desonide WHO ATC
0-L D07AB09 triamcinolone WHO ATC
0-L D07AB10 alclometasone WHO ATC
0-L D07AB11 hydrocortisone buteprate WHO ATC
0-L D07AB19 dexamethasone WHO ATC
0-L D07AB21 clocortolone WHO ATC
0-L D07AB30 combinations of corticosteroids WHO ATC
0-L D07AC Corticosteroids, potent (group III) WHO ATC
0-L D07AC01 betamethasone WHO ATC
0-L D07AC02 fluclorolone WHO ATC
0-L D07AC03 desoximetasone WHO ATC
0-L D07AC04 fluocinolone acetonide WHO ATC
0-L D07AC05 fluocortolone WHO ATC
0-L D07AC06 diflucortolone WHO ATC
0-L D07AC07 fludroxycortide WHO ATC
0-L D07AC08 fluocinonide WHO ATC
0-L D07AC09 budesonide WHO ATC
0-L D07AC10 diflorasone WHO ATC
0-L D07AC11 amcinonide WHO ATC
0-L D07AC12 halometasone WHO ATC
0-L D07AC13 mometasone WHO ATC
0-L D07AC14 methylprednisolone aceponate WHO ATC
0-L D07AC15 beclometasone WHO ATC
0-L D07AC16 hydrocortisone aceponate WHO ATC
0-L D07AC17 fluticasone WHO ATC
0-L D07AC18 prednicarbate WHO ATC
0-L D07AC19 difluprednate WHO ATC
0-L D07AC21 ulobetasol WHO ATC
0-L D07AD Corticosteroids, very potent (group IV) WHO ATC
0-L D07AD01 clobetasol WHO ATC
0-L D07AD02 halcinonide WHO ATC
0-L D07B CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS WHO ATC
0-L D07BA Corticosteroids, weak, combinations with antiseptics WHO ATC
0-L D07BA01 prednisolone and antiseptics WHO ATC
0-L D07BA04 hydrocortisone and antiseptics WHO ATC
0-L D07BB Corticosteroids, moderately potent, combinations with antiseptics WHO ATC
0-L D07BB01 flumetasone and antiseptics WHO ATC
0-L D07BB02 desonide and antiseptics WHO ATC
0-L D07BB03 triamcinolone and antiseptics WHO ATC
0-L D07BB04 hydrocortisone butyrate and antiseptics WHO ATC
0-L D07BC Corticosteroids, potent, combinations with antiseptics WHO ATC
0-L D07BC01 betamethasone and antiseptics WHO ATC
0-L D07BC02 fluocinolone acetonide and antiseptics WHO ATC
0-L D07BC03 fluocortolone and antiseptics WHO ATC
0-L D07BC04 diflucortolone and antiseptics WHO ATC
0-L D07BD Corticosteroids, very potent, combinations with antiseptics WHO ATC
0-L D07C CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS WHO ATC
0-L D07CA Corticosteroids, weak, combinations with antibiotics WHO ATC
0-L D07CA01 hydrocortisone and antibiotics WHO ATC
0-L D07CA02 methylprednisolone and antibiotics WHO ATC
0-L D07CA03 prednisolone and antibiotics WHO ATC
0-L D07CB Corticosteroids, moderately potent, combinations with antibiotics WHO ATC
0-L D07CB01 triamcinolone and antibiotics WHO ATC
0-L D07CB02 fluprednidene and antibiotics WHO ATC
0-L D07CB03 fluorometholone and antibiotics WHO ATC
0-L D07CB04 dexamethasone and antibiotics WHO ATC
0-L D07CB05 flumetasone and antibiotics WHO ATC
0-L D07CC Corticosteroids, potent, combinations with antibiotics WHO ATC
0-L D07CC01 betamethasone and antibiotics WHO ATC
0-L D07CC02 fluocinolone acetonide and antibiotics WHO ATC
0-L D07CC03 fludroxycortide and antibiotics WHO ATC
0-L D07CC04 beclometasone and antibiotics WHO ATC
0-L D07CC05 fluocinonide and antibiotics WHO ATC
0-L D07CC06 fluocortolone and antibiotics WHO ATC
0-L D07CD Corticosteroids, very potent, combinations with antibiotics WHO ATC
0-L D07CD01 clobetasol and antibiotics WHO ATC
0-L D07X CORTICOSTEROIDS, OTHER COMBINATIONS WHO ATC
0-L D07XA Corticosteroids, weak, other combinations WHO ATC
0-L D07XA01 hydrocortisone WHO ATC
0-L D07XA02 prednisolone WHO ATC
0-L D07XB Corticosteroids, moderately potent, other combinations WHO ATC
0-L D07XB01 flumetasone WHO ATC
0-L D07XB02 triamcinolone WHO ATC
0-L D07XB03 fluprednidene WHO ATC
0-L D07XB04 fluorometholone WHO ATC
0-L D07XB05 dexamethasone WHO ATC
0-L D07XB30 combinations of corticosteroids WHO ATC
0-L D07XC Corticosteroids, potent, other combinations WHO ATC
0-L D07XC01 betamethasone WHO ATC
0-L D07XC02 desoximetasone WHO ATC
0-L D07XC03 mometasone WHO ATC
0-L D07XC04 diflucortolone WHO ATC
0-L D07XD Corticosteroids, very potent, other combinations WHO ATC
0-L D08 ANTISEPTICS AND DISINFECTANTS WHO ATC
0-L D08A ANTISEPTICS AND DISINFECTANTS WHO ATC
0-L D08AA Acridine derivatives WHO ATC
0-L D08AA01 ethacridine lactate WHO ATC
0-L D08AA02 aminoacridine WHO ATC
0-L D08AA03 euflavine WHO ATC
0-L D08AB Aluminium agents WHO ATC
0-L D08AC Biguanides and amidines WHO ATC
0-L D08AC01 dibrompropamidine WHO ATC
0-L D08AC02 chlorhexidine WHO ATC
0-L D08AC03 propamidine WHO ATC
0-L D08AC04 hexamidine WHO ATC
0-L D08AC05 polihexanide WHO ATC
0-L D08AC52 chlorhexidine, combinations WHO ATC
0-L D08AD Boric acid products WHO ATC
0-L D08AE Phenol and derivatives WHO ATC
0-L D08AE01 hexachlorophene WHO ATC
0-L D08AE02 policresulen WHO ATC
0-L D08AE03 phenol WHO ATC
0-L D08AE04 triclosan WHO ATC
0-L D08AE05 chloroxylenol WHO ATC
0-L D08AE06 biphenylol WHO ATC
0-L D08AF Nitrofuran derivatives WHO ATC
0-L D08AF01 nitrofural WHO ATC
0-L D08AG Iodine products WHO ATC
0-L D08AG01 iodine/octylphenoxypolyglycolether WHO ATC
0-L D08AG02 povidone-iodine WHO ATC
0-L D08AG03 iodine WHO ATC
0-L D08AG04 diiodohydroxypropane WHO ATC
0-L D08AH Quinoline derivatives WHO ATC
0-L D08AH01 dequalinium WHO ATC
0-L D08AH02 chlorquinaldol WHO ATC
0-L D08AH03 oxyquinoline WHO ATC
0-L D08AH30 clioquinol WHO ATC
0-L D08AJ Quaternary ammonium compounds WHO ATC
0-L D08AJ01 benzalkonium WHO ATC
0-L D08AJ02 cetrimonium WHO ATC
0-L D08AJ03 cetylpyridinium WHO ATC
0-L D08AJ04 cetrimide WHO ATC
0-L D08AJ05 benzoxonium chloride WHO ATC
0-L D08AJ06 didecyldimethylammonium chloride WHO ATC
0-L D08AJ08 benzethonium chloride WHO ATC
0-L D08AJ57 octenidine, combinations WHO ATC
0-L D08AJ58 benzethonium chloride, combinations WHO ATC
0-L D08AJ59 dodeclonium bromide, combinations WHO ATC
0-L D08AK Mercurial products WHO ATC
0-L D08AK01 mercuric amidochloride WHO ATC
0-L D08AK02 phenylmercuric borate WHO ATC
0-L D08AK03 mercuric chloride WHO ATC
0-L D08AK04 mercurochrome WHO ATC
0-L D08AK05 mercury, metallic WHO ATC
0-L D08AK06 thiomersal WHO ATC
0-L D08AK30 mercuric iodide WHO ATC
0-L D08AL Silver compounds WHO ATC
0-L D08AL01 silver nitrate WHO ATC
0-L D08AL30 silver WHO ATC
0-L D08AX Other antiseptics and disinfectants WHO ATC
0-L D08AX01 hydrogen peroxide WHO ATC
0-L D08AX02 eosin WHO ATC
0-L D08AX03 propanol WHO ATC
0-L D08AX04 tosylchloramide sodium WHO ATC
0-L D08AX05 isopropanol WHO ATC
0-L D08AX06 potassium permanganate WHO ATC
0-L D08AX07 sodium hypochlorite WHO ATC
0-L D08AX08 ethanol WHO ATC
0-L D08AX53 propanol, combinations WHO ATC
0-L D09 MEDICATED DRESSINGS WHO ATC
0-L D09A MEDICATED DRESSINGS WHO ATC
0-L D09AA Medicated dressings with antiinfectives WHO ATC
0-L D09AA01 framycetin WHO ATC
0-L D09AA02 fusidic acid WHO ATC
0-L D09AA03 nitrofural WHO ATC
0-L D09AA04 phenylmercuric nitrate WHO ATC
0-L D09AA05 benzododecinium WHO ATC
0-L D09AA06 triclosan WHO ATC
0-L D09AA07 cetylpyridinium WHO ATC
0-L D09AA08 aluminium chlorohydrate WHO ATC
0-L D09AA09 povidone-iodine WHO ATC
0-L D09AA10 clioquinol WHO ATC
0-L D09AA11 benzalkonium WHO ATC
0-L D09AA12 chlorhexidine WHO ATC
0-L D09AA13 iodoform WHO ATC
0-L D09AB Zinc bandages WHO ATC
0-L D09AB01 zinc bandage without supplements WHO ATC
0-L D09AB02 zinc bandage with supplements WHO ATC
0-L D09AX Soft paraffin dressings WHO ATC
0-L D10 ANTI-ACNE PREPARATIONS WHO ATC
0-L D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE WHO ATC
0-L D10AA Corticosteroids, combinations for treatment of acne WHO ATC
0-L D10AA01 fluorometholone WHO ATC
0-L D10AA02 methylprednisolone WHO ATC
0-L D10AA03 dexamethasone WHO ATC
0-L D10AB Preparations containing sulfur WHO ATC
0-L D10AB01 bithionol WHO ATC
0-L D10AB02 sulfur WHO ATC
0-L D10AB03 tioxolone WHO ATC
0-L D10AB05 mesulfen WHO ATC
0-L D10AD Retinoids for topical use in acne WHO ATC
0-L D10AD01 tretinoin WHO ATC
0-L D10AD02 retinol WHO ATC
0-L D10AD03 adapalene WHO ATC
0-L D10AD04 isotretinoin WHO ATC
0-L D10AD05 motretinide WHO ATC
0-L D10AD51 tretinoin, combinations WHO ATC
0-L D10AD53 adapalene, combinations WHO ATC
0-L D10AD54 isotretinoin, combinations WHO ATC
0-L D10AE Peroxides WHO ATC
0-L D10AE01 benzoyl peroxide WHO ATC
0-L D10AE51 benzoyl peroxide, combinations WHO ATC
0-L D10AF Antiinfectives for treatment of acne WHO ATC
0-L D10AF01 clindamycin WHO ATC
0-L D10AF02 erythromycin WHO ATC
0-L D10AF03 chloramphenicol WHO ATC
0-L D10AF04 meclocycline WHO ATC
0-L D10AF51 clindamycin, combinations WHO ATC
0-L D10AF52 erythromycin, combinations WHO ATC
0-L D10AX Other anti-acne preparations for topical use WHO ATC
0-L D10AX01 aluminium chloride WHO ATC
0-L D10AX02 resorcinol WHO ATC
0-L D10AX03 azelaic acid WHO ATC
0-L D10AX04 aluminium oxide WHO ATC
0-L D10AX05 dapsone WHO ATC
0-L D10AX30 various combinations WHO ATC
0-L D10B ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE WHO ATC
0-L D10BA Retinoids for treatment of acne WHO ATC
0-L D10BA01 isotretinoin WHO ATC
0-L D10BX Other anti-acne preparations for systemic use WHO ATC
0-L D10BX01 ichtasol WHO ATC
0-L D11 OTHER DERMATOLOGICAL PREPARATIONS WHO ATC
0-L D11A OTHER DERMATOLOGICAL PREPARATIONS WHO ATC
0-L D11AA Antihidrotics WHO ATC
0-L D11AC Medicated shampoos WHO ATC
0-L D11AC01 cetrimide WHO ATC
0-L D11AC02 cadmium compounds WHO ATC
0-L D11AC03 selenium compounds WHO ATC
0-L D11AC06 povidone-iodine WHO ATC
0-L D11AC08 sulfur compounds WHO ATC
0-L D11AC09 xenysalate WHO ATC
0-L D11AC30 others WHO ATC
0-L D11AE Androgens for topical use WHO ATC
0-L D11AE01 metandienone WHO ATC
0-L D11AF Wart and anti-corn preparations WHO ATC
0-L D11AH Agents for atopic dermatitis, excluding corticosteroids WHO ATC
0-L D11AH01 tacrolimus WHO ATC
0-L D11AH02 pimecrolimus WHO ATC
0-L D11AH03 cromoglicic acid WHO ATC
0-L D11AX Other dermatologicals WHO ATC
0-L D11AX01 minoxidil WHO ATC
0-L D11AX02 gamolenic acid WHO ATC
0-L D11AX03 calcium gluconate WHO ATC
0-L D11AX04 lithium succinate WHO ATC
0-L D11AX05 magnesium sulfate WHO ATC
0-L D11AX06 mequinol WHO ATC
0-L D11AX08 tiratricol WHO ATC
0-L D11AX09 oxaceprol WHO ATC
0-L D11AX10 finasteride WHO ATC
0-L D11AX11 hydroquinone WHO ATC
0-L D11AX12 pyrithione zinc WHO ATC
0-L D11AX13 monobenzone WHO ATC
0-L D11AX16 eflornithine WHO ATC
0-L D11AX18 diclofenac WHO ATC
0-L D11AX19 alitretinoin WHO ATC
0-L D11AX52 gamolenic acid, combinations WHO ATC
0-L D11AX57 collagen, combinations WHO ATC
0-L G GENITO URINARY SYSTEM AND SEX HORMONES WHO ATC
0-L G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS WHO ATC
0-L G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONSWITH CORTICOSTEROIDS WHO ATC
0-L G01AA Antibiotics WHO ATC
0-L G01AA01 nystatin WHO ATC
0-L G01AA02 natamycin WHO ATC
0-L G01AA03 amphotericin B WHO ATC
0-L G01AA04 candicidin WHO ATC
0-L G01AA05 chloramphenicol WHO ATC
0-L G01AA06 hachimycin WHO ATC
0-L G01AA07 oxytetracycline WHO ATC
0-L G01AA08 carfecillin WHO ATC
0-L G01AA09 mepartricin WHO ATC
0-L G01AA10 clindamycin WHO ATC
0-L G01AA11 pentamycin WHO ATC
0-L G01AA51 nystatin, combinations WHO ATC
0-L G01AB Arsenic compounds WHO ATC
0-L G01AB01 acetarsol WHO ATC
0-L G01AC Quinoline derivatives WHO ATC
0-L G01AC01 diiodohydroxyquinoline WHO ATC
0-L G01AC02 clioquinol WHO ATC
0-L G01AC03 chlorquinaldol WHO ATC
0-L G01AC05 dequalinium WHO ATC
0-L G01AC06 broxyquinoline WHO ATC
0-L G01AC30 oxyquinoline WHO ATC
0-L G01AD Organic acids WHO ATC
0-L G01AD01 lactic acid WHO ATC
0-L G01AD02 acetic acid WHO ATC
0-L G01AD03 ascorbic acid WHO ATC
0-L G01AE Sulfonamides WHO ATC
0-L G01AE01 sulfatolamide WHO ATC
0-L G01AE10 combinations of sulfonamides WHO ATC
0-L G01AF Imidazole derivatives WHO ATC
0-L G01AF01 metronidazole WHO ATC
0-L G01AF02 clotrimazole WHO ATC
0-L G01AF04 miconazole WHO ATC
0-L G01AF05 econazole WHO ATC
0-L G01AF06 ornidazole WHO ATC
0-L G01AF07 isoconazole WHO ATC
0-L G01AF08 tioconazole WHO ATC
0-L G01AF11 ketoconazole WHO ATC
0-L G01AF12 fenticonazole WHO ATC
0-L G01AF13 azanidazole WHO ATC
0-L G01AF14 propenidazole WHO ATC
0-L G01AF15 butoconazole WHO ATC
0-L G01AF16 omoconazole WHO ATC
0-L G01AF17 oxiconazole WHO ATC
0-L G01AF18 flutrimazole WHO ATC
0-L G01AF20 combinations of imidazole derivatives WHO ATC
0-L G01AG Triazole derivatives WHO ATC
0-L G01AG02 terconazole WHO ATC
0-L G01AX Other antiinfectives and antiseptics WHO ATC
0-L G01AX01 clodantoin WHO ATC
0-L G01AX02 inosine WHO ATC
0-L G01AX03 policresulen WHO ATC
0-L G01AX05 nifuratel WHO ATC
0-L G01AX06 furazolidone WHO ATC
0-L G01AX09 methylrosaniline WHO ATC
0-L G01AX11 povidone-iodine WHO ATC
0-L G01AX12 ciclopirox WHO ATC
0-L G01AX13 protiofate WHO ATC
0-L G01AX14 lactobacillus fermentum WHO ATC
0-L G01AX15 copper usnate WHO ATC
0-L G01AX66 octenidine, combinations WHO ATC
0-L G01B ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS WHO ATC
0-L G01BA Antibiotics and corticosteroids WHO ATC
0-L G01BC Quinoline derivatives and corticosteroids WHO ATC
0-L G01BD Antiseptics and corticosteroids WHO ATC
0-L G01BE Sulfonamides and corticosteroids WHO ATC
0-L G01BF Imidazole derivatives and corticosteroids WHO ATC
0-L G02 OTHER GYNECOLOGICALS WHO ATC
0-L G02A OXYTOCICS WHO ATC
0-L G02AB Ergot alkaloids WHO ATC
0-L G02AB01 methylergometrine WHO ATC
0-L G02AB02 ergot alkaloids WHO ATC
0-L G02AB03 ergometrine WHO ATC
0-L G02AC Ergot alkaloids and oxytocin incl. analogues, in combination WHO ATC
0-L G02AC01 methylergometrine and oxytocin WHO ATC
0-L G02AD Prostaglandins WHO ATC
0-L G02AD01 dinoprost WHO ATC
0-L G02AD02 dinoprostone WHO ATC
0-L G02AD03 gemeprost WHO ATC
0-L G02AD04 carboprost WHO ATC
0-L G02AD05 sulprostone WHO ATC
0-L G02AD06 misoprostol WHO ATC
0-L G02AX Other oxytocics WHO ATC
0-L G02B CONTRACEPTIVES FOR TOPICAL USE WHO ATC
0-L G02BA Intrauterine contraceptives WHO ATC
0-L G02BA01 plastic IUD WHO ATC
0-L G02BA02 plastic IUD with copper WHO ATC
0-L G02BA03 plastic IUD with progestogen WHO ATC
0-L G02BB Intravaginal contraceptives WHO ATC
0-L G02BB01 vaginal ring with progestogen and estrogen WHO ATC
0-L G02C OTHER GYNECOLOGICALS WHO ATC
0-L G02CA Sympathomimetics, labour repressants WHO ATC
0-L G02CA01 ritodrine WHO ATC
0-L G02CA02 buphenine WHO ATC
0-L G02CA03 fenoterol WHO ATC
0-L G02CB Prolactine inhibitors WHO ATC
0-L G02CB01 bromocriptine WHO ATC
0-L G02CB02 lisuride WHO ATC
0-L G02CB03 cabergoline WHO ATC
0-L G02CB04 quinagolide WHO ATC
0-L G02CB05 metergoline WHO ATC
0-L G02CB06 terguride WHO ATC
0-L G02CC Antiinflammatory products for vaginal administration WHO ATC
0-L G02CC01 ibuprofen WHO ATC
0-L G02CC02 naproxen WHO ATC
0-L G02CC03 benzydamine WHO ATC
0-L G02CC04 flunoxaprofen WHO ATC
0-L G02CX Other gynecologicals WHO ATC
0-L G02CX01 atosiban WHO ATC
0-L G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM WHO ATC
0-L G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE WHO ATC
0-L G03AA Progestogens and estrogens, fixed combinations WHO ATC
0-L G03AA01 etynodiol and estrogen WHO ATC
0-L G03AA02 quingestanol and estrogen WHO ATC
0-L G03AA03 lynestrenol and estrogen WHO ATC
0-L G03AA04 megestrol and estrogen WHO ATC
0-L G03AA05 norethisterone and estrogen WHO ATC
0-L G03AA06 norgestrel and estrogen WHO ATC
0-L G03AA07 levonorgestrel and estrogen WHO ATC
0-L G03AA08 medroxyprogesterone and estrogen WHO ATC
0-L G03AA09 desogestrel and estrogen WHO ATC
0-L G03AA10 gestodene and estrogen WHO ATC
0-L G03AA11 norgestimate and estrogen WHO ATC
0-L G03AA12 drospirenone and estrogen WHO ATC
0-L G03AA13 norelgestromin and estrogen WHO ATC
0-L G03AA14 nomegestrol and estrogen WHO ATC
0-L G03AB Progestogens and estrogens, sequential preparations WHO ATC
0-L G03AB01 megestrol and estrogen WHO ATC
0-L G03AB02 lynestrenol and estrogen WHO ATC
0-L G03AB03 levonorgestrel and estrogen WHO ATC
0-L G03AB04 norethisterone and estrogen WHO ATC
0-L G03AB05 desogestrel and estrogen WHO ATC
0-L G03AB06 gestodene and estrogen WHO ATC
0-L G03AB07 chlormadinone and estrogen WHO ATC
0-L G03AC Progestogens WHO ATC
0-L G03AC01 norethisterone WHO ATC
0-L G03AC02 lynestrenol WHO ATC
0-L G03AC03 levonorgestrel WHO ATC
0-L G03AC04 quingestanol WHO ATC
0-L G03AC05 megestrol WHO ATC
0-L G03AC06 medroxyprogesterone WHO ATC
0-L G03AC07 norgestrienone WHO ATC
0-L G03AC08 etonogestrel WHO ATC
0-L G03AC09 desogestrel WHO ATC
0-L G03B ANDROGENS WHO ATC
0-L G03BA 3-oxoandrosten (4) derivatives WHO ATC
0-L G03BA01 fluoxymesterone WHO ATC
0-L G03BA02 methyltestosterone WHO ATC
0-L G03BA03 testosterone WHO ATC
0-L G03BB 5-androstanon (3) derivatives WHO ATC
0-L G03BB01 mesterolone WHO ATC
0-L G03BB02 androstanolone WHO ATC
0-L G03C ESTROGENS WHO ATC
0-L G03CA Natural and semisynthetic estrogens, plain WHO ATC
0-L G03CA01 ethinylestradiol WHO ATC
0-L G03CA03 estradiol WHO ATC
0-L G03CA04 estriol WHO ATC
0-L G03CA06 chlorotrianisene WHO ATC
0-L G03CA07 estrone WHO ATC
0-L G03CA09 promestriene WHO ATC
0-L G03CA53 estradiol, combinations WHO ATC
0-L G03CA57 conjugated estrogens WHO ATC
0-L G03CB Synthetic estrogens, plain WHO ATC
0-L G03CB01 dienestrol WHO ATC
0-L G03CB02 diethylstilbestrol WHO ATC
0-L G03CB03 methallenestril WHO ATC
0-L G03CB04 moxestrol WHO ATC
0-L G03CC Estrogens, combinations with other drugs WHO ATC
0-L G03CC02 dienestrol WHO ATC
0-L G03CC03 methallenestril WHO ATC
0-L G03CC04 estrone WHO ATC
0-L G03CC05 diethylstilbestrol WHO ATC
0-L G03CC06 estriol WHO ATC
0-L G03CX Other estrogens WHO ATC
0-L G03CX01 tibolone WHO ATC
0-L G03D PROGESTOGENS WHO ATC
0-L G03DA Pregnen (4) derivatives WHO ATC
0-L G03DA01 gestonorone WHO ATC
0-L G03DA02 medroxyprogesterone WHO ATC
0-L G03DA03 hydroxyprogesterone WHO ATC
0-L G03DA04 progesterone WHO ATC
0-L G03DB Pregnadien derivatives WHO ATC
0-L G03DB01 dydrogesterone WHO ATC
0-L G03DB02 megestrol WHO ATC
0-L G03DB03 medrogestone WHO ATC
0-L G03DB04 nomegestrol WHO ATC
0-L G03DB05 demegestone WHO ATC
0-L G03DB06 chlormadinone WHO ATC
0-L G03DB07 promegestone WHO ATC
0-L G03DC Estren derivatives WHO ATC
0-L G03DC01 allylestrenol WHO ATC
0-L G03DC02 norethisterone WHO ATC
0-L G03DC03 lynestrenol WHO ATC
0-L G03DC04 ethisterone WHO ATC
0-L G03DC06 etynodiol WHO ATC
0-L G03DC31 methylestrenolone WHO ATC
0-L G03E ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION WHO ATC
0-L G03EA Androgens and estrogens WHO ATC
0-L G03EA01 methyltestosterone and estrogen WHO ATC
0-L G03EA02 testosterone and estrogen WHO ATC
0-L G03EA03 prasterone and estrogen WHO ATC
0-L G03EB Androgen, progestogen and estrogen in combination WHO ATC
0-L G03EK Androgens and female sex hormones in combination with other drugs WHO ATC
0-L G03EK01 methyltestosterone WHO ATC
0-L G03F PROGESTOGENS AND ESTROGENS IN COMBINATION WHO ATC
0-L G03FA Progestogens and estrogens, fixed combinations WHO ATC
0-L G03FA01 norethisterone and estrogen WHO ATC
0-L G03FA02 hydroxyprogesterone and estrogen WHO ATC
0-L G03FA03 ethisterone and estrogen WHO ATC
0-L G03FA04 progesterone and estrogen WHO ATC
0-L G03FA05 methylnortestosterone and estrogen WHO ATC
0-L G03FA06 etynodiol and estrogen WHO ATC
0-L G03FA07 lynestrenol and estrogen WHO ATC
0-L G03FA08 megestrol and estrogen WHO ATC
0-L G03FA09 noretynodrel and estrogen WHO ATC
0-L G03FA10 norgestrel and estrogen WHO ATC
0-L G03FA11 levonorgestrel and estrogen WHO ATC
0-L G03FA12 medroxyprogesterone and estrogen WHO ATC
0-L G03FA13 norgestimate and estrogen WHO ATC
0-L G03FA14 dydrogesterone and estrogen WHO ATC
0-L G03FA15 dienogest and estrogen WHO ATC
0-L G03FA16 trimegestone and estrogen WHO ATC
0-L G03FA17 drospirenone and estrogen WHO ATC
0-L G03FB Progestogens and estrogens, sequential preparations WHO ATC
0-L G03FB01 norgestrel and estrogen WHO ATC
0-L G03FB02 lynestrenol and estrogen WHO ATC
0-L G03FB03 chlormadinone and estrogen WHO ATC
0-L G03FB04 megestrol and estrogen WHO ATC
0-L G03FB05 norethisterone and estrogen WHO ATC
0-L G03FB06 medroxyprogesterone and estrogen WHO ATC
0-L G03FB07 medrogestone and estrogen WHO ATC
0-L G03FB08 dydrogesterone and estrogen WHO ATC
0-L G03FB09 levonorgestrel and estrogen WHO ATC
0-L G03FB10 desogestrel and estrogen WHO ATC
0-L G03FB11 trimegestone and estrogen WHO ATC
0-L G03G GONADOTROPINS AND OTHER OVULATION STIMULANTS WHO ATC
0-L G03GA Gonadotropins WHO ATC
0-L G03GA01 chorionic gonadotrophin WHO ATC
0-L G03GA02 human menopausal gonadotrophin WHO ATC
0-L G03GA03 serum gonadotrophin WHO ATC
0-L G03GA04 urofollitropin WHO ATC
0-L G03GA05 follitropin alfa WHO ATC
0-L G03GA06 follitropin beta WHO ATC
0-L G03GA07 lutropin alfa WHO ATC
0-L G03GA08 choriogonadotropin alfa WHO ATC
0-L G03GA09 corifollitropin alfa WHO ATC
0-L G03GA30 combinations WHO ATC
0-L G03GB Ovulation stimulants, synthetic WHO ATC
0-L G03GB01 cyclofenil WHO ATC
0-L G03GB02 clomifene WHO ATC
0-L G03GB03 epimestrol WHO ATC
0-L G03H ANTIANDROGENS WHO ATC
0-L G03HA Antiandrogens, plain WHO ATC
0-L G03HA01 cyproterone WHO ATC
0-L G03HB Antiandrogens and estrogens WHO ATC
0-L G03HB01 cyproterone and estrogen WHO ATC
0-L G03X OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM WHO ATC
0-L G03XA Antigonadotropins and similar agents WHO ATC
0-L G03XA01 danazol WHO ATC
0-L G03XA02 gestrinone WHO ATC
0-L G03XB Antiprogestogens WHO ATC
0-L G03XB01 mifepristone WHO ATC
0-L G03XC Selective estrogen receptor modulators WHO ATC
0-L G03XC01 raloxifene WHO ATC
0-L G03XC02 bazedoxifene WHO ATC
0-L G04 UROLOGICALS WHO ATC
0-L G04B OTHER UROLOGICALS, INCL. ANTISPASMODICS WHO ATC
0-L G04BA Acidifiers WHO ATC
0-L G04BA01 ammonium chloride WHO ATC
0-L G04BA03 calcium chloride WHO ATC
0-L G04BC Urinary concrement solvents WHO ATC
0-L G04BD Urinary antispasmodics WHO ATC
0-L G04BD01 emepronium WHO ATC
0-L G04BD02 flavoxate WHO ATC
0-L G04BD03 meladrazine WHO ATC
0-L G04BD04 oxybutynin WHO ATC
0-L G04BD05 terodiline WHO ATC
0-L G04BD06 propiverine WHO ATC
0-L G04BD07 tolterodine WHO ATC
0-L G04BD08 solifenacin WHO ATC
0-L G04BD09 trospium WHO ATC
0-L G04BD10 darifenacin WHO ATC
0-L G04BD11 fesoterodine WHO ATC
0-L G04BE Drugs used in erectile dysfunction WHO ATC
0-L G04BE01 alprostadil WHO ATC
0-L G04BE02 papaverine WHO ATC
0-L G04BE03 sildenafil WHO ATC
0-L G04BE04 yohimbine WHO ATC
0-L G04BE05 phentolamine WHO ATC
0-L G04BE06 moxisylyte WHO ATC
0-L G04BE07 apomorphine WHO ATC
0-L G04BE08 tadalafil WHO ATC
0-L G04BE09 vardenafil WHO ATC
0-L G04BE30 combinations WHO ATC
0-L G04BE52 papaverine, combinations WHO ATC
0-L G04BX Other urologicals WHO ATC
0-L G04BX01 magnesium hydroxide WHO ATC
0-L G04BX03 acetohydroxamic acid WHO ATC
0-L G04BX06 phenazopyridine WHO ATC
0-L G04BX10 succinimide WHO ATC
0-L G04BX11 collagen WHO ATC
0-L G04BX12 phenyl salicylate WHO ATC
0-L G04BX13 dimethyl sulfoxide WHO ATC
0-L G04BX14 dapoxetine WHO ATC
0-L G04C DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY WHO ATC
0-L G04CA Alpha-adrenoreceptor antagonists WHO ATC
0-L G04CA01 alfuzosin WHO ATC
0-L G04CA02 tamsulosin WHO ATC
0-L G04CA03 terazosin WHO ATC
0-L G04CA04 silodosin WHO ATC
0-L G04CA51 alfuzosin and finasteride WHO ATC
0-L G04CA52 tamsulosin and dutasteride WHO ATC
0-L G04CB Testosterone-5-alpha reductase inhibitors WHO ATC
0-L G04CB01 finasteride WHO ATC
0-L G04CB02 dutasteride WHO ATC
0-L G04CX Other drugs used in benign prostatic hypertrophy WHO ATC
0-L G04CX01 pygeum africanum WHO ATC
0-L G04CX02 serenoa repens WHO ATC
0-L G04CX03 mepartricin WHO ATC
0-L H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS WHO ATC
0-L H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES WHO ATC
0-L H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES WHO ATC
0-L H01AA ACTH WHO ATC
0-L H01AA01 corticotropin WHO ATC
0-L H01AA02 tetracosactide WHO ATC
0-L H01AB Thyrotropin WHO ATC
0-L H01AB01 thyrotropin WHO ATC
0-L H01AC Somatropin and somatropin agonists WHO ATC
0-L H01AC01 somatropin WHO ATC
0-L H01AC02 somatrem WHO ATC
0-L H01AC03 mecasermin WHO ATC
0-L H01AC04 sermorelin WHO ATC
0-L H01AC05 mecasermin rinfabate WHO ATC
0-L H01AX Other anterior pituitary lobe hormones and analogues WHO ATC
0-L H01AX01 pegvisomant WHO ATC
0-L H01B POSTERIOR PITUITARY LOBE HORMONES WHO ATC
0-L H01BA Vasopressin and analogues WHO ATC
0-L H01BA01 vasopressin WHO ATC
0-L H01BA02 desmopressin WHO ATC
0-L H01BA03 lypressin WHO ATC
0-L H01BA04 terlipressin WHO ATC
0-L H01BA05 ornipressin WHO ATC
0-L H01BA06 argipressin WHO ATC
0-L H01BB Oxytocin and analogues WHO ATC
0-L H01BB01 demoxytocin WHO ATC
0-L H01BB02 oxytocin WHO ATC
0-L H01BB03 carbetocin WHO ATC
0-L H01C HYPOTHALAMIC HORMONES WHO ATC
0-L H01CA Gonadotropin-releasing hormones WHO ATC
0-L H01CA01 gonadorelin WHO ATC
0-L H01CA02 nafarelin WHO ATC
0-L H01CA03 histrelin WHO ATC
0-L H01CB Antigrowth hormones WHO ATC
0-L H01CB01 somatostatin WHO ATC
0-L H01CB02 octreotide WHO ATC
0-L H01CB03 lanreotide WHO ATC
0-L H01CB04 vapreotide WHO ATC
0-L H01CC Anti-gonadotropin-releasing hormones WHO ATC
0-L H01CC01 ganirelix WHO ATC
0-L H01CC02 cetrorelix WHO ATC
0-L H02 CORTICOSTEROIDS FOR SYSTEMIC USE WHO ATC
0-L H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN WHO ATC
0-L H02AA Mineralocorticoids WHO ATC
0-L H02AA01 aldosterone WHO ATC
0-L H02AA02 fludrocortisone WHO ATC
0-L H02AA03 desoxycortone WHO ATC
0-L H02AB Glucocorticoids WHO ATC
0-L H02AB01 betamethasone WHO ATC
0-L H02AB02 dexamethasone WHO ATC
0-L H02AB03 fluocortolone WHO ATC
0-L H02AB04 methylprednisolone WHO ATC
0-L H02AB05 paramethasone WHO ATC
0-L H02AB06 prednisolone WHO ATC
0-L H02AB07 prednisone WHO ATC
0-L H02AB08 triamcinolone WHO ATC
0-L H02AB09 hydrocortisone WHO ATC
0-L H02AB10 cortisone WHO ATC
0-L H02AB11 prednylidene WHO ATC
0-L H02AB12 rimexolone WHO ATC
0-L H02AB13 deflazacort WHO ATC
0-L H02AB14 cloprednol WHO ATC
0-L H02AB15 meprednisone WHO ATC
0-L H02AB17 cortivazol WHO ATC
0-L H02B CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS WHO ATC
0-L H02BX Corticosteroids for systemic use, combinations WHO ATC
0-L H02BX01 methylprednisolone, combinations WHO ATC
0-L H02C ANTIADRENAL PREPARATIONS WHO ATC
0-L H02CA Anticorticosteroids WHO ATC
0-L H02CA01 trilostane WHO ATC
0-L H03 THYROID THERAPY WHO ATC
0-L H03A THYROID PREPARATIONS WHO ATC
0-L H03AA Thyroid hormones WHO ATC
0-L H03AA01 levothyroxine sodium WHO ATC
0-L H03AA02 liothyronine sodium WHO ATC
0-L H03AA03 combinations of levothyroxine and liothyronine WHO ATC
0-L H03AA04 tiratricol WHO ATC
0-L H03AA05 thyroid gland preparations WHO ATC
0-L H03B ANTITHYROID PREPARATIONS WHO ATC
0-L H03BA Thiouracils WHO ATC
0-L H03BA01 methylthiouracil WHO ATC
0-L H03BA02 propylthiouracil WHO ATC
0-L H03BA03 benzylthiouracil WHO ATC
0-L H03BB Sulfur-containing imidazole derivatives WHO ATC
0-L H03BB01 carbimazole WHO ATC
0-L H03BB02 thiamazole WHO ATC
0-L H03BB52 thiamazole, combinations WHO ATC
0-L H03BC Perchlorates WHO ATC
0-L H03BC01 potassium perchlorate WHO ATC
0-L H03BX Other antithyroid preparations WHO ATC
0-L H03BX01 diiodotyrosine WHO ATC
0-L H03BX02 dibromotyrosine WHO ATC
0-L H03C IODINE THERAPY WHO ATC
0-L H03CA Iodine therapy WHO ATC
0-L H04 PANCREATIC HORMONES WHO ATC
0-L H04A GLYCOGENOLYTIC HORMONES WHO ATC
0-L H04AA Glycogenolytic hormones WHO ATC
0-L H04AA01 glucagon WHO ATC
0-L H05 CALCIUM HOMEOSTASIS WHO ATC
0-L H05A PARATHYROID HORMONES AND ANALOGUES WHO ATC
0-L H05AA Parathyroid hormones and analogues WHO ATC
0-L H05AA01 parathyroid gland extract WHO ATC
0-L H05AA02 teriparatide WHO ATC
0-L H05AA03 parathyroid hormone WHO ATC
0-L H05B ANTI-PARATHYROID AGENTS WHO ATC
0-L H05BA Calcitonin preparations WHO ATC
0-L H05BA01 calcitonin (salmon synthetic) WHO ATC
0-L H05BA02 calcitonin (pork natural) WHO ATC
0-L H05BA03 calcitonin (human synthetic) WHO ATC
0-L H05BA04 elcatonin WHO ATC
0-L H05BX Other anti-parathyroid agents WHO ATC
0-L H05BX01 cinacalcet WHO ATC
0-L H05BX02 paricalcitol WHO ATC
0-L H05BX03 doxercalciferol WHO ATC
0-L J ANTIINFECTIVES FOR SYSTEMIC USE WHO ATC
0-L J01 ANTIBACTERIALS FOR SYSTEMIC USE WHO ATC
0-L J01A TETRACYCLINES WHO ATC
0-L J01AA Tetracyclines WHO ATC
0-L J01AA01 demeclocycline WHO ATC
0-L J01AA02 doxycycline WHO ATC
0-L J01AA03 chlortetracycline WHO ATC
0-L J01AA04 lymecycline WHO ATC
0-L J01AA05 metacycline WHO ATC
0-L J01AA06 oxytetracycline WHO ATC
0-L J01AA07 tetracycline WHO ATC
0-L J01AA08 minocycline WHO ATC
0-L J01AA09 rolitetracycline WHO ATC
0-L J01AA10 penimepicycline WHO ATC
0-L J01AA11 clomocycline WHO ATC
0-L J01AA12 tigecycline WHO ATC
0-L J01AA20 combinations of tetracyclines WHO ATC
0-L J01AA56 oxytetracycline, combinations WHO ATC
0-L J01B AMPHENICOLS WHO ATC
0-L J01BA Amphenicols WHO ATC
0-L J01BA01 chloramphenicol WHO ATC
0-L J01BA02 thiamphenicol WHO ATC
0-L J01BA52 thiamphenicol, combinations WHO ATC
0-L J01C BETA-LACTAM ANTIBACTERIALS, PENICILLINS WHO ATC
0-L J01CA Penicillins with extended spectrum WHO ATC
0-L J01CA01 ampicillin WHO ATC
0-L J01CA02 pivampicillin WHO ATC
0-L J01CA03 carbenicillin WHO ATC
0-L J01CA04 amoxicillin WHO ATC
0-L J01CA05 carindacillin WHO ATC
0-L J01CA06 bacampicillin WHO ATC
0-L J01CA07 epicillin WHO ATC
0-L J01CA08 pivmecillinam WHO ATC
0-L J01CA09 azlocillin WHO ATC
0-L J01CA10 mezlocillin WHO ATC
0-L J01CA11 mecillinam WHO ATC
0-L J01CA12 piperacillin WHO ATC
0-L J01CA13 ticarcillin WHO ATC
0-L J01CA14 metampicillin WHO ATC
0-L J01CA15 talampicillin WHO ATC
0-L J01CA16 sulbenicillin WHO ATC
0-L J01CA17 temocillin WHO ATC
0-L J01CA18 hetacillin WHO ATC
0-L J01CA20 combinations WHO ATC
0-L J01CA51 ampicillin, combinations WHO ATC
0-L J01CE Beta-lactamase sensitive penicillins WHO ATC
0-L J01CE01 benzylpenicillin WHO ATC
0-L J01CE02 phenoxymethylpenicillin WHO ATC
0-L J01CE03 propicillin WHO ATC
0-L J01CE04 azidocillin WHO ATC
0-L J01CE05 pheneticillin WHO ATC
0-L J01CE06 penamecillin WHO ATC
0-L J01CE07 clometocillin WHO ATC
0-L J01CE08 benzathine benzylpenicillin WHO ATC
0-L J01CE09 procaine benzylpenicillin WHO ATC
0-L J01CE10 benzathine phenoxymethylpenicillin WHO ATC
0-L J01CE30 combinations WHO ATC
0-L J01CF Beta-lactamase resistant penicillins WHO ATC
0-L J01CF01 dicloxacillin WHO ATC
0-L J01CF02 cloxacillin WHO ATC
0-L J01CF03 meticillin WHO ATC
0-L J01CF04 oxacillin WHO ATC
0-L J01CF05 flucloxacillin WHO ATC
0-L J01CG Beta-lactamase inhibitors WHO ATC
0-L J01CG01 sulbactam WHO ATC
0-L J01CG02 tazobactam WHO ATC
0-L J01CR Combinations of penicillins, incl. beta-lactamase inhibitors WHO ATC
0-L J01CR01 ampicillin and enzyme inhibitor WHO ATC
0-L J01CR02 amoxicillin and enzyme inhibitor WHO ATC
0-L J01CR03 ticarcillin and enzyme inhibitor WHO ATC
0-L J01CR04 sultamicillin WHO ATC
0-L J01CR05 piperacillin and enzyme inhibitor WHO ATC
0-L J01CR50 combinations of penicillins WHO ATC
0-L J01D OTHER BETA-LACTAM ANTIBACTERIALS WHO ATC
0-L J01DB First-generation cephalosporins WHO ATC
0-L J01DB01 cefalexin WHO ATC
0-L J01DB02 cefaloridine WHO ATC
0-L J01DB03 cefalotin WHO ATC
0-L J01DB04 cefazolin WHO ATC
0-L J01DB05 cefadroxil WHO ATC
0-L J01DB06 cefazedone WHO ATC
0-L J01DB07 cefatrizine WHO ATC
0-L J01DB08 cefapirin WHO ATC
0-L J01DB09 cefradine WHO ATC
0-L J01DB10 cefacetrile WHO ATC
0-L J01DB11 cefroxadine WHO ATC
0-L J01DB12 ceftezole WHO ATC
0-L J01DC Second-generation cephalosporins WHO ATC
0-L J01DC01 cefoxitin WHO ATC
0-L J01DC02 cefuroxime WHO ATC
0-L J01DC03 cefamandole WHO ATC
0-L J01DC04 cefaclor WHO ATC
0-L J01DC05 cefotetan WHO ATC
0-L J01DC06 cefonicid WHO ATC
0-L J01DC07 cefotiam WHO ATC
0-L J01DC08 loracarbef WHO ATC
0-L J01DC09 cefmetazole WHO ATC
0-L J01DC10 cefprozil WHO ATC
0-L J01DC11 ceforanide WHO ATC
0-L J01DD Third-generation cephalosporins WHO ATC
0-L J01DD01 cefotaxime WHO ATC
0-L J01DD02 ceftazidime WHO ATC
0-L J01DD03 cefsulodin WHO ATC
0-L J01DD04 ceftriaxone WHO ATC
0-L J01DD05 cefmenoxime WHO ATC
0-L J01DD06 latamoxef WHO ATC
0-L J01DD07 ceftizoxime WHO ATC
0-L J01DD08 cefixime WHO ATC
0-L J01DD09 cefodizime WHO ATC
0-L J01DD10 cefetamet WHO ATC
0-L J01DD11 cefpiramide WHO ATC
0-L J01DD12 cefoperazone WHO ATC
0-L J01DD13 cefpodoxime WHO ATC
0-L J01DD14 ceftibuten WHO ATC
0-L J01DD15 cefdinir WHO ATC
0-L J01DD16 cefditoren WHO ATC
0-L J01DD17 cefcapene WHO ATC
0-L J01DD54 ceftriaxone, combinations WHO ATC
0-L J01DD62 cefoperazone, combinations WHO ATC
0-L J01DE Fourth-generation cephalosporins WHO ATC
0-L J01DE01 cefepime WHO ATC
0-L J01DE02 cefpirome WHO ATC
0-L J01DE03 cefozopran WHO ATC
0-L J01DF Monobactams WHO ATC
0-L J01DF01 aztreonam WHO ATC
0-L J01DH Carbapenems WHO ATC
0-L J01DH02 meropenem WHO ATC
0-L J01DH03 ertapenem WHO ATC
0-L J01DH04 doripenem WHO ATC
0-L J01DH05 biapenem WHO ATC
0-L J01DH51 imipenem and enzyme inhibitor WHO ATC
0-L J01DH55 panipenem and betamipron WHO ATC
0-L J01DI Other cephalosporins WHO ATC
0-L J01DI01 ceftobiprole medocaril WHO ATC
0-L J01E SULFONAMIDES AND TRIMETHOPRIM WHO ATC
0-L J01EA Trimethoprim and derivatives WHO ATC
0-L J01EA01 trimethoprim WHO ATC
0-L J01EA02 brodimoprim WHO ATC
0-L J01EA03 iclaprim WHO ATC
0-L J01EB Short-acting sulfonamides WHO ATC
0-L J01EB01 sulfaisodimidine WHO ATC
0-L J01EB02 sulfamethizole WHO ATC
0-L J01EB03 sulfadimidine WHO ATC
0-L J01EB04 sulfapyridine WHO ATC
0-L J01EB05 sulfafurazole WHO ATC
0-L J01EB06 sulfanilamide WHO ATC
0-L J01EB07 sulfathiazole WHO ATC
0-L J01EB08 sulfathiourea WHO ATC
0-L J01EB20 combinations WHO ATC
0-L J01EC Intermediate-acting sulfonamides WHO ATC
0-L J01EC01 sulfamethoxazole WHO ATC
0-L J01EC02 sulfadiazine WHO ATC
0-L J01EC03 sulfamoxole WHO ATC
0-L J01EC20 combinations WHO ATC
0-L J01ED Long-acting sulfonamides WHO ATC
0-L J01ED01 sulfadimethoxine WHO ATC
0-L J01ED02 sulfalene WHO ATC
0-L J01ED03 sulfametomidine WHO ATC
0-L J01ED04 sulfametoxydiazine WHO ATC
0-L J01ED05 sulfamethoxypyridazine WHO ATC
0-L J01ED06 sulfaperin WHO ATC
0-L J01ED07 sulfamerazine WHO ATC
0-L J01ED08 sulfaphenazole WHO ATC
0-L J01ED09 sulfamazone WHO ATC
0-L J01ED20 combinations WHO ATC
0-L J01EE Combinations of sulfonamides and trimethoprim, incl. derivatives WHO ATC
0-L J01EE01 sulfamethoxazole and trimethoprim WHO ATC
0-L J01EE02 sulfadiazine and trimethoprim WHO ATC
0-L J01EE03 sulfametrole and trimethoprim WHO ATC
0-L J01EE04 sulfamoxole and trimethoprim WHO ATC
0-L J01EE05 sulfadimidine and trimethoprim WHO ATC
0-L J01EE06 sulfadiazine and tetroxoprim WHO ATC
0-L J01EE07 sulfamerazine and trimethoprim WHO ATC
0-L J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS WHO ATC
0-L J01FA Macrolides WHO ATC
0-L J01FA01 erythromycin WHO ATC
0-L J01FA02 spiramycin WHO ATC
0-L J01FA03 midecamycin WHO ATC
0-L J01FA05 oleandomycin WHO ATC
0-L J01FA06 roxithromycin WHO ATC
0-L J01FA07 josamycin WHO ATC
0-L J01FA08 troleandomycin WHO ATC
0-L J01FA09 clarithromycin WHO ATC
0-L J01FA10 azithromycin WHO ATC
0-L J01FA11 miocamycin WHO ATC
0-L J01FA12 rokitamycin WHO ATC
0-L J01FA13 dirithromycin WHO ATC
0-L J01FA14 flurithromycin WHO ATC
0-L J01FA15 telithromycin WHO ATC
0-L J01FF Lincosamides WHO ATC
0-L J01FF01 clindamycin WHO ATC
0-L J01FF02 lincomycin WHO ATC
0-L J01FG Streptogramins WHO ATC
0-L J01FG01 pristinamycin WHO ATC
0-L J01FG02 quinupristin/dalfopristin WHO ATC
0-L J01G AMINOGLYCOSIDE ANTIBACTERIALS WHO ATC
0-L J01GA Streptomycins WHO ATC
0-L J01GA01 streptomycin WHO ATC
0-L J01GA02 streptoduocin WHO ATC
0-L J01GB Other aminoglycosides WHO ATC
0-L J01GB01 tobramycin WHO ATC
0-L J01GB03 gentamicin WHO ATC
0-L J01GB04 kanamycin WHO ATC
0-L J01GB05 neomycin WHO ATC
0-L J01GB06 amikacin WHO ATC
0-L J01GB07 netilmicin WHO ATC
0-L J01GB08 sisomicin WHO ATC
0-L J01GB09 dibekacin WHO ATC
0-L J01GB10 ribostamycin WHO ATC
0-L J01GB11 isepamicin WHO ATC
0-L J01GB12 arbekacin WHO ATC
0-L J01M QUINOLONE ANTIBACTERIALS WHO ATC
0-L J01MA Fluoroquinolones WHO ATC
0-L J01MA01 ofloxacin WHO ATC
0-L J01MA02 ciprofloxacin WHO ATC
0-L J01MA03 pefloxacin WHO ATC
0-L J01MA04 enoxacin WHO ATC
0-L J01MA05 temafloxacin WHO ATC
0-L J01MA06 norfloxacin WHO ATC
0-L J01MA07 lomefloxacin WHO ATC
0-L J01MA08 fleroxacin WHO ATC
0-L J01MA09 sparfloxacin WHO ATC
0-L J01MA10 rufloxacin WHO ATC
0-L J01MA11 grepafloxacin WHO ATC
0-L J01MA12 levofloxacin WHO ATC
0-L J01MA13 trovafloxacin WHO ATC
0-L J01MA14 moxifloxacin WHO ATC
0-L J01MA15 gemifloxacin WHO ATC
0-L J01MA16 gatifloxacin WHO ATC
0-L J01MA17 prulifloxacin WHO ATC
0-L J01MA18 pazufloxacin WHO ATC
0-L J01MA19 garenoxacin WHO ATC
0-L J01MB Other quinolones WHO ATC
0-L J01MB01 rosoxacin WHO ATC
0-L J01MB02 nalidixic acid WHO ATC
0-L J01MB03 piromidic acid WHO ATC
0-L J01MB04 pipemidic acid WHO ATC
0-L J01MB05 oxolinic acid WHO ATC
0-L J01MB06 cinoxacin WHO ATC
0-L J01MB07 flumequine WHO ATC
0-L J01R COMBINATIONS OF ANTIBACTERIALS WHO ATC
0-L J01RA Combinations of antibacterials WHO ATC
0-L J01RA01 penicillins, combinations with other antibacterials WHO ATC
0-L J01RA02 sulfonamides, combinations with other antibacterials (excl. trimethoprim) WHO ATC
0-L J01RA03 cefuroxime, combinations with other antibacterials WHO ATC
0-L J01RA04 spiramycin, combinations with other antibacterials WHO ATC
0-L J01X OTHER ANTIBACTERIALS WHO ATC
0-L J01XA Glycopeptide antibacterials WHO ATC
0-L J01XA01 vancomycin WHO ATC
0-L J01XA02 teicoplanin WHO ATC
0-L J01XA03 telavancin WHO ATC
0-L J01XA04 dalbavancin WHO ATC
0-L J01XA05 oritavancin WHO ATC
0-L J01XB Polymyxins WHO ATC
0-L J01XB01 colistin WHO ATC
0-L J01XB02 polymyxin B WHO ATC
0-L J01XC Steroid antibacterials WHO ATC
0-L J01XC01 fusidic acid WHO ATC
0-L J01XD Imidazole derivatives WHO ATC
0-L J01XD01 metronidazole WHO ATC
0-L J01XD02 tinidazole WHO ATC
0-L J01XD03 ornidazole WHO ATC
0-L J01XE Nitrofuran derivatives WHO ATC
0-L J01XE01 nitrofurantoin WHO ATC
0-L J01XE02 nifurtoinol WHO ATC
0-L J01XX Other antibacterials WHO ATC
0-L J01XX01 fosfomycin WHO ATC
0-L J01XX02 xibornol WHO ATC
0-L J01XX03 clofoctol WHO ATC
0-L J01XX04 spectinomycin WHO ATC
0-L J01XX05 methenamine WHO ATC
0-L J01XX06 mandelic acid WHO ATC
0-L J01XX07 nitroxoline WHO ATC
0-L J01XX08 linezolid WHO ATC
0-L J01XX09 daptomycin WHO ATC
0-L J01XX10 bacitracin WHO ATC
0-L J02 ANTIMYCOTICS FOR SYSTEMIC USE WHO ATC
0-L J02A ANTIMYCOTICS FOR SYSTEMIC USE WHO ATC
0-L J02AA Antibiotics WHO ATC
0-L J02AA01 amphotericin B WHO ATC
0-L J02AA02 hachimycin WHO ATC
0-L J02AB Imidazole derivatives WHO ATC
0-L J02AB01 miconazole WHO ATC
0-L J02AB02 ketoconazole WHO ATC
0-L J02AC Triazole derivatives WHO ATC
0-L J02AC01 fluconazole WHO ATC
0-L J02AC02 itraconazole WHO ATC
0-L J02AC03 voriconazole WHO ATC
0-L J02AC04 posaconazole WHO ATC
0-L J02AX Other antimycotics for systemic use WHO ATC
0-L J02AX01 flucytosine WHO ATC
0-L J02AX04 caspofungin WHO ATC
0-L J02AX05 micafungin WHO ATC
0-L J02AX06 anidulafungin WHO ATC
0-L J04 ANTIMYCOBACTERIALS WHO ATC
0-L J04A DRUGS FOR TREATMENT OF TUBERCULOSIS WHO ATC
0-L J04AA Aminosalicylic acid and derivatives WHO ATC
0-L J04AA01 aminosalicylic acid WHO ATC
0-L J04AA02 sodium aminosalicylate WHO ATC
0-L J04AA03 calcium aminosalicylate WHO ATC
0-L J04AB Antibiotics WHO ATC
0-L J04AB01 cycloserine WHO ATC
0-L J04AB02 rifampicin WHO ATC
0-L J04AB03 rifamycin WHO ATC
0-L J04AB04 rifabutin WHO ATC
0-L J04AB05 rifapentine WHO ATC
0-L J04AB30 capreomycin WHO ATC
0-L J04AC Hydrazides WHO ATC
0-L J04AC01 isoniazid WHO ATC
0-L J04AC51 isoniazid, combinations WHO ATC
0-L J04AD Thiocarbamide derivatives WHO ATC
0-L J04AD01 protionamide WHO ATC
0-L J04AD02 tiocarlide WHO ATC
0-L J04AD03 ethionamide WHO ATC
0-L J04AK Other drugs for treatment of tuberculosis WHO ATC
0-L J04AK01 pyrazinamide WHO ATC
0-L J04AK02 ethambutol WHO ATC
0-L J04AK03 terizidone WHO ATC
0-L J04AK04 morinamide WHO ATC
0-L J04AM Combinations of drugs for treatment of tuberculosis WHO ATC
0-L J04AM01 streptomycin and isoniazid WHO ATC
0-L J04AM02 rifampicin and isoniazid WHO ATC
0-L J04AM03 ethambutol and isoniazid WHO ATC
0-L J04AM04 thioacetazone and isoniazid WHO ATC
0-L J04AM05 rifampicin, pyrazinamide and isoniazid WHO ATC
0-L J04AM06 rifampicin, pyrazinamide, ethambutol and isoniazid WHO ATC
0-L J04B DRUGS FOR TREATMENT OF LEPRA WHO ATC
0-L J04BA Drugs for treatment of lepra WHO ATC
0-L J04BA01 clofazimine WHO ATC
0-L J04BA02 dapsone WHO ATC
0-L J04BA03 aldesulfone sodium WHO ATC
0-L J05 ANTIVIRALS FOR SYSTEMIC USE WHO ATC
0-L J05A DIRECT ACTING ANTIVIRALS WHO ATC
0-L J05AA Thiosemicarbazones WHO ATC
0-L J05AA01 metisazone WHO ATC
0-L J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors WHO ATC
0-L J05AB01 aciclovir WHO ATC
0-L J05AB02 idoxuridine WHO ATC
0-L J05AB03 vidarabine WHO ATC
0-L J05AB04 ribavirin WHO ATC
0-L J05AB06 ganciclovir WHO ATC
0-L J05AB09 famciclovir WHO ATC
0-L J05AB11 valaciclovir WHO ATC
0-L J05AB12 cidofovir WHO ATC
0-L J05AB13 penciclovir WHO ATC
0-L J05AB14 valganciclovir WHO ATC
0-L J05AB15 brivudine WHO ATC
0-L J05AC Cyclic amines WHO ATC
0-L J05AC02 rimantadine WHO ATC
0-L J05AC03 tromantadine WHO ATC
0-L J05AD Phosphonic acid derivatives WHO ATC
0-L J05AD01 foscarnet WHO ATC
0-L J05AD02 fosfonet WHO ATC
0-L J05AE Protease inhibitors WHO ATC
0-L J05AE01 saquinavir WHO ATC
0-L J05AE02 indinavir WHO ATC
0-L J05AE03 ritonavir WHO ATC
0-L J05AE04 nelfinavir WHO ATC
0-L J05AE05 amprenavir WHO ATC
0-L J05AE06 lopinavir WHO ATC
0-L J05AE07 fosamprenavir WHO ATC
0-L J05AE08 atazanavir WHO ATC
0-L J05AE09 tipranavir WHO ATC
0-L J05AE10 darunavir WHO ATC
0-L J05AF Nucleoside and nucleotide reverse transcriptase inhibitors WHO ATC
0-L J05AF01 zidovudine WHO ATC
0-L J05AF02 didanosine WHO ATC
0-L J05AF03 zalcitabine WHO ATC
0-L J05AF04 stavudine WHO ATC
0-L J05AF05 lamivudine WHO ATC
0-L J05AF06 abacavir WHO ATC
0-L J05AF07 tenofovir disoproxil WHO ATC
0-L J05AF08 adefovir dipivoxil WHO ATC
0-L J05AF09 emtricitabine WHO ATC
0-L J05AF10 entecavir WHO ATC
0-L J05AF11 telbivudine WHO ATC
0-L J05AF12 clevudine WHO ATC
0-L J05AG Non-nucleoside reverse transcriptase inhibitors WHO ATC
0-L J05AG01 nevirapine WHO ATC
0-L J05AG02 delavirdine WHO ATC
0-L J05AG03 efavirenz WHO ATC
0-L J05AG04 etravirine WHO ATC
0-L J05AH Neuraminidase inhibitors WHO ATC
0-L J05AH01 zanamivir WHO ATC
0-L J05AH02 oseltamivir WHO ATC
0-L J05AR Antivirals for treatment of HIV infections, combinations WHO ATC
0-L J05AR01 zidovudine and lamivudine WHO ATC
0-L J05AR02 lamivudine and abacavir WHO ATC
0-L J05AR03 tenofovir disoproxil and emtricitabine WHO ATC
0-L J05AR04 zidovudine, lamivudine and abacavir WHO ATC
0-L J05AR05 zidovudine, lamivudine and nevirapine WHO ATC
0-L J05AR06 emtricitabine, tenofovir disoproxil and efavirenz WHO ATC
0-L J05AR07 stavudine, lamivudine and nevirapine WHO ATC
0-L J05AX Other antivirals WHO ATC
0-L J05AX01 moroxydine WHO ATC
0-L J05AX02 lysozyme WHO ATC
0-L J05AX05 inosine pranobex WHO ATC
0-L J05AX06 pleconaril WHO ATC
0-L J05AX07 enfuvirtide WHO ATC
0-L J05AX08 raltegravir WHO ATC
0-L J05AX09 maraviroc WHO ATC
0-L J05AX10 maribavir WHO ATC
0-L J06 IMMUNE SERA AND IMMUNOGLOBULINS WHO ATC
0-L J06A IMMUNE SERA WHO ATC
0-L J06AA Immune sera WHO ATC
0-L J06AA01 diphtheria antitoxin WHO ATC
0-L J06AA02 tetanus antitoxin WHO ATC
0-L J06AA03 snake venom antiserum WHO ATC
0-L J06AA04 botulinum antitoxin WHO ATC
0-L J06AA05 gas-gangrene sera WHO ATC
0-L J06AA06 rabies serum WHO ATC
0-L J06B IMMUNOGLOBULINS WHO ATC
0-L J06BA Immunoglobulins, normal human WHO ATC
0-L J06BA01 immunoglobulins, normal human, for extravascular adm. WHO ATC
0-L J06BA02 immunoglobulins, normal human, for intravascular adm. WHO ATC
0-L J06BB Specific immunoglobulins WHO ATC
0-L J06BB01 anti-D (rh) immunoglobulin WHO ATC
0-L J06BB02 tetanus immunoglobulin WHO ATC
0-L J06BB03 varicella/zoster immunoglobulin WHO ATC
0-L J06BB04 hepatitis B immunoglobulin WHO ATC
0-L J06BB05 rabies immunoglobulin WHO ATC
0-L J06BB06 rubella immunoglobulin WHO ATC
0-L J06BB07 vaccinia immunoglobulin WHO ATC
0-L J06BB08 staphylococcus immunoglobulin WHO ATC
0-L J06BB09 cytomegalovirus immunoglobulin WHO ATC
0-L J06BB10 diphtheria immunoglobulin WHO ATC
0-L J06BB11 hepatitis A immunoglobulin WHO ATC
0-L J06BB12 encephalitis, tick borne immunoglobulin WHO ATC
0-L J06BB13 pertussis immunoglobulin WHO ATC
0-L J06BB14 measles immunoglobulin WHO ATC
0-L J06BB15 mumps immunoglobulin WHO ATC
0-L J06BB16 palivizumab WHO ATC
0-L J06BB30 combinations WHO ATC
0-L J06BC Other immunoglobulins WHO ATC
0-L J06BC01 nebacumab WHO ATC
0-L J07 VACCINES WHO ATC
0-L J07A BACTERIAL VACCINES WHO ATC
0-L J07AC Anthrax vaccines WHO ATC
0-L J07AC01 anthrax antigen WHO ATC
0-L J07AD Brucellosis vaccines WHO ATC
0-L J07AD01 brucella antigen WHO ATC
0-L J07AE Cholera vaccines WHO ATC
0-L J07AE01 cholera, inactivated, whole cell WHO ATC
0-L J07AE02 cholera, live attenuated WHO ATC
0-L J07AE51 cholera, combinations with typhoid vaccine, inactivated, whole cell WHO ATC
0-L J07AF Diphtheria vaccines WHO ATC
0-L J07AF01 diphtheria toxoid WHO ATC
0-L J07AG Hemophilus influenzae B vaccines WHO ATC
0-L J07AG01 hemophilus influenzae B, purified antigen conjugated WHO ATC
0-L J07AG51 hemophilus influenzae B, combinations with toxoids WHO ATC
0-L J07AG52 hemophilus influenzae B, combinations with pertussis and toxoids WHO ATC
0-L J07AG53 hemophilus influenzae B, combinations with meningococcus C, conjugated WHO ATC
0-L J07AH Meningococcal vaccines WHO ATC
0-L J07AH01 meningococcus A, purified polysaccharides antigen WHO ATC
0-L J07AH02 other meningococcal monovalent purified polysaccharides antigen WHO ATC
0-L J07AH03 meningococcus, bivalent purified polysaccharides antigen WHO ATC
0-L J07AH04 meningococcus, tetravalent purified polysaccharides antigen WHO ATC
0-L J07AH05 other meningococcal polyvalent purified polysaccharides antigen WHO ATC
0-L J07AH06 meningococcus B, outer membrane vesicle vaccine WHO ATC
0-L J07AH07 meningococcus C, purified polysaccharides antigen conjugated WHO ATC
0-L J07AH08 meningococcus, tetravalent purified polysaccharides antigen conjugated WHO ATC
0-L J07AJ Pertussis vaccines WHO ATC
0-L J07AJ01 pertussis, inactivated, whole cell WHO ATC
0-L J07AJ02 pertussis, purified antigen WHO ATC
0-L J07AJ51 pertussis, inactivated, whole cell, combinations with toxoids WHO ATC
0-L J07AJ52 pertussis, purified antigen, combinations with toxoids WHO ATC
0-L J07AK Plague vaccines WHO ATC
0-L J07AK01 plague, inactivated, whole cell WHO ATC
0-L J07AL Pneumococcal vaccines WHO ATC
0-L J07AL01 pneumococcus, purified polysaccharides antigen WHO ATC
0-L J07AL02 pneumococcus, purified polysaccharides antigen conjugated WHO ATC
0-L J07AL52 pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated WHO ATC
0-L J07AM Tetanus vaccines WHO ATC
0-L J07AM01 tetanus toxoid WHO ATC
0-L J07AM51 tetanus toxoid, combinations with diphtheria toxoid WHO ATC
0-L J07AM52 tetanus toxoid, combinations with tetanus immunoglobulin WHO ATC
0-L J07AN Tuberculosis vaccines WHO ATC
0-L J07AN01 tuberculosis, live attenuated WHO ATC
0-L J07AP Typhoid vaccines WHO ATC
0-L J07AP01 typhoid, oral, live attenuated WHO ATC
0-L J07AP02 typhoid, inactivated, whole cell WHO ATC
0-L J07AP03 typhoid, purified polysaccharide antigen WHO ATC
0-L J07AP10 typhoid, combinations with paratyphi types WHO ATC
0-L J07AR Typhus (exanthematicus) vaccines WHO ATC
0-L J07AR01 typhus exanthematicus, inactivated, whole cell WHO ATC
0-L J07AX Other bacterial vaccines WHO ATC
0-L J07B VIRAL VACCINES WHO ATC
0-L J07BA Encephalitis vaccines WHO ATC
0-L J07BA01 encephalitis, tick borne, inactivated, whole virus WHO ATC
0-L J07BA02 encephalitis, Japanese, inactivated, whole virus WHO ATC
0-L J07BB Influenza vaccines WHO ATC
0-L J07BB01 influenza, inactivated, whole virus WHO ATC
0-L J07BB02 influenza, inactivated, split virus or surface antigen WHO ATC
0-L J07BB03 influenza, live attenuated WHO ATC
0-L J07BC Hepatitis vaccines WHO ATC
0-L J07BC01 hepatitis B, purified antigen WHO ATC
0-L J07BC02 hepatitis A, inactivated, whole virus WHO ATC
0-L J07BC20 combinations WHO ATC
0-L J07BD Measles vaccines WHO ATC
0-L J07BD01 measles, live attenuated WHO ATC
0-L J07BD51 measles, combinations with mumps, live attenuated WHO ATC
0-L J07BD52 measles, combinations with mumps and rubella, live attenuated WHO ATC
0-L J07BD53 measles, combinations with rubella, live attenuated WHO ATC
0-L J07BD54 measles, combinations with mumps, rubella and varicella, live attenuated WHO ATC
0-L J07BE Mumps vaccines WHO ATC
0-L J07BE01 mumps, live attenuated WHO ATC
0-L J07BF Poliomyelitis vaccines WHO ATC
0-L J07BF01 poliomyelitis oral, monovalent live attenuated WHO ATC
0-L J07BF02 poliomyelitis oral, trivalent, live attenuated WHO ATC
0-L J07BF03 poliomyelitis, trivalent, inactivated, whole virus WHO ATC
0-L J07BG Rabies vaccines WHO ATC
0-L J07BG01 rabies, inactivated, whole virus WHO ATC
0-L J07BH Rota virus diarrhea vaccines WHO ATC
0-L J07BH01 rota virus, live attenuated WHO ATC
0-L J07BH02 rota virus, pentavalent, live, reassorted WHO ATC
0-L J07BJ Rubella vaccines WHO ATC
0-L J07BJ01 rubella, live attenuated WHO ATC
0-L J07BJ51 rubella, combinations with mumps, live attenuated WHO ATC
0-L J07BK Varicella zoster vaccines WHO ATC
0-L J07BK01 varicella, live attenuated WHO ATC
0-L J07BK02 zoster, live attenuated WHO ATC
0-L J07BL Yellow fever vaccines WHO ATC
0-L J07BL01 yellow fever, live attenuated WHO ATC
0-L J07BM Papillomavirus vaccines WHO ATC
0-L J07BM01 papillomavirus (human types 6, 11, 16, 18) WHO ATC
0-L J07BM02 papillomavirus (human types 16, 18) WHO ATC
0-L J07BX Other viral vaccines WHO ATC
0-L J07C BACTERIAL AND VIRAL VACCINES, COMBINED WHO ATC
0-L J07CA Bacterial and viral vaccines, combined WHO ATC
0-L J07CA01 diphtheria-poliomyelitis-tetanus WHO ATC
0-L J07CA02 diphtheria-pertussis-poliomyelitis-tetanus WHO ATC
0-L J07CA03 diphtheria-rubella-tetanus WHO ATC
0-L J07CA04 hemophilus influenzae B and poliomyelitis WHO ATC
0-L J07CA05 diphtheria-hepatitis B-pertussis-tetanus WHO ATC
0-L J07CA06 diphtheria-Hemophilus influenzae B-pertussis-poliomyelitis-tetanus WHO ATC
0-L J07CA07 diphtheria-hepatitis B-tetanus WHO ATC
0-L J07CA08 hemophilus influenzae B and hepatitis B WHO ATC
0-L J07CA09 diphtheria-Hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B WHO ATC
0-L J07CA10 typhoid-hepatitis A WHO ATC
0-L J07CA11 diphtheria-Hemophilus influenzae B-pertussis-tetanus-hepatitis B WHO ATC
0-L J07CA12 diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B WHO ATC
0-L J07CA13 diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C WHO ATC
0-L J07X OTHER VACCINES WHO ATC
0-L L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS WHO ATC
0-L L01 ANTINEOPLASTIC AGENTS WHO ATC
0-L L01A ALKYLATING AGENTS WHO ATC
0-L L01AA Nitrogen mustard analogues WHO ATC
0-L L01AA01 cyclophosphamide WHO ATC
0-L L01AA02 chlorambucil WHO ATC
0-L L01AA03 melphalan WHO ATC
0-L L01AA05 chlormethine WHO ATC
0-L L01AA06 ifosfamide WHO ATC
0-L L01AA07 trofosfamide WHO ATC
0-L L01AA08 prednimustine WHO ATC
0-L L01AA09 bendamustine WHO ATC
0-L L01AB Alkyl sulfonates WHO ATC
0-L L01AB01 busulfan WHO ATC
0-L L01AB02 treosulfan WHO ATC
0-L L01AB03 mannosulfan WHO ATC
0-L L01AC Ethylene imines WHO ATC
0-L L01AC01 thiotepa WHO ATC
0-L L01AC02 triaziquone WHO ATC
0-L L01AC03 carboquone WHO ATC
0-L L01AD Nitrosoureas WHO ATC
0-L L01AD01 carmustine WHO ATC
0-L L01AD02 lomustine WHO ATC
0-L L01AD03 semustine WHO ATC
0-L L01AD04 streptozocin WHO ATC
0-L L01AD05 fotemustine WHO ATC
0-L L01AD06 nimustine WHO ATC
0-L L01AD07 ranimustine WHO ATC
0-L L01AG Epoxides WHO ATC
0-L L01AG01 etoglucid WHO ATC
0-L L01AX Other alkylating agents WHO ATC
0-L L01AX01 mitobronitol WHO ATC
0-L L01AX02 pipobroman WHO ATC
0-L L01AX03 temozolomide WHO ATC
0-L L01AX04 dacarbazine WHO ATC
0-L L01B ANTIMETABOLITES WHO ATC
0-L L01BA Folic acid analogues WHO ATC
0-L L01BA01 methotrexate WHO ATC
0-L L01BA03 raltitrexed WHO ATC
0-L L01BA04 pemetrexed WHO ATC
0-L L01BA05 pralatrexate WHO ATC
0-L L01BB Purine analogues WHO ATC
0-L L01BB02 mercaptopurine WHO ATC
0-L L01BB03 tioguanine WHO ATC
0-L L01BB04 cladribine WHO ATC
0-L L01BB05 fludarabine WHO ATC
0-L L01BB06 clofarabine WHO ATC
0-L L01BB07 nelarabine WHO ATC
0-L L01BC Pyrimidine analogues WHO ATC
0-L L01BC01 cytarabine WHO ATC
0-L L01BC02 fluorouracil WHO ATC
0-L L01BC03 tegafur WHO ATC
0-L L01BC04 carmofur WHO ATC
0-L L01BC05 gemcitabine WHO ATC
0-L L01BC06 capecitabine WHO ATC
0-L L01BC07 azacitidine WHO ATC
0-L L01BC08 decitabine WHO ATC
0-L L01BC52 fluorouracil, combinations WHO ATC
0-L L01BC53 tegafur, combinations WHO ATC
0-L L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS WHO ATC
0-L L01CA Vinca alkaloids and analogues WHO ATC
0-L L01CA01 vinblastine WHO ATC
0-L L01CA02 vincristine WHO ATC
0-L L01CA03 vindesine WHO ATC
0-L L01CA04 vinorelbine WHO ATC
0-L L01CA05 vinflunine WHO ATC
0-L L01CB Podophyllotoxin derivatives WHO ATC
0-L L01CB01 etoposide WHO ATC
0-L L01CB02 teniposide WHO ATC
0-L L01CC Colchicine derivatives WHO ATC
0-L L01CC01 demecolcine WHO ATC
0-L L01CD Taxanes WHO ATC
0-L L01CD01 paclitaxel WHO ATC
0-L L01CD02 docetaxel WHO ATC
0-L L01CD03 paclitaxel poliglumex WHO ATC
0-L L01CX Other plant alkaloids and natural products WHO ATC
0-L L01CX01 trabectedin WHO ATC
0-L L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES WHO ATC
0-L L01DA Actinomycines WHO ATC
0-L L01DA01 dactinomycin WHO ATC
0-L L01DB Anthracyclines and related substances WHO ATC
0-L L01DB01 doxorubicin WHO ATC
0-L L01DB02 daunorubicin WHO ATC
0-L L01DB03 epirubicin WHO ATC
0-L L01DB04 aclarubicin WHO ATC
0-L L01DB05 zorubicin WHO ATC
0-L L01DB06 idarubicin WHO ATC
0-L L01DB07 mitoxantrone WHO ATC
0-L L01DB08 pirarubicin WHO ATC
0-L L01DB09 valrubicin WHO ATC
0-L L01DC Other cytotoxic antibiotics WHO ATC
0-L L01DC01 bleomycin WHO ATC
0-L L01DC02 plicamycin WHO ATC
0-L L01DC03 mitomycin WHO ATC
0-L L01DC04 ixabepilone WHO ATC
0-L L01X OTHER ANTINEOPLASTIC AGENTS WHO ATC
0-L L01XA Platinum compounds WHO ATC
0-L L01XA01 cisplatin WHO ATC
0-L L01XA02 carboplatin WHO ATC
0-L L01XA03 oxaliplatin WHO ATC
0-L L01XA04 satraplatin WHO ATC
0-L L01XB Methylhydrazines WHO ATC
0-L L01XB01 procarbazine WHO ATC
0-L L01XC Monoclonal antibodies WHO ATC
0-L L01XC01 edrecolomab WHO ATC
0-L L01XC02 rituximab WHO ATC
0-L L01XC03 trastuzumab WHO ATC
0-L L01XC04 alemtuzumab WHO ATC
0-L L01XC05 gemtuzumab WHO ATC
0-L L01XC06 cetuximab WHO ATC
0-L L01XC07 bevacizumab WHO ATC
0-L L01XC08 panitumumab WHO ATC
0-L L01XC09 catumaxomab WHO ATC
0-L L01XC10 ofatumumab WHO ATC
0-L L01XD Sensitizers used in photodynamic/radiation therapy WHO ATC
0-L L01XD01 porfimer sodium WHO ATC
0-L L01XD03 methyl aminolevulinate WHO ATC
0-L L01XD04 aminolevulinic acid WHO ATC
0-L L01XD05 temoporfin WHO ATC
0-L L01XD06 efaproxiral WHO ATC
0-L L01XE Protein kinase inhibitors WHO ATC
0-L L01XE01 imatinib WHO ATC
0-L L01XE02 gefitinib WHO ATC
0-L L01XE03 erlotinib WHO ATC
0-L L01XE04 sunitinib WHO ATC
0-L L01XE05 sorafenib WHO ATC
0-L L01XE06 dasatinib WHO ATC
0-L L01XE07 lapatinib WHO ATC
0-L L01XE08 nilotinib WHO ATC
0-L L01XE09 temsirolimus WHO ATC
0-L L01XE10 everolimus WHO ATC
0-L L01XE11 pazopanib WHO ATC
0-L L01XX Other antineoplastic agents WHO ATC
0-L L01XX01 amsacrine WHO ATC
0-L L01XX02 asparaginase WHO ATC
0-L L01XX03 altretamine WHO ATC
0-L L01XX05 hydroxycarbamide WHO ATC
0-L L01XX07 lonidamine WHO ATC
0-L L01XX08 pentostatin WHO ATC
0-L L01XX09 miltefosine WHO ATC
0-L L01XX10 masoprocol WHO ATC
0-L L01XX11 estramustine WHO ATC
0-L L01XX14 tretinoin WHO ATC
0-L L01XX16 mitoguazone WHO ATC
0-L L01XX17 topotecan WHO ATC
0-L L01XX18 tiazofurine WHO ATC
0-L L01XX19 irinotecan WHO ATC
0-L L01XX22 alitretinoin WHO ATC
0-L L01XX23 mitotane WHO ATC
0-L L01XX24 pegaspargase WHO ATC
0-L L01XX25 bexarotene WHO ATC
0-L L01XX27 arsenic trioxide WHO ATC
0-L L01XX29 denileukin diftitox WHO ATC
0-L L01XX32 bortezomib WHO ATC
0-L L01XX33 celecoxib WHO ATC
0-L L01XX35 anagrelide WHO ATC
0-L L01XX36 oblimersen WHO ATC
0-L L01XX37 sitimagene ceradenovec WHO ATC
0-L L01XX38 vorinostat WHO ATC
0-L L01XX39 romidepsin WHO ATC
0-L L01XY Combinations of antineoplastic agents WHO ATC
0-L L02 ENDOCRINE THERAPY WHO ATC
0-L L02A HORMONES AND RELATED AGENTS WHO ATC
0-L L02AA Estrogens WHO ATC
0-L L02AA01 diethylstilbestrol WHO ATC
0-L L02AA02 polyestradiol phosphate WHO ATC
0-L L02AA03 ethinylestradiol WHO ATC
0-L L02AA04 fosfestrol WHO ATC
0-L L02AB Progestogens WHO ATC
0-L L02AB01 megestrol WHO ATC
0-L L02AB02 medroxyprogesterone WHO ATC
0-L L02AB03 gestonorone WHO ATC
0-L L02AE Gonadotropin releasing hormone analogues WHO ATC
0-L L02AE01 buserelin WHO ATC
0-L L02AE02 leuprorelin WHO ATC
0-L L02AE03 goserelin WHO ATC
0-L L02AE04 triptorelin WHO ATC
0-L L02AX Other hormones WHO ATC
0-L L02B HORMONE ANTAGONISTS AND RELATED AGENTS WHO ATC
0-L L02BA Anti-estrogens WHO ATC
0-L L02BA01 tamoxifen WHO ATC
0-L L02BA02 toremifene WHO ATC
0-L L02BA03 fulvestrant WHO ATC
0-L L02BB Anti-androgens WHO ATC
0-L L02BB01 flutamide WHO ATC
0-L L02BB02 nilutamide WHO ATC
0-L L02BB03 bicalutamide WHO ATC
0-L L02BG Enzyme inhibitors WHO ATC
0-L L02BG01 aminoglutethimide WHO ATC
0-L L02BG02 formestane WHO ATC
0-L L02BG03 anastrozole WHO ATC
0-L L02BG04 letrozole WHO ATC
0-L L02BG05 vorozole WHO ATC
0-L L02BG06 exemestane WHO ATC
0-L L02BX Other hormone antagonists and related agents WHO ATC
0-L L02BX01 abarelix WHO ATC
0-L L02BX02 degarelix WHO ATC
0-L L03 IMMUNOSTIMULANTS WHO ATC
0-L L03A IMMUNOSTIMULANTS WHO ATC
0-L L03AA Colony stimulating factors WHO ATC
0-L L03AA02 filgrastim WHO ATC
0-L L03AA03 molgramostim WHO ATC
0-L L03AA09 sargramostim WHO ATC
0-L L03AA10 lenograstim WHO ATC
0-L L03AA12 ancestim WHO ATC
0-L L03AA13 pegfilgrastim WHO ATC
0-L L03AB Interferons WHO ATC
0-L L03AB01 interferon alfa natural WHO ATC
0-L L03AB02 interferon beta natural WHO ATC
0-L L03AB03 interferon gamma WHO ATC
0-L L03AB04 interferon alfa-2a WHO ATC
0-L L03AB05 interferon alfa-2b WHO ATC
0-L L03AB06 interferon alfa-n1 WHO ATC
0-L L03AB07 interferon beta-1a WHO ATC
0-L L03AB08 interferon beta-1b WHO ATC
0-L L03AB09 interferon alfacon-1 WHO ATC
0-L L03AB10 peginterferon alfa-2b WHO ATC
0-L L03AB11 peginterferon alfa-2a WHO ATC
0-L L03AB60 peginterferon alfa-2b, combinations WHO ATC
0-L L03AB61 peginterferon alfa-2a, combinations WHO ATC
0-L L03AC Interleukins WHO ATC
0-L L03AC01 aldesleukin WHO ATC
0-L L03AC02 oprelvekin WHO ATC
0-L L03AX Other immunostimulants WHO ATC
0-L L03AX01 lentinan WHO ATC
0-L L03AX02 roquinimex WHO ATC
0-L L03AX03 BCG vaccine WHO ATC
0-L L03AX04 pegademase WHO ATC
0-L L03AX05 pidotimod WHO ATC
0-L L03AX07 poly I:C WHO ATC
0-L L03AX08 poly ICLC WHO ATC
0-L L03AX09 thymopentin WHO ATC
0-L L03AX10 immunocyanin WHO ATC
0-L L03AX11 tasonermin WHO ATC
0-L L03AX12 melanoma vaccine WHO ATC
0-L L03AX13 glatiramer acetate WHO ATC
0-L L03AX14 histamine dihydrochloride WHO ATC
0-L L03AX15 mifamurtide WHO ATC
0-L L03AX16 plerixafor WHO ATC
0-L L04 IMMUNOSUPPRESSANTS WHO ATC
0-L L04A IMMUNOSUPPRESSANTS WHO ATC
0-L L04AA Selective immunosuppressants WHO ATC
0-L L04AA02 muromonab-CD3 WHO ATC
0-L L04AA03 antilymphocyte immunoglobulin (horse) WHO ATC
0-L L04AA04 antithymocyte immunoglobulin (rabbit) WHO ATC
0-L L04AA06 mycophenolic acid WHO ATC
0-L L04AA10 sirolimus WHO ATC
0-L L04AA13 leflunomide WHO ATC
0-L L04AA15 alefacept WHO ATC
0-L L04AA18 everolimus WHO ATC
0-L L04AA19 gusperimus WHO ATC
0-L L04AA21 efalizumab WHO ATC
0-L L04AA22 abetimus WHO ATC
0-L L04AA23 natalizumab WHO ATC
0-L L04AA24 abatacept WHO ATC
0-L L04AA25 eculizumab WHO ATC
0-L L04AB Tumor necrosis factor alpha (TNF-α) inhibitors WHO ATC
0-L L04AB01 etanercept WHO ATC
0-L L04AB02 infliximab WHO ATC
0-L L04AB03 afelimomab WHO ATC
0-L L04AB04 adalimumab WHO ATC
0-L L04AB05 certolizumab pegol WHO ATC
0-L L04AB06 golimumab WHO ATC
0-L L04AC Interleukin inhibitors WHO ATC
0-L L04AC01 daclizumab WHO ATC
0-L L04AC02 basiliximab WHO ATC
0-L L04AC03 anakinra WHO ATC
0-L L04AC04 rilonacept WHO ATC
0-L L04AC05 ustekinumab WHO ATC
0-L L04AC06 mepolizumab WHO ATC
0-L L04AC07 tocilizumab WHO ATC
0-L L04AC08 canakinumab WHO ATC
0-L L04AD Calcineurin inhibitors WHO ATC
0-L L04AD01 ciclosporin WHO ATC
0-L L04AD02 tacrolimus WHO ATC
0-L L04AX Other immunosuppressants WHO ATC
0-L L04AX01 azathioprine WHO ATC
0-L L04AX02 thalidomide WHO ATC
0-L L04AX03 methotrexate WHO ATC
0-L L04AX04 lenalidomide WHO ATC
0-L M MUSCULO-SKELETAL SYSTEM WHO ATC
0-L M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS WHO ATC
0-L M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS WHO ATC
0-L M01AA Butylpyrazolidines WHO ATC
0-L M01AA01 phenylbutazone WHO ATC
0-L M01AA02 mofebutazone WHO ATC
0-L M01AA03 oxyphenbutazone WHO ATC
0-L M01AA05 clofezone WHO ATC
0-L M01AA06 kebuzone WHO ATC
0-L M01AB Acetic acid derivatives and related substances WHO ATC
0-L M01AB01 indometacin WHO ATC
0-L M01AB02 sulindac WHO ATC
0-L M01AB03 tolmetin WHO ATC
0-L M01AB04 zomepirac WHO ATC
0-L M01AB05 diclofenac WHO ATC
0-L M01AB06 alclofenac WHO ATC
0-L M01AB07 bumadizone WHO ATC
0-L M01AB08 etodolac WHO ATC
0-L M01AB09 lonazolac WHO ATC
0-L M01AB10 fentiazac WHO ATC
0-L M01AB11 acemetacin WHO ATC
0-L M01AB12 difenpiramide WHO ATC
0-L M01AB13 oxametacin WHO ATC
0-L M01AB14 proglumetacin WHO ATC
0-L M01AB15 ketorolac WHO ATC
0-L M01AB16 aceclofenac WHO ATC
0-L M01AB17 bufexamac WHO ATC
0-L M01AB51 indometacin, combinations WHO ATC
0-L M01AB55 diclofenac, combinations WHO ATC
0-L M01AC Oxicams WHO ATC
0-L M01AC01 piroxicam WHO ATC
0-L M01AC02 tenoxicam WHO ATC
0-L M01AC04 droxicam WHO ATC
0-L M01AC05 lornoxicam WHO ATC
0-L M01AC06 meloxicam WHO ATC
0-L M01AE Propionic acid derivatives WHO ATC
0-L M01AE01 ibuprofen WHO ATC
0-L M01AE02 naproxen WHO ATC
0-L M01AE03 ketoprofen WHO ATC
0-L M01AE04 fenoprofen WHO ATC
0-L M01AE05 fenbufen WHO ATC
0-L M01AE06 benoxaprofen WHO ATC
0-L M01AE07 suprofen WHO ATC
0-L M01AE08 pirprofen WHO ATC
0-L M01AE09 flurbiprofen WHO ATC
0-L M01AE10 indoprofen WHO ATC
0-L M01AE11 tiaprofenic acid WHO ATC
0-L M01AE12 oxaprozin WHO ATC
0-L M01AE13 ibuproxam WHO ATC
0-L M01AE14 dexibuprofen WHO ATC
0-L M01AE15 flunoxaprofen WHO ATC
0-L M01AE16 alminoprofen WHO ATC
0-L M01AE17 dexketoprofen WHO ATC
0-L M01AE51 ibuprofen, combinations WHO ATC
0-L M01AE53 ketoprofen, combinations WHO ATC
0-L M01AG Fenamates WHO ATC
0-L M01AG01 mefenamic acid WHO ATC
0-L M01AG02 tolfenamic acid WHO ATC
0-L M01AG03 flufenamic acid WHO ATC
0-L M01AG04 meclofenamic acid WHO ATC
0-L M01AH Coxibs WHO ATC
0-L M01AH01 celecoxib WHO ATC
0-L M01AH02 rofecoxib WHO ATC
0-L M01AH03 valdecoxib WHO ATC
0-L M01AH04 parecoxib WHO ATC
0-L M01AH05 etoricoxib WHO ATC
0-L M01AH06 lumiracoxib WHO ATC
0-L M01AX Other antiinflammatory and antirheumatic agents, non-steroids WHO ATC
0-L M01AX01 nabumetone WHO ATC
0-L M01AX02 niflumic acid WHO ATC
0-L M01AX04 azapropazone WHO ATC
0-L M01AX05 glucosamine WHO ATC
0-L M01AX07 benzydamine WHO ATC
0-L M01AX12 glucosaminoglycan polysulfate WHO ATC
0-L M01AX13 proquazone WHO ATC
0-L M01AX14 orgotein WHO ATC
0-L M01AX17 nimesulide WHO ATC
0-L M01AX18 feprazone WHO ATC
0-L M01AX21 diacerein WHO ATC
0-L M01AX22 morniflumate WHO ATC
0-L M01AX23 tenidap WHO ATC
0-L M01AX24 oxaceprol WHO ATC
0-L M01AX25 chondroitin sulfate WHO ATC
0-L M01AX68 feprazone, combinations WHO ATC
0-L M01B ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION WHO ATC
0-L M01BA Antiinflammatory/antirheumatic agents in combination with corticosteroids WHO ATC
0-L M01BA01 phenylbutazone and corticosteroids WHO ATC
0-L M01BA02 dipyrocetyl and corticosteroids WHO ATC
0-L M01BA03 acetylsalicylic acid and corticosteroids WHO ATC
0-L M01BX Other antiinflammatory/antirheumatic agents in combination with other drugs WHO ATC
0-L M01C SPECIFIC ANTIRHEUMATIC AGENTS WHO ATC
0-L M01CA Quinolines WHO ATC
0-L M01CA03 oxycinchophen WHO ATC
0-L M01CB Gold preparations WHO ATC
0-L M01CB01 sodium aurothiomalate WHO ATC
0-L M01CB02 sodium aurotiosulfate WHO ATC
0-L M01CB03 auranofin WHO ATC
0-L M01CB04 aurothioglucose WHO ATC
0-L M01CB05 aurotioprol WHO ATC
0-L M01CC Penicillamine and similar agents WHO ATC
0-L M01CC01 penicillamine WHO ATC
0-L M01CC02 bucillamine WHO ATC
0-L M01CX Other specific antirheumatic agents WHO ATC
0-L M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN WHO ATC
0-L M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN WHO ATC
0-L M02AA Antiinflammatory preparations, non-steroids for topical use WHO ATC
0-L M02AA01 phenylbutazone WHO ATC
0-L M02AA02 mofebutazone WHO ATC
0-L M02AA03 clofezone WHO ATC
0-L M02AA04 oxyphenbutazone WHO ATC
0-L M02AA05 benzydamine WHO ATC
0-L M02AA06 etofenamate WHO ATC
0-L M02AA07 piroxicam WHO ATC
0-L M02AA08 felbinac WHO ATC
0-L M02AA09 bufexamac WHO ATC
0-L M02AA10 ketoprofen WHO ATC
0-L M02AA11 bendazac WHO ATC
0-L M02AA12 naproxen WHO ATC
0-L M02AA13 ibuprofen WHO ATC
0-L M02AA14 fentiazac WHO ATC
0-L M02AA15 diclofenac WHO ATC
0-L M02AA16 feprazone WHO ATC
0-L M02AA17 niflumic acid WHO ATC
0-L M02AA18 meclofenamic acid WHO ATC
0-L M02AA19 flurbiprofen WHO ATC
0-L M02AA21 tolmetin WHO ATC
0-L M02AA22 suxibuzone WHO ATC
0-L M02AA23 indometacin WHO ATC
0-L M02AA24 nifenazone WHO ATC
0-L M02AA25 aceclofenac WHO ATC
0-L M02AB Capsaicin and similar agents WHO ATC
0-L M02AB01 capsaicin WHO ATC
0-L M02AB02 zucapsaicin WHO ATC
0-L M02AC Preparations with salicylic acid derivatives WHO ATC
0-L M02AX Other topical products for joint and muscular pain WHO ATC
0-L M02AX02 tolazoline WHO ATC
0-L M02AX03 dimethyl sulfoxide WHO ATC
0-L M02AX10 various WHO ATC
0-L M03 MUSCLE RELAXANTS WHO ATC
0-L M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS WHO ATC
0-L M03AA Curare alkaloids WHO ATC
0-L M03AA01 alcuronium WHO ATC
0-L M03AA02 tubocurarine WHO ATC
0-L M03AA04 dimethyltubocurarine WHO ATC
0-L M03AB Choline derivatives WHO ATC
0-L M03AB01 suxamethonium WHO ATC
0-L M03AC Other quaternary ammonium compounds WHO ATC
0-L M03AC01 pancuronium WHO ATC
0-L M03AC02 gallamine WHO ATC
0-L M03AC03 vecuronium WHO ATC
0-L M03AC04 atracurium WHO ATC
0-L M03AC05 hexafluronium WHO ATC
0-L M03AC06 pipecuronium bromide WHO ATC
0-L M03AC07 doxacurium chloride WHO ATC
0-L M03AC08 fazadinium bromide WHO ATC
0-L M03AC09 rocuronium bromide WHO ATC
0-L M03AC10 mivacurium chloride WHO ATC
0-L M03AC11 cisatracurium WHO ATC
0-L M03AX Other muscle relaxants, peripherally acting agents WHO ATC
0-L M03AX01 botulinum toxin WHO ATC
0-L M03B MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS WHO ATC
0-L M03BA Carbamic acid esters WHO ATC
0-L M03BA01 phenprobamate WHO ATC
0-L M03BA02 carisoprodol WHO ATC
0-L M03BA03 methocarbamol WHO ATC
0-L M03BA04 styramate WHO ATC
0-L M03BA05 febarbamate WHO ATC
0-L M03BA51 phenprobamate, combinations excl. psycholeptics WHO ATC
0-L M03BA52 carisoprodol, combinations excl. psycholeptics WHO ATC
0-L M03BA53 methocarbamol, combinations excl. psycholeptics WHO ATC
0-L M03BA71 phenprobamate, combinations with psycholeptics WHO ATC
0-L M03BA72 carisoprodol, combinations with psycholeptics WHO ATC
0-L M03BA73 methocarbamol, combinations with psycholeptics WHO ATC
0-L M03BB Oxazol, thiazine, and triazine derivatives WHO ATC
0-L M03BB02 chlormezanone WHO ATC
0-L M03BB03 chlorzoxazone WHO ATC
0-L M03BB52 chlormezanone, combinations excl. psycholeptics WHO ATC
0-L M03BB53 chlorzoxazone, combinations excl. psycholeptics WHO ATC
0-L M03BB72 chlormezanone, combinations with psycholeptics WHO ATC
0-L M03BB73 chlorzoxazone, combinations with psycholeptics WHO ATC
0-L M03BC Ethers, chemically close to antihistamines WHO ATC
0-L M03BC01 orphenadrine (citrate) WHO ATC
0-L M03BC51 orphenadrine, combinations WHO ATC
0-L M03BX Other centrally acting agents WHO ATC
0-L M03BX01 baclofen WHO ATC
0-L M03BX02 tizanidine WHO ATC
0-L M03BX03 pridinol WHO ATC
0-L M03BX04 tolperisone WHO ATC
0-L M03BX05 thiocolchicoside WHO ATC
0-L M03BX06 mephenesin WHO ATC
0-L M03BX07 tetrazepam WHO ATC
0-L M03BX08 cyclobenzaprine WHO ATC
0-L M03BX09 eperisone WHO ATC
0-L M03BX30 fenyramidol WHO ATC
0-L M03C MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS WHO ATC
0-L M03CA Dantrolene and derivatives WHO ATC
0-L M03CA01 dantrolene WHO ATC
0-L M04 ANTIGOUT PREPARATIONS WHO ATC
0-L M04A ANTIGOUT PREPARATIONS WHO ATC
0-L M04AA Preparations inhibiting uric acid production WHO ATC
0-L M04AA01 allopurinol WHO ATC
0-L M04AA02 tisopurine WHO ATC
0-L M04AA03 febuxostat WHO ATC
0-L M04AA51 allopurinol, combinations WHO ATC
0-L M04AB Preparations increasing uric acid excretion WHO ATC
0-L M04AB01 probenecid WHO ATC
0-L M04AB02 sulfinpyrazone WHO ATC
0-L M04AB03 benzbromarone WHO ATC
0-L M04AB04 isobromindione WHO ATC
0-L M04AC Preparations with no effect on uric acid metabolism WHO ATC
0-L M04AC01 colchicine WHO ATC
0-L M04AC02 cinchophen WHO ATC
0-L M04AX Other antigout preparations WHO ATC
0-L M04AX01 urate oxidase WHO ATC
0-L M04AX02 pegloticase WHO ATC
0-L M05 DRUGS FOR TREATMENT OF BONE DISEASES WHO ATC
0-L M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION WHO ATC
0-L M05BA Bisphosphonates WHO ATC
0-L M05BA01 etidronic acid WHO ATC
0-L M05BA02 clodronic acid WHO ATC
0-L M05BA03 pamidronic acid WHO ATC
0-L M05BA04 alendronic acid WHO ATC
0-L M05BA05 tiludronic acid WHO ATC
0-L M05BA06 ibandronic acid WHO ATC
0-L M05BA07 risedronic acid WHO ATC
0-L M05BA08 zoledronic acid WHO ATC
0-L M05BB Bisphosphonates, combinations WHO ATC
0-L M05BB01 etidronic acid and calcium, sequential WHO ATC
0-L M05BB02 risedronic acid and calcium, sequential WHO ATC
0-L M05BB03 alendronic acid and colecalciferol WHO ATC
0-L M05BB04 risedronic acid, calcium and colecalciferol, sequential WHO ATC
0-L M05BC Bone morphogenetic proteins WHO ATC
0-L M05BC01 dibotermin alfa WHO ATC
0-L M05BC02 eptotermin alfa WHO ATC
0-L M05BX Other drugs affecting bone structure and mineralization WHO ATC
0-L M05BX01 ipriflavone WHO ATC
0-L M05BX02 aluminium chlorohydrate WHO ATC
0-L M05BX03 strontium ranelate WHO ATC
0-L M05BX04 denosumab WHO ATC
0-L M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM WHO ATC
0-L M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM WHO ATC
0-L M09AA Quinine and derivatives WHO ATC
0-L M09AA01 hydroquinine WHO ATC
0-L M09AA72 quinine, combinations with psycholeptics WHO ATC
0-L M09AB Enzymes WHO ATC
0-L M09AB01 chymopapain WHO ATC
0-L M09AB52 trypsin, combinations WHO ATC
0-L M09AX Other drugs for disorders of the musculo-skeletal system WHO ATC
0-L M09AX01 hyaluronic acid WHO ATC
0-L N NERVOUS SYSTEM WHO ATC
0-L N01 ANESTHETICS WHO ATC
0-L N01A ANESTHETICS, GENERAL WHO ATC
0-L N01AA Ethers WHO ATC
0-L N01AA01 diethyl ether WHO ATC
0-L N01AA02 vinyl ether WHO ATC
0-L N01AB Halogenated hydrocarbons WHO ATC
0-L N01AB01 halothane WHO ATC
0-L N01AB02 chloroform WHO ATC
0-L N01AB04 enflurane WHO ATC
0-L N01AB05 trichloroethylene WHO ATC
0-L N01AB06 isoflurane WHO ATC
0-L N01AB07 desflurane WHO ATC
0-L N01AB08 sevoflurane WHO ATC
0-L N01AF Barbiturates, plain WHO ATC
0-L N01AF01 methohexital WHO ATC
0-L N01AF02 hexobarbital WHO ATC
0-L N01AF03 thiopental WHO ATC
0-L N01AG Barbiturates in combination with other drugs WHO ATC
0-L N01AG01 narcobarbital WHO ATC
0-L N01AH Opioid anesthetics WHO ATC
0-L N01AH01 fentanyl WHO ATC
0-L N01AH02 alfentanil WHO ATC
0-L N01AH03 sufentanil WHO ATC
0-L N01AH04 phenoperidine WHO ATC
0-L N01AH05 anileridine WHO ATC
0-L N01AH06 remifentanil WHO ATC
0-L N01AH51 fentanyl, combinations WHO ATC
0-L N01AX Other general anesthetics WHO ATC
0-L N01AX01 droperidol WHO ATC
0-L N01AX03 ketamine WHO ATC
0-L N01AX04 propanidid WHO ATC
0-L N01AX05 alfaxalone WHO ATC
0-L N01AX07 etomidate WHO ATC
0-L N01AX10 propofol WHO ATC
0-L N01AX11 sodium oxybate WHO ATC
0-L N01AX13 nitrous oxide WHO ATC
0-L N01AX14 esketamine WHO ATC
0-L N01AX15 xenon WHO ATC
0-L N01AX63 nitrous oxide, combinations WHO ATC
0-L N01B ANESTHETICS, LOCAL WHO ATC
0-L N01BA Esters of aminobenzoic acid WHO ATC
0-L N01BA01 metabutethamine WHO ATC
0-L N01BA02 procaine WHO ATC
0-L N01BA03 tetracaine WHO ATC
0-L N01BA04 chloroprocaine WHO ATC
0-L N01BA05 benzocaine WHO ATC
0-L N01BA52 procaine, combinations WHO ATC
0-L N01BB Amides WHO ATC
0-L N01BB01 bupivacaine WHO ATC
0-L N01BB02 lidocaine WHO ATC
0-L N01BB03 mepivacaine WHO ATC
0-L N01BB04 prilocaine WHO ATC
0-L N01BB05 butanilicaine WHO ATC
0-L N01BB06 cinchocaine WHO ATC
0-L N01BB07 etidocaine WHO ATC
0-L N01BB08 articaine WHO ATC
0-L N01BB09 ropivacaine WHO ATC
0-L N01BB10 levobupivacaine WHO ATC
0-L N01BB20 combinations WHO ATC
0-L N01BB51 bupivacaine, combinations WHO ATC
0-L N01BB52 lidocaine, combinations WHO ATC
0-L N01BB53 mepivacaine, combinations WHO ATC
0-L N01BB54 prilocaine, combinations WHO ATC
0-L N01BB57 etidocaine, combinations WHO ATC
0-L N01BB58 articaine, combinations WHO ATC
0-L N01BC Esters of benzoic acid WHO ATC
0-L N01BC01 cocaine WHO ATC
0-L N01BX Other local anesthetics WHO ATC
0-L N01BX01 ethyl chloride WHO ATC
0-L N01BX02 dyclonine WHO ATC
0-L N01BX03 phenol WHO ATC
0-L N01BX04 capsaicin WHO ATC
0-L N02 ANALGESICS WHO ATC
0-L N02A OPIOIDS WHO ATC
0-L N02AA Natural opium alkaloids WHO ATC
0-L N02AA01 morphine WHO ATC
0-L N02AA02 opium WHO ATC
0-L N02AA03 hydromorphone WHO ATC
0-L N02AA04 nicomorphine WHO ATC
0-L N02AA05 oxycodone WHO ATC
0-L N02AA08 dihydrocodeine WHO ATC
0-L N02AA09 diamorphine WHO ATC
0-L N02AA10 papaveretum WHO ATC
0-L N02AA51 morphine, combinations WHO ATC
0-L N02AA55 oxycodone, combinations WHO ATC
0-L N02AA58 dihydrocodeine, combinations WHO ATC
0-L N02AA59 codeine, combinations excl. psycholeptics WHO ATC
0-L N02AA79 codeine, combinations with psycholeptics WHO ATC
0-L N02AB Phenylpiperidine derivatives WHO ATC
0-L N02AB01 ketobemidone WHO ATC
0-L N02AB02 pethidine WHO ATC
0-L N02AB03 fentanyl WHO ATC
0-L N02AB52 pethidine, combinations excl. psycholeptics WHO ATC
0-L N02AB72 pethidine, combinations with psycholeptics WHO ATC
0-L N02AC Diphenylpropylamine derivatives WHO ATC
0-L N02AC01 dextromoramide WHO ATC
0-L N02AC03 piritramide WHO ATC
0-L N02AC04 dextropropoxyphene WHO ATC
0-L N02AC05 bezitramide WHO ATC
0-L N02AC52 methadone, comb. excl. psycholeptics WHO ATC
0-L N02AC54 dextropropoxyphene, comb. excl. psycholeptics WHO ATC
0-L N02AC74 dextropropoxyphene, comb. with psycholeptics WHO ATC
0-L N02AD Benzomorphan derivatives WHO ATC
0-L N02AD01 pentazocine WHO ATC
0-L N02AD02 phenazocine WHO ATC
0-L N02AE Oripavine derivatives WHO ATC
0-L N02AE01 buprenorphine WHO ATC
0-L N02AF Morphinan derivatives WHO ATC
0-L N02AF01 butorphanol WHO ATC
0-L N02AF02 nalbuphine WHO ATC
0-L N02AG Opioids in combination with antispasmodics WHO ATC
0-L N02AG01 morphine and antispasmodics WHO ATC
0-L N02AG02 ketobemidone and antispasmodics WHO ATC
0-L N02AG03 pethidine and antispasmodics WHO ATC
0-L N02AG04 hydromorphone and antispasmodics WHO ATC
0-L N02AX Other opioids WHO ATC
0-L N02AX01 tilidine WHO ATC
0-L N02AX02 tramadol WHO ATC
0-L N02AX03 dezocine WHO ATC
0-L N02AX05 meptazinol WHO ATC
0-L N02AX06 tapentadol WHO ATC
0-L N02AX52 tramadol, combinations WHO ATC
0-L N02B OTHER ANALGESICS AND ANTIPYRETICS WHO ATC
0-L N02BA Salicylic acid and derivatives WHO ATC
0-L N02BA01 acetylsalicylic acid WHO ATC
0-L N02BA02 aloxiprin WHO ATC
0-L N02BA03 choline salicylate WHO ATC
0-L N02BA04 sodium salicylate WHO ATC
0-L N02BA05 salicylamide WHO ATC
0-L N02BA06 salsalate WHO ATC
0-L N02BA07 ethenzamide WHO ATC
0-L N02BA08 morpholine salicylate WHO ATC
0-L N02BA09 dipyrocetyl WHO ATC
0-L N02BA10 benorilate WHO ATC
0-L N02BA11 diflunisal WHO ATC
0-L N02BA12 potassium salicylate WHO ATC
0-L N02BA14 guacetisal WHO ATC
0-L N02BA15 carbasalate calcium WHO ATC
0-L N02BA16 imidazole salicylate WHO ATC
0-L N02BA51 acetylsalicylic acid, combinations excl. psycholeptics WHO ATC
0-L N02BA55 salicylamide, combinations excl. psycholeptics WHO ATC
0-L N02BA57 ethenzamide, combinations excl. psycholeptics WHO ATC
0-L N02BA59 dipyrocetyl, combinations excl. psycholeptics WHO ATC
0-L N02BA65 carbasalate calcium combinations excl. psycholeptics WHO ATC
0-L N02BA71 acetylsalicylic acid, combinations with psycholeptics WHO ATC
0-L N02BA75 salicylamide, combinations with psycholeptics WHO ATC
0-L N02BA77 ethenzamide, combinations with psycholeptics WHO ATC
0-L N02BA79 dipyrocetyl, combinations with psycholeptics WHO ATC
0-L N02BB Pyrazolones WHO ATC
0-L N02BB01 phenazone WHO ATC
0-L N02BB02 metamizole sodium WHO ATC
0-L N02BB03 aminophenazone WHO ATC
0-L N02BB04 propyphenazone WHO ATC
0-L N02BB05 nifenazone WHO ATC
0-L N02BB51 phenazone, combinations excl. psycholeptics WHO ATC
0-L N02BB52 metamizole sodium, combinations excl. psycholeptics WHO ATC
0-L N02BB53 aminophenazone, combinations excl. psycholeptics WHO ATC
0-L N02BB54 propyphenazone, combinations excl. psycholeptics WHO ATC
0-L N02BB71 phenazone, combinations with psycholeptics WHO ATC
0-L N02BB72 metamizole sodium, combinations with psycholeptics WHO ATC
0-L N02BB73 aminophenazone, combinations with psycholeptics WHO ATC
0-L N02BB74 propyphenazone, combinations with psycholeptics WHO ATC
0-L N02BE Anilides WHO ATC
0-L N02BE01 paracetamol WHO ATC
0-L N02BE03 phenacetin WHO ATC
0-L N02BE04 bucetin WHO ATC
0-L N02BE05 propacetamol WHO ATC
0-L N02BE51 paracetamol, combinations excl. psycholeptics WHO ATC
0-L N02BE53 phenacetin, combinations excl. psycholeptics WHO ATC
0-L N02BE54 bucetin, combinations excl. psycholeptics WHO ATC
0-L N02BE71 paracetamol, combinations with psycholeptics WHO ATC
0-L N02BE73 phenacetin, combinations with psycholeptics WHO ATC
0-L N02BE74 bucetin, combinations with psycholeptics WHO ATC
0-L N02BG Other analgesics and antipyretics WHO ATC
0-L N02BG02 rimazolium WHO ATC
0-L N02BG03 glafenine WHO ATC
0-L N02BG04 floctafenine WHO ATC
0-L N02BG05 viminol WHO ATC
0-L N02BG06 nefopam WHO ATC
0-L N02BG07 flupirtine WHO ATC
0-L N02BG08 ziconotide WHO ATC
0-L N02BG09 methoxyflurane WHO ATC
0-L N02BG10 nabiximols WHO ATC
0-L N02C ANTIMIGRAINE PREPARATIONS WHO ATC
0-L N02CA Ergot alkaloids WHO ATC
0-L N02CA01 dihydroergotamine WHO ATC
0-L N02CA02 ergotamine WHO ATC
0-L N02CA04 methysergide WHO ATC
0-L N02CA07 lisuride WHO ATC
0-L N02CA51 dihydroergotamine, combinations WHO ATC
0-L N02CA52 ergotamine, combinations excl. psycholeptics WHO ATC
0-L N02CA72 ergotamine, combinations with psycholeptics WHO ATC
0-L N02CB Corticosteroid derivatives WHO ATC
0-L N02CB01 flumedroxone WHO ATC
0-L N02CC Selective serotonin (5HT1) agonists WHO ATC
0-L N02CC01 sumatriptan WHO ATC
0-L N02CC02 naratriptan WHO ATC
0-L N02CC03 zolmitriptan WHO ATC
0-L N02CC04 rizatriptan WHO ATC
0-L N02CC05 almotriptan WHO ATC
0-L N02CC06 eletriptan WHO ATC
0-L N02CC07 frovatriptan WHO ATC
0-L N02CX Other antimigraine preparations WHO ATC
0-L N02CX01 pizotifen WHO ATC
0-L N02CX02 clonidine WHO ATC
0-L N02CX03 iprazochrome WHO ATC
0-L N02CX05 dimetotiazine WHO ATC
0-L N02CX06 oxetorone WHO ATC
0-L N03 ANTIEPILEPTICS WHO ATC
0-L N03A ANTIEPILEPTICS WHO ATC
0-L N03AA Barbiturates and derivatives WHO ATC
0-L N03AA01 methylphenobarbital WHO ATC
0-L N03AA02 phenobarbital WHO ATC
0-L N03AA03 primidone WHO ATC
0-L N03AA04 barbexaclone WHO ATC
0-L N03AA30 metharbital WHO ATC
0-L N03AB Hydantoin derivatives WHO ATC
0-L N03AB01 ethotoin WHO ATC
0-L N03AB02 phenytoin WHO ATC
0-L N03AB03 amino(diphenylhydantoin) valeric acid WHO ATC
0-L N03AB04 mephenytoin WHO ATC
0-L N03AB05 fosphenytoin WHO ATC
0-L N03AB52 phenytoin, combinations WHO ATC
0-L N03AB54 mephenytoin, combinations WHO ATC
0-L N03AC Oxazolidine derivatives WHO ATC
0-L N03AC01 paramethadione WHO ATC
0-L N03AC02 trimethadione WHO ATC
0-L N03AC03 ethadione WHO ATC
0-L N03AD Succinimide derivatives WHO ATC
0-L N03AD01 ethosuximide WHO ATC
0-L N03AD02 phensuximide WHO ATC
0-L N03AD03 mesuximide WHO ATC
0-L N03AD51 ethosuximide, combinations WHO ATC
0-L N03AE Benzodiazepine derivatives WHO ATC
0-L N03AE01 clonazepam WHO ATC
0-L N03AF Carboxamide derivatives WHO ATC
0-L N03AF01 carbamazepine WHO ATC
0-L N03AF02 oxcarbazepine WHO ATC
0-L N03AF03 rufinamide WHO ATC
0-L N03AF04 eslicarbazepine WHO ATC
0-L N03AG Fatty acid derivatives WHO ATC
0-L N03AG01 valproic acid WHO ATC
0-L N03AG02 valpromide WHO ATC
0-L N03AG03 aminobutyric acid WHO ATC
0-L N03AG04 vigabatrin WHO ATC
0-L N03AG05 progabide WHO ATC
0-L N03AG06 tiagabine WHO ATC
0-L N03AX Other antiepileptics WHO ATC
0-L N03AX03 sultiame WHO ATC
0-L N03AX07 phenacemide WHO ATC
0-L N03AX09 lamotrigine WHO ATC
0-L N03AX10 felbamate WHO ATC
0-L N03AX11 topiramate WHO ATC
0-L N03AX12 gabapentin WHO ATC
0-L N03AX13 pheneturide WHO ATC
0-L N03AX14 levetiracetam WHO ATC
0-L N03AX15 zonisamide WHO ATC
0-L N03AX16 pregabalin WHO ATC
0-L N03AX17 stiripentol WHO ATC
0-L N03AX18 lacosamide WHO ATC
0-L N03AX19 carisbamate WHO ATC
0-L N03AX30 beclamide WHO ATC
0-L N04 ANTI-PARKINSON DRUGS WHO ATC
0-L N04A ANTICHOLINERGIC AGENTS WHO ATC
0-L N04AA Tertiary amines WHO ATC
0-L N04AA01 trihexyphenidyl WHO ATC
0-L N04AA02 biperiden WHO ATC
0-L N04AA03 metixene WHO ATC
0-L N04AA04 procyclidine WHO ATC
0-L N04AA05 profenamine WHO ATC
0-L N04AA08 dexetimide WHO ATC
0-L N04AA09 phenglutarimide WHO ATC
0-L N04AA10 mazaticol WHO ATC
0-L N04AA11 bornaprine WHO ATC
0-L N04AA12 tropatepine WHO ATC
0-L N04AB Ethers chemically close to antihistamines WHO ATC
0-L N04AB01 etanautine WHO ATC
0-L N04AB02 orphenadrine (chloride) WHO ATC
0-L N04AC Ethers of tropine or tropine derivatives WHO ATC
0-L N04AC01 benzatropine WHO ATC
0-L N04AC30 etybenzatropine WHO ATC
0-L N04B DOPAMINERGIC AGENTS WHO ATC
0-L N04BA Dopa and dopa derivatives WHO ATC
0-L N04BA01 levodopa WHO ATC
0-L N04BA02 levodopa and decarboxylase inhibitor WHO ATC
0-L N04BA03 levodopa, decarboxylase inhibitor and COMT inhibitor WHO ATC
0-L N04BA04 melevodopa WHO ATC
0-L N04BA05 melevodopa and decarboxylase inhibitor WHO ATC
0-L N04BA06 etilevodopa and decarboxylase inhibitor WHO ATC
0-L N04BB Adamantane derivatives WHO ATC
0-L N04BB01 amantadine WHO ATC
0-L N04BC Dopamine agonists WHO ATC
0-L N04BC01 bromocriptine WHO ATC
0-L N04BC02 pergolide WHO ATC
0-L N04BC03 dihydroergocryptine mesylate WHO ATC
0-L N04BC04 ropinirole WHO ATC
0-L N04BC05 pramipexole WHO ATC
0-L N04BC06 cabergoline WHO ATC
0-L N04BC07 apomorphine WHO ATC
0-L N04BC08 piribedil WHO ATC
0-L N04BC09 rotigotine WHO ATC
0-L N04BD Monoamine oxidase B inhibitors WHO ATC
0-L N04BD01 selegiline WHO ATC
0-L N04BD02 rasagiline WHO ATC
0-L N04BX Other dopaminergic agents WHO ATC
0-L N04BX01 tolcapone WHO ATC
0-L N04BX02 entacapone WHO ATC
0-L N04BX03 budipine WHO ATC
0-L N05 PSYCHOLEPTICS WHO ATC
0-L N05A ANTIPSYCHOTICS WHO ATC
0-L N05AA Phenothiazines with aliphatic side-chain WHO ATC
0-L N05AA01 chlorpromazine WHO ATC
0-L N05AA02 levomepromazine WHO ATC
0-L N05AA03 promazine WHO ATC
0-L N05AA04 acepromazine WHO ATC
0-L N05AA05 triflupromazine WHO ATC
0-L N05AA06 cyamemazine WHO ATC
0-L N05AA07 chlorproethazine WHO ATC
0-L N05AB Phenothiazines with piperazine structure WHO ATC
0-L N05AB01 dixyrazine WHO ATC
0-L N05AB02 fluphenazine WHO ATC
0-L N05AB03 perphenazine WHO ATC
0-L N05AB04 prochlorperazine WHO ATC
0-L N05AB05 thiopropazate WHO ATC
0-L N05AB06 trifluoperazine WHO ATC
0-L N05AB07 acetophenazine WHO ATC
0-L N05AB08 thioproperazine WHO ATC
0-L N05AB09 butaperazine WHO ATC
0-L N05AB10 perazine WHO ATC
0-L N05AC Phenothiazines with piperidine structure WHO ATC
0-L N05AC01 periciazine WHO ATC
0-L N05AC02 thioridazine WHO ATC
0-L N05AC03 mesoridazine WHO ATC
0-L N05AC04 pipotiazine WHO ATC
0-L N05AD Butyrophenone derivatives WHO ATC
0-L N05AD01 haloperidol WHO ATC
0-L N05AD02 trifluperidol WHO ATC
0-L N05AD03 melperone WHO ATC
0-L N05AD04 moperone WHO ATC
0-L N05AD05 pipamperone WHO ATC
0-L N05AD06 bromperidol WHO ATC
0-L N05AD07 benperidol WHO ATC
0-L N05AD08 droperidol WHO ATC
0-L N05AD09 fluanisone WHO ATC
0-L N05AE Indole derivatives WHO ATC
0-L N05AE01 oxypertine WHO ATC
0-L N05AE02 molindone WHO ATC
0-L N05AE03 sertindole WHO ATC
0-L N05AE04 ziprasidone WHO ATC
0-L N05AF Thioxanthene derivatives WHO ATC
0-L N05AF01 flupentixol WHO ATC
0-L N05AF02 clopenthixol WHO ATC
0-L N05AF03 chlorprothixene WHO ATC
0-L N05AF04 tiotixene WHO ATC
0-L N05AF05 zuclopenthixol WHO ATC
0-L N05AG Diphenylbutylpiperidine derivatives WHO ATC
0-L N05AG01 fluspirilene WHO ATC
0-L N05AG02 pimozide WHO ATC
0-L N05AG03 penfluridol WHO ATC
0-L N05AH Diazepines, oxazepines, thiazepines and oxepines WHO ATC
0-L N05AH01 loxapine WHO ATC
0-L N05AH02 clozapine WHO ATC
0-L N05AH03 olanzapine WHO ATC
0-L N05AH04 quetiapine WHO ATC
0-L N05AH05 asenapine WHO ATC
0-L N05AH06 clotiapine WHO ATC
0-L N05AL Benzamides WHO ATC
0-L N05AL01 sulpiride WHO ATC
0-L N05AL02 sultopride WHO ATC
0-L N05AL03 tiapride WHO ATC
0-L N05AL04 remoxipride WHO ATC
0-L N05AL05 amisulpride WHO ATC
0-L N05AL06 veralipride WHO ATC
0-L N05AL07 levosulpiride WHO ATC
0-L N05AN Lithium WHO ATC
0-L N05AN01 lithium WHO ATC
0-L N05AX Other antipsychotics WHO ATC
0-L N05AX07 prothipendyl WHO ATC
0-L N05AX08 risperidone WHO ATC
0-L N05AX10 mosapramine WHO ATC
0-L N05AX11 zotepine WHO ATC
0-L N05AX12 aripiprazole WHO ATC
0-L N05AX13 paliperidone WHO ATC
0-L N05B ANXIOLYTICS WHO ATC
0-L N05BA Benzodiazepine derivatives WHO ATC
0-L N05BA01 diazepam WHO ATC
0-L N05BA02 chlordiazepoxide WHO ATC
0-L N05BA03 medazepam WHO ATC
0-L N05BA04 oxazepam WHO ATC
0-L N05BA05 potassium clorazepate WHO ATC
0-L N05BA06 lorazepam WHO ATC
0-L N05BA07 adinazolam WHO ATC
0-L N05BA08 bromazepam WHO ATC
0-L N05BA09 clobazam WHO ATC
0-L N05BA10 ketazolam WHO ATC
0-L N05BA11 prazepam WHO ATC
0-L N05BA12 alprazolam WHO ATC
0-L N05BA13 halazepam WHO ATC
0-L N05BA14 pinazepam WHO ATC
0-L N05BA15 camazepam WHO ATC
0-L N05BA16 nordazepam WHO ATC
0-L N05BA17 fludiazepam WHO ATC
0-L N05BA18 ethyl loflazepate WHO ATC
0-L N05BA19 etizolam WHO ATC
0-L N05BA21 clotiazepam WHO ATC
0-L N05BA22 cloxazolam WHO ATC
0-L N05BA23 tofisopam WHO ATC
0-L N05BA56 lorazepam, combinations WHO ATC
0-L N05BB Diphenylmethane derivatives WHO ATC
0-L N05BB01 hydroxyzine WHO ATC
0-L N05BB02 captodiame WHO ATC
0-L N05BB51 hydroxyzine, combinations WHO ATC
0-L N05BC Carbamates WHO ATC
0-L N05BC01 meprobamate WHO ATC
0-L N05BC03 emylcamate WHO ATC
0-L N05BC04 mebutamate WHO ATC
0-L N05BC51 meprobamate, combinations WHO ATC
0-L N05BD Dibenzo-bicyclo-octadiene derivatives WHO ATC
0-L N05BD01 benzoctamine WHO ATC
0-L N05BE Azaspirodecanedione derivatives WHO ATC
0-L N05BE01 buspirone WHO ATC
0-L N05BX Other anxiolytics WHO ATC
0-L N05BX01 mephenoxalone WHO ATC
0-L N05BX02 gedocarnil WHO ATC
0-L N05BX03 etifoxine WHO ATC
0-L N05C HYPNOTICS AND SEDATIVES WHO ATC
0-L N05CA Barbiturates, plain WHO ATC
0-L N05CA01 pentobarbital WHO ATC
0-L N05CA02 amobarbital WHO ATC
0-L N05CA03 butobarbital WHO ATC
0-L N05CA04 barbital WHO ATC
0-L N05CA05 aprobarbital WHO ATC
0-L N05CA06 secobarbital WHO ATC
0-L N05CA07 talbutal WHO ATC
0-L N05CA08 vinylbital WHO ATC
0-L N05CA09 vinbarbital WHO ATC
0-L N05CA10 cyclobarbital WHO ATC
0-L N05CA11 heptabarbital WHO ATC
0-L N05CA12 reposal WHO ATC
0-L N05CA15 methohexital WHO ATC
0-L N05CA16 hexobarbital WHO ATC
0-L N05CA19 thiopental WHO ATC
0-L N05CA20 etallobarbital WHO ATC
0-L N05CA21 allobarbital WHO ATC
0-L N05CA22 proxibarbal WHO ATC
0-L N05CB Barbiturates, combinations WHO ATC
0-L N05CB01 combinations of barbiturates WHO ATC
0-L N05CB02 barbiturates in combination with other drugs WHO ATC
0-L N05CC Aldehydes and derivatives WHO ATC
0-L N05CC01 chloral hydrate WHO ATC
0-L N05CC02 chloralodol WHO ATC
0-L N05CC03 acetylglycinamide chloral hydrate WHO ATC
0-L N05CC04 dichloralphenazone WHO ATC
0-L N05CC05 paraldehyde WHO ATC
0-L N05CD Benzodiazepine derivatives WHO ATC
0-L N05CD01 flurazepam WHO ATC
0-L N05CD02 nitrazepam WHO ATC
0-L N05CD03 flunitrazepam WHO ATC
0-L N05CD04 estazolam WHO ATC
0-L N05CD05 triazolam WHO ATC
0-L N05CD06 lormetazepam WHO ATC
0-L N05CD07 temazepam WHO ATC
0-L N05CD08 midazolam WHO ATC
0-L N05CD09 brotizolam WHO ATC
0-L N05CD10 quazepam WHO ATC
0-L N05CD11 loprazolam WHO ATC
0-L N05CD12 doxefazepam WHO ATC
0-L N05CD13 cinolazepam WHO ATC
0-L N05CE Piperidinedione derivatives WHO ATC
0-L N05CE01 glutethimide WHO ATC
0-L N05CE02 methyprylon WHO ATC
0-L N05CE03 pyrithyldione WHO ATC
0-L N05CF Benzodiazepine related drugs WHO ATC
0-L N05CF01 zopiclone WHO ATC
0-L N05CF02 zolpidem WHO ATC
0-L N05CF03 zaleplon WHO ATC
0-L N05CF04 eszopiclone WHO ATC
0-L N05CH Melatonin receptor agonists WHO ATC
0-L N05CH01 melatonin WHO ATC
0-L N05CH02 ramelteon WHO ATC
0-L N05CM Other hypnotics and sedatives WHO ATC
0-L N05CM01 methaqualone WHO ATC
0-L N05CM02 clomethiazole WHO ATC
0-L N05CM03 bromisoval WHO ATC
0-L N05CM04 carbromal WHO ATC
0-L N05CM05 scopolamine WHO ATC
0-L N05CM06 propiomazine WHO ATC
0-L N05CM07 triclofos WHO ATC
0-L N05CM08 ethchlorvynol WHO ATC
0-L N05CM09 valerian WHO ATC
0-L N05CM10 hexapropymate WHO ATC
0-L N05CM11 bromides WHO ATC
0-L N05CM12 apronal WHO ATC
0-L N05CM13 valnoctamide WHO ATC
0-L N05CM15 methylpentynol WHO ATC
0-L N05CM16 niaprazine WHO ATC
0-L N05CM18 dexmedetomidine WHO ATC
0-L N05CX Hypnotics and sedatives in combination, excl. barbiturates WHO ATC
0-L N05CX01 meprobamate, combinations WHO ATC
0-L N05CX02 methaqualone, combinations WHO ATC
0-L N05CX03 methylpentynol, combinations WHO ATC
0-L N05CX04 clomethiazole, combinations WHO ATC
0-L N05CX05 emepronium, combinations WHO ATC
0-L N05CX06 dipiperonylaminoethanol, combinations WHO ATC
0-L N06 PSYCHOANALEPTICS WHO ATC
0-L N06A ANTIDEPRESSANTS WHO ATC
0-L N06AA Non-selective monoamine reuptake inhibitors WHO ATC
0-L N06AA01 desipramine WHO ATC
0-L N06AA02 imipramine WHO ATC
0-L N06AA03 imipramine oxide WHO ATC
0-L N06AA04 clomipramine WHO ATC
0-L N06AA05 opipramol WHO ATC
0-L N06AA06 trimipramine WHO ATC
0-L N06AA07 lofepramine WHO ATC
0-L N06AA08 dibenzepin WHO ATC
0-L N06AA09 amitriptyline WHO ATC
0-L N06AA10 nortriptyline WHO ATC
0-L N06AA11 protriptyline WHO ATC
0-L N06AA12 doxepin WHO ATC
0-L N06AA13 iprindole WHO ATC
0-L N06AA14 melitracen WHO ATC
0-L N06AA15 butriptyline WHO ATC
0-L N06AA16 dosulepin WHO ATC
0-L N06AA17 amoxapine WHO ATC
0-L N06AA18 dimetacrine WHO ATC
0-L N06AA19 amineptine WHO ATC
0-L N06AA21 maprotiline WHO ATC
0-L N06AA23 quinupramine WHO ATC
0-L N06AB Selective serotonin reuptake inhibitors WHO ATC
0-L N06AB02 zimeldine WHO ATC
0-L N06AB03 fluoxetine WHO ATC
0-L N06AB04 citalopram WHO ATC
0-L N06AB05 paroxetine WHO ATC
0-L N06AB06 sertraline WHO ATC
0-L N06AB07 alaproclate WHO ATC
0-L N06AB08 fluvoxamine WHO ATC
0-L N06AB09 etoperidone WHO ATC
0-L N06AB10 escitalopram WHO ATC
0-L N06AF Monoamine oxidase inhibitors, non-selective WHO ATC
0-L N06AF01 isocarboxazid WHO ATC
0-L N06AF02 nialamide WHO ATC
0-L N06AF03 phenelzine WHO ATC
0-L N06AF04 tranylcypromine WHO ATC
0-L N06AF05 iproniazide WHO ATC
0-L N06AF06 iproclozide WHO ATC
0-L N06AG Monoamine oxidase A inhibitors WHO ATC
0-L N06AG02 moclobemide WHO ATC
0-L N06AG03 toloxatone WHO ATC
0-L N06AX Other antidepressants WHO ATC
0-L N06AX01 oxitriptan WHO ATC
0-L N06AX02 tryptophan WHO ATC
0-L N06AX03 mianserin WHO ATC
0-L N06AX04 nomifensine WHO ATC
0-L N06AX05 trazodone WHO ATC
0-L N06AX06 nefazodone WHO ATC
0-L N06AX07 minaprine WHO ATC
0-L N06AX08 bifemelane WHO ATC
0-L N06AX09 viloxazine WHO ATC
0-L N06AX10 oxaflozane WHO ATC
0-L N06AX11 mirtazapine WHO ATC
0-L N06AX12 bupropion WHO ATC
0-L N06AX13 medifoxamine WHO ATC
0-L N06AX14 tianeptine WHO ATC
0-L N06AX15 pivagabine WHO ATC
0-L N06AX16 venlafaxine WHO ATC
0-L N06AX17 milnacipran WHO ATC
0-L N06AX18 reboxetine WHO ATC
0-L N06AX19 gepirone WHO ATC
0-L N06AX21 duloxetine WHO ATC
0-L N06AX22 agomelatine WHO ATC
0-L N06AX23 desvenlafaxine WHO ATC
0-L N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS WHO ATC
0-L N06BA Centrally acting sympathomimetics WHO ATC
0-L N06BA01 amfetamine WHO ATC
0-L N06BA02 dexamfetamine WHO ATC
0-L N06BA03 metamfetamine WHO ATC
0-L N06BA04 methylphenidate WHO ATC
0-L N06BA05 pemoline WHO ATC
0-L N06BA06 fencamfamin WHO ATC
0-L N06BA07 modafinil WHO ATC
0-L N06BA08 fenozolone WHO ATC
0-L N06BA09 atomoxetine WHO ATC
0-L N06BA10 fenetylline WHO ATC
0-L N06BA11 dexmethylphenidate WHO ATC
0-L N06BC Xanthine derivatives WHO ATC
0-L N06BC01 caffeine WHO ATC
0-L N06BC02 propentofylline WHO ATC
0-L N06BX Other psychostimulants and nootropics WHO ATC
0-L N06BX01 meclofenoxate WHO ATC
0-L N06BX02 pyritinol WHO ATC
0-L N06BX03 piracetam WHO ATC
0-L N06BX04 deanol WHO ATC
0-L N06BX05 fipexide WHO ATC
0-L N06BX06 citicoline WHO ATC
0-L N06BX07 oxiracetam WHO ATC
0-L N06BX08 pirisudanol WHO ATC
0-L N06BX09 linopirdine WHO ATC
0-L N06BX10 nizofenone WHO ATC
0-L N06BX11 aniracetam WHO ATC
0-L N06BX12 acetylcarnitine WHO ATC
0-L N06BX13 idebenone WHO ATC
0-L N06BX14 prolintane WHO ATC
0-L N06BX15 pipradrol WHO ATC
0-L N06BX16 pramiracetam WHO ATC
0-L N06BX17 adrafinil WHO ATC
0-L N06BX18 vinpocetine WHO ATC
0-L N06C PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION WHO ATC
0-L N06CA Antidepressants in combination with psycholeptics WHO ATC
0-L N06CA01 amitriptyline and psycholeptics WHO ATC
0-L N06CA02 melitracen and psycholeptics WHO ATC
0-L N06CB Psychostimulants in combination with psycholeptics WHO ATC
0-L N06D ANTI-DEMENTIA DRUGS WHO ATC
0-L N06DA Anticholinesterases WHO ATC
0-L N06DA01 tacrine WHO ATC
0-L N06DA02 donepezil WHO ATC
0-L N06DA03 rivastigmine WHO ATC
0-L N06DA04 galantamine WHO ATC
0-L N06DX Other anti-dementia drugs WHO ATC
0-L N06DX01 memantine WHO ATC
0-L N06DX02 ginkgo biloba WHO ATC
0-L N07 OTHER NERVOUS SYSTEM DRUGS WHO ATC
0-L N07A PARASYMPATHOMIMETICS WHO ATC
0-L N07AA Anticholinesterases WHO ATC
0-L N07AA01 neostigmine WHO ATC
0-L N07AA02 pyridostigmine WHO ATC
0-L N07AA03 distigmine WHO ATC
0-L N07AA30 ambenonium WHO ATC
0-L N07AA51 neostigmine, combinations WHO ATC
0-L N07AB Choline esters WHO ATC
0-L N07AB01 carbachol WHO ATC
0-L N07AB02 bethanechol WHO ATC
0-L N07AX Other parasympathomimetics WHO ATC
0-L N07AX01 pilocarpine WHO ATC
0-L N07AX02 choline alfoscerate WHO ATC
0-L N07AX03 cevimeline WHO ATC
0-L N07B DRUGS USED IN ADDICTIVE DISORDERS WHO ATC
0-L N07BA Drugs used in nicotine dependence WHO ATC
0-L N07BA01 nicotine WHO ATC
0-L N07BA03 varenicline WHO ATC
0-L N07BB Drugs used in alcohol dependence WHO ATC
0-L N07BB01 disulfiram WHO ATC
0-L N07BB02 calcium carbimide WHO ATC
0-L N07BB03 acamprosate WHO ATC
0-L N07BB04 naltrexone WHO ATC
0-L N07BC Drugs used in opioid dependence WHO ATC
0-L N07BC01 buprenorphine WHO ATC
0-L N07BC02 methadone WHO ATC
0-L N07BC03 levacetylmethadol WHO ATC
0-L N07BC04 lofexidine WHO ATC
0-L N07BC51 buprenorphine, combinations WHO ATC
0-L N07C ANTIVERTIGO PREPARATIONS WHO ATC
0-L N07CA Antivertigo preparations WHO ATC
0-L N07CA01 betahistine WHO ATC
0-L N07CA02 cinnarizine WHO ATC
0-L N07CA03 flunarizine WHO ATC
0-L N07CA04 acetylleucine WHO ATC
0-L N07CA52 cinnarizine, combinations WHO ATC
0-L N07X OTHER NERVOUS SYSTEM DRUGS WHO ATC
0-L N07XA Gangliosides and ganglioside derivatives WHO ATC
0-L N07XX Other nervous system drugs WHO ATC
0-L N07XX01 tirilazad WHO ATC
0-L N07XX02 riluzole WHO ATC
0-L N07XX03 xaliproden WHO ATC
0-L N07XX04 sodium oxybate WHO ATC
0-L N07XX05 amifampridine WHO ATC
0-L N07XX06 tetrabenazine WHO ATC
0-L P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS WHO ATC
0-L P01 ANTIPROTOZOALS WHO ATC
0-L P01A AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES WHO ATC
0-L P01AA Hydroxyquinoline derivatives WHO ATC
0-L P01AA01 broxyquinoline WHO ATC
0-L P01AA02 clioquinol WHO ATC
0-L P01AA04 chlorquinaldol WHO ATC
0-L P01AA05 tilbroquinol WHO ATC
0-L P01AA52 clioquinol, combinations WHO ATC
0-L P01AB Nitroimidazole derivatives WHO ATC
0-L P01AB01 metronidazole WHO ATC
0-L P01AB02 tinidazole WHO ATC
0-L P01AB03 ornidazole WHO ATC
0-L P01AB04 azanidazole WHO ATC
0-L P01AB05 propenidazole WHO ATC
0-L P01AB06 nimorazole WHO ATC
0-L P01AB07 secnidazole WHO ATC
0-L P01AC Dichloroacetamide derivatives WHO ATC
0-L P01AC01 diloxanide WHO ATC
0-L P01AC02 clefamide WHO ATC
0-L P01AC03 etofamide WHO ATC
0-L P01AC04 teclozan WHO ATC
0-L P01AR Arsenic compounds WHO ATC
0-L P01AR01 arsthinol WHO ATC
0-L P01AR02 difetarsone WHO ATC
0-L P01AR03 glycobiarsol WHO ATC
0-L P01AR53 glycobiarsol, combinations WHO ATC
0-L P01AX Other agents against amoebiasis and other protozoal diseases WHO ATC
0-L P01AX01 chiniofon WHO ATC
0-L P01AX02 emetine WHO ATC
0-L P01AX04 phanquinone WHO ATC
0-L P01AX05 mepacrine WHO ATC
0-L P01AX06 atovaquone WHO ATC
0-L P01AX07 trimetrexate WHO ATC
0-L P01AX08 tenonitrozole WHO ATC
0-L P01AX09 dihydroemetine WHO ATC
0-L P01AX10 fumagillin WHO ATC
0-L P01AX11 nitazoxanide WHO ATC
0-L P01AX52 emetine, combinations WHO ATC
0-L P01B ANTIMALARIALS WHO ATC
0-L P01BA Aminoquinolines WHO ATC
0-L P01BA01 chloroquine WHO ATC
0-L P01BA02 hydroxychloroquine WHO ATC
0-L P01BA03 primaquine WHO ATC
0-L P01BA06 amodiaquine WHO ATC
0-L P01BB Biguanides WHO ATC
0-L P01BB01 proguanil WHO ATC
0-L P01BB02 cycloguanil embonate WHO ATC
0-L P01BB51 proguanil, combinations WHO ATC
0-L P01BC Methanolquinolines WHO ATC
0-L P01BC01 quinine WHO ATC
0-L P01BC02 mefloquine WHO ATC
0-L P01BD Diaminopyrimidines WHO ATC
0-L P01BD01 pyrimethamine WHO ATC
0-L P01BD51 pyrimethamine, combinations WHO ATC
0-L P01BE Artemisinin and derivatives WHO ATC
0-L P01BE01 artemisinin WHO ATC
0-L P01BE02 artemether WHO ATC
0-L P01BE03 artesunate WHO ATC
0-L P01BE04 artemotil WHO ATC
0-L P01BE05 artenimol WHO ATC
0-L P01BE52 artemether, combinations WHO ATC
0-L P01BX Other antimalarials WHO ATC
0-L P01BX01 halofantrine WHO ATC
0-L P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS WHO ATC
0-L P01CA Nitroimidazole derivatives WHO ATC
0-L P01CA02 benznidazole WHO ATC
0-L P01CB Antimony compounds WHO ATC
0-L P01CB01 meglumine antimonate WHO ATC
0-L P01CB02 sodium stibogluconate WHO ATC
0-L P01CC Nitrofuran derivatives WHO ATC
0-L P01CC01 nifurtimox WHO ATC
0-L P01CC02 nitrofural WHO ATC
0-L P01CD Arsenic compounds WHO ATC
0-L P01CD01 melarsoprol WHO ATC
0-L P01CD02 acetarsol WHO ATC
0-L P01CX Other agents against leishmaniasis and trypanosomiasis WHO ATC
0-L P01CX01 pentamidine isethionate WHO ATC
0-L P01CX02 suramin sodium WHO ATC
0-L P01CX03 eflornithine WHO ATC
0-L P02 ANTHELMINTICS WHO ATC
0-L P02B ANTITREMATODALS WHO ATC
0-L P02BA Quinoline derivatives and related substances WHO ATC
0-L P02BA01 praziquantel WHO ATC
0-L P02BA02 oxamniquine WHO ATC
0-L P02BB Organophosphorous compounds WHO ATC
0-L P02BB01 metrifonate WHO ATC
0-L P02BX Other antitrematodal agents WHO ATC
0-L P02BX01 bithionol WHO ATC
0-L P02BX02 niridazole WHO ATC
0-L P02BX03 stibophen WHO ATC
0-L P02BX04 triclabendazole WHO ATC
0-L P02C ANTINEMATODAL AGENTS WHO ATC
0-L P02CA Benzimidazole derivatives WHO ATC
0-L P02CA01 mebendazole WHO ATC
0-L P02CA02 tiabendazole WHO ATC
0-L P02CA03 albendazole WHO ATC
0-L P02CA04 ciclobendazole WHO ATC
0-L P02CA05 flubendazole WHO ATC
0-L P02CA06 fenbendazole WHO ATC
0-L P02CA51 mebendazole, combinations WHO ATC
0-L P02CB Piperazine and derivatives WHO ATC
0-L P02CB01 piperazine WHO ATC
0-L P02CB02 diethylcarbamazine WHO ATC
0-L P02CC Tetrahydropyrimidine derivatives WHO ATC
0-L P02CC01 pyrantel WHO ATC
0-L P02CC02 oxantel WHO ATC
0-L P02CE Imidazothiazole derivatives WHO ATC
0-L P02CE01 levamisole WHO ATC
0-L P02CF Avermectines WHO ATC
0-L P02CF01 ivermectin WHO ATC
0-L P02CX Other antinematodals WHO ATC
0-L P02CX01 pyrvinium WHO ATC
0-L P02CX02 bephenium WHO ATC
0-L P02D ANTICESTODALS WHO ATC
0-L P02DA Salicylic acid derivatives WHO ATC
0-L P02DA01 niclosamide WHO ATC
0-L P02DX Other anticestodals WHO ATC
0-L P02DX01 desaspidin WHO ATC
0-L P02DX02 dichlorophen WHO ATC
0-L P03 ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS WHO ATC
0-L P03A ECTOPARASITICIDES, INCL. SCABICIDES WHO ATC
0-L P03AA Sulfur containing products WHO ATC
0-L P03AA01 dixanthogen WHO ATC
0-L P03AA02 potassium polysulfide WHO ATC
0-L P03AA03 mesulfen WHO ATC
0-L P03AA04 disulfiram WHO ATC
0-L P03AA05 thiram WHO ATC
0-L P03AA54 disulfiram, combinations WHO ATC
0-L P03AB Chlorine containing products WHO ATC
0-L P03AB01 clofenotane WHO ATC
0-L P03AB02 lindane WHO ATC
0-L P03AB51 clofenotane, combinations WHO ATC
0-L P03AC Pyrethrines, incl. synthetic compounds WHO ATC
0-L P03AC01 pyrethrum WHO ATC
0-L P03AC02 bioallethrin WHO ATC
0-L P03AC03 phenothrin WHO ATC
0-L P03AC04 permethrin WHO ATC
0-L P03AC51 pyrethrum, combinations WHO ATC
0-L P03AC52 bioallethrin, combinations WHO ATC
0-L P03AC53 phenothrin, combinations WHO ATC
0-L P03AC54 permethrin, combinations WHO ATC
0-L P03AX Other ectoparasiticides, incl. scabicides WHO ATC
0-L P03AX01 benzyl benzoate WHO ATC
0-L P03AX02 copper oleinate WHO ATC
0-L P03AX03 malathion WHO ATC
0-L P03AX04 quassia WHO ATC
0-L P03B INSECTICIDES AND REPELLENTS WHO ATC
0-L P03BA Pyrethrines WHO ATC
0-L P03BA01 cyfluthrin WHO ATC
0-L P03BA02 cypermethrin WHO ATC
0-L P03BA03 decamethrin WHO ATC
0-L P03BA04 tetramethrin WHO ATC
0-L P03BX Other insecticides and repellents WHO ATC
0-L P03BX01 diethyltoluamide WHO ATC
0-L P03BX02 dimethylphthalate WHO ATC
0-L P03BX03 dibutylphthalate WHO ATC
0-L P03BX04 dibutylsuccinate WHO ATC
0-L P03BX05 dimethylcarbate WHO ATC
0-L P03BX06 etohexadiol WHO ATC
0-L R RESPIRATORY SYSTEM WHO ATC
0-L R01 NASAL PREPARATIONS WHO ATC
0-L R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE WHO ATC
0-L R01AA Sympathomimetics, plain WHO ATC
0-L R01AA02 cyclopentamine WHO ATC
0-L R01AA03 ephedrine WHO ATC
0-L R01AA04 phenylephrine WHO ATC
0-L R01AA05 oxymetazoline WHO ATC
0-L R01AA06 tetryzoline WHO ATC
0-L R01AA07 xylometazoline WHO ATC
0-L R01AA08 naphazoline WHO ATC
0-L R01AA09 tramazoline WHO ATC
0-L R01AA10 metizoline WHO ATC
0-L R01AA11 tuaminoheptane WHO ATC
0-L R01AA12 fenoxazoline WHO ATC
0-L R01AA13 tymazoline WHO ATC
0-L R01AA14 epinephrine WHO ATC
0-L R01AB Sympathomimetics, combinations excl. corticosteroids WHO ATC
0-L R01AB01 phenylephrine WHO ATC
0-L R01AB02 naphazoline WHO ATC
0-L R01AB03 tetryzoline WHO ATC
0-L R01AB05 ephedrine WHO ATC
0-L R01AB06 xylometazoline WHO ATC
0-L R01AB07 oxymetazoline WHO ATC
0-L R01AB08 tuaminoheptane WHO ATC
0-L R01AC Antiallergic agents, excl. corticosteroids WHO ATC
0-L R01AC01 cromoglicic acid WHO ATC
0-L R01AC02 levocabastine WHO ATC
0-L R01AC03 azelastine WHO ATC
0-L R01AC04 antazoline WHO ATC
0-L R01AC05 spaglumic acid WHO ATC
0-L R01AC06 thonzylamine WHO ATC
0-L R01AC07 nedocromil WHO ATC
0-L R01AC08 olopatadine WHO ATC
0-L R01AC51 cromoglicic acid, combinations WHO ATC
0-L R01AD Corticosteroids WHO ATC
0-L R01AD01 beclometasone WHO ATC
0-L R01AD02 prednisolone WHO ATC
0-L R01AD03 dexamethasone WHO ATC
0-L R01AD04 flunisolide WHO ATC
0-L R01AD05 budesonide WHO ATC
0-L R01AD06 betamethasone WHO ATC
0-L R01AD07 tixocortol WHO ATC
0-L R01AD08 fluticasone WHO ATC
0-L R01AD09 mometasone WHO ATC
0-L R01AD11 triamcinolone WHO ATC
0-L R01AD12 fluticasone furoate WHO ATC
0-L R01AD52 prednisolone, combinations WHO ATC
0-L R01AD53 dexamethasone, combinations WHO ATC
0-L R01AD57 tixocortol, combinations WHO ATC
0-L R01AD60 hydrocortisone, combinations WHO ATC
0-L R01AX Other nasal preparations WHO ATC
0-L R01AX01 calcium hexamine thiocyanate WHO ATC
0-L R01AX02 retinol WHO ATC
0-L R01AX03 ipratropium bromide WHO ATC
0-L R01AX05 ritiometan WHO ATC
0-L R01AX06 mupirocin WHO ATC
0-L R01AX07 hexamidine WHO ATC
0-L R01AX08 framycetin WHO ATC
0-L R01AX09 hyaluronic acid WHO ATC
0-L R01AX10 various WHO ATC
0-L R01AX30 combinations WHO ATC
0-L R01B NASAL DECONGESTANTS FOR SYSTEMIC USE WHO ATC
0-L R01BA Sympathomimetics WHO ATC
0-L R01BA01 phenylpropanolamine WHO ATC
0-L R01BA02 pseudoephedrine WHO ATC
0-L R01BA03 phenylephrine WHO ATC
0-L R01BA51 phenylpropanolamine, combinations WHO ATC
0-L R01BA52 pseudoephedrine, combinations WHO ATC
0-L R01BA53 phenylephrine, combinations WHO ATC
0-L R02 THROAT PREPARATIONS WHO ATC
0-L R02A THROAT PREPARATIONS WHO ATC
0-L R02AA Antiseptics WHO ATC
0-L R02AA01 ambazone WHO ATC
0-L R02AA02 dequalinium WHO ATC
0-L R02AA03 dichlorobenzyl alcohol WHO ATC
0-L R02AA05 chlorhexidine WHO ATC
0-L R02AA06 cetylpyridinium WHO ATC
0-L R02AA09 benzethonium WHO ATC
0-L R02AA10 myristyl-benzalkonium WHO ATC
0-L R02AA11 chlorquinaldol WHO ATC
0-L R02AA12 hexylresorcinol WHO ATC
0-L R02AA13 acriflavinium chloride WHO ATC
0-L R02AA14 oxyquinoline WHO ATC
0-L R02AA15 povidone-iodine WHO ATC
0-L R02AA16 benzalkonium WHO ATC
0-L R02AA17 cetrimonium WHO ATC
0-L R02AA18 hexamidine WHO ATC
0-L R02AA19 phenol WHO ATC
0-L R02AA20 various WHO ATC
0-L R02AB Antibiotics WHO ATC
0-L R02AB01 neomycin WHO ATC
0-L R02AB02 tyrothricin WHO ATC
0-L R02AB03 fusafungine WHO ATC
0-L R02AB04 bacitracin WHO ATC
0-L R02AB30 gramicidin WHO ATC
0-L R02AD Anesthetics, local WHO ATC
0-L R02AD01 benzocaine WHO ATC
0-L R02AD02 lidocaine WHO ATC
0-L R02AD03 cocaine WHO ATC
0-L R02AD04 dyclonine WHO ATC
0-L R02AX Other throat preparations WHO ATC
0-L R02AX01 flurbiprofen WHO ATC
0-L R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES WHO ATC
0-L R03A ADRENERGICS, INHALANTS WHO ATC
0-L R03AA Alpha- and beta-adrenoreceptor agonists WHO ATC
0-L R03AA01 epinephrine WHO ATC
0-L R03AB Non-selective beta-adrenoreceptor agonists WHO ATC
0-L R03AB02 isoprenaline WHO ATC
0-L R03AB03 orciprenaline WHO ATC
0-L R03AC Selective beta-2-adrenoreceptor agonists WHO ATC
0-L R03AC02 salbutamol WHO ATC
0-L R03AC03 terbutaline WHO ATC
0-L R03AC04 fenoterol WHO ATC
0-L R03AC05 rimiterol WHO ATC
0-L R03AC06 hexoprenaline WHO ATC
0-L R03AC07 isoetarine WHO ATC
0-L R03AC08 pirbuterol WHO ATC
0-L R03AC09 tretoquinol WHO ATC
0-L R03AC10 carbuterol WHO ATC
0-L R03AC11 tulobuterol WHO ATC
0-L R03AC12 salmeterol WHO ATC
0-L R03AC13 formoterol WHO ATC
0-L R03AC14 clenbuterol WHO ATC
0-L R03AC15 reproterol WHO ATC
0-L R03AC16 procaterol WHO ATC
0-L R03AC17 bitolterol WHO ATC
0-L R03AC18 indacaterol WHO ATC
0-L R03AH Combinations of adrenergics WHO ATC
0-L R03AK Adrenergics and other drugs for obstructive airway diseases WHO ATC
0-L R03AK01 epinephrine and other drugs for obstructive airway diseases WHO ATC
0-L R03AK02 isoprenaline and other drugs for obstructive airway diseases WHO ATC
0-L R03AK03 fenoterol and other drugs for obstructive airway diseases WHO ATC
0-L R03AK04 salbutamol and other drugs for obstructive airway diseases WHO ATC
0-L R03AK05 reproterol and other drugs for obstructive airway diseases WHO ATC
0-L R03AK06 salmeterol and other drugs for obstructive airway diseases WHO ATC
0-L R03AK07 formoterol and other drugs for obstructive airway diseases WHO ATC
0-L R03B OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS WHO ATC
0-L R03BA Glucocorticoids WHO ATC
0-L R03BA01 beclometasone WHO ATC
0-L R03BA02 budesonide WHO ATC
0-L R03BA03 flunisolide WHO ATC
0-L R03BA04 betamethasone WHO ATC
0-L R03BA05 fluticasone WHO ATC
0-L R03BA06 triamcinolone WHO ATC
0-L R03BA07 mometasone WHO ATC
0-L R03BA08 ciclesonide WHO ATC
0-L R03BB Anticholinergics WHO ATC
0-L R03BB01 ipratropium bromide WHO ATC
0-L R03BB02 oxitropium bromide WHO ATC
0-L R03BB03 stramoni preparations WHO ATC
0-L R03BB04 tiotropium bromide WHO ATC
0-L R03BC Antiallergic agents, excl. corticosteroids WHO ATC
0-L R03BC01 cromoglicic acid WHO ATC
0-L R03BC03 nedocromil WHO ATC
0-L R03BX Other drugs for obstructive airway diseases, inhalants WHO ATC
0-L R03BX01 fenspiride WHO ATC
0-L R03C ADRENERGICS FOR SYSTEMIC USE WHO ATC
0-L R03CA Alpha- and beta-adrenoreceptor agonists WHO ATC
0-L R03CA02 ephedrine WHO ATC
0-L R03CB Non-selective beta-adrenoreceptor agonists WHO ATC
0-L R03CB01 isoprenaline WHO ATC
0-L R03CB02 methoxyphenamine WHO ATC
0-L R03CB03 orciprenaline WHO ATC
0-L R03CB51 isoprenaline, combinations WHO ATC
0-L R03CB53 orciprenaline, combinations WHO ATC
0-L R03CC Selective beta-2-adrenoreceptor agonists WHO ATC
0-L R03CC02 salbutamol WHO ATC
0-L R03CC03 terbutaline WHO ATC
0-L R03CC04 fenoterol WHO ATC
0-L R03CC05 hexoprenaline WHO ATC
0-L R03CC06 isoetarine WHO ATC
0-L R03CC07 pirbuterol WHO ATC
0-L R03CC08 procaterol WHO ATC
0-L R03CC09 tretoquinol WHO ATC
0-L R03CC10 carbuterol WHO ATC
0-L R03CC11 tulobuterol WHO ATC
0-L R03CC12 bambuterol WHO ATC
0-L R03CC13 clenbuterol WHO ATC
0-L R03CC14 reproterol WHO ATC
0-L R03CC53 terbutaline, combinations WHO ATC
0-L R03CK Adrenergics and other drugs for obstructive airway diseases WHO ATC
0-L R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES WHO ATC
0-L R03DA Xanthines WHO ATC
0-L R03DA01 diprophylline WHO ATC
0-L R03DA02 choline theophyllinate WHO ATC
0-L R03DA03 proxyphylline WHO ATC
0-L R03DA04 theophylline WHO ATC
0-L R03DA05 aminophylline WHO ATC
0-L R03DA06 etamiphylline WHO ATC
0-L R03DA07 theobromine WHO ATC
0-L R03DA08 bamifylline WHO ATC
0-L R03DA09 acefylline piperazine WHO ATC
0-L R03DA10 bufylline WHO ATC
0-L R03DA11 doxofylline WHO ATC
0-L R03DA20 combinations of xanthines WHO ATC
0-L R03DA51 diprophylline, combinations WHO ATC
0-L R03DA54 theophylline, combinations excl. psycholeptics WHO ATC
0-L R03DA55 aminophylline, combinations WHO ATC
0-L R03DA57 theobromine, combinations WHO ATC
0-L R03DA74 theophylline, combinations with psycholeptics WHO ATC
0-L R03DB Xanthines and adrenergics WHO ATC
0-L R03DB01 diprophylline and adrenergics WHO ATC
0-L R03DB02 choline theophyllinate and adrenergics WHO ATC
0-L R03DB03 proxyphylline and adrenergics WHO ATC
0-L R03DB04 theophylline and adrenergics WHO ATC
0-L R03DB05 aminophylline and adrenergics WHO ATC
0-L R03DB06 etamiphylline and adrenergics WHO ATC
0-L R03DC Leukotriene receptor antagonists WHO ATC
0-L R03DC01 zafirlukast WHO ATC
0-L R03DC02 pranlukast WHO ATC
0-L R03DC03 montelukast WHO ATC
0-L R03DC04 ibudilast WHO ATC
0-L R03DX Other systemic drugs for obstructive airway diseases WHO ATC
0-L R03DX01 amlexanox WHO ATC
0-L R03DX02 eprozinol WHO ATC
0-L R03DX03 fenspiride WHO ATC
0-L R03DX05 omalizumab WHO ATC
0-L R03DX06 seratrodast WHO ATC
0-L R03DX07 roflumilast WHO ATC
0-L R05 COUGH AND COLD PREPARATIONS WHO ATC
0-L R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS WHO ATC
0-L R05CA Expectorants WHO ATC
0-L R05CA01 tyloxapol WHO ATC
0-L R05CA02 potassium iodide WHO ATC
0-L R05CA03 guaifenesin WHO ATC
0-L R05CA04 ipecacuanha WHO ATC
0-L R05CA05 althea root WHO ATC
0-L R05CA06 senega WHO ATC
0-L R05CA07 antimony pentasulfide WHO ATC
0-L R05CA08 creosote WHO ATC
0-L R05CA09 guaiacolsulfonate WHO ATC
0-L R05CA10 combinations WHO ATC
0-L R05CA11 levoverbenone WHO ATC
0-L R05CB Mucolytics WHO ATC
0-L R05CB01 acetylcysteine WHO ATC
0-L R05CB02 bromhexine WHO ATC
0-L R05CB03 carbocisteine WHO ATC
0-L R05CB04 eprazinone WHO ATC
0-L R05CB05 mesna WHO ATC
0-L R05CB06 ambroxol WHO ATC
0-L R05CB07 sobrerol WHO ATC
0-L R05CB08 domiodol WHO ATC
0-L R05CB09 letosteine WHO ATC
0-L R05CB10 combinations WHO ATC
0-L R05CB11 stepronin WHO ATC
0-L R05CB12 tiopronin WHO ATC
0-L R05CB13 dornase alfa (desoxyribonuclease) WHO ATC
0-L R05CB14 neltenexine WHO ATC
0-L R05CB15 erdosteine WHO ATC
0-L R05D COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS WHO ATC
0-L R05DA Opium alkaloids and derivatives WHO ATC
0-L R05DA01 ethylmorphine WHO ATC
0-L R05DA03 hydrocodone WHO ATC
0-L R05DA04 codeine WHO ATC
0-L R05DA05 opium alkaloids with morphine WHO ATC
0-L R05DA06 normethadone WHO ATC
0-L R05DA07 noscapine WHO ATC
0-L R05DA08 pholcodine WHO ATC
0-L R05DA09 dextromethorphan WHO ATC
0-L R05DA10 thebacon WHO ATC
0-L R05DA11 dimemorfan WHO ATC
0-L R05DA12 acetyldihydrocodeine WHO ATC
0-L R05DA20 combinations WHO ATC
0-L R05DB Other cough suppressants WHO ATC
0-L R05DB01 benzonatate WHO ATC
0-L R05DB02 benproperine WHO ATC
0-L R05DB03 clobutinol WHO ATC
0-L R05DB04 isoaminile WHO ATC
0-L R05DB05 pentoxyverine WHO ATC
0-L R05DB07 oxolamine WHO ATC
0-L R05DB09 oxeladin WHO ATC
0-L R05DB10 clofedanol WHO ATC
0-L R05DB11 pipazetate WHO ATC
0-L R05DB12 bibenzonium bromide WHO ATC
0-L R05DB13 butamirate WHO ATC
0-L R05DB14 fedrilate WHO ATC
0-L R05DB15 zipeprol WHO ATC
0-L R05DB16 dibunate WHO ATC
0-L R05DB17 droxypropine WHO ATC
0-L R05DB18 prenoxdiazine WHO ATC
0-L R05DB19 dropropizine WHO ATC
0-L R05DB20 combinations WHO ATC
0-L R05DB21 cloperastine WHO ATC
0-L R05DB22 meprotixol WHO ATC
0-L R05DB23 piperidione WHO ATC
0-L R05DB24 tipepidine WHO ATC
0-L R05DB25 morclofone WHO ATC
0-L R05DB26 nepinalone WHO ATC
0-L R05DB27 levodropropizine WHO ATC
0-L R05DB28 dimethoxanate WHO ATC
0-L R05F COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS WHO ATC
0-L R05FA Opium derivatives and expectorants WHO ATC
0-L R05FA01 opium derivatives and mucolytics WHO ATC
0-L R05FA02 opium derivatives and expectorants WHO ATC
0-L R05FB Other cough suppressants and expectorants WHO ATC
0-L R05FB01 cough suppressants and mucolytics WHO ATC
0-L R05FB02 cough suppressants and expectorants WHO ATC
0-L R05X OTHER COLD COMBINATION PREPARATIONS WHO ATC
0-L R06 ANTIHISTAMINES FOR SYSTEMIC USE WHO ATC
0-L R06A ANTIHISTAMINES FOR SYSTEMIC USE WHO ATC
0-L R06AA Aminoalkyl ethers WHO ATC
0-L R06AA01 bromazine WHO ATC
0-L R06AA02 diphenhydramine WHO ATC
0-L R06AA04 clemastine WHO ATC
0-L R06AA06 chlorphenoxamine WHO ATC
0-L R06AA07 diphenylpyraline WHO ATC
0-L R06AA08 carbinoxamine WHO ATC
0-L R06AA09 doxylamine WHO ATC
0-L R06AA52 diphenhydramine, combinations WHO ATC
0-L R06AA54 clemastine, combinations WHO ATC
0-L R06AA56 chlorphenoxamine, combinations WHO ATC
0-L R06AA57 diphenylpyraline, combinations WHO ATC
0-L R06AB Substituted alkylamines WHO ATC
0-L R06AB01 brompheniramine WHO ATC
0-L R06AB02 dexchlorpheniramine WHO ATC
0-L R06AB03 dimetindene WHO ATC
0-L R06AB04 chlorphenamine WHO ATC
0-L R06AB05 pheniramine WHO ATC
0-L R06AB06 dexbrompheniramine WHO ATC
0-L R06AB07 talastine WHO ATC
0-L R06AB51 brompheniramine, combinations WHO ATC
0-L R06AB52 dexchlorpheniramine, combinations WHO ATC
0-L R06AB54 chlorphenamine, combinations WHO ATC
0-L R06AB56 dexbrompheniramine, combinations WHO ATC
0-L R06AC Substituted ethylene diamines WHO ATC
0-L R06AC01 mepyramine WHO ATC
0-L R06AC02 histapyrrodine WHO ATC
0-L R06AC03 chloropyramine WHO ATC
0-L R06AC04 tripelennamine WHO ATC
0-L R06AC05 methapyrilene WHO ATC
0-L R06AC06 thonzylamine WHO ATC
0-L R06AC52 histapyrrodine, combinations WHO ATC
0-L R06AC53 chloropyramine, combinations WHO ATC
0-L R06AD Phenothiazine derivatives WHO ATC
0-L R06AD01 alimemazine WHO ATC
0-L R06AD02 promethazine WHO ATC
0-L R06AD03 thiethylperazine WHO ATC
0-L R06AD04 methdilazine WHO ATC
0-L R06AD05 hydroxyethylpromethazine WHO ATC
0-L R06AD06 thiazinam WHO ATC
0-L R06AD07 mequitazine WHO ATC
0-L R06AD08 oxomemazine WHO ATC
0-L R06AD09 isothipendyl WHO ATC
0-L R06AD52 promethazine, combinations WHO ATC
0-L R06AD55 hydroxyethylpromethazine, combinations WHO ATC
0-L R06AE Piperazine derivatives WHO ATC
0-L R06AE01 buclizine WHO ATC
0-L R06AE03 cyclizine WHO ATC
0-L R06AE04 chlorcyclizine WHO ATC
0-L R06AE05 meclozine WHO ATC
0-L R06AE06 oxatomide WHO ATC
0-L R06AE07 cetirizine WHO ATC
0-L R06AE09 levocetirizine WHO ATC
0-L R06AE51 buclizine, combinations WHO ATC
0-L R06AE53 cyclizine, combinations WHO ATC
0-L R06AE55 meclozine, combinations WHO ATC
0-L R06AK Combinations of antihistamines WHO ATC
0-L R06AX Other antihistamines for systemic use WHO ATC
0-L R06AX01 bamipine WHO ATC
0-L R06AX02 cyproheptadine WHO ATC
0-L R06AX03 thenalidine WHO ATC
0-L R06AX04 phenindamine WHO ATC
0-L R06AX05 antazoline WHO ATC
0-L R06AX07 triprolidine WHO ATC
0-L R06AX08 pyrrobutamine WHO ATC
0-L R06AX09 azatadine WHO ATC
0-L R06AX11 astemizole WHO ATC
0-L R06AX12 terfenadine WHO ATC
0-L R06AX13 loratadine WHO ATC
0-L R06AX15 mebhydrolin WHO ATC
0-L R06AX16 deptropine WHO ATC
0-L R06AX17 ketotifen WHO ATC
0-L R06AX18 acrivastine WHO ATC
0-L R06AX19 azelastine WHO ATC
0-L R06AX21 tritoqualine WHO ATC
0-L R06AX22 ebastine WHO ATC
0-L R06AX23 pimethixene WHO ATC
0-L R06AX24 epinastine WHO ATC
0-L R06AX25 mizolastine WHO ATC
0-L R06AX26 fexofenadine WHO ATC
0-L R06AX27 desloratadine WHO ATC
0-L R06AX28 rupatadine WHO ATC
0-L R06AX53 thenalidine, combinations WHO ATC
0-L R06AX58 pyrrobutamine, combinations WHO ATC
0-L R07 OTHER RESPIRATORY SYSTEM PRODUCTS WHO ATC
0-L R07A OTHER RESPIRATORY SYSTEM PRODUCTS WHO ATC
0-L R07AA Lung surfactants WHO ATC
0-L R07AA01 colfosceril palmitate WHO ATC
0-L R07AA02 natural phospholipids WHO ATC
0-L R07AA30 combinations WHO ATC
0-L R07AB Respiratory stimulants WHO ATC
0-L R07AB01 doxapram WHO ATC
0-L R07AB02 nikethamide WHO ATC
0-L R07AB03 pentetrazol WHO ATC
0-L R07AB04 etamivan WHO ATC
0-L R07AB05 bemegride WHO ATC
0-L R07AB06 prethcamide WHO ATC
0-L R07AB07 almitrine WHO ATC
0-L R07AB08 dimefline WHO ATC
0-L R07AB09 mepixanox WHO ATC
0-L R07AB52 nikethamide, combinations WHO ATC
0-L R07AB53 pentetrazol, combinations WHO ATC
0-L R07AX Other respiratory system products WHO ATC
0-L R07AX01 nitric oxide WHO ATC
0-L S SENSORY ORGANS WHO ATC
0-L S01 OPHTHALMOLOGICALS WHO ATC
0-L S01A ANTIINFECTIVES WHO ATC
0-L S01AA Antibiotics WHO ATC
0-L S01AA01 chloramphenicol WHO ATC
0-L S01AA02 chlortetracycline WHO ATC
0-L S01AA03 neomycin WHO ATC
0-L S01AA04 oxytetracycline WHO ATC
0-L S01AA05 tyrothricin WHO ATC
0-L S01AA07 framycetin WHO ATC
0-L S01AA09 tetracycline WHO ATC
0-L S01AA10 natamycin WHO ATC
0-L S01AA11 gentamicin WHO ATC
0-L S01AA12 tobramycin WHO ATC
0-L S01AA13 fusidic acid WHO ATC
0-L S01AA14 benzylpenicillin WHO ATC
0-L S01AA15 dihydrostreptomycin WHO ATC
0-L S01AA16 rifamycin WHO ATC
0-L S01AA17 erythromycin WHO ATC
0-L S01AA18 polymyxin B WHO ATC
0-L S01AA19 ampicillin WHO ATC
0-L S01AA20 antibiotics in combination with other drugs WHO ATC
0-L S01AA21 amikacin WHO ATC
0-L S01AA22 micronomicin WHO ATC
0-L S01AA23 netilmicin WHO ATC
0-L S01AA24 kanamycin WHO ATC
0-L S01AA25 azidamfenicol WHO ATC
0-L S01AA26 azithromycin WHO ATC
0-L S01AA30 combinations of different antibiotics WHO ATC
0-L S01AB Sulfonamides WHO ATC
0-L S01AB01 sulfamethizole WHO ATC
0-L S01AB02 sulfafurazole WHO ATC
0-L S01AB03 sulfadicramide WHO ATC
0-L S01AB04 sulfacetamide WHO ATC
0-L S01AB05 sulfafenazol WHO ATC
0-L S01AD Antivirals WHO ATC
0-L S01AD01 idoxuridine WHO ATC
0-L S01AD02 trifluridine WHO ATC
0-L S01AD03 aciclovir WHO ATC
0-L S01AD05 interferon WHO ATC
0-L S01AD06 vidarabine WHO ATC
0-L S01AD07 famciclovir WHO ATC
0-L S01AD08 fomivirsen WHO ATC
0-L S01AD09 ganciclovir WHO ATC
0-L S01AX Other antiinfectives WHO ATC
0-L S01AX01 mercury compounds WHO ATC
0-L S01AX02 silver compounds WHO ATC
0-L S01AX03 zinc compounds WHO ATC
0-L S01AX04 nitrofural WHO ATC
0-L S01AX05 bibrocathol WHO ATC
0-L S01AX06 resorcinol WHO ATC
0-L S01AX07 sodium borate WHO ATC
0-L S01AX08 hexamidine WHO ATC
0-L S01AX09 chlorhexidine WHO ATC
0-L S01AX10 sodium propionate WHO ATC
0-L S01AX11 ofloxacin WHO ATC
0-L S01AX12 norfloxacin WHO ATC
0-L S01AX13 ciprofloxacin WHO ATC
0-L S01AX14 dibrompropamidine WHO ATC
0-L S01AX15 propamidine WHO ATC
0-L S01AX16 picloxydine WHO ATC
0-L S01AX17 lomefloxacin WHO ATC
0-L S01AX18 povidone-iodine WHO ATC
0-L S01AX19 levofloxacin WHO ATC
0-L S01AX21 gatifloxacin WHO ATC
0-L S01AX22 moxifloxacin WHO ATC
0-L S01B ANTIINFLAMMATORY AGENTS WHO ATC
0-L S01BA Corticosteroids, plain WHO ATC
0-L S01BA01 dexamethasone WHO ATC
0-L S01BA02 hydrocortisone WHO ATC
0-L S01BA03 cortisone WHO ATC
0-L S01BA04 prednisolone WHO ATC
0-L S01BA05 triamcinolone WHO ATC
0-L S01BA06 betamethasone WHO ATC
0-L S01BA07 fluorometholone WHO ATC
0-L S01BA08 medrysone WHO ATC
0-L S01BA09 clobetasone WHO ATC
0-L S01BA10 alclometasone WHO ATC
0-L S01BA11 desonide WHO ATC
0-L S01BA12 formocortal WHO ATC
0-L S01BA13 rimexolone WHO ATC
0-L S01BA14 loteprednol WHO ATC
0-L S01BA15 fluocinolone acetonide WHO ATC
0-L S01BB Corticosteroids and mydriatics in combination WHO ATC
0-L S01BB01 hydrocortisone and mydriatics WHO ATC
0-L S01BB02 prednisolone and mydriatics WHO ATC
0-L S01BB03 fluorometholone and mydriatics WHO ATC
0-L S01BB04 betamethasone and mydriatics WHO ATC
0-L S01BC Antiinflammatory agents, non-steroids WHO ATC
0-L S01BC01 indometacin WHO ATC
0-L S01BC02 oxyphenbutazone WHO ATC
0-L S01BC03 diclofenac WHO ATC
0-L S01BC04 flurbiprofen WHO ATC
0-L S01BC05 ketorolac WHO ATC
0-L S01BC06 piroxicam WHO ATC
0-L S01BC07 bendazac WHO ATC
0-L S01BC08 salicylic acid WHO ATC
0-L S01BC09 pranoprofen WHO ATC
0-L S01BC10 nepafenac WHO ATC
0-L S01BC11 bromfenac WHO ATC
0-L S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION WHO ATC
0-L S01CA Corticosteroids and antiinfectives in combination WHO ATC
0-L S01CA01 dexamethasone and antiinfectives WHO ATC
0-L S01CA02 prednisolone and antiinfectives WHO ATC
0-L S01CA03 hydrocortisone and antiinfectives WHO ATC
0-L S01CA04 fluocortolone and antiinfectives WHO ATC
0-L S01CA05 betamethasone and antiinfectives WHO ATC
0-L S01CA06 fludrocortisone and antiinfectives WHO ATC
0-L S01CA07 fluorometholone and antiinfectives WHO ATC
0-L S01CA08 methylprednisolone and antiinfectives WHO ATC
0-L S01CA09 chloroprednisone and antiinfectives WHO ATC
0-L S01CA10 fluocinolone acetonide and antiinfectives WHO ATC
0-L S01CA11 clobetasone and antiinfectives WHO ATC
0-L S01CB Corticosteroids/antiinfectives/mydriatics in combination WHO ATC
0-L S01CB01 dexamethasone WHO ATC
0-L S01CB02 prednisolone WHO ATC
0-L S01CB03 hydrocortisone WHO ATC
0-L S01CB04 betamethasone WHO ATC
0-L S01CB05 fluorometholone WHO ATC
0-L S01CC Antiinflammatory agents, non-steroids and antiinfectives in combination WHO ATC
0-L S01CC01 diclofenac and antiinfectives WHO ATC
0-L S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS WHO ATC
0-L S01EA Sympathomimetics in glaucoma therapy WHO ATC
0-L S01EA01 epinephrine WHO ATC
0-L S01EA02 dipivefrine WHO ATC
0-L S01EA03 apraclonidine WHO ATC
0-L S01EA04 clonidine WHO ATC
0-L S01EA05 brimonidine WHO ATC
0-L S01EA51 epinephrine, combinations WHO ATC
0-L S01EB Parasympathomimetics WHO ATC
0-L S01EB01 pilocarpine WHO ATC
0-L S01EB02 carbachol WHO ATC
0-L S01EB03 ecothiopate WHO ATC
0-L S01EB04 demecarium WHO ATC
0-L S01EB05 physostigmine WHO ATC
0-L S01EB06 neostigmine WHO ATC
0-L S01EB07 fluostigmine WHO ATC
0-L S01EB08 aceclidine WHO ATC
0-L S01EB09 acetylcholine WHO ATC
0-L S01EB10 paraoxon WHO ATC
0-L S01EB51 pilocarpine, combinations WHO ATC
0-L S01EB58 aceclidine, combinations WHO ATC
0-L S01EC Carbonic anhydrase inhibitors WHO ATC
0-L S01EC01 acetazolamide WHO ATC
0-L S01EC02 diclofenamide WHO ATC
0-L S01EC03 dorzolamide WHO ATC
0-L S01EC04 brinzolamide WHO ATC
0-L S01EC05 methazolamide WHO ATC
0-L S01ED Beta blocking agents1) WHO ATC
0-L S01ED01 timolol WHO ATC
0-L S01ED02 betaxolol WHO ATC
0-L S01ED03 levobunolol WHO ATC
0-L S01ED04 metipranolol WHO ATC
0-L S01ED05 carteolol WHO ATC
0-L S01ED06 befunolol WHO ATC
0-L S01ED51 timolol, combinations WHO ATC
0-L S01ED52 betaxolol, combinations WHO ATC
0-L S01ED54 metipranolol, combinations WHO ATC
0-L S01ED55 carteolol, combinations WHO ATC
0-L S01EE Prostaglandin analogues1) WHO ATC
0-L S01EE01 latanoprost WHO ATC
0-L S01EE02 unoprostone WHO ATC
0-L S01EE03 bimatoprost WHO ATC
0-L S01EE04 travoprost WHO ATC
0-L S01EE05 tafluprost WHO ATC
0-L S01EX Other antiglaucoma preparations WHO ATC
0-L S01EX01 guanethidine WHO ATC
0-L S01EX02 dapiprazole WHO ATC
0-L S01F MYDRIATICS AND CYCLOPLEGICS WHO ATC
0-L S01FA Anticholinergics WHO ATC
0-L S01FA01 atropine WHO ATC
0-L S01FA02 scopolamine WHO ATC
0-L S01FA03 methylscopolamine WHO ATC
0-L S01FA04 cyclopentolate WHO ATC
0-L S01FA05 homatropine WHO ATC
0-L S01FA06 tropicamide WHO ATC
0-L S01FA56 tropicamide, combinations WHO ATC
0-L S01FB Sympathomimetics excl. antiglaucoma preparations WHO ATC
0-L S01FB01 phenylephrine WHO ATC
0-L S01FB02 ephedrine WHO ATC
0-L S01FB03 ibopamine WHO ATC
0-L S01G DECONGESTANTS AND ANTIALLERGICS WHO ATC
0-L S01GA Sympathomimetics used as decongestants WHO ATC
0-L S01GA01 naphazoline WHO ATC
0-L S01GA02 tetryzoline WHO ATC
0-L S01GA03 xylometazoline WHO ATC
0-L S01GA04 oxymetazoline WHO ATC
0-L S01GA05 phenylephrine WHO ATC
0-L S01GA06 oxedrine WHO ATC
0-L S01GA51 naphazoline, combinations WHO ATC
0-L S01GA52 tetryzoline, combinations WHO ATC
0-L S01GA53 xylometazoline, combinations WHO ATC
0-L S01GA55 phenylephrine, combinations WHO ATC
0-L S01GA56 oxedrine, combinations WHO ATC
0-L S01GX Other antiallergics WHO ATC
0-L S01GX01 cromoglicic acid WHO ATC
0-L S01GX02 levocabastine WHO ATC
0-L S01GX03 spaglumic acid WHO ATC
0-L S01GX04 nedocromil WHO ATC
0-L S01GX05 lodoxamide WHO ATC
0-L S01GX06 emedastine WHO ATC
0-L S01GX07 azelastine WHO ATC
0-L S01GX08 ketotifen WHO ATC
0-L S01GX09 olopatadine WHO ATC
0-L S01GX10 epinastine WHO ATC
0-L S01GX51 cromoglicic acid, combinations WHO ATC
0-L S01H LOCAL ANESTHETICS WHO ATC
0-L S01HA Local anesthetics WHO ATC
0-L S01HA01 cocaine WHO ATC
0-L S01HA02 oxybuprocaine WHO ATC
0-L S01HA03 tetracaine WHO ATC
0-L S01HA04 proxymetacaine WHO ATC
0-L S01HA05 procaine WHO ATC
0-L S01HA06 cinchocaine WHO ATC
0-L S01HA07 lidocaine WHO ATC
0-L S01HA30 combinations WHO ATC
0-L S01J DIAGNOSTIC AGENTS WHO ATC
0-L S01JA Colouring agents WHO ATC
0-L S01JA01 fluorescein WHO ATC
0-L S01JA02 rose bengal sodium WHO ATC
0-L S01JA51 fluorescein, combinations WHO ATC
0-L S01JX Other ophthalmological diagnostic agents WHO ATC
0-L S01K SURGICAL AIDS WHO ATC
0-L S01KA Viscoelastic substances WHO ATC
0-L S01KA01 hyaluronic acid WHO ATC
0-L S01KA02 hypromellose WHO ATC
0-L S01KA51 hyaluronic acid, combinations WHO ATC
0-L S01KX Other surgical aids WHO ATC
0-L S01KX01 chymotrypsin WHO ATC
0-L S01L OCULAR VASCULAR DISORDER AGENTS WHO ATC
0-L S01LA Antineovascularisation agents WHO ATC
0-L S01LA01 verteporfin WHO ATC
0-L S01LA02 anecortave WHO ATC
0-L S01LA03 pegaptanib WHO ATC
0-L S01LA04 ranibizumab WHO ATC
0-L S01X OTHER OPHTHALMOLOGICALS WHO ATC
0-L S01XA Other ophthalmologicals WHO ATC
0-L S01XA01 guaiazulen WHO ATC
0-L S01XA02 retinol WHO ATC
0-L S01XA03 sodium chloride, hypertonic WHO ATC
0-L S01XA04 potassium iodide WHO ATC
0-L S01XA05 sodium edetate WHO ATC
0-L S01XA06 ethylmorphine WHO ATC
0-L S01XA07 alum WHO ATC
0-L S01XA08 acetylcysteine WHO ATC
0-L S01XA09 iodoheparinate WHO ATC
0-L S01XA10 inosine WHO ATC
0-L S01XA11 nandrolone WHO ATC
0-L S01XA12 dexpanthenol WHO ATC
0-L S01XA13 alteplase WHO ATC
0-L S01XA14 heparin WHO ATC
0-L S01XA15 ascorbic acid WHO ATC
0-L S01XA18 ciclosporin WHO ATC
0-L S01XA20 artificial tears and other indifferent preparations WHO ATC
0-L S02 OTOLOGICALS WHO ATC
0-L S02A ANTIINFECTIVES WHO ATC
0-L S02AA Antiinfectives WHO ATC
0-L S02AA01 chloramphenicol WHO ATC
0-L S02AA02 nitrofural WHO ATC
0-L S02AA03 boric acid WHO ATC
0-L S02AA04 aluminium acetotartrate WHO ATC
0-L S02AA05 clioquinol WHO ATC
0-L S02AA06 hydrogen peroxide WHO ATC
0-L S02AA07 neomycin WHO ATC
0-L S02AA08 tetracycline WHO ATC
0-L S02AA09 chlorhexidine WHO ATC
0-L S02AA10 acetic acid WHO ATC
0-L S02AA11 polymyxin B WHO ATC
0-L S02AA12 rifamycin WHO ATC
0-L S02AA13 miconazole WHO ATC
0-L S02AA14 gentamicin WHO ATC
0-L S02AA15 ciprofloxacin WHO ATC
0-L S02AA16 ofloxacin WHO ATC
0-L S02AA30 antiinfectives, combinations WHO ATC
0-L S02B CORTICOSTEROIDS WHO ATC
0-L S02BA Corticosteroids WHO ATC
0-L S02BA01 hydrocortisone WHO ATC
0-L S02BA03 prednisolone WHO ATC
0-L S02BA06 dexamethasone WHO ATC
0-L S02BA07 betamethasone WHO ATC
0-L S02BA08 fluocinolone acetonide WHO ATC
0-L S02C CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION WHO ATC
0-L S02CA Corticosteroids and antiinfectives in combination WHO ATC
0-L S02CA01 prednisolone and antiinfectives WHO ATC
0-L S02CA02 flumetasone and antiinfectives WHO ATC
0-L S02CA03 hydrocortisone and antiinfectives WHO ATC
0-L S02CA04 triamcinolone and antiinfectives WHO ATC
0-L S02CA05 fluocinolone acetonide and antiinfectives WHO ATC
0-L S02CA06 dexamethasone and antiinfectives WHO ATC
0-L S02CA07 fludrocortisone and antiinfectives WHO ATC
0-L S02D OTHER OTOLOGICALS WHO ATC
0-L S02DA Analgesics and anesthetics WHO ATC
0-L S02DA01 lidocaine WHO ATC
0-L S02DA02 cocaine WHO ATC
0-L S02DA03 phenazone WHO ATC
0-L S02DA30 combinations WHO ATC
0-L S02DC Indifferent preparations WHO ATC
0-L S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS WHO ATC
0-L S03A ANTIINFECTIVES WHO ATC
0-L S03AA Antiinfectives WHO ATC
0-L S03AA01 neomycin WHO ATC
0-L S03AA02 tetracycline WHO ATC
0-L S03AA03 polymyxin B WHO ATC
0-L S03AA04 chlorhexidine WHO ATC
0-L S03AA05 hexamidine WHO ATC
0-L S03AA06 gentamicin WHO ATC
0-L S03AA07 ciprofloxacin WHO ATC
0-L S03AA08 chloramphenicol WHO ATC
0-L S03AA30 antiinfectives, combinations WHO ATC
0-L S03B CORTICOSTEROIDS WHO ATC
0-L S03BA Corticosteroids WHO ATC
0-L S03BA01 dexamethasone WHO ATC
0-L S03BA02 prednisolone WHO ATC
0-L S03BA03 betamethasone WHO ATC
0-L S03C CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION WHO ATC
0-L S03CA Corticosteroids and antiinfectives in combination WHO ATC
0-L S03CA01 dexamethasone and antiinfectives WHO ATC
0-L S03CA02 prednisolone and antiinfectives WHO ATC
0-L S03CA04 hydrocortisone and antiinfectives WHO ATC
0-L S03CA05 fludrocortisone and antiinfectives WHO ATC
0-L S03CA06 betamethasone and antiinfectives WHO ATC
0-L S03D OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS WHO ATC
0-L V VARIOUS WHO ATC
0-L V01 ALLERGENS WHO ATC
0-L V01A ALLERGENS WHO ATC
0-L V01AA Allergen extracts WHO ATC
0-L V01AA01 feather WHO ATC
0-L V01AA02 grass pollen WHO ATC
0-L V01AA03 house dust mites WHO ATC
0-L V01AA04 mould fungus and yeast fungus WHO ATC
0-L V01AA05 tree pollen WHO ATC
0-L V01AA07 insects WHO ATC
0-L V01AA08 food WHO ATC
0-L V01AA09 textiles WHO ATC
0-L V01AA10 flowers WHO ATC
0-L V01AA11 animals WHO ATC
0-L V01AA20 various WHO ATC
0-L V03 ALL OTHER THERAPEUTIC PRODUCTS WHO ATC
0-L V03A ALL OTHER THERAPEUTIC PRODUCTS WHO ATC
0-L V03AB Antidotes WHO ATC
0-L V03AB01 ipecacuanha WHO ATC
0-L V03AB02 nalorphine WHO ATC
0-L V03AB03 edetates WHO ATC
0-L V03AB04 pralidoxime WHO ATC
0-L V03AB05 prednisolone and promethazine WHO ATC
0-L V03AB06 thiosulfate WHO ATC
0-L V03AB08 sodium nitrite WHO ATC
0-L V03AB09 dimercaprol WHO ATC
0-L V03AB13 obidoxime WHO ATC
0-L V03AB14 protamine WHO ATC
0-L V03AB15 naloxone WHO ATC
0-L V03AB16 ethanol WHO ATC
0-L V03AB17 methylthioninium chloride WHO ATC
0-L V03AB18 potassium permanganate WHO ATC
0-L V03AB19 physostigmine WHO ATC
0-L V03AB20 copper sulfate WHO ATC
0-L V03AB21 potassium iodide WHO ATC
0-L V03AB22 amyl nitrite WHO ATC
0-L V03AB23 acetylcysteine WHO ATC
0-L V03AB24 digitalis antitoxin WHO ATC
0-L V03AB25 flumazenil WHO ATC
0-L V03AB26 methionine WHO ATC
0-L V03AB27 4-dimethylaminophenol WHO ATC
0-L V03AB29 cholinesterase WHO ATC
0-L V03AB31 prussian blue WHO ATC
0-L V03AB32 glutathione WHO ATC
0-L V03AB33 hydroxocobalamin WHO ATC
0-L V03AB34 fomepizole WHO ATC
0-L V03AB35 sugammadex WHO ATC
0-L V03AC Iron chelating agents WHO ATC
0-L V03AC01 deferoxamine WHO ATC
0-L V03AC02 deferiprone WHO ATC
0-L V03AC03 deferasirox WHO ATC
0-L V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia WHO ATC
0-L V03AE01 polystyrene sulfonate WHO ATC
0-L V03AE02 sevelamer WHO ATC
0-L V03AE03 lanthanum carbonate WHO ATC
0-L V03AE04 calcium acetate and magnesium carbonate WHO ATC
0-L V03AF Detoxifying agents for antineoplastic treatment WHO ATC
0-L V03AF01 mesna WHO ATC
0-L V03AF02 dexrazoxane WHO ATC
0-L V03AF03 calcium folinate WHO ATC
0-L V03AF04 calcium levofolinate WHO ATC
0-L V03AF05 amifostine WHO ATC
0-L V03AF06 sodium folinate WHO ATC
0-L V03AF07 rasburicase WHO ATC
0-L V03AF08 palifermin WHO ATC
0-L V03AF09 glucarpidase WHO ATC
0-L V03AF10 sodium levofolinate WHO ATC
0-L V03AG Drugs for treatment of hypercalcemia WHO ATC
0-L V03AG01 sodium cellulose phosphate WHO ATC
0-L V03AH Drugs for treatment of hypoglycemia WHO ATC
0-L V03AH01 diazoxide WHO ATC
0-L V03AK Tissue adhesives WHO ATC
0-L V03AM Drugs for embolisation WHO ATC
0-L V03AN Medical gases WHO ATC
0-L V03AN01 oxygen WHO ATC
0-L V03AN02 carbon dioxide WHO ATC
0-L V03AN03 helium WHO ATC
0-L V03AN04 nitrogen WHO ATC
0-L V03AN05 medical air WHO ATC
0-L V03AX Other therapeutic products WHO ATC
0-L V03AX02 nalfurafine WHO ATC
0-L V03AZ Nerve depressants WHO ATC
0-L V03AZ01 ethanol WHO ATC
0-L V04 DIAGNOSTIC AGENTS WHO ATC
0-L V04B URINE TESTS WHO ATC
0-L V04C OTHER DIAGNOSTIC AGENTS WHO ATC
0-L V04CA Tests for diabetes WHO ATC
0-L V04CA01 tolbutamide WHO ATC
0-L V04CA02 glucose WHO ATC
0-L V04CB Tests for fat absorption WHO ATC
0-L V04CB01 vitamin A concentrates WHO ATC
0-L V04CC Tests for bile duct patency WHO ATC
0-L V04CC01 sorbitol WHO ATC
0-L V04CC02 magnesium sulfate WHO ATC
0-L V04CC03 sincalide WHO ATC
0-L V04CC04 ceruletide WHO ATC
0-L V04CD Tests for pituitary function WHO ATC
0-L V04CD01 metyrapone WHO ATC
0-L V04CD03 sermorelin WHO ATC
0-L V04CD04 corticorelin WHO ATC
0-L V04CD05 somatorelin WHO ATC
0-L V04CE Tests for liver functional capacity WHO ATC
0-L V04CE01 galactose WHO ATC
0-L V04CE02 sulfobromophthalein WHO ATC
0-L V04CF Tuberculosis diagnostics WHO ATC
0-L V04CF01 tuberculin WHO ATC
0-L V04CG Tests for gastric secretion WHO ATC
0-L V04CG01 cation exchange resins WHO ATC
0-L V04CG02 betazole WHO ATC
0-L V04CG03 histamine phosphate WHO ATC
0-L V04CG04 pentagastrin WHO ATC
0-L V04CG05 methylthioninium chloride WHO ATC
0-L V04CG30 caffeine and sodium benzoate WHO ATC
0-L V04CH Tests for renal function WHO ATC
0-L V04CH01 inulin and other polyfructosans WHO ATC
0-L V04CH02 indigo carmine WHO ATC
0-L V04CH03 phenolsulfonphthalein WHO ATC
0-L V04CH04 alsactide WHO ATC
0-L V04CH30 aminohippuric acid WHO ATC
0-L V04CJ Tests for thyreoidea function WHO ATC
0-L V04CJ01 thyrotropin WHO ATC
0-L V04CJ02 protirelin WHO ATC
0-L V04CK Tests for pancreatic function WHO ATC
0-L V04CK01 secretin WHO ATC
0-L V04CK02 pancreozymin (cholecystokinin) WHO ATC
0-L V04CK03 bentiromide WHO ATC
0-L V04CL Tests for allergic diseases WHO ATC
0-L V04CM Tests for fertility disturbances WHO ATC
0-L V04CM01 gonadorelin WHO ATC
0-L V04CX Other diagnostic agents WHO ATC
0-L V06 GENERAL NUTRIENTS WHO ATC
0-L V06A DIET FORMULATIONS FOR TREATMENT OF OBESITY WHO ATC
0-L V06AA Low-energy diets WHO ATC
0-L V06B PROTEIN SUPPLEMENTS WHO ATC
0-L V06C INFANT FORMULAS WHO ATC
0-L V06CA Nutrients without phenylalanine WHO ATC
0-L V06D OTHER NUTRIENTS WHO ATC
0-L V06DA Carbohydrates/proteins/minerals/vitamins, combinations WHO ATC
0-L V06DB Fat/carbohydrates/proteins/minerals/vitamins, combinations WHO ATC
0-L V06DC Carbohydrates WHO ATC
0-L V06DC01 glucose WHO ATC
0-L V06DC02 fructose WHO ATC
0-L V06DD Amino acids, incl. combinations with polypeptides WHO ATC
0-L V06DE Amino acids/carbohydrates/minerals/vitamins, combinations WHO ATC
0-L V06DF Milk substitutes WHO ATC
0-L V06DX Other combinations of nutrients WHO ATC
0-L V07 ALL OTHER NON-THERAPEUTIC PRODUCTS WHO ATC
0-L V07A ALL OTHER NON-THERAPEUTIC PRODUCTS WHO ATC
0-L V07AA Plasters WHO ATC
0-L V07AB Solvents and diluting agents, incl. irrigating solutions WHO ATC
0-L V07AC Blood transfusion, auxiliary products WHO ATC
0-L V07AD Blood tests, auxiliary products WHO ATC
0-L V07AN Incontinence equipment WHO ATC
0-L V07AR Sensitivity tests, discs and tablets WHO ATC
0-L V07AS Stomi equipment WHO ATC
0-L V07AT Cosmetics WHO ATC
0-L V07AV Technical disinfectants WHO ATC
0-L V07AX Washing agents etc. WHO ATC
0-L V07AY Other non-therapeutic auxiliary products WHO ATC
0-L V07AZ Chemicals and reagents for analysis WHO ATC
0-L V08 CONTRAST MEDIA WHO ATC
0-L V08A X-RAY CONTRAST MEDIA, IODINATED WHO ATC
0-L V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media WHO ATC
0-L V08AA01 diatrizoic acid WHO ATC
0-L V08AA02 metrizoic acid WHO ATC
0-L V08AA03 iodamide WHO ATC
0-L V08AA04 iotalamic acid WHO ATC
0-L V08AA05 ioxitalamic acid WHO ATC
0-L V08AA06 ioglicic acid WHO ATC
0-L V08AA07 acetrizoic acid WHO ATC
0-L V08AA08 iocarmic acid WHO ATC
0-L V08AA09 methiodal WHO ATC
0-L V08AA10 diodone WHO ATC
0-L V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media WHO ATC
0-L V08AB01 metrizamide WHO ATC
0-L V08AB02 iohexol WHO ATC
0-L V08AB03 ioxaglic acid WHO ATC
0-L V08AB04 iopamidol WHO ATC
0-L V08AB05 iopromide WHO ATC
0-L V08AB06 iotrolan WHO ATC
0-L V08AB07 ioversol WHO ATC
0-L V08AB08 iopentol WHO ATC
0-L V08AB09 iodixanol WHO ATC
0-L V08AB10 iomeprol WHO ATC
0-L V08AB11 iobitridol WHO ATC
0-L V08AB12 ioxilan WHO ATC
0-L V08AC Watersoluble, hepatotropic X-ray contrast media WHO ATC
0-L V08AC01 iodoxamic acid WHO ATC
0-L V08AC02 iotroxic acid WHO ATC
0-L V08AC03 ioglycamic acid WHO ATC
0-L V08AC04 adipiodone WHO ATC
0-L V08AC05 iobenzamic acid WHO ATC
0-L V08AC06 iopanoic acid WHO ATC
0-L V08AC07 iocetamic acid WHO ATC
0-L V08AC08 sodium iopodate WHO ATC
0-L V08AC09 tyropanoic acid WHO ATC
0-L V08AC10 calcium iopodate WHO ATC
0-L V08AD Non-watersoluble X-ray contrast media WHO ATC
0-L V08AD01 ethyl esters of iodised fatty acids WHO ATC
0-L V08AD02 iopydol WHO ATC
0-L V08AD03 propyliodone WHO ATC
0-L V08AD04 iofendylate WHO ATC
0-L V08B X-RAY CONTRAST MEDIA, NON-IODINATED WHO ATC
0-L V08BA Barium sulfate containing X-ray contrast media WHO ATC
0-L V08BA01 barium sulfate with suspending agents WHO ATC
0-L V08BA02 barium sulfate without suspending agents WHO ATC
0-L V08C MAGNETIC RESONANCE IMAGING CONTRAST MEDIA WHO ATC
0-L V08CA Paramagnetic contrast media WHO ATC
0-L V08CA01 gadopentetic acid WHO ATC
0-L V08CA02 gadoteric acid WHO ATC
0-L V08CA03 gadodiamide WHO ATC
0-L V08CA04 gadoteridol WHO ATC
0-L V08CA05 mangafodipir WHO ATC
0-L V08CA06 gadoversetamide WHO ATC
0-L V08CA07 ferric ammonium citrate WHO ATC
0-L V08CA08 gadobenic acid WHO ATC
0-L V08CA09 gadobutrol WHO ATC
0-L V08CA10 gadoxetic acid WHO ATC
0-L V08CA11 gadofosveset WHO ATC
0-L V08CB Superparamagnetic contrast media WHO ATC
0-L V08CB01 ferumoxsil WHO ATC
0-L V08CB02 ferristene WHO ATC
0-L V08CB03 iron oxide, nanoparticles WHO ATC
0-L V08CX Other magnetic resonance imaging contrast media WHO ATC
0-L V08CX01 perflubron WHO ATC
0-L V08D ULTRASOUND CONTRAST MEDIA WHO ATC
0-L V08DA Ultrasound contrast media WHO ATC
0-L V08DA01 microspheres of human albumin WHO ATC
0-L V08DA02 microparticles of galactose WHO ATC
0-L V08DA03 perflenapent WHO ATC
0-L V08DA04 microspheres of phospholipids WHO ATC
0-L V08DA05 sulfur hexafluoride WHO ATC
0-L V09 DIAGNOSTIC RADIOPHARMACEUTICALS WHO ATC
0-L V09A CENTRAL NERVOUS SYSTEM WHO ATC
0-L V09AA Technetium (99mTc) compounds WHO ATC
0-L V09AA01 technetium (99mTc) exametazime WHO ATC
0-L V09AA02 technetium (99mTc) bicisate WHO ATC
0-L V09AB Iodine (123I) compounds WHO ATC
0-L V09AB01 iodine iofetamine (123I) WHO ATC
0-L V09AB02 iodine iolopride (123I) WHO ATC
0-L V09AB03 iodine ioflupane (123I) WHO ATC
0-L V09AX Other central nervous system diagnostic radiopharmaceuticals WHO ATC
0-L V09AX01 indium (111In) pentetic acid WHO ATC
0-L V09AX03 iodine (124I) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane WHO ATC
0-L V09B SKELETON WHO ATC
0-L V09BA Technetium (99mTc) compounds WHO ATC
0-L V09BA01 technetium (99mTc) oxidronic acid WHO ATC
0-L V09BA02 technetium (99mTc) medronic acid WHO ATC
0-L V09BA03 technetium (99mTc) pyrophosphate WHO ATC
0-L V09BA04 technetium (99mTc) butedronic acid WHO ATC
0-L V09C RENAL SYSTEM WHO ATC
0-L V09CA Technetium (99mTc) compounds WHO ATC
0-L V09CA01 technetium (99mTc) pentetic acid WHO ATC
0-L V09CA02 technetium (99mTc) succimer WHO ATC
0-L V09CA03 technetium (99mTc) mertiatide WHO ATC
0-L V09CA04 technetium (99mTc) gluceptate WHO ATC
0-L V09CA05 technetium (99mTc) gluconate WHO ATC
0-L V09CX Other renal system diagnostic radiopharmaceuticals WHO ATC
0-L V09CX01 sodium iodohippurate (123I) WHO ATC
0-L V09CX02 sodium iodohippurate (131I) WHO ATC
0-L V09CX03 sodium iothalamate (125I) WHO ATC
0-L V09CX04 chromium (51Cr) edetate WHO ATC
0-L V09D HEPATIC AND RETICULO ENDOTHELIAL SYSTEM WHO ATC
0-L V09DA Technetium (99mTc) compounds WHO ATC
0-L V09DA01 technetium (99mTc) disofenin WHO ATC
0-L V09DA02 technetium (99mTc) etifenin WHO ATC
0-L V09DA03 technetium (99mTc) lidofenin WHO ATC
0-L V09DA04 technetium (99mTc) mebrofenin WHO ATC
0-L V09DA05 technetium (99mTc) galtifenin WHO ATC
0-L V09DB Technetium (99mTc), particles and colloids WHO ATC
0-L V09DB01 technetium (99mTc) nanocolloid WHO ATC
0-L V09DB02 technetium (99mTc) microcolloid WHO ATC
0-L V09DB03 technetium (99mTc) millimicrospheres WHO ATC
0-L V09DB04 technetium (99mTc) tin colloid WHO ATC
0-L V09DB05 technetium (99mTc) sulfur colloid WHO ATC
0-L V09DB06 technetium (99mTc) rheniumsulfide colloid WHO ATC
0-L V09DB07 technetium (99mTc) phytate WHO ATC
0-L V09DX Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals WHO ATC
0-L V09DX01 selenium (75Se) tauroselcholic acid WHO ATC
0-L V09E RESPIRATORY SYSTEM WHO ATC
0-L V09EA Technetium (99mTc), inhalants WHO ATC
0-L V09EA01 technetium (99mTc) pentetic acid WHO ATC
0-L V09EA02 technetium (99mTc) technegas WHO ATC
0-L V09EA03 technetium (99mTc) nanocolloid WHO ATC
0-L V09EB Technetium (99mTc), particles for injection WHO ATC
0-L V09EB01 technetium (99mTc) macrosalb WHO ATC
0-L V09EB02 technetium (99mTc) microspheres WHO ATC
0-L V09EX Other respiratory system diagnostic radiopharmaceuticals WHO ATC
0-L V09EX01 krypton (81mKr) gas WHO ATC
0-L V09EX02 xenon (127Xe) gas WHO ATC
0-L V09EX03 xenon (133Xe) gas WHO ATC
0-L V09F THYROID WHO ATC
0-L V09FX Various thyroid diagnostic radiopharmaceuticals WHO ATC
0-L V09FX01 technetium (99mTc) pertechnetate WHO ATC
0-L V09FX02 sodium iodide (123I) WHO ATC
0-L V09FX03 sodium iodide (131I) WHO ATC
0-L V09FX04 sodium iodide (124I) WHO ATC
0-L V09G CARDIOVASCULAR SYSTEM WHO ATC
0-L V09GA Technetium (99mTc) compounds WHO ATC
0-L V09GA01 technetium (99mTc) sestamibi WHO ATC
0-L V09GA02 technetium (99mTc) tetrofosmin WHO ATC
0-L V09GA03 technetium (99mTc) teboroxime WHO ATC
0-L V09GA04 technetium (99mTc) human albumin WHO ATC
0-L V09GA05 technetium (99mTc) furifosmin WHO ATC
0-L V09GA06 technetium (99mTc) stannous agent labelled cells WHO ATC
0-L V09GA07 technetium (99mTc) apcitide WHO ATC
0-L V09GB Iodine (125I) compounds WHO ATC
0-L V09GB01 fibrinogen (125I) WHO ATC
0-L V09GB02 iodine (125I) human albumin WHO ATC
0-L V09GX Other cardiovascular system diagnostic radiopharmaceuticals WHO ATC
0-L V09GX01 thallium (201Tl) chloride WHO ATC
0-L V09GX02 indium (111In) imciromab WHO ATC
0-L V09GX03 chromium (51Cr) chromate labelled cells WHO ATC
0-L V09H INFLAMMATION AND INFECTION DETECTION WHO ATC
0-L V09HA Technetium (99mTc) compounds WHO ATC
0-L V09HA01 technetium (99mTc) human immunoglobulin WHO ATC
0-L V09HA02 technetium (99mTc) exametazime labelled cells WHO ATC
0-L V09HA03 technetium (99mTc) antigranulocyte antibody WHO ATC
0-L V09HA04 technetium (99mTc) sulesomab WHO ATC
0-L V09HB Indium (111In) compounds WHO ATC
0-L V09HB01 indium (111In) oxinate labelled cells WHO ATC
0-L V09HB02 indium (111In) tropolonate labelled cells WHO ATC
0-L V09HX Other diagnostic radiopharmaceuticals for inflammation and infection detection WHO ATC
0-L V09HX01 gallium (67Ga) citrate WHO ATC
0-L V09I TUMOUR DETECTION WHO ATC
0-L V09IA Technetium (99mTc) compounds WHO ATC
0-L V09IA01 technetium (99mTc) antiCarcinoEmbryonicAntigen antibody WHO ATC
0-L V09IA02 technetium (99mTc) antimelanoma antibody WHO ATC
0-L V09IA03 technetium (99mTc) pentavalent succimer WHO ATC
0-L V09IA04 technetium (99mTc) votumumab WHO ATC
0-L V09IA05 technetium (99mTc) depreotide WHO ATC
0-L V09IA06 technetium (99mTc) arcitumomab WHO ATC
0-L V09IB Indium (111In) compounds WHO ATC
0-L V09IB01 indium (111In) pentetreotide WHO ATC
0-L V09IB02 indium (111In) satumomab pendetide WHO ATC
0-L V09IB03 indium (111In) antiovariumcarcinoma antibody WHO ATC
0-L V09IB04 indium (111In) capromab pendetide WHO ATC
0-L V09IX Other diagnostic radiopharmaceuticals for tumour detection WHO ATC
0-L V09IX01 iobenguane (123I) WHO ATC
0-L V09IX02 iobenguane (131I) WHO ATC
0-L V09IX03 iodine (125I) CC49-monoclonal antibody WHO ATC
0-L V09IX04 fludeoxyglucose (18F) WHO ATC
0-L V09IX05 fluorodopa (18F) WHO ATC
0-L V09IX06 sodium fluoride (18F) WHO ATC
0-L V09IX07 fluoromethylcholine (18F) WHO ATC
0-L V09X OTHER DIAGNOSTIC RADIOPHARMACEUTICALS WHO ATC
0-L V09XA Iodine (131I) compounds WHO ATC
0-L V09XA01 iodine (131I) norcholesterol WHO ATC
0-L V09XA02 iodocholesterol (131I) WHO ATC
0-L V09XA03 iodine (131I) human albumin WHO ATC
0-L V09XX Various diagnostic radiopharmaceuticals WHO ATC
0-L V09XX01 cobalt (57Co) cyanocobalamine WHO ATC
0-L V09XX02 cobalt (58Co) cyanocobalamine WHO ATC
0-L V09XX03 selenium (75Se) norcholesterol WHO ATC
0-L V09XX04 ferric (59Fe) citrate WHO ATC
0-L V10 THERAPEUTIC RADIOPHARMACEUTICALS WHO ATC
0-L V10A ANTIINFLAMMATORY AGENTS WHO ATC
0-L V10AA Yttrium (90Y) compounds WHO ATC
0-L V10AA01 yttrium (90Y) citrate colloid WHO ATC
0-L V10AA02 yttrium (90Y) ferrihydroxide colloid WHO ATC
0-L V10AA03 yttrium (90Y) silicate colloid WHO ATC
0-L V10AX Other antiinflammatory therapeutic radiopharmaceuticals WHO ATC
0-L V10AX01 phosphorous (32P) chromicphosphate colloid WHO ATC
0-L V10AX02 samarium (153Sm) hydroxyapatite colloid WHO ATC
0-L V10AX03 dysprosium (165Dy) colloid WHO ATC
0-L V10AX04 erbium (169Er) citrate colloid WHO ATC
0-L V10AX05 rhenium (186Re) sulfide colloid WHO ATC
0-L V10AX06 gold (198Au) colloidal WHO ATC
0-L V10B PAIN PALLIATION (BONE SEEKING AGENTS) WHO ATC
0-L V10BX Various pain palliation radiopharmaceuticals WHO ATC
0-L V10BX01 strontium (89Sr) chloride WHO ATC
0-L V10BX02 samarium (153Sm) lexidronam WHO ATC
0-L V10BX03 rhenium (186Re) etidronic acid WHO ATC
0-L V10X OTHER THERAPEUTIC RADIOPHARMACEUTICALS WHO ATC
0-L V10XA Iodine (131I) compounds WHO ATC
0-L V10XA01 sodium iodide (131I) WHO ATC
0-L V10XA02 iobenguane (131I) WHO ATC
0-L V10XA53 tositumomab/iodine (131I) tositumomab WHO ATC
0-L V10XX Various therapeutic radiopharmaceuticals WHO ATC
0-L V10XX01 sodium phosphate (32P) WHO ATC
0-L V10XX02 ibritumomab tiuxetan (90Y) WHO ATC
0-L V20 SURGICAL DRESSINGS WHO ATC
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 14:39:58 - status: Closed
  Author Alexander Henket
Description Value set left unchanged with full enumeration
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:26:58
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑10‑24 10:19:20 - status: Open
  Author Giorgio Cangioli
Description Value set in epSOS are defined as enumeration of concepts derived by a single code system version.
We are aware that this leads to a set sustainability issues that will be faced by the future EU initiatives / projects (epSOS ends in Dic 2013).
Your suggestion can be taken in account "for future consideration", for the time being we are asked only to define in ART /DECOR what is the current state-of-the-art of the CDA epSOS specifciations,
tracking Tracking 2013‑10‑14 15:58:23 - status: Open
  Author Alexander Henket
Description Issue:

The value set is 5592 items and might change over time.

Proposal:

Suggest *not* to enumerate this list, but to do a codesystem binding instead. This means that systems should get a copy of this valueset through other means than this specification.

 (epsos-issue-5) epSOS Dose Form, Package and RouteOfAdministration have same codesystem
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.5)
Last assignment to Alexander Henket

Issue epSOS Dose Form, Package and RouteOfAdministration have same codesystem
Id epsos-issue-5
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-2 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSDoseForm 1.3.6.1.4.1.12559.11.10.1.3.1.42.2 2010 - 2013‑06‑03 Draft
Source Code System:
  • 1.3.6.1.4.1.12559.11.10.1.3.1.44.1 EDQM
Level/ Type Code Display Name Code System Description
0-L 10101000 Oral drops, solution EDQM
0-L 10102000 Oral drops, suspension EDQM
0-L 10103000 Oral drops, emulsion EDQM
0-L 10104000 Oral liquid EDQM
0-L 10105000 Oral solution EDQM
0-L 10106000 Oral suspension EDQM
0-L 10107000 Oral emulsion EDQM
0-L 10108000 Oral gel EDQM
0-L 10109000 Oral paste EDQM
0-L 10110000 Powder for oral solution EDQM
0-L 10111000 Powder for oral suspension EDQM
0-L 10112000 Granules for oral solution EDQM
0-L 10113000 Granules for oral suspension EDQM
0-L 10114000 Powder and solvent for oral solution EDQM
0-L 10115000 Powder and solvent for oral suspension EDQM
0-L 10116000 Lyophilisate for suspension EDQM
0-L 10117000 Syrup EDQM
0-L 10118000 Powder for syrup EDQM
0-L 10119000 Granules for syrup EDQM
0-L 10120000 Soluble tablet EDQM
0-L 10121000 Dispersible tablet EDQM
0-L 10122000 Herbal tea EDQM
0-L 10201000 Oral powder EDQM
0-L 10202000 Instant herbal tea EDQM
0-L 10203000 Effervescent powder EDQM
0-L 10204000 Granules EDQM
0-L 10205000 Effervescent granules EDQM
0-L 10206000 Gastro-resistant granules EDQM
0-L 10207000 Prolonged-release granules EDQM
0-L 10208000 Modified-release granules EDQM
0-L 10209000 Cachet EDQM
0-L 10210000 Capsule, hard EDQM
0-L 10211000 Capsule, soft EDQM
0-L 10212000 Gastro-resistant capsule, hard EDQM
0-L 10213000 Gastro-resistant capsule, soft EDQM
0-L 10214000 Chewable capsule, soft EDQM
0-L 10215000 Prolonged-release capsule, hard EDQM
0-L 10216000 Prolonged-release capsule, soft EDQM
0-L 10217000 Modified-release capsule, hard EDQM
0-L 10218000 Modified-release capsule, soft EDQM
0-L 10219000 Tablet EDQM
0-L 10220000 Coated tablet EDQM
0-L 10221000 Film-coated tablet EDQM
0-L 10222000 Effervescent tablet EDQM
0-L 10223000 Orodispersible tablet EDQM
0-L 10224000 Oral lyophilisate EDQM
0-L 10225000 Gastro-resistant tablet EDQM
0-L 10226000 Prolonged-release tablet EDQM
0-L 10227000 Modified-release tablet EDQM
0-L 10228000 Chewable tablet EDQM
0-L 10229000 Medicated chewing-gum EDQM
0-L 10230000 Oral gum EDQM
0-L 10231000 Pillules EDQM
0-L 10236100 Orodispersible film EDQM
0-L 10301000 Gargle EDQM
0-L 10302000 Concentrate for gargle EDQM
0-L 10303000 Gargle, powder for solution EDQM
0-L 10304000 Gargle, tablet for solution EDQM
0-L 10305000 Oromucosal solution EDQM
0-L 10306000 Oromucosal suspension EDQM
0-L 10307000 Oromucosal drops EDQM
0-L 10308000 Oromucosal spray EDQM
0-L 10309000 Sublingual spray EDQM
0-L 10310000 Mouthwash EDQM
0-L 10311000 Mouthwash, tablet for solution EDQM
0-L 10312000 Gingival solution EDQM
0-L 10313000 Oromucosal gel EDQM
0-L 10314000 Oromucosal paste EDQM
0-L 10314005 Oromucosal ointment EDQM
0-L 10314010 Oromucosal cream EDQM
0-L 10314011 Buccal film EDQM
0-L 10315000 Gingival gel EDQM
0-L 10316000 Gingival paste EDQM
0-L 10317000 Oromucosal capsule EDQM
0-L 10318000 Sublingual tablet EDQM
0-L 10319000 Muco-adhesive buccal tablet EDQM
0-L 10320000 Buccal tablet EDQM
0-L 10321000 Lozenge EDQM
0-L 10322000 Compressed lozenge EDQM
0-L 10323000 Pastille EDQM
0-L 10401000 Periodontal powder EDQM
0-L 10402000 Dental gel EDQM
0-L 10403000 Dental stick EDQM
0-L 10404000 Dental insert EDQM
0-L 10405000 Dental powder EDQM
0-L 10406000 Dental solution EDQM
0-L 10407000 Dental suspension EDQM
0-L 10408000 Dental emulsion EDQM
0-L 10409000 Toothpaste EDQM
0-L 10410000 Periodontal gel EDQM
0-L 10411000 Periodontal insert EDQM
0-L 10501000 Bath additive EDQM
0-L 10502000 Cream EDQM
0-L 10503000 Gel EDQM
0-L 10504000 Ointment EDQM
0-L 10505000 Cutaneous paste EDQM
0-L 10506000 Medicated plaster EDQM
0-L 10507000 Cutaneous foam EDQM
0-L 10508000 Shampoo EDQM
0-L 10509000 Cutaneous spray, solution EDQM
0-L 10510000 Cutaneous spray, suspension EDQM
0-L 10511000 Cutaneous spray, powder EDQM
0-L 10512000 Cutaneous liquid EDQM
0-L 10513000 Cutaneous solution EDQM
0-L 10514000 Concentrate for cutaneous solution EDQM
0-L 10515000 Cutaneous suspension EDQM
0-L 10516000 Cutaneous emulsion EDQM
0-L 10517000 Cutaneous powder EDQM
0-L 10517500 Cutaneous patch EDQM
0-L 10518000 Solution for iontophoresis EDQM
0-L 10519000 Transdermal patch EDQM
0-L 10520000 Collodion EDQM
0-L 10521000 Medicated nail lacquer EDQM
0-L 10521500 Nail solution EDQM
0-L 10522000 Poultice EDQM
0-L 10523000 Cutaneous stick EDQM
0-L 10524000 Cutaneous sponge EDQM
0-L 10525000 Impregnated dressing EDQM
0-L 10539500 Scrub EDQM
0-L 10546500 Transdermal spray, solution EDQM
0-L 10547000 Transdermal system EDQM
0-L 10548000 Solution for skin-prick test EDQM
0-L 10549000 Solution for skin-scratch test EDQM
0-L 10550000 Plaster for provocation test EDQM
0-L 10601000 Eye cream EDQM
0-L 10602000 Eye gel EDQM
0-L 10603000 Eye ointment EDQM
0-L 10604000 Eye drops, solution EDQM
0-L 10604500 Eye drops, emulsion EDQM
0-L 10605000 Eye drops, suspension EDQM
0-L 10606000 Eye drops, powder and solvent for solution EDQM
0-L 10607000 Eye drops, powder and solvent for suspension EDQM
0-L 10608000 Eye drops, solvent for reconstitution EDQM
0-L 10609000 Eye drops, prolonged-release EDQM
0-L 10610000 Eye lotion EDQM
0-L 10611000 Eye lotion, solvent for reconstitution EDQM
0-L 10612000 Ophthalmic insert EDQM
0-L 10613000 Ophthalmic strip EDQM
0-L 10701000 Ear cream EDQM
0-L 10702000 Ear gel EDQM
0-L 10703000 Ear ointment EDQM
0-L 10704000 Ear drops, solution EDQM
0-L 10705000 Ear drops, suspension EDQM
0-L 10706000 Ear drops, emulsion EDQM
0-L 10707000 Ear drops, powder and solvent for suspension EDQM
0-L 10708000 Ear powder EDQM
0-L 10709000 Ear spray, solution EDQM
0-L 10710000 Ear spray, suspension EDQM
0-L 10711000 Ear spray, emulsion EDQM
0-L 10712000 Ear wash, solution EDQM
0-L 10713000 Ear wash, emulsion EDQM
0-L 10714000 Ear tampon EDQM
0-L 10715000 Ear stick EDQM
0-L 10801000 Nasal cream EDQM
0-L 10802000 Nasal gel EDQM
0-L 10803000 Nasal ointment EDQM
0-L 10804000 Nasal drops, solution EDQM
0-L 10805000 Nasal drops, suspension EDQM
0-L 10806000 Nasal drops, emulsion EDQM
0-L 10807000 Nasal powder EDQM
0-L 10808000 Nasal spray, solution EDQM
0-L 10809000 Nasal spray, suspension EDQM
0-L 10810000 Nasal spray, emulsion EDQM
0-L 10811000 Nasal wash EDQM
0-L 10812000 Nasal stick EDQM
0-L 10900500 Intravaginal ring EDQM
0-L 10901000 Vaginal cream EDQM
0-L 10902000 Vaginal gel EDQM
0-L 10903000 Vaginal ointment EDQM
0-L 10904000 Vaginal foam EDQM
0-L 10905000 Vaginal solution EDQM
0-L 10906000 Vaginal suspension EDQM
0-L 10907000 Vaginal emulsion EDQM
0-L 10908000 Tablet for vaginal solution EDQM
0-L 10909000 Pessary EDQM
0-L 10910000 Vaginal capsule, hard EDQM
0-L 10911000 Vaginal capsule, soft EDQM
0-L 10912000 Vaginal tablet EDQM
0-L 10913000 Effervescent vaginal tablet EDQM
0-L 10914000 Medicated vaginal tampon EDQM
0-L 10915000 Vaginal delivery system EDQM
0-L 10916000 Vaginal sponge EDQM
0-L 11001000 Rectal cream EDQM
0-L 11002000 Rectal gel EDQM
0-L 11003000 Rectal ointment EDQM
0-L 11004000 Rectal foam EDQM
0-L 11005000 Rectal solution EDQM
0-L 11006000 Rectal suspension EDQM
0-L 11007000 Rectal emulsion EDQM
0-L 11008000 Concentrate for rectal solution EDQM
0-L 11009000 Powder for rectal solution EDQM
0-L 11010 Oral drops EDQM
0-L 11010000 Powder for rectal suspension EDQM
0-L 11011000 Tablet for rectal solution EDQM
0-L 11012000 Tablet for rectal suspension EDQM
0-L 11013000 Suppository EDQM
0-L 11014000 Rectal capsule EDQM
0-L 11015000 Rectal tampon EDQM
0-L 11050 Oral liquid EDQM
0-L 11101000 Nebuliser solution EDQM
0-L 11102000 Nebuliser suspension EDQM
0-L 11103000 Powder for nebuliser suspension EDQM
0-L 11104000 Powder for nebuliser solution EDQM
0-L 11105000 Nebuliser emulsion EDQM
0-L 11106000 Pressurised inhalation, solution EDQM
0-L 11107000 Pressurised inhalation, suspension EDQM
0-L 11108000 Pressurised inhalation, emulsion EDQM
0-L 11109000 Inhalation powder EDQM
0-L 11110000 Inhalation powder, hard capsule EDQM
0-L 11111000 Inhalation powder, pre-dispensed EDQM
0-L 11112000 Inhalation vapour, powder EDQM
0-L 11113000 Inhalation vapour, capsule EDQM
0-L 11114000 Inhalation vapour, solution EDQM
0-L 11115000 Inhalation vapour, tablet EDQM
0-L 11116000 Inhalation vapour, ointment EDQM
0-L 11117000 Inhalation vapour, liquid EDQM
0-L 11118000 Inhalation gas EDQM
0-L 11201000 Solution for injection EDQM
0-L 11202000 Suspension for injection EDQM
0-L 11203000 Emulsion for injection EDQM
0-L 11204000 Gel for injection EDQM
0-L 11205000 Powder for solution for injection EDQM
0-L 11206000 Powder for suspension for injection EDQM
0-L 11207000 Powder and solvent for solution for injection EDQM
0-L 11208000 Powder and solvent for suspension for injection EDQM
0-L 11209000 Concentrate for solution for injection EDQM
0-L 11210000 Solution for infusion EDQM
0-L 11210500 Solution for infusion in administration system EDQM
0-L 11211000 Emulsion for infusion EDQM
0-L 11212000 Powder for solution for infusion EDQM
0-L 11213000 Concentrate for solution for infusion EDQM
0-L 11214000 Powder and solvent for solution for infusion EDQM
0-L 11214500 Lyophilisate and solvent for solution for injection EDQM
0-L 11215000 Lyophilisate for solution for infusion EDQM
0-L 11216000 Solvent for parenteral use EDQM
0-L 11217000 Lyophilisate for solution for injection EDQM
0-L 11218000 Lyophilisate for suspension for injection EDQM
0-L 11301000 Implant EDQM
0-L 11302000 Implantation tablet EDQM
0-L 11303000 Implantation chain EDQM
0-L 11303500 Implantation suspension EDQM
0-L 11304000 Powder and solvent for implantation paste EDQM
0-L 11401000 Solution for peritoneal dialysis EDQM
0-L 11402000 Solution for haemofiltration EDQM
0-L 11403000 Solution for haemodiafiltration EDQM
0-L 11404000 Solution for haemodialysis EDQM
0-L 11405000 Concentrate for haemodialysis solution EDQM
0-L 11501000 Solution for intravesical use EDQM
0-L 11502000 Bladder irrigation EDQM
0-L 11503000 Powder for bladder irrigation EDQM
0-L 11504000 Urethral gel EDQM
0-L 11505000 Urethral stick EDQM
0-L 11601000 Endotracheopulmonary instillation, solution EDQM
0-L 11602000 Endotracheopulmonary instillation, powder for solution EDQM
0-L 11603000 Endotracheopulmonary instillation, suspension EDQM
0-L 11604000 Endotracheopulmonary instillation, powder and solvent for solution EDQM
0-L 11701000 Endocervical gel EDQM
0-L 11702000 Powder and solvent for endocervical gel EDQM
0-L 11901000 Intrauterine delivery system EDQM
0-L 11902000 Intrauterine solution EDQM
0-L 11903000 Intrauterine suspension EDQM
0-L 11904000 Intrauterine emulsion EDQM
0-L 11905000 Intrauterine tablet EDQM
0-L 11906000 Intrauterine capsule EDQM
0-L 12004000 Nebulisation solution EDQM
0-L 12100 Capsule EDQM
0-L 12100500 Absorbable coated sponge EDQM
0-L 12101000 Denture lacquer EDQM
0-L 12102000 Anticoagulant and preservative solution for blood EDQM
0-L 12103000 Solution for blood fraction modification EDQM
0-L 12104000 Wound stick EDQM
0-L 12105000 Radiopharmaceutical precursor EDQM
0-L 12106000 Radionuclide generator EDQM
0-L 12107000 Kit for radiopharmaceutical preparation EDQM
0-L 12108000 Gastroenteral solution EDQM
0-L 12109000 Dispersion EDQM
0-L 12109500 Fibrin sealant-powder and solvent for fibrin sealant EDQM
0-L 12110000 Gastroenteral suspension EDQM
0-L 12111000 Gastroenteral emulsion EDQM
0-L 12112000 Solution for organ preservation EDQM
0-L 12113000 Irrigation solution EDQM
0-L 12114000 Stomach irrigation EDQM
0-L 12115000 Sealant EDQM
0-L 12115500 Solution of perfusion of organs EDQM
0-L 12116000 Powder and solvent for sealant EDQM
0-L 12117000 Impregnated pad EDQM
0-L 12118000 Living tissue equivalent EDQM
0-L 12119000 Medicated sponge EDQM
0-L 12120 Gastro-resistant capsule EDQM
0-L 12120000 Intestinal gel EDQM
0-L 12130000 Medicated thread EDQM
0-L 12131000 Solution for provocation test EDQM
0-L 12150 Prolonged-release capsule EDQM
0-L 12200 Tablet EDQM
0-L 12301000 Medicinal gas, compressed EDQM
0-L 12302000 Medicinal gas, cryogenic EDQM
0-L 12303000 Medicinal gas, liquefied EDQM
0-L 13050 Oromucosal liquid EDQM
0-L 13220 Lozenge EDQM
0-L 14050 Dental liquid EDQM
0-L 15090 Cutaneous spray EDQM
0-L 15130 Cutaneous liquid EDQM
0-L 16040 Eye drops EDQM
0-L 17040 Ear drops EDQM
0-L 17090 Ear spray EDQM
0-L 17120 Ear wash EDQM
0-L 18040 Nasal drops EDQM
0-L 18080 Nasal spray EDQM
0-L 19050 Vaginal liquid EDQM
0-L 19100 Vaginal capsule EDQM
0-L 20050 Enema EDQM
0-L 21010 Nebuliser liquid EDQM
0-L 21060 Pressurised inhalation EDQM
0-L 21100 Inhalation powder EDQM
0-L 21140 Inhalation vapour EDQM
0-L 22010 Injection EDQM
0-L 22050 Powder for injection EDQM
0-L 22090 Sterile concentrate EDQM
0-L 22100 Infusion EDQM
0-L 22120 Powder for infusion EDQM
0-L 26010 Endotracheopulmonary instillation EDQM
0-L 29020 Intrauterine liquid EDQM
0-L 30047500 Pouch EDQM
0-L 31030 Blood fraction modifier EDQM
0-L 31080 Gastroenteral liquid EDQM
0-L 50001000 Chewable/dispersible tablet EDQM
0-L 50001250 Coated granules in sachet EDQM
0-L 50001500 Concentrate and diluent for solution for infusion EDQM
0-L 50002000 Concentrate and solvent for concentrate for solution for infusion EDQM
0-L 50003000 Concentrate and solvent for cutaneous solution EDQM
0-L 50004000 Concentrate and solvent for cutaneous use EDQM
0-L 50005000 Concentrate and solvent for injection EDQM
0-L 50006000 Concentrate and solvent for solution for infusion EDQM
0-L 50007000 Concentrate and solvent for solution for injection EDQM
0-L 50008000 Concentrate and solvent for suspension for injection EDQM
0-L 50009000 Concentrate for cutaneous spray, emulsion EDQM
0-L 50009300 Concentrate for dispersion for infusion EDQM
0-L 50009500 Concentrate for emulsion for infusion EDQM
0-L 50010000 Concentrate for oral solution EDQM
0-L 50011000 Concentrate for oral/rectal solution EDQM
0-L 50012000 Concentrate for peritoneal dialysis solution EDQM
0-L 50013000 Concentrate for solution for intravesical use EDQM
0-L 50013500 Concentrate for spray emulsion EDQM
0-L 50014000 Concentrate for suspension for infusion EDQM
0-L 50015000 Cutaneous and nasal ointment EDQM
0-L 50015300 Cutaneous/oromucosal/oral solution EDQM
0-L 50015400 Cutaneous/oromucosal spray EDQM
0-L 50015500 Cutaneous spray, emulsion EDQM
0-L 50016000 Cutaneous spray, ointment EDQM
0-L 50017000 Dental paste EDQM
0-L 50018000 Ear/eye drops, solution EDQM
0-L 50019000 Ear/eye oinment EDQM
0-L 50020000 Ear/eye/nose drops, solution EDQM
0-L 50020500 Effervescent buccal tablet EDQM
0-L 50021000 Emulsion for injection/infusion EDQM
0-L 50021500 Emulsion and suspension for emulsion for injection EDQM
0-L 50022000 Endosinusial wash, suspension EDQM
0-L 50023000 Eye drops, solution in single-dose container EDQM
0-L 50023500 Film coated gastro-resistant tablet EDQM
0-L 50024000 Gargle/mouthwash EDQM
0-L 50025000 Gastro-resistant coated tablet EDQM
0-L 50026000 Gastro-resistant granules for oral suspension EDQM
0-L 50026250 Gastro-resistant prolonged-release tablet EDQM
0-L 50026500 Granules and solvent for oral suspension EDQM
0-L 50027000 Granules and solvent for suspension for injection EDQM
0-L 50028000 Granules for oral and rectal suspension EDQM
0-L 50029000 Granules for oral drops, solution EDQM
0-L 50029250 Granules for use in drinking water EDQM
0-L 50029500 Granules for vaginal solution EDQM
0-L 50029600 Hard capsule with gastro-resistant pellets EDQM
0-L 50029700 Herbal tea in bag EDQM
0-L 50030000 Inhalation powder, tablet EDQM
0-L 50031000 Inhalation vapour, effervescent tablet EDQM
0-L 50032000 Inhalation vapour, emulsion EDQM
0-L 50033000 Inhalation vapour, impregnated pad EDQM
0-L 50033300 Intrauterine foam EDQM
0-L 50033500 Intravitreal implant in applicator EDQM
0-L 50034000 Liquefied gas for dental use EDQM
0-L 50035000 Modified-release film-coated tablet EDQM
0-L 50036000 Modified-release granules for oral suspension EDQM
0-L 50036100 Muco-adhesive buccal prolonged-release tablet EDQM
0-L 50036500 Nasal/oromucosal solution EDQM
0-L 50037000 Nasal spray and oromucosal solution EDQM
0-L 50037250 Nasal spray, solution in single-dose container EDQM
0-L 50037750 Oral drops, liquid EDQM
0-L 50038000 Oral/rectal suspension EDQM
0-L 50038500 Oral solution/concentrate for nebuliser solution EDQM
0-L 50039000 Oromucosal patch EDQM
0-L 50039300 Oromucosal powder in pouch EDQM
0-L 50039500 Oromucosal/laryngopharyngeal solution EDQM
0-L 50040000 Oromucosal/laryngopharyngeal solution/spray EDQM
0-L 50041000 Pillules in single-dose container EDQM
0-L 50041500 Powder and solution for solution for injection EDQM
0-L 50042000 Powder and solvent for concentrate for solution for infusion EDQM
0-L 50043000 Powder for concentrate for solution for infusion EDQM
0-L 50044000 Powder and solvent for cutaneous solution EDQM
0-L 50044500 Powder and solvent for dispersion for injection EDQM
0-L 50045000 Powder and solvent for endosinusial solution EDQM
0-L 50045500 Powder and solvent for epilesional solution EDQM
0-L 50046000 Powder and solvent for gingival gel EDQM
0-L 50047000 Powder and solvent for instillation solution for intraocular use EDQM
0-L 50047500 Powder and solvent for intravesical solution EDQM
0-L 50047700 Powder and solvent for nebuliser solution EDQM
0-L 50048000 Powder and solvent for prolonged-release suspension for injection EDQM
0-L 50048250 Powder and solvent for solution for injection in pre-filled syringe EDQM
0-L 50048300 Powder and solvent for suspension for injection in pre-filled syringe EDQM
0-L 50048500 Powder and suspension for suspension for injection EDQM
0-L 50048600 Powder, dispersion and solvent for concentrate for dispersion for injection EDQM
0-L 50048750 Powder for concentrate for dispersion for infusion EDQM
0-L 50049000 Powder for concentrate for haemodialysis solution, EDQM
0-L 50049100 Powder for concentrate for intravesical suspension EDQM
0-L 50049250 Powder for concentrate for solution for injection/infusion EDQM
0-L 50049270 Powder for dental solution EDQM
0-L 50049300 Powder for epilesional solution EDQM
0-L 50049500 Powder for implantation suspension EDQM
0-L 50050000 Powder for intravesical solution EDQM
0-L 50051000 Powder for intravesical suspension EDQM
0-L 50051100 Powder for mouth wash EDQM
0-L 50052000 Powder for oral/rectal suspension EDQM
0-L 50053000 Powder for solution for injection or infusion EDQM
0-L 50053500 Powder for solution for injection/infusion EDQM
0-L 50054000 Powder for solution for intravesical use EDQM
0-L 50055000 Powder for solution for nasal spray EDQM
0-L 50055500 Prolonged-release film-coated tablet EDQM
0-L 50056000 Prolonged-release granules for oral suspension EDQM
0-L 50056500 Radiopharmaceutical precursor, solution EDQM
0-L 50057000 Solution for haemodialysis/haemofiltration EDQM
0-L 50058000 Solution for infusion and oral solution EDQM
0-L 50059000 Solution for injection/concentrate for solution for infusion EDQM
0-L 50060000 Solution for injection/infusion EDQM
0-L 50060100 Solution for injection in cartridge EDQM
0-L 50060200 Solution for injection in pre-filled pen EDQM
0-L 50060300 Solution for injection in pre-filled syringe EDQM
0-L 50060400 Solution for injection in pre-filled syringe with automatic needle guard EDQM
0-L 50060500 Solution for injection/infusion in pre-filled syringe EDQM
0-L 50061000 Solution for intraperitoneal use EDQM
0-L 50061300 Solution for use in drinking water EDQM
0-L 50061500 Solution for sealant EDQM
0-L 50061600 Solvent for nasal use EDQM
0-L 50062000 Suspension and effervescent granules for oral suspension EDQM
0-L 50062500 Suspension and solution for spray EDQM
0-L 50063000 Suspension for infusion EDQM
0-L 50063100 Suspension for injection in cartridge EDQM
0-L 50063200 Suspension for injection in pre-filled pen EDQM
0-L 50063300 Suspension for injection in pre-filled syringe EDQM
0-L 50063500 Suspension for use in drinking water EDQM
0-L 50064000 Tablet and solvent for rectal suspension EDQM
0-L 50065000 Tablet and powder for oral solution EDQM
0-L 50066000 Tablet for oral suspension EDQM
0-L 50070000 Oral suspension for use in drinking water EDQM
0-L 50071000 Powder and solvent for dental gel EDQM
0-L 50072000 Powder for use in drinking water EDQM
0-L 50073000 Powder for solution for intraocular irrigation EDQM
0-L 50074000 Solvent for solution for intraocular irrigation EDQM
0-L 50076000 Solvent for solution for infusion EDQM
0-L 50077000 Dispersion for injection EDQM
0-L 50078000 Gas and solvent for dispersion for injection/infusion EDQM
0-L 50079000 Concentrate for solution for injection/infusion EDQM
0-L 50080000 Powder and solvent for solution for injection/infusion EDQM
0-L 50081000 Inhalation solution EDQM
0-L 50082000 Oral drops, powder for suspension EDQM
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
Value set epsos-valueset-3 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSPackage 1.3.6.1.4.1.12559.11.10.1.3.1.42.3 2010 - 2013‑06‑03 Draft
Source Code System:
  • 1.3.6.1.4.1.12559.11.10.1.3.1.44.1 EDQM
Level/ Type Code Display Name Code System Description
0-L 30000500 Administration system EDQM
0-L 30001000 Ampoule EDQM
0-L 30002000 Applicator EDQM
0-L 30004000 Bag EDQM
0-L 30006000 Barrel EDQM
0-L 30007000 Blister EDQM
0-L 30008000 Bottle EDQM
0-L 30009000 Box EDQM
0-L 30010000 Brush EDQM
0-L 30011000 Brush applicator EDQM
0-L 30012000 Cannula EDQM
0-L 30013000 Cap EDQM
0-L 30014000 Cartridge EDQM
0-L 30015000 Child-resistant closure EDQM
0-L 30016000 Cup EDQM
0-L 30017000 Dabbing applicator EDQM
0-L 30019000 Dredging applicator EDQM
0-L 30020000 Dredging container EDQM
0-L 30022000 Dropper applicator EDQM
0-L 30023000 Dropper container EDQM
0-L 30023005 Fixed cryogenic vessel EDQM
0-L 30024000 Gas cylinder EDQM
0-L 30025000 High pressure transdermal delivery device EDQM
0-L 30026000 Implanter EDQM
0-L 30026500 Inhaler EDQM
0-L 30027000 In-ovo injection device EDQM
0-L 30028000 Injection needle EDQM
0-L 30029000 Injection syringe EDQM
0-L 30031000 Intramammary syringe EDQM
0-L 30032000 Jar EDQM
0-L 30033000 Measuring device EDQM
0-L 30034000 Measuring spoon EDQM
0-L 30035000 Metering pump EDQM
0-L 30036000 Metering valve EDQM
0-L 30036005 Mobile cryogenic vessel EDQM
0-L 30037000 Mouthpiece EDQM
0-L 30038000 Multidose container EDQM
0-L 30039000 Multidose container with airless pump EDQM
0-L 30040000 Multipuncturer EDQM
0-L 30041000 Nasal applicator EDQM
0-L 30042000 Nebuliser EDQM
0-L 30043000 Needle applicator EDQM
0-L 30044000 Nozzle EDQM
0-L 30045000 Oral syringe EDQM
0-L 30046000 Pipette EDQM
0-L 30047000 Pipette applicator EDQM
0-L 30048000 Pour-on container EDQM
0-L 30049000 Pre-filled gastroenteral tube EDQM
0-L 30050000 Pre-filled pen EDQM
0-L 30051000 Pre-filled syringe EDQM
0-L 30052000 Pressurised container EDQM
0-L 30053000 Prick test applicator EDQM
0-L 30053500 Roll-on container EDQM
0-L 30054000 Sachet EDQM
0-L 30055000 Scarifier EDQM
0-L 30056000 Screw cap EDQM
0-L 30057000 Single-dose container EDQM
0-L 30058000 Spatula EDQM
0-L 30059000 Spot-on applicator EDQM
0-L 30060000 Spray container EDQM
0-L 30061000 Spray pump EDQM
0-L 30062000 Spray valve EDQM
0-L 30063000 Stab vaccinator EDQM
0-L 30064000 Stopper EDQM
0-L 30064500 Straw EDQM
0-L 30065000 Strip EDQM
0-L 30066000 Tablet container EDQM
0-L 30067000 Tube EDQM
0-L 30069000 Vial EDQM
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
Value set epsos-valueset-12 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSRouteofAdministration 1.3.6.1.4.1.12559.11.10.1.3.1.42.12 2010 - 2013‑06‑03 Draft
Source Code System:
  • 1.3.6.1.4.1.12559.11.10.1.3.1.44.1 EDQM
Level/ Type Code Display Name Code System Description
0-L 20001000 Auricular use EDQM
0-L 20002500 Buccal use EDQM
0-L 20003000 Cutaneous use EDQM
0-L 20004000 Dental use EDQM
0-L 20006000 Endocervical use EDQM
0-L 20007000 Endosinusial use EDQM
0-L 20008000 Endotracheopulmonary use EDQM
0-L 20009000 Epidural use EDQM
0-L 20010000 Epilesional use EDQM
0-L 20011000 Extraamniotic use EDQM
0-L 20011500 Extracorporeal use EDQM
0-L 20013000 Gastroenteral use EDQM
0-L 20013500 Gastric use EDQM
0-L 20014000 Gingival use EDQM
0-L 20015000 Hemodialysis EDQM
0-L 20015500 Implantation EDQM
0-L 20020000 Inhalation use EDQM
0-L 20021000 Intestinal use EDQM
0-L 20022000 Intraamniotic use EDQM
0-L 20023000 Intraarterial use EDQM
0-L 20024000 Intraarticular use EDQM
0-L 20025000 Intrabursal use EDQM
0-L 20026000 Intracardiac use EDQM
0-L 20026500 Intracartilaginous use EDQM
0-L 20027000 Intracavernous use EDQM
0-L 20027010 Intracerebral use EDQM
0-L 20028000 Intracervical use EDQM
0-L 20028500 Intracisternal use EDQM
0-L 20029000 Intracoronary use EDQM
0-L 20030000 Intradermal use EDQM
0-L 20031000 Intradiscal use EDQM
0-L 20031500 Intraepidermal use EDQM
0-L 20032000 Intralesional use EDQM
0-L 20033000 Intralymphatic use EDQM
0-L 20035000 Intramuscular use EDQM
0-L 20036000 Intraocular use EDQM
0-L 20036500 Intraosseous use EDQM
0-L 20037000 Intrapericardial use EDQM
0-L 20038000 Intraperitoneal use EDQM
0-L 20039000 Intrapleural use EDQM
0-L 20039500 Intraprostatic use EDQM
0-L 20041000 Intrasternal use EDQM
0-L 20042000 Intrathecal use EDQM
0-L 20043000 Intratumoral use EDQM
0-L 20044000 Intrauterine use EDQM
0-L 20045000 Intravenous use EDQM
0-L 20046000 Intravesical use EDQM
0-L 20047000 Intravitreal use EDQM
0-L 20047500 Iontophoresis EDQM
0-L 20048000 Laryngopharyngeal use EDQM
0-L 20049000 Nasal use EDQM
0-L 20050000 Nebulisation use EDQM
0-L 20051000 Ocular use EDQM
0-L 20053000 Oral use EDQM
0-L 20054000 Oromucosal use EDQM
0-L 20055000 Oropharyngeal use EDQM
0-L 20056000 Paravertebral use EDQM
0-L 20057000 Periarticular use EDQM
0-L 20058000 Perineural use EDQM
0-L 20059000 Periodontal use EDQM
0-L 20059300 Periosseous use EDQM
0-L 20059500 Posterior juxtascleral use EDQM
0-L 20061000 Rectal use EDQM
0-L 20061500 Retrobulbar use EDQM
0-L 20062000 Route of administration not applicable EDQM
0-L 20063000 Skin scarification EDQM
0-L 20065000 Subconjunctival use EDQM
0-L 20066000 Subcutaneous use EDQM
0-L 20067000 Sublingual use EDQM
0-L 20067500 Submucosal use EDQM
0-L 20070000 Transdermal use EDQM
0-L 20071000 Urethral use EDQM
0-L 20072000 Vaginal use EDQM
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 14:40:51 - status: Closed
  Author Alexander Henket
Description Value sets left unchanged
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:28:50
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑10‑24 10:22:26 - status: Open
  Author Giorgio Cangioli
Description Yes all of these Value set are derived from the same code system EDQM. This OID has been assigned by the project since there is no a registered OID for it
tracking Tracking 2013‑10‑14 15:58:23 - status: Open
  Author Alexander Henket
Description Issue:

Valuesets for dose form, packages, and route of administration have the same OID for the codesystem ('1.3.6.1.4.1.12559.11.10.1.3.1.44.1'). Is this correct?

 (epsos-issue-6) Invalidity Id code does not have a valueset
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.6)
Last assignment to Alexander Henket

Issue Invalidity Id code does not have a valueset
Id epsos-issue-6
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Data element epsos-dataelement-100 "Invalidity code" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medical Problems / Disability or function
Invalidity code
Id epsos-dataelement-100
Description Code that identifies the invalidity
Value Domain Type code
Example 73761001
tracking Tracking 2013‑11‑28 14:44:53 - status: Closed
  Author Alexander Henket
Description Removed Invalidity code from MRO, PS and HCER scenarios
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:28:22
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑10‑24 10:25:41 - status: Open
  Author Giorgio Cangioli
Description This is a Known issue recorded in the open issues of KT 1.4.10. No value set was agreed for this concept therefore is mentioned because includ din the data set, but actually not used.
tracking Tracking 2013‑10‑14 21:21:23 - status: Open
  Author Alexander Henket
Description Issue:

Invality Id Code would appear to be coded, but there's no valueset to support it

Requirement no. Data element CDA / IHE PCC (WP3.1/WP3.2 label) PCC Section Template CDA XPath expression
PCC Entry content modules CDA XPath expression
R14.2 Invalidity Id code
(Invalidity Id code) 		section[templateId/[@root='1.3.6.1 .4.1.19376.1.5.3.1.3.17']/text

 (epsos-issue-7) Relationship between allergy code / agent code
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.7)
Last assignment to Alexander Henket

Issue Relationship between allergy code / agent code
Id epsos-issue-7
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Data element epsos-dataelement-58 "Allergy" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data
folder  Allergy
Id epsos-dataelement-58
Description Allergies and intolerances
Used in 3 scenarios, inherited once
target This concept is used in transaction Return MRO (0..* Required) in scenario
target This concept is used in transaction Send HCER to country A (0..* Required) in scenario
target This concept is used in transaction Return PS of country A (0..*) in scenario
tracking Tracking 2013‑11‑28 14:55:26 - status: Closed
  Author Alexander Henket
Description Added new valueSet with complete code system binding on WHO ATC, and added a second binding on Agent code
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:46:52
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑11‑10 19:46:44 - status: Open
  Author Giorgio Cangioli
Description When common value set were discussed, basing also on the CDA template applied, it was agreed to convey the kind of allergy/intolerance in one lement and the agent in a different element (i.e not to have specific codes for "allergy to eggs" or "intolerance to eggs") but say kind of adverse reaction = allergy agent = eggs.

the agent code can be bound to two different value sets depending on if it is a drug or not
tracking Tracking 2013‑10‑16 13:48:06 - status: Open
  Author Alexander Henket
Description Issue:

Allergy code contains among other things Drug Allergy, but Agent code is explicitly about NoDrugs. Potential for inconsistency.
Unclear why the contents of Agent code could not be conveyed in Allergy code, thereby eliminating the need for Agent code. This avoids inconsistencies.

 (epsos-issue-8) Value set epSOSActCode without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.8)
Last assignment to Alexander Henket

Issue Value set epSOSActCode without dataset binding
Id epsos-issue-8
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-29 (2013‑06‑03)
tracking Tracking 2013‑11‑28 15:01:42 - status: Closed
  Author Alexander Henket
Description Value set epSOSActCode removed
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:30:23
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑10‑24 10:31:34 - status: Open
  Author Giorgio Cangioli
Description Not used you can remove it from the value set.
tracking Tracking 2013‑10‑16 13:51:29 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-9) Value set epSOSActSite without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.9)
Last assignment to Alexander Henket

Issue Value set epSOSActSite without dataset binding
Id epsos-issue-9
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-44 (2013‑06‑03)
tracking Tracking 2013‑11‑28 15:03:17 - status: Closed
  Author Alexander Henket
Description Value set removed
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:47:14
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑10‑24 10:35:01 - status: Open
  Author Giorgio Cangioli
Description Added in a second stage of the project was not accepted by clinician that defined the data set. It is still in the MVC for historical reasons but is not expected to be used.
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-11) Value set epSOSDoseForm without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.11)
Last assignment to Alexander Henket

Issue Value set epSOSDoseForm without dataset binding
Id epsos-issue-11
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-2 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSDoseForm 1.3.6.1.4.1.12559.11.10.1.3.1.42.2 2010 - 2013‑06‑03 Draft
Source Code System:
  • 1.3.6.1.4.1.12559.11.10.1.3.1.44.1 EDQM
Level/ Type Code Display Name Code System Description
0-L 10101000 Oral drops, solution EDQM
0-L 10102000 Oral drops, suspension EDQM
0-L 10103000 Oral drops, emulsion EDQM
0-L 10104000 Oral liquid EDQM
0-L 10105000 Oral solution EDQM
0-L 10106000 Oral suspension EDQM
0-L 10107000 Oral emulsion EDQM
0-L 10108000 Oral gel EDQM
0-L 10109000 Oral paste EDQM
0-L 10110000 Powder for oral solution EDQM
0-L 10111000 Powder for oral suspension EDQM
0-L 10112000 Granules for oral solution EDQM
0-L 10113000 Granules for oral suspension EDQM
0-L 10114000 Powder and solvent for oral solution EDQM
0-L 10115000 Powder and solvent for oral suspension EDQM
0-L 10116000 Lyophilisate for suspension EDQM
0-L 10117000 Syrup EDQM
0-L 10118000 Powder for syrup EDQM
0-L 10119000 Granules for syrup EDQM
0-L 10120000 Soluble tablet EDQM
0-L 10121000 Dispersible tablet EDQM
0-L 10122000 Herbal tea EDQM
0-L 10201000 Oral powder EDQM
0-L 10202000 Instant herbal tea EDQM
0-L 10203000 Effervescent powder EDQM
0-L 10204000 Granules EDQM
0-L 10205000 Effervescent granules EDQM
0-L 10206000 Gastro-resistant granules EDQM
0-L 10207000 Prolonged-release granules EDQM
0-L 10208000 Modified-release granules EDQM
0-L 10209000 Cachet EDQM
0-L 10210000 Capsule, hard EDQM
0-L 10211000 Capsule, soft EDQM
0-L 10212000 Gastro-resistant capsule, hard EDQM
0-L 10213000 Gastro-resistant capsule, soft EDQM
0-L 10214000 Chewable capsule, soft EDQM
0-L 10215000 Prolonged-release capsule, hard EDQM
0-L 10216000 Prolonged-release capsule, soft EDQM
0-L 10217000 Modified-release capsule, hard EDQM
0-L 10218000 Modified-release capsule, soft EDQM
0-L 10219000 Tablet EDQM
0-L 10220000 Coated tablet EDQM
0-L 10221000 Film-coated tablet EDQM
0-L 10222000 Effervescent tablet EDQM
0-L 10223000 Orodispersible tablet EDQM
0-L 10224000 Oral lyophilisate EDQM
0-L 10225000 Gastro-resistant tablet EDQM
0-L 10226000 Prolonged-release tablet EDQM
0-L 10227000 Modified-release tablet EDQM
0-L 10228000 Chewable tablet EDQM
0-L 10229000 Medicated chewing-gum EDQM
0-L 10230000 Oral gum EDQM
0-L 10231000 Pillules EDQM
0-L 10236100 Orodispersible film EDQM
0-L 10301000 Gargle EDQM
0-L 10302000 Concentrate for gargle EDQM
0-L 10303000 Gargle, powder for solution EDQM
0-L 10304000 Gargle, tablet for solution EDQM
0-L 10305000 Oromucosal solution EDQM
0-L 10306000 Oromucosal suspension EDQM
0-L 10307000 Oromucosal drops EDQM
0-L 10308000 Oromucosal spray EDQM
0-L 10309000 Sublingual spray EDQM
0-L 10310000 Mouthwash EDQM
0-L 10311000 Mouthwash, tablet for solution EDQM
0-L 10312000 Gingival solution EDQM
0-L 10313000 Oromucosal gel EDQM
0-L 10314000 Oromucosal paste EDQM
0-L 10314005 Oromucosal ointment EDQM
0-L 10314010 Oromucosal cream EDQM
0-L 10314011 Buccal film EDQM
0-L 10315000 Gingival gel EDQM
0-L 10316000 Gingival paste EDQM
0-L 10317000 Oromucosal capsule EDQM
0-L 10318000 Sublingual tablet EDQM
0-L 10319000 Muco-adhesive buccal tablet EDQM
0-L 10320000 Buccal tablet EDQM
0-L 10321000 Lozenge EDQM
0-L 10322000 Compressed lozenge EDQM
0-L 10323000 Pastille EDQM
0-L 10401000 Periodontal powder EDQM
0-L 10402000 Dental gel EDQM
0-L 10403000 Dental stick EDQM
0-L 10404000 Dental insert EDQM
0-L 10405000 Dental powder EDQM
0-L 10406000 Dental solution EDQM
0-L 10407000 Dental suspension EDQM
0-L 10408000 Dental emulsion EDQM
0-L 10409000 Toothpaste EDQM
0-L 10410000 Periodontal gel EDQM
0-L 10411000 Periodontal insert EDQM
0-L 10501000 Bath additive EDQM
0-L 10502000 Cream EDQM
0-L 10503000 Gel EDQM
0-L 10504000 Ointment EDQM
0-L 10505000 Cutaneous paste EDQM
0-L 10506000 Medicated plaster EDQM
0-L 10507000 Cutaneous foam EDQM
0-L 10508000 Shampoo EDQM
0-L 10509000 Cutaneous spray, solution EDQM
0-L 10510000 Cutaneous spray, suspension EDQM
0-L 10511000 Cutaneous spray, powder EDQM
0-L 10512000 Cutaneous liquid EDQM
0-L 10513000 Cutaneous solution EDQM
0-L 10514000 Concentrate for cutaneous solution EDQM
0-L 10515000 Cutaneous suspension EDQM
0-L 10516000 Cutaneous emulsion EDQM
0-L 10517000 Cutaneous powder EDQM
0-L 10517500 Cutaneous patch EDQM
0-L 10518000 Solution for iontophoresis EDQM
0-L 10519000 Transdermal patch EDQM
0-L 10520000 Collodion EDQM
0-L 10521000 Medicated nail lacquer EDQM
0-L 10521500 Nail solution EDQM
0-L 10522000 Poultice EDQM
0-L 10523000 Cutaneous stick EDQM
0-L 10524000 Cutaneous sponge EDQM
0-L 10525000 Impregnated dressing EDQM
0-L 10539500 Scrub EDQM
0-L 10546500 Transdermal spray, solution EDQM
0-L 10547000 Transdermal system EDQM
0-L 10548000 Solution for skin-prick test EDQM
0-L 10549000 Solution for skin-scratch test EDQM
0-L 10550000 Plaster for provocation test EDQM
0-L 10601000 Eye cream EDQM
0-L 10602000 Eye gel EDQM
0-L 10603000 Eye ointment EDQM
0-L 10604000 Eye drops, solution EDQM
0-L 10604500 Eye drops, emulsion EDQM
0-L 10605000 Eye drops, suspension EDQM
0-L 10606000 Eye drops, powder and solvent for solution EDQM
0-L 10607000 Eye drops, powder and solvent for suspension EDQM
0-L 10608000 Eye drops, solvent for reconstitution EDQM
0-L 10609000 Eye drops, prolonged-release EDQM
0-L 10610000 Eye lotion EDQM
0-L 10611000 Eye lotion, solvent for reconstitution EDQM
0-L 10612000 Ophthalmic insert EDQM
0-L 10613000 Ophthalmic strip EDQM
0-L 10701000 Ear cream EDQM
0-L 10702000 Ear gel EDQM
0-L 10703000 Ear ointment EDQM
0-L 10704000 Ear drops, solution EDQM
0-L 10705000 Ear drops, suspension EDQM
0-L 10706000 Ear drops, emulsion EDQM
0-L 10707000 Ear drops, powder and solvent for suspension EDQM
0-L 10708000 Ear powder EDQM
0-L 10709000 Ear spray, solution EDQM
0-L 10710000 Ear spray, suspension EDQM
0-L 10711000 Ear spray, emulsion EDQM
0-L 10712000 Ear wash, solution EDQM
0-L 10713000 Ear wash, emulsion EDQM
0-L 10714000 Ear tampon EDQM
0-L 10715000 Ear stick EDQM
0-L 10801000 Nasal cream EDQM
0-L 10802000 Nasal gel EDQM
0-L 10803000 Nasal ointment EDQM
0-L 10804000 Nasal drops, solution EDQM
0-L 10805000 Nasal drops, suspension EDQM
0-L 10806000 Nasal drops, emulsion EDQM
0-L 10807000 Nasal powder EDQM
0-L 10808000 Nasal spray, solution EDQM
0-L 10809000 Nasal spray, suspension EDQM
0-L 10810000 Nasal spray, emulsion EDQM
0-L 10811000 Nasal wash EDQM
0-L 10812000 Nasal stick EDQM
0-L 10900500 Intravaginal ring EDQM
0-L 10901000 Vaginal cream EDQM
0-L 10902000 Vaginal gel EDQM
0-L 10903000 Vaginal ointment EDQM
0-L 10904000 Vaginal foam EDQM
0-L 10905000 Vaginal solution EDQM
0-L 10906000 Vaginal suspension EDQM
0-L 10907000 Vaginal emulsion EDQM
0-L 10908000 Tablet for vaginal solution EDQM
0-L 10909000 Pessary EDQM
0-L 10910000 Vaginal capsule, hard EDQM
0-L 10911000 Vaginal capsule, soft EDQM
0-L 10912000 Vaginal tablet EDQM
0-L 10913000 Effervescent vaginal tablet EDQM
0-L 10914000 Medicated vaginal tampon EDQM
0-L 10915000 Vaginal delivery system EDQM
0-L 10916000 Vaginal sponge EDQM
0-L 11001000 Rectal cream EDQM
0-L 11002000 Rectal gel EDQM
0-L 11003000 Rectal ointment EDQM
0-L 11004000 Rectal foam EDQM
0-L 11005000 Rectal solution EDQM
0-L 11006000 Rectal suspension EDQM
0-L 11007000 Rectal emulsion EDQM
0-L 11008000 Concentrate for rectal solution EDQM
0-L 11009000 Powder for rectal solution EDQM
0-L 11010 Oral drops EDQM
0-L 11010000 Powder for rectal suspension EDQM
0-L 11011000 Tablet for rectal solution EDQM
0-L 11012000 Tablet for rectal suspension EDQM
0-L 11013000 Suppository EDQM
0-L 11014000 Rectal capsule EDQM
0-L 11015000 Rectal tampon EDQM
0-L 11050 Oral liquid EDQM
0-L 11101000 Nebuliser solution EDQM
0-L 11102000 Nebuliser suspension EDQM
0-L 11103000 Powder for nebuliser suspension EDQM
0-L 11104000 Powder for nebuliser solution EDQM
0-L 11105000 Nebuliser emulsion EDQM
0-L 11106000 Pressurised inhalation, solution EDQM
0-L 11107000 Pressurised inhalation, suspension EDQM
0-L 11108000 Pressurised inhalation, emulsion EDQM
0-L 11109000 Inhalation powder EDQM
0-L 11110000 Inhalation powder, hard capsule EDQM
0-L 11111000 Inhalation powder, pre-dispensed EDQM
0-L 11112000 Inhalation vapour, powder EDQM
0-L 11113000 Inhalation vapour, capsule EDQM
0-L 11114000 Inhalation vapour, solution EDQM
0-L 11115000 Inhalation vapour, tablet EDQM
0-L 11116000 Inhalation vapour, ointment EDQM
0-L 11117000 Inhalation vapour, liquid EDQM
0-L 11118000 Inhalation gas EDQM
0-L 11201000 Solution for injection EDQM
0-L 11202000 Suspension for injection EDQM
0-L 11203000 Emulsion for injection EDQM
0-L 11204000 Gel for injection EDQM
0-L 11205000 Powder for solution for injection EDQM
0-L 11206000 Powder for suspension for injection EDQM
0-L 11207000 Powder and solvent for solution for injection EDQM
0-L 11208000 Powder and solvent for suspension for injection EDQM
0-L 11209000 Concentrate for solution for injection EDQM
0-L 11210000 Solution for infusion EDQM
0-L 11210500 Solution for infusion in administration system EDQM
0-L 11211000 Emulsion for infusion EDQM
0-L 11212000 Powder for solution for infusion EDQM
0-L 11213000 Concentrate for solution for infusion EDQM
0-L 11214000 Powder and solvent for solution for infusion EDQM
0-L 11214500 Lyophilisate and solvent for solution for injection EDQM
0-L 11215000 Lyophilisate for solution for infusion EDQM
0-L 11216000 Solvent for parenteral use EDQM
0-L 11217000 Lyophilisate for solution for injection EDQM
0-L 11218000 Lyophilisate for suspension for injection EDQM
0-L 11301000 Implant EDQM
0-L 11302000 Implantation tablet EDQM
0-L 11303000 Implantation chain EDQM
0-L 11303500 Implantation suspension EDQM
0-L 11304000 Powder and solvent for implantation paste EDQM
0-L 11401000 Solution for peritoneal dialysis EDQM
0-L 11402000 Solution for haemofiltration EDQM
0-L 11403000 Solution for haemodiafiltration EDQM
0-L 11404000 Solution for haemodialysis EDQM
0-L 11405000 Concentrate for haemodialysis solution EDQM
0-L 11501000 Solution for intravesical use EDQM
0-L 11502000 Bladder irrigation EDQM
0-L 11503000 Powder for bladder irrigation EDQM
0-L 11504000 Urethral gel EDQM
0-L 11505000 Urethral stick EDQM
0-L 11601000 Endotracheopulmonary instillation, solution EDQM
0-L 11602000 Endotracheopulmonary instillation, powder for solution EDQM
0-L 11603000 Endotracheopulmonary instillation, suspension EDQM
0-L 11604000 Endotracheopulmonary instillation, powder and solvent for solution EDQM
0-L 11701000 Endocervical gel EDQM
0-L 11702000 Powder and solvent for endocervical gel EDQM
0-L 11901000 Intrauterine delivery system EDQM
0-L 11902000 Intrauterine solution EDQM
0-L 11903000 Intrauterine suspension EDQM
0-L 11904000 Intrauterine emulsion EDQM
0-L 11905000 Intrauterine tablet EDQM
0-L 11906000 Intrauterine capsule EDQM
0-L 12004000 Nebulisation solution EDQM
0-L 12100 Capsule EDQM
0-L 12100500 Absorbable coated sponge EDQM
0-L 12101000 Denture lacquer EDQM
0-L 12102000 Anticoagulant and preservative solution for blood EDQM
0-L 12103000 Solution for blood fraction modification EDQM
0-L 12104000 Wound stick EDQM
0-L 12105000 Radiopharmaceutical precursor EDQM
0-L 12106000 Radionuclide generator EDQM
0-L 12107000 Kit for radiopharmaceutical preparation EDQM
0-L 12108000 Gastroenteral solution EDQM
0-L 12109000 Dispersion EDQM
0-L 12109500 Fibrin sealant-powder and solvent for fibrin sealant EDQM
0-L 12110000 Gastroenteral suspension EDQM
0-L 12111000 Gastroenteral emulsion EDQM
0-L 12112000 Solution for organ preservation EDQM
0-L 12113000 Irrigation solution EDQM
0-L 12114000 Stomach irrigation EDQM
0-L 12115000 Sealant EDQM
0-L 12115500 Solution of perfusion of organs EDQM
0-L 12116000 Powder and solvent for sealant EDQM
0-L 12117000 Impregnated pad EDQM
0-L 12118000 Living tissue equivalent EDQM
0-L 12119000 Medicated sponge EDQM
0-L 12120 Gastro-resistant capsule EDQM
0-L 12120000 Intestinal gel EDQM
0-L 12130000 Medicated thread EDQM
0-L 12131000 Solution for provocation test EDQM
0-L 12150 Prolonged-release capsule EDQM
0-L 12200 Tablet EDQM
0-L 12301000 Medicinal gas, compressed EDQM
0-L 12302000 Medicinal gas, cryogenic EDQM
0-L 12303000 Medicinal gas, liquefied EDQM
0-L 13050 Oromucosal liquid EDQM
0-L 13220 Lozenge EDQM
0-L 14050 Dental liquid EDQM
0-L 15090 Cutaneous spray EDQM
0-L 15130 Cutaneous liquid EDQM
0-L 16040 Eye drops EDQM
0-L 17040 Ear drops EDQM
0-L 17090 Ear spray EDQM
0-L 17120 Ear wash EDQM
0-L 18040 Nasal drops EDQM
0-L 18080 Nasal spray EDQM
0-L 19050 Vaginal liquid EDQM
0-L 19100 Vaginal capsule EDQM
0-L 20050 Enema EDQM
0-L 21010 Nebuliser liquid EDQM
0-L 21060 Pressurised inhalation EDQM
0-L 21100 Inhalation powder EDQM
0-L 21140 Inhalation vapour EDQM
0-L 22010 Injection EDQM
0-L 22050 Powder for injection EDQM
0-L 22090 Sterile concentrate EDQM
0-L 22100 Infusion EDQM
0-L 22120 Powder for infusion EDQM
0-L 26010 Endotracheopulmonary instillation EDQM
0-L 29020 Intrauterine liquid EDQM
0-L 30047500 Pouch EDQM
0-L 31030 Blood fraction modifier EDQM
0-L 31080 Gastroenteral liquid EDQM
0-L 50001000 Chewable/dispersible tablet EDQM
0-L 50001250 Coated granules in sachet EDQM
0-L 50001500 Concentrate and diluent for solution for infusion EDQM
0-L 50002000 Concentrate and solvent for concentrate for solution for infusion EDQM
0-L 50003000 Concentrate and solvent for cutaneous solution EDQM
0-L 50004000 Concentrate and solvent for cutaneous use EDQM
0-L 50005000 Concentrate and solvent for injection EDQM
0-L 50006000 Concentrate and solvent for solution for infusion EDQM
0-L 50007000 Concentrate and solvent for solution for injection EDQM
0-L 50008000 Concentrate and solvent for suspension for injection EDQM
0-L 50009000 Concentrate for cutaneous spray, emulsion EDQM
0-L 50009300 Concentrate for dispersion for infusion EDQM
0-L 50009500 Concentrate for emulsion for infusion EDQM
0-L 50010000 Concentrate for oral solution EDQM
0-L 50011000 Concentrate for oral/rectal solution EDQM
0-L 50012000 Concentrate for peritoneal dialysis solution EDQM
0-L 50013000 Concentrate for solution for intravesical use EDQM
0-L 50013500 Concentrate for spray emulsion EDQM
0-L 50014000 Concentrate for suspension for infusion EDQM
0-L 50015000 Cutaneous and nasal ointment EDQM
0-L 50015300 Cutaneous/oromucosal/oral solution EDQM
0-L 50015400 Cutaneous/oromucosal spray EDQM
0-L 50015500 Cutaneous spray, emulsion EDQM
0-L 50016000 Cutaneous spray, ointment EDQM
0-L 50017000 Dental paste EDQM
0-L 50018000 Ear/eye drops, solution EDQM
0-L 50019000 Ear/eye oinment EDQM
0-L 50020000 Ear/eye/nose drops, solution EDQM
0-L 50020500 Effervescent buccal tablet EDQM
0-L 50021000 Emulsion for injection/infusion EDQM
0-L 50021500 Emulsion and suspension for emulsion for injection EDQM
0-L 50022000 Endosinusial wash, suspension EDQM
0-L 50023000 Eye drops, solution in single-dose container EDQM
0-L 50023500 Film coated gastro-resistant tablet EDQM
0-L 50024000 Gargle/mouthwash EDQM
0-L 50025000 Gastro-resistant coated tablet EDQM
0-L 50026000 Gastro-resistant granules for oral suspension EDQM
0-L 50026250 Gastro-resistant prolonged-release tablet EDQM
0-L 50026500 Granules and solvent for oral suspension EDQM
0-L 50027000 Granules and solvent for suspension for injection EDQM
0-L 50028000 Granules for oral and rectal suspension EDQM
0-L 50029000 Granules for oral drops, solution EDQM
0-L 50029250 Granules for use in drinking water EDQM
0-L 50029500 Granules for vaginal solution EDQM
0-L 50029600 Hard capsule with gastro-resistant pellets EDQM
0-L 50029700 Herbal tea in bag EDQM
0-L 50030000 Inhalation powder, tablet EDQM
0-L 50031000 Inhalation vapour, effervescent tablet EDQM
0-L 50032000 Inhalation vapour, emulsion EDQM
0-L 50033000 Inhalation vapour, impregnated pad EDQM
0-L 50033300 Intrauterine foam EDQM
0-L 50033500 Intravitreal implant in applicator EDQM
0-L 50034000 Liquefied gas for dental use EDQM
0-L 50035000 Modified-release film-coated tablet EDQM
0-L 50036000 Modified-release granules for oral suspension EDQM
0-L 50036100 Muco-adhesive buccal prolonged-release tablet EDQM
0-L 50036500 Nasal/oromucosal solution EDQM
0-L 50037000 Nasal spray and oromucosal solution EDQM
0-L 50037250 Nasal spray, solution in single-dose container EDQM
0-L 50037750 Oral drops, liquid EDQM
0-L 50038000 Oral/rectal suspension EDQM
0-L 50038500 Oral solution/concentrate for nebuliser solution EDQM
0-L 50039000 Oromucosal patch EDQM
0-L 50039300 Oromucosal powder in pouch EDQM
0-L 50039500 Oromucosal/laryngopharyngeal solution EDQM
0-L 50040000 Oromucosal/laryngopharyngeal solution/spray EDQM
0-L 50041000 Pillules in single-dose container EDQM
0-L 50041500 Powder and solution for solution for injection EDQM
0-L 50042000 Powder and solvent for concentrate for solution for infusion EDQM
0-L 50043000 Powder for concentrate for solution for infusion EDQM
0-L 50044000 Powder and solvent for cutaneous solution EDQM
0-L 50044500 Powder and solvent for dispersion for injection EDQM
0-L 50045000 Powder and solvent for endosinusial solution EDQM
0-L 50045500 Powder and solvent for epilesional solution EDQM
0-L 50046000 Powder and solvent for gingival gel EDQM
0-L 50047000 Powder and solvent for instillation solution for intraocular use EDQM
0-L 50047500 Powder and solvent for intravesical solution EDQM
0-L 50047700 Powder and solvent for nebuliser solution EDQM
0-L 50048000 Powder and solvent for prolonged-release suspension for injection EDQM
0-L 50048250 Powder and solvent for solution for injection in pre-filled syringe EDQM
0-L 50048300 Powder and solvent for suspension for injection in pre-filled syringe EDQM
0-L 50048500 Powder and suspension for suspension for injection EDQM
0-L 50048600 Powder, dispersion and solvent for concentrate for dispersion for injection EDQM
0-L 50048750 Powder for concentrate for dispersion for infusion EDQM
0-L 50049000 Powder for concentrate for haemodialysis solution, EDQM
0-L 50049100 Powder for concentrate for intravesical suspension EDQM
0-L 50049250 Powder for concentrate for solution for injection/infusion EDQM
0-L 50049270 Powder for dental solution EDQM
0-L 50049300 Powder for epilesional solution EDQM
0-L 50049500 Powder for implantation suspension EDQM
0-L 50050000 Powder for intravesical solution EDQM
0-L 50051000 Powder for intravesical suspension EDQM
0-L 50051100 Powder for mouth wash EDQM
0-L 50052000 Powder for oral/rectal suspension EDQM
0-L 50053000 Powder for solution for injection or infusion EDQM
0-L 50053500 Powder for solution for injection/infusion EDQM
0-L 50054000 Powder for solution for intravesical use EDQM
0-L 50055000 Powder for solution for nasal spray EDQM
0-L 50055500 Prolonged-release film-coated tablet EDQM
0-L 50056000 Prolonged-release granules for oral suspension EDQM
0-L 50056500 Radiopharmaceutical precursor, solution EDQM
0-L 50057000 Solution for haemodialysis/haemofiltration EDQM
0-L 50058000 Solution for infusion and oral solution EDQM
0-L 50059000 Solution for injection/concentrate for solution for infusion EDQM
0-L 50060000 Solution for injection/infusion EDQM
0-L 50060100 Solution for injection in cartridge EDQM
0-L 50060200 Solution for injection in pre-filled pen EDQM
0-L 50060300 Solution for injection in pre-filled syringe EDQM
0-L 50060400 Solution for injection in pre-filled syringe with automatic needle guard EDQM
0-L 50060500 Solution for injection/infusion in pre-filled syringe EDQM
0-L 50061000 Solution for intraperitoneal use EDQM
0-L 50061300 Solution for use in drinking water EDQM
0-L 50061500 Solution for sealant EDQM
0-L 50061600 Solvent for nasal use EDQM
0-L 50062000 Suspension and effervescent granules for oral suspension EDQM
0-L 50062500 Suspension and solution for spray EDQM
0-L 50063000 Suspension for infusion EDQM
0-L 50063100 Suspension for injection in cartridge EDQM
0-L 50063200 Suspension for injection in pre-filled pen EDQM
0-L 50063300 Suspension for injection in pre-filled syringe EDQM
0-L 50063500 Suspension for use in drinking water EDQM
0-L 50064000 Tablet and solvent for rectal suspension EDQM
0-L 50065000 Tablet and powder for oral solution EDQM
0-L 50066000 Tablet for oral suspension EDQM
0-L 50070000 Oral suspension for use in drinking water EDQM
0-L 50071000 Powder and solvent for dental gel EDQM
0-L 50072000 Powder for use in drinking water EDQM
0-L 50073000 Powder for solution for intraocular irrigation EDQM
0-L 50074000 Solvent for solution for intraocular irrigation EDQM
0-L 50076000 Solvent for solution for infusion EDQM
0-L 50077000 Dispersion for injection EDQM
0-L 50078000 Gas and solvent for dispersion for injection/infusion EDQM
0-L 50079000 Concentrate for solution for injection/infusion EDQM
0-L 50080000 Powder and solvent for solution for injection/infusion EDQM
0-L 50081000 Inhalation solution EDQM
0-L 50082000 Oral drops, powder for suspension EDQM
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 15:07:16 - status: Closed
  Author Alexander Henket
Description Flipped the datatype of dataset field Pharmaceutical Dose Form from string to code and added the binding to epSOSDoseForm
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:47:32
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑10‑24 10:38:56 - status: Open
  Author Giorgio Cangioli
Description the doseform is one of the attributes used for describing the medicinal product, mentioned both in D3.1 and D3.9.1 Appendix B1
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-12) Value set epSOSIllnessesAndDisorders without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.12)
Last assignment to Alexander Henket

Issue Value set epSOSIllnessesAndDisorders without dataset binding
Id epsos-issue-12
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-5 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSIllnessesandDisorders 1.3.6.1.4.1.12559.11.10.1.3.1.42.5 2008 - 2013‑06‑03 Draft
Source Code System:
  • 1.3.6.1.4.1.12559.11.10.1.3.1.44.2 ICD-10
Level/ Type Code Display Name Code System Description
0-L A00 Cholera ICD-10
0-L A01 Typhoid and paratyphoid fevers ICD-10
0-L A02 Other salmonella infections ICD-10
0-L A03 Shigellosis ICD-10
0-L A04 Other bacterial intestinal infections ICD-10
0-L A05 Other bacterial foodborne intoxications, not elsewhere classified ICD-10
0-L A06 Amoebiasis ICD-10
0-L A07 Other protozoal intestinal diseases ICD-10
0-L A08 Viral and other specified intestinal infections ICD-10
0-L A09 Diarrhoea and gastroenteritis of presumed infectious origin ICD-10
0-L A15 Respiratory tuberculosis, bacteriologically and histologically confirmed ICD-10
0-L A16 Respiratory tuberculosis, not confirmed bacteriologically or histologically ICD-10
0-L A17 Tuberculosis of nervous system ICD-10
0-L A18 Tuberculosis of other organs ICD-10
0-L A19 Miliary tuberculosis ICD-10
0-L A20 Plague ICD-10
0-L A21 Tularaemia ICD-10
0-L A22 Anthrax ICD-10
0-L A23 Brucellosis ICD-10
0-L A24 Glanders and melioidosis ICD-10
0-L A25 Rat-bite fevers ICD-10
0-L A26 Erysipeloid ICD-10
0-L A27 Leptospirosis ICD-10
0-L A28 Other zoonotic bacterial diseases, not elsewhere classified ICD-10
0-L A30 Leprosy [Hansen's disease] ICD-10
0-L A31 Infection due to other mycobacteria ICD-10
0-L A32 Listeriosis ICD-10
0-L A33 Tetanus neonatorum ICD-10
0-L A34 Obstetrical tetanus ICD-10
0-L A35 Other tetanus ICD-10
0-L A36 Diphtheria ICD-10
0-L A37 Whooping cough ICD-10
0-L A38 Scarlet fever ICD-10
0-L A39 Meningococcal infection ICD-10
0-L A40 Streptococcal septicaemia ICD-10
0-L A41 Other septicaemia ICD-10
0-L A42 Actinomycosis ICD-10
0-L A43 Nocardiosis ICD-10
0-L A44 Bartonellosis ICD-10
0-L A46 Erysipelas ICD-10
0-L A48 Other bacterial diseases, not elsewhere classified ICD-10
0-L A49 Bacterial infection of unspecified site ICD-10
0-L A50 Congenital syphilis ICD-10
0-L A51 Early syphilis ICD-10
0-L A52 Late syphilis ICD-10
0-L A53 Other and unspecified syphilis ICD-10
0-L A54 Gonococcal infection ICD-10
0-L A55 Chlamydial lymphogranuloma (venereum) ICD-10
0-L A56 Other sexually transmitted chlamydial diseases ICD-10
0-L A57 Chancroid ICD-10
0-L A58 Granuloma inguinale ICD-10
0-L A59 Trichomoniasis ICD-10
0-L A60 Anogenital herpesviral [herpes simplex] infection ICD-10
0-L A63 Other predominantly sexually transmitted diseases, not elsewhere classified ICD-10
0-L A64 Unspecified sexually transmitted disease ICD-10
0-L A65 Nonvenereal syphilis ICD-10
0-L A66 Yaws ICD-10
0-L A67 Pinta [carate] ICD-10
0-L A68 Relapsing fevers ICD-10
0-L A69 Other spirochaetal infections ICD-10
0-L A70 Chlamydia psittaci infection ICD-10
0-L A71 Trachoma ICD-10
0-L A74 Other diseases caused by chlamydiae ICD-10
0-L A75 Typhus fever ICD-10
0-L A77 Spotted fever [tick-borne rickettsioses] ICD-10
0-L A78 Q fever ICD-10
0-L A79 Other rickettsioses ICD-10
0-L A80 Acute poliomyelitis ICD-10
0-L A81 Atypical virus infections of central nervous system ICD-10
0-L A82 Rabies ICD-10
0-L A83 Mosquito-borne viral encephalitis ICD-10
0-L A84 Tick-borne viral encephalitis ICD-10
0-L A85 Other viral encephalitis, not elsewhere classified ICD-10
0-L A86 Unspecified viral encephalitis ICD-10
0-L A87 Viral meningitis ICD-10
0-L A88 Other viral infections of central nervous system, not elsewhere classified ICD-10
0-L A89 Unspecified viral infection of central nervous system ICD-10
0-L A90 Dengue fever [classical dengue] ICD-10
0-L A91 Dengue haemorrhagic fever ICD-10
0-L A92 Other mosquito-borne viral fevers ICD-10
0-L A93 Other arthropod-borne viral fevers, not elsewhere classified ICD-10
0-L A94 Unspecified arthropod-borne viral fever ICD-10
0-L A95 Yellow fever ICD-10
0-L A96 Arenaviral haemorrhagic fever ICD-10
0-L A98 Other viral haemorrhagic fevers, not elsewhere classified ICD-10
0-L A99 Unspecified viral haemorrhagic fever ICD-10
0-L B00 Herpesviral [herpes simplex] infections ICD-10
0-L B01 Varicella [chickenpox] ICD-10
0-L B02 Zoster [herpes zoster] ICD-10
0-L B03 Smallpox ICD-10
0-L B04 Monkeypox ICD-10
0-L B05 Measles ICD-10
0-L B06 Rubella [German measles] ICD-10
0-L B07 Viral warts ICD-10
0-L B08 Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified ICD-10
0-L B09 Unspecified viral infection characterized by skin and mucous membrane lesions ICD-10
0-L B15 Acute hepatitis A ICD-10
0-L B16 Acute hepatitis B ICD-10
0-L B17 Other acute viral hepatitis ICD-10
0-L B18 Chronic viral hepatitis ICD-10
0-L B19 Unspecified viral hepatitis ICD-10
0-L B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases ICD-10
0-L B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms ICD-10
0-L B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases ICD-10
0-L B23 Human immunodeficiency virus [HIV] disease resulting in other conditions ICD-10
0-L B24 Unspecified human immunodeficiency virus [HIV] disease ICD-10
0-L B25 Cytomegaloviral disease ICD-10
0-L B26 Mumps ICD-10
0-L B27 Infectious mononucleosis ICD-10
0-L B30 Viral conjunctivitis ICD-10
0-L B33 Other viral diseases, not elsewhere classified ICD-10
0-L B34 Viral infection of unspecified site ICD-10
0-L B35 Dermatophytosis ICD-10
0-L B36 Other superficial mycoses ICD-10
0-L B37 Candidiasis ICD-10
0-L B38 Coccidioidomycosis ICD-10
0-L B39 Histoplasmosis ICD-10
0-L B40 Blastomycosis ICD-10
0-L B41 Paracoccidioidomycosis ICD-10
0-L B42 Sporotrichosis ICD-10
0-L B43 Chromomycosis and phaeomycotic abscess ICD-10
0-L B44 Aspergillosis ICD-10
0-L B45 Cryptococcosis ICD-10
0-L B46 Zygomycosis ICD-10
0-L B47 Mycetoma ICD-10
0-L B48 Other mycoses, not elsewhere classified ICD-10
0-L B49 Unspecified mycosis ICD-10
0-L B50 Plasmodium falciparum malaria ICD-10
0-L B51 Plasmodium vivax malaria ICD-10
0-L B52 Plasmodium malariae malaria ICD-10
0-L B53 Other parasitologically confirmed malaria ICD-10
0-L B54 Unspecified malaria ICD-10
0-L B55 Leishmaniasis ICD-10
0-L B56 African trypanosomiasis ICD-10
0-L B57 Chagas' disease ICD-10
0-L B58 Toxoplasmosis ICD-10
0-L B59 Pneumocystosis ICD-10
0-L B60 Other protozoal diseases, not elsewhere classified ICD-10
0-L B64 Unspecified protozoal disease ICD-10
0-L B65 Schistosomiasis [bilharziasis] ICD-10
0-L B66 Other fluke infections ICD-10
0-L B67 Echinococcosis ICD-10
0-L B68 Taeniasis ICD-10
0-L B69 Cysticercosis ICD-10
0-L B70 Diphyllobothriasis and sparganosis ICD-10
0-L B71 Other cestode infections ICD-10
0-L B72 Dracunculiasis ICD-10
0-L B73 Onchocerciasis ICD-10
0-L B74 Filariasis ICD-10
0-L B75 Trichinellosis ICD-10
0-L B76 Hookworm diseases ICD-10
0-L B77 Ascariasis ICD-10
0-L B78 Strongyloidiasis ICD-10
0-L B79 Trichuriasis ICD-10
0-L B80 Enterobiasis ICD-10
0-L B81 Other intestinal helminthiases, not elsewhere classified ICD-10
0-L B82 Unspecified intestinal parasitism ICD-10
0-L B83 Other helminthiases ICD-10
0-L B85 Pediculosis and phthiriasis ICD-10
0-L B86 Scabies ICD-10
0-L B87 Myiasis ICD-10
0-L B88 Other infestations ICD-10
0-L B89 Unspecified parasitic disease ICD-10
0-L B90 Sequelae of tuberculosis ICD-10
0-L B91 Sequelae of poliomyelitis ICD-10
0-L B92 Sequelae of leprosy ICD-10
0-L B94 Sequelae of other and unspecified infectious and parasitic diseases ICD-10
0-L B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters ICD-10
0-L B96 Other bacterial agents as the cause of diseases classified to other chapters ICD-10
0-L B97 Viral agents as the cause of diseases classified to other chapters ICD-10
0-L B99 Other and unspecified infectious diseases ICD-10
0-L C00 Malignant neoplasm of lip ICD-10
0-L C01 Malignant neoplasm of base of tongue ICD-10
0-L C02 Malignant neoplasm of other and unspecified parts of tongue ICD-10
0-L C03 Malignant neoplasm of gum ICD-10
0-L C04 Malignant neoplasm of floor of mouth ICD-10
0-L C05 Malignant neoplasm of palate ICD-10
0-L C06 Malignant neoplasm of other and unspecified parts of mouth ICD-10
0-L C07 Malignant neoplasm of parotid gland ICD-10
0-L C08 Malignant neoplasm of other and unspecified major salivary glands ICD-10
0-L C09 Malignant neoplasm of tonsil ICD-10
0-L C10 Malignant neoplasm of oropharynx ICD-10
0-L C11 Malignant neoplasm of nasopharynx ICD-10
0-L C12 Malignant neoplasm of piriform sinus ICD-10
0-L C13 Malignant neoplasm of hypopharynx ICD-10
0-L C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx ICD-10
0-L C15 Malignant neoplasm of oesophagus ICD-10
0-L C16 Malignant neoplasm of stomach ICD-10
0-L C17 Malignant neoplasm of small intestine ICD-10
0-L C18 Malignant neoplasm of colon ICD-10
0-L C19 Malignant neoplasm of rectosigmoid junction ICD-10
0-L C20 Malignant neoplasm of rectum ICD-10
0-L C21 Malignant neoplasm of anus and anal canal ICD-10
0-L C22 Malignant neoplasm of liver and intrahepatic bile ducts ICD-10
0-L C23 Malignant neoplasm of gallbladder ICD-10
0-L C24 Malignant neoplasm of other and unspecified parts of biliary tract ICD-10
0-L C25 Malignant neoplasm of pancreas ICD-10
0-L C26 Malignant neoplasm of other and ill-defined digestive organs ICD-10
0-L C30 Malignant neoplasm of nasal cavity and middle ear ICD-10
0-L C31 Malignant neoplasm of accessory sinuses ICD-10
0-L C32 Malignant neoplasm of larynx ICD-10
0-L C33 Malignant neoplasm of trachea ICD-10
0-L C34 Malignant neoplasm of bronchus and lung ICD-10
0-L C37 Malignant neoplasm of thymus ICD-10
0-L C38 Malignant neoplasm of heart, mediastinum and pleura ICD-10
0-L C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs ICD-10
0-L C40 Malignant neoplasm of bone and articular cartilage of limbs ICD-10
0-L C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites ICD-10
0-L C43 Malignant melanoma of skin ICD-10
0-L C44 Other malignant neoplasms of skin ICD-10
0-L C45 Mesothelioma ICD-10
0-L C46 Kaposi's sarcoma ICD-10
0-L C47 Malignant neoplasm of peripheral nerves and autonomic nervous system ICD-10
0-L C48 Malignant neoplasm of retroperitoneum and peritoneum ICD-10
0-L C49 Malignant neoplasm of other connective and soft tissue ICD-10
0-L C50 Malignant neoplasm of breast ICD-10
0-L C51 Malignant neoplasm of vulva ICD-10
0-L C52 Malignant neoplasm of vagina ICD-10
0-L C53 Malignant neoplasm of cervix uteri ICD-10
0-L C54 Malignant neoplasm of corpus uteri ICD-10
0-L C55 Malignant neoplasm of uterus, part unspecified ICD-10
0-L C56 Malignant neoplasm of ovary ICD-10
0-L C57 Malignant neoplasm of other and unspecified female genital organs ICD-10
0-L C58 Malignant neoplasm of placenta ICD-10
0-L C60 Malignant neoplasm of penis ICD-10
0-L C61 Malignant neoplasm of prostate ICD-10
0-L C62 Malignant neoplasm of testis ICD-10
0-L C63 Malignant neoplasm of other and unspecified male genital organs ICD-10
0-L C64 Malignant neoplasm of kidney, except renal pelvis ICD-10
0-L C65 Malignant neoplasm of renal pelvis ICD-10
0-L C66 Malignant neoplasm of ureter ICD-10
0-L C67 Malignant neoplasm of bladder ICD-10
0-L C68 Malignant neoplasm of other and unspecified urinary organs ICD-10
0-L C69 Malignant neoplasm of eye and adnexa ICD-10
0-L C70 Malignant neoplasm of meninges ICD-10
0-L C71 Malignant neoplasm of brain ICD-10
0-L C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system ICD-10
0-L C73 Malignant neoplasm of thyroid gland ICD-10
0-L C74 Malignant neoplasm of adrenal gland ICD-10
0-L C75 Malignant neoplasm of other endocrine glands and related structures ICD-10
0-L C76 Malignant neoplasm of other and ill-defined sites ICD-10
0-L C77 Secondary and unspecified malignant neoplasm of lymph nodes ICD-10
0-L C78 Secondary malignant neoplasm of respiratory and digestive organs ICD-10
0-L C79 Secondary malignant neoplasm of other sites ICD-10
0-L C80 Malignant neoplasm without specification of site ICD-10
0-L C81 Hodgkin's disease ICD-10
0-L C82 Follicular [nodular] non-Hodgkin's lymphoma ICD-10
0-L C83 Diffuse non-Hodgkin's lymphoma ICD-10
0-L C84 Peripheral and cutaneous T-cell lymphomas ICD-10
0-L C85 Other and unspecified types of non-Hodgkin's lymphoma ICD-10
0-L C88 Malignant immunoproliferative diseases ICD-10
0-L C90 Multiple myeloma and malignant plasma cell neoplasms ICD-10
0-L C91 Lymphoid leukaemia ICD-10
0-L C92 Myeloid leukaemia ICD-10
0-L C93 Monocytic leukaemia ICD-10
0-L C94 Other leukaemias of specified cell type ICD-10
0-L C95 Leukaemia of unspecified cell type ICD-10
0-L C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue ICD-10
0-L C97 Malignant neoplasms of independent (primary) multiple sites ICD-10
0-L D00 Carcinoma in situ of oral cavity, oesophagus and stomach ICD-10
0-L D01 Carcinoma in situ of other and unspecified digestive organs ICD-10
0-L D02 Carcinoma in situ of middle ear and respiratory system ICD-10
0-L D03 Melanoma in situ ICD-10
0-L D04 Carcinoma in situ of skin ICD-10
0-L D05 Carcinoma in situ of breast ICD-10
0-L D06 Carcinoma in situ of cervix uteri ICD-10
0-L D07 Carcinoma in situ of other and unspecified genital organs ICD-10
0-L D09 Carcinoma in situ of other and unspecified sites ICD-10
0-L D10 Benign neoplasm of mouth and pharynx ICD-10
0-L D11 Benign neoplasm of major salivary glands ICD-10
0-L D12 Benign neoplasm of colon, rectum, anus and anal canal ICD-10
0-L D13 Benign neoplasm of other and ill-defined parts of digestive system ICD-10
0-L D14 Benign neoplasm of middle ear and respiratory system ICD-10
0-L D15 Benign neoplasm of other and unspecified intrathoracic organs ICD-10
0-L D16 Benign neoplasm of bone and articular cartilage ICD-10
0-L D17 Benign lipomatous neoplasm ICD-10
0-L D18 Haemangioma and lymphangioma, any site ICD-10
0-L D19 Benign neoplasm of mesothelial tissue ICD-10
0-L D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum ICD-10
0-L D21 Other benign neoplasms of connective and other soft tissue ICD-10
0-L D22 Melanocytic naevi ICD-10
0-L D23 Other benign neoplasms of skin ICD-10
0-L D24 Benign neoplasm of breast ICD-10
0-L D25 Leiomyoma of uterus ICD-10
0-L D26 Other benign neoplasms of uterus ICD-10
0-L D27 Benign neoplasm of ovary ICD-10
0-L D28 Benign neoplasm of other and unspecified female genital organs ICD-10
0-L D29 Benign neoplasm of male genital organs ICD-10
0-L D30 Benign neoplasm of urinary organs ICD-10
0-L D31 Benign neoplasm of eye and adnexa ICD-10
0-L D32 Benign neoplasm of meninges ICD-10
0-L D33 Benign neoplasm of brain and other parts of central nervous system ICD-10
0-L D34 Benign neoplasm of thyroid gland ICD-10
0-L D35 Benign neoplasm of other and unspecified endocrine glands ICD-10
0-L D36 Benign neoplasm of other and unspecified sites ICD-10
0-L D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs ICD-10
0-L D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs ICD-10
0-L D39 Neoplasm of uncertain or unknown behaviour of female genital organs ICD-10
0-L D40 Neoplasm of uncertain or unknown behaviour of male genital organs ICD-10
0-L D41 Neoplasm of uncertain or unknown behaviour of urinary organs ICD-10
0-L D42 Neoplasm of uncertain or unknown behaviour of meninges ICD-10
0-L D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system ICD-10
0-L D44 Neoplasm of uncertain or unknown behaviour of endocrine glands ICD-10
0-L D45 Polycythaemia vera ICD-10
0-L D46 Myelodysplastic syndromes ICD-10
0-L D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue ICD-10
0-L D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites ICD-10
0-L D50 Iron deficiency anaemia ICD-10
0-L D51 Vitamin B12 deficiency anaemia ICD-10
0-L D52 Folate deficiency anaemia ICD-10
0-L D53 Other nutritional anaemias ICD-10
0-L D55 Anaemia due to enzyme disorders ICD-10
0-L D56 Thalassaemia ICD-10
0-L D57 Sickle-cell disorders ICD-10
0-L D58 Other hereditary haemolytic anaemias ICD-10
0-L D59 Acquired haemolytic anaemia ICD-10
0-L D60 Acquired pure red cell aplasia [erythroblastopenia] ICD-10
0-L D61 Other aplastic anaemias ICD-10
0-L D62 Acute posthaemorrhagic anaemia ICD-10
0-L D63 Anaemia in chronic diseases classified elsewhere ICD-10
0-L D64 Other anaemias ICD-10
0-L D65 Disseminated intravascular coagulation [defibrination syndrome] ICD-10
0-L D66 Hereditary factor VIII deficiency ICD-10
0-L D67 Hereditary factor IX deficiency ICD-10
0-L D68 Other coagulation defects ICD-10
0-L D68.2 Hereditary deficiency of other clotting factors ICD-10
0-L D68.3 Haemorrhagic disorder due to circulating anticoagulants ICD-10
0-L D68.4 Acquired coagulation factor deficiency ICD-10
0-L D69 Purpura and other haemorrhagic conditions ICD-10
0-L D70 Agranulocytosis ICD-10
0-L D71 Functional disorders of polymorphonuclear neutrophils ICD-10
0-L D72 Other disorders of white blood cells ICD-10
0-L D73 Diseases of spleen ICD-10
0-L D74 Methaemoglobinaemia ICD-10
0-L D75 Other diseases of blood and blood-forming organs ICD-10
0-L D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system ICD-10
0-L D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere ICD-10
0-L D80 Immunodeficiency with predominantly antibody defects ICD-10
0-L D81 Combined immunodeficiencies ICD-10
0-L D82 Immunodeficiency associated with other major defects ICD-10
0-L D83 Common variable immunodeficiency ICD-10
0-L D84 Other immunodeficiencies ICD-10
0-L D86 Sarcoidosis ICD-10
0-L D89 Other disorders involving the immune mechanism, not elsewhere classified ICD-10
0-L E00 Congenital iodine-deficiency syndrome ICD-10
0-L E01 Iodine-deficiency-related thyroid disorders and allied conditions ICD-10
0-L E02 Subclinical iodine-deficiency hypothyroidism ICD-10
0-L E03 Other hypothyroidism ICD-10
0-L E04 Other nontoxic goitre ICD-10
0-L E05 Thyrotoxicosis [hyperthyroidism] ICD-10
0-L E06 Thyroiditis ICD-10
0-L E07 Other disorders of thyroid ICD-10
0-L E10 Insulin-dependent diabetes mellitus ICD-10
0-L E11 Non-insulin-dependent diabetes mellitus ICD-10
0-L E12 Malnutrition-related diabetes mellitus ICD-10
0-L E13 Other specified diabetes mellitus ICD-10
0-L E14 Unspecified diabetes mellitus ICD-10
0-L E15 Nondiabetic hypoglycaemic coma ICD-10
0-L E16 Other disorders of pancreatic internal secretion ICD-10
0-L E20 Hypoparathyroidism ICD-10
0-L E21 Hyperparathyroidism and other disorders of parathyroid gland ICD-10
0-L E22 Hyperfunction of pituitary gland ICD-10
0-L E23 Hypofunction and other disorders of pituitary gland ICD-10
0-L E24 Cushing's syndrome ICD-10
0-L E25 Adrenogenital disorders ICD-10
0-L E26 Hyperaldosteronism ICD-10
0-L E27 Other disorders of adrenal gland ICD-10
0-L E27.2 Addisonian crisis ICD-10
0-L E28 Ovarian dysfunction ICD-10
0-L E29 Testicular dysfunction ICD-10
0-L E30 Disorders of puberty, not elsewhere classified ICD-10
0-L E31 Polyglandular dysfunction ICD-10
0-L E32 Diseases of thymus ICD-10
0-L E34 Other endocrine disorders ICD-10
0-L E35 Disorders of endocrine glands in diseases classified elsewhere ICD-10
0-L E40 Kwashiorkor ICD-10
0-L E41 Nutritional marasmus ICD-10
0-L E42 Marasmic kwashiorkor ICD-10
0-L E43 Unspecified severe protein-energy malnutrition ICD-10
0-L E44 Protein-energy malnutrition of moderate and mild degree ICD-10
0-L E45 Retarded development following protein-energy malnutrition ICD-10
0-L E46 Unspecified protein-energy malnutrition ICD-10
0-L E50 Vitamin A deficiency ICD-10
0-L E51 Thiamine deficiency ICD-10
0-L E52 Niacin deficiency [pellagra] ICD-10
0-L E53 Deficiency of other B group vitamins ICD-10
0-L E54 Ascorbic acid deficiency ICD-10
0-L E55 Vitamin D deficiency ICD-10
0-L E56 Other vitamin deficiencies ICD-10
0-L E58 Dietary calcium deficiency ICD-10
0-L E59 Dietary selenium deficiency ICD-10
0-L E60 Dietary zinc deficiency ICD-10
0-L E61 Deficiency of other nutrient elements ICD-10
0-L E63 Other nutritional deficiencies ICD-10
0-L E64 Sequelae of malnutrition and other nutritional deficiencies ICD-10
0-L E65 Localized adiposity ICD-10
0-L E66 Obesity ICD-10
0-L E67 Other hyperalimentation ICD-10
0-L E68 Sequelae of hyperalimentation ICD-10
0-L E70 Disorders of aromatic amino-acid metabolism ICD-10
0-L E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism ICD-10
0-L E72 Other disorders of amino-acid metabolism ICD-10
0-L E73 Lactose intolerance ICD-10
0-L E74 Other disorders of carbohydrate metabolism ICD-10
0-L E75 Disorders of sphingolipid metabolism and other lipid storage disorders ICD-10
0-L E76 Disorders of glycosaminoglycan metabolism ICD-10
0-L E77 Disorders of glycoprotein metabolism ICD-10
0-L E78 Disorders of lipoprotein metabolism and other lipidaemias ICD-10
0-L E79 Disorders of purine and pyrimidine metabolism ICD-10
0-L E80 Disorders of porphyrin and bilirubin metabolism ICD-10
0-L E83 Disorders of mineral metabolism ICD-10
0-L E84 Cystic fibrosis ICD-10
0-L E85 Amyloidosis ICD-10
0-L E86 Volume depletion ICD-10
0-L E87 Other disorders of fluid, electrolyte and acid-base balance ICD-10
0-L E88 Other metabolic disorders ICD-10
0-L E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified ICD-10
0-L E90 Nutritional and metabolic disorders in diseases classified elsewhere ICD-10
0-L F00 Dementia in Alzheimer's disease ICD-10
0-L F01 Vascular dementia ICD-10
0-L F02 Dementia in other diseases classified elsewhere ICD-10
0-L F03 Unspecified dementia ICD-10
0-L F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances ICD-10
0-L F05 Delirium, not induced by alcohol and other psychoactive substances ICD-10
0-L F06 Other mental disorders due to brain damage and dysfunction and to physical disease ICD-10
0-L F07 Personality and behavioural disorders due to brain disease, damage and dysfunction ICD-10
0-L F09 Unspecified organic or symptomatic mental disorder ICD-10
0-L F10 Mental and behavioural disorders due to use of alcohol ICD-10
0-L F11 Mental and behavioural disorders due to use of opioids ICD-10
0-L F12 Mental and behavioural disorders due to use of cannabinoids ICD-10
0-L F13 Mental and behavioural disorders due to use of sedatives or hypnotics ICD-10
0-L F14 Mental and behavioural disorders due to use of cocaine ICD-10
0-L F15 Mental and behavioural disorders due to use of other stimulants, including caffeine ICD-10
0-L F16 Mental and behavioural disorders due to use of hallucinogens ICD-10
0-L F17 Mental and behavioural disorders due to use of tobacco ICD-10
0-L F18 Mental and behavioural disorders due to use of volatile solvents ICD-10
0-L F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances ICD-10
0-L F20 Schizophrenia ICD-10
0-L F21 Schizotypal disorder ICD-10
0-L F22 Persistent delusional disorders ICD-10
0-L F23 Acute and transient psychotic disorders ICD-10
0-L F24 Induced delusional disorder ICD-10
0-L F25 Schizoaffective disorders ICD-10
0-L F28 Other nonorganic psychotic disorders ICD-10
0-L F29 Unspecified nonorganic psychosis ICD-10
0-L F30 Manic episode ICD-10
0-L F31 Bipolar affective disorder ICD-10
0-L F32 Depressive episode ICD-10
0-L F33 Recurrent depressive disorder ICD-10
0-L F34 Persistent mood [affective] disorders ICD-10
0-L F38 Other mood [affective] disorders ICD-10
0-L F39 Unspecified mood [affective] disorder ICD-10
0-L F40 Phobic anxiety disorders ICD-10
0-L F41 Other anxiety disorders ICD-10
0-L F42 Obsessive-compulsive disorder ICD-10
0-L F43 Reaction to severe stress, and adjustment disorders ICD-10
0-L F44 Dissociative [conversion] disorders ICD-10
0-L F45 Somatoform disorders ICD-10
0-L F48 Other neurotic disorders ICD-10
0-L F50 Eating disorders ICD-10
0-L F51 Nonorganic sleep disorders ICD-10
0-L F52 Sexual dysfunction, not caused by organic disorder or disease ICD-10
0-L F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified ICD-10
0-L F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere ICD-10
0-L F55 Abuse of non-dependence-producing substances ICD-10
0-L F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors ICD-10
0-L F60 Specific personality disorders ICD-10
0-L F61 Mixed and other personality disorders ICD-10
0-L F62 Enduring personality changes, not attributable to brain damage and disease ICD-10
0-L F63 Habit and impulse disorders ICD-10
0-L F64 Gender identity disorders ICD-10
0-L F65 Disorders of sexual preference ICD-10
0-L F66 Psychological and behavioural disorders associated with sexual development and orientation ICD-10
0-L F68 Other disorders of adult personality and behaviour ICD-10
0-L F69 Unspecified disorder of adult personality and behaviour ICD-10
0-L F70 Mild mental retardation ICD-10
0-L F71 Moderate mental retardation ICD-10
0-L F72 Severe mental retardation ICD-10
0-L F73 Profound mental retardation ICD-10
0-L F78 Other mental retardation ICD-10
0-L F79 Unspecified mental retardation ICD-10
0-L F80 Specific developmental disorders of speech and language ICD-10
0-L F81 Specific developmental disorders of scholastic skills ICD-10
0-L F82 Specific developmental disorder of motor function ICD-10
0-L F83 Mixed specific developmental disorders ICD-10
0-L F84 Pervasive developmental disorders ICD-10
0-L F88 Other disorders of psychological development ICD-10
0-L F89 Unspecified disorder of psychological development ICD-10
0-L F90 Hyperkinetic disorders ICD-10
0-L F91 Conduct disorders ICD-10
0-L F92 Mixed disorders of conduct and emotions ICD-10
0-L F93 Emotional disorders with onset specific to childhood ICD-10
0-L F94 Disorders of social functioning with onset specific to childhood and adolescence ICD-10
0-L F95 Tic disorders ICD-10
0-L F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence ICD-10
0-L F99 Mental disorder, not otherwise specified ICD-10
0-L G00 Bacterial meningitis, not elsewhere classified ICD-10
0-L G01 Meningitis in bacterial diseases classified elsewhere ICD-10
0-L G02 Meningitis in other infectious and parasitic diseases classified elsewhere ICD-10
0-L G03 Meningitis due to other and unspecified causes ICD-10
0-L G04 Encephalitis, myelitis and encephalomyelitis ICD-10
0-L G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere ICD-10
0-L G06 Intracranial and intraspinal abscess and granuloma ICD-10
0-L G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere ICD-10
0-L G08 Intracranial and intraspinal phlebitis and thrombophlebitis ICD-10
0-L G09 Sequelae of inflammatory diseases of central nervous system ICD-10
0-L G10 Huntington's disease ICD-10
0-L G11 Hereditary ataxia ICD-10
0-L G12 Spinal muscular atrophy and related syndromes ICD-10
0-L G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere ICD-10
0-L G20 Parkinson's disease ICD-10
0-L G21 Secondary parkinsonism ICD-10
0-L G22 Parkinsonism in diseases classified elsewhere ICD-10
0-L G23 Other degenerative diseases of basal ganglia ICD-10
0-L G24 Dystonia ICD-10
0-L G25 Other extrapyramidal and movement disorders ICD-10
0-L G26 Extrapyramidal and movement disorders in diseases classified elsewhere ICD-10
0-L G30 Alzheimer's disease ICD-10
0-L G31 Other degenerative diseases of nervous system, not elsewhere classified ICD-10
0-L G32 Other degenerative disorders of nervous system in diseases classified elsewhere ICD-10
0-L G35 Multiple sclerosis ICD-10
0-L G36 Other acute disseminated demyelination ICD-10
0-L G37 Other demyelinating diseases of central nervous system ICD-10
0-L G40 Epilepsy ICD-10
0-L G41 Status epilepticus ICD-10
0-L G43 Migraine ICD-10
0-L G44 Other headache syndromes ICD-10
0-L G45 Transient cerebral ischaemic attacks and related syndromes ICD-10
0-L G46 Vascular syndromes of brain in cerebrovascular diseases ICD-10
0-L G47 Sleep disorders ICD-10
0-L G50 Disorders of trigeminal nerve ICD-10
0-L G51 Facial nerve disorders ICD-10
0-L G52 Disorders of other cranial nerves ICD-10
0-L G53 Cranial nerve disorders in diseases classified elsewhere ICD-10
0-L G54 Nerve root and plexus disorders ICD-10
0-L G55 Nerve root and plexus compressions in diseases classified elsewhere ICD-10
0-L G56 Mononeuropathies of upper limb ICD-10
0-L G57 Mononeuropathies of lower limb ICD-10
0-L G58 Other mononeuropathies ICD-10
0-L G59 Mononeuropathy in diseases classified elsewhere ICD-10
0-L G60 Hereditary and idiopathic neuropathy ICD-10
0-L G61 Inflammatory polyneuropathy ICD-10
0-L G62 Other polyneuropathies ICD-10
0-L G63 Polyneuropathy in diseases classified elsewhere ICD-10
0-L G64 Other disorders of peripheral nervous system ICD-10
0-L G70 Myasthenia gravis and other myoneural disorders ICD-10
0-L G71 Primary disorders of muscles ICD-10
0-L G72 Other myopathies ICD-10
0-L G73 Disorders of myoneural junction and muscle in diseases classified elsewhere ICD-10
0-L G80 Cerebral palsy ICD-10
0-L G81 Hemiplegia ICD-10
0-L G82 Paraplegia and tetraplegia ICD-10
0-L G83 Other paralytic syndromes ICD-10
0-L G90 Disorders of autonomic nervous system ICD-10
0-L G91 Hydrocephalus ICD-10
0-L G92 Toxic encephalopathy ICD-10
0-L G93 Other disorders of brain ICD-10
0-L G94 Other disorders of brain in diseases classified elsewhere ICD-10
0-L G95 Other diseases of spinal cord ICD-10
0-L G96 Other disorders of central nervous system ICD-10
0-L G97 Postprocedural disorders of nervous system, not elsewhere classified ICD-10
0-L G98 Other disorders of nervous system, not elsewhere classified ICD-10
0-L G99 Other disorders of nervous system in diseases classified elsewhere ICD-10
0-L H00 Hordeolum and chalazion ICD-10
0-L H01 Other inflammation of eyelid ICD-10
0-L H02 Other disorders of eyelid ICD-10
0-L H03 Disorders of eyelid in diseases classified elsewhere ICD-10
0-L H04 Disorders of lacrimal system ICD-10
0-L H05 Disorders of orbit ICD-10
0-L H06 Disorders of lacrimal system and orbit in diseases classified elsewhere ICD-10
0-L H10 Conjunctivitis ICD-10
0-L H11 Other disorders of conjunctiva ICD-10
0-L H13 Disorders of conjunctiva in diseases classified elsewhere ICD-10
0-L H15 Disorders of sclera ICD-10
0-L H16 Keratitis ICD-10
0-L H17 Corneal scars and opacities ICD-10
0-L H18 Other disorders of cornea ICD-10
0-L H19 Disorders of sclera and cornea in diseases classified elsewhere ICD-10
0-L H20 Iridocyclitis ICD-10
0-L H21 Other disorders of iris and ciliary body ICD-10
0-L H22 Disorders of iris and ciliary body in diseases classified elsewhere ICD-10
0-L H25 Senile cataract ICD-10
0-L H26 Other cataract ICD-10
0-L H27 Other disorders of lens ICD-10
0-L H28 Cataract and other disorders of lens in diseases classified elsewhere ICD-10
0-L H30 Chorioretinal inflammation ICD-10
0-L H31 Other disorders of choroid ICD-10
0-L H32 Chorioretinal disorders in diseases classified elsewhere ICD-10
0-L H33 Retinal detachments and breaks ICD-10
0-L H34 Retinal vascular occlusions ICD-10
0-L H35 Other retinal disorders ICD-10
0-L H36 Retinal disorders in diseases classified elsewhere ICD-10
0-L H40 Glaucoma ICD-10
0-L H42 Glaucoma in diseases classified elsewhere ICD-10
0-L H43 Disorders of vitreous body ICD-10
0-L H44 Disorders of globe ICD-10
0-L H45 Disorders of vitreous body and globe in diseases classified elsewhere ICD-10
0-L H46 Optic neuritis ICD-10
0-L H47 Other disorders of optic [2nd] nerve and visual pathways ICD-10
0-L H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere ICD-10
0-L H49 Paralytic strabismus ICD-10
0-L H50 Other strabismus ICD-10
0-L H51 Other disorders of binocular movement ICD-10
0-L H52 Disorders of refraction and accommodation ICD-10
0-L H53 Visual disturbances ICD-10
0-L H54 Blindness and low vision ICD-10
0-L H55 Nystagmus and other irregular eye movements ICD-10
0-L H57 Other disorders of eye and adnexa ICD-10
0-L H58 Other disorders of eye and adnexa in diseases classified elsewhere ICD-10
0-L H59 Postprocedural disorders of eye and adnexa, not elsewhere classified ICD-10
0-L H60 Otitis externa ICD-10
0-L H61 Other disorders of external ear ICD-10
0-L H62 Disorders of external ear in diseases classified elsewhere ICD-10
0-L H65 Nonsuppurative otitis media ICD-10
0-L H66 Suppurative and unspecified otitis media ICD-10
0-L H67 Otitis media in diseases classified elsewhere ICD-10
0-L H68 Eustachian salpingitis and obstruction ICD-10
0-L H69 Other disorders of Eustachian tube ICD-10
0-L H70 Mastoiditis and related conditions ICD-10
0-L H71 Cholesteatoma of middle ear ICD-10
0-L H72 Perforation of tympanic membrane ICD-10
0-L H73 Other disorders of tympanic membrane ICD-10
0-L H74 Other disorders of middle ear and mastoid ICD-10
0-L H75 Other disorders of middle ear and mastoid in diseases classified elsewhere ICD-10
0-L H80 Otosclerosis ICD-10
0-L H81 Disorders of vestibular function ICD-10
0-L H82 Vertiginous syndromes in diseases classified elsewhere ICD-10
0-L H83 Other diseases of inner ear ICD-10
0-L H90 Conductive and sensorineural hearing loss ICD-10
0-L H91 Other hearing loss ICD-10
0-L H92 Otalgia and effusion of ear ICD-10
0-L H93 Other disorders of ear, not elsewhere classified ICD-10
0-L H94 Other disorders of ear in diseases classified elsewhere ICD-10
0-L H95 Postprocedural disorders of ear and mastoid process, not elsewhere classified ICD-10
0-L I00 Rheumatic fever without mention of heart involvement ICD-10
0-L I01 Rheumatic fever with heart involvement ICD-10
0-L I02 Rheumatic chorea ICD-10
0-L I05 Rheumatic mitral valve diseases ICD-10
0-L I06 Rheumatic aortic valve diseases ICD-10
0-L I07 Rheumatic tricuspid valve diseases ICD-10
0-L I08 Multiple valve diseases ICD-10
0-L I09 Other rheumatic heart diseases ICD-10
0-L I10 Essential (primary) hypertension ICD-10
0-L I11 Hypertensive heart disease ICD-10
0-L I12 Hypertensive renal disease ICD-10
0-L I13 Hypertensive heart and renal disease ICD-10
0-L I15 Secondary hypertension ICD-10
0-L I20 Angina pectoris ICD-10
0-L I21 Acute myocardial infarction ICD-10
0-L I22 Subsequent myocardial infarction ICD-10
0-L I23 Certain current complications following acute myocardial infarction ICD-10
0-L I24 Other acute ischaemic heart diseases ICD-10
0-L I25 Chronic ischaemic heart disease ICD-10
0-L I26 Pulmonary embolism ICD-10
0-L I27 Other pulmonary heart diseases ICD-10
0-L I28 Other diseases of pulmonary vessels ICD-10
0-L I30 Acute pericarditis ICD-10
0-L I31 Other diseases of pericardium ICD-10
0-L I32 Pericarditis in diseases classified elsewhere ICD-10
0-L I33 Acute and subacute endocarditis ICD-10
0-L I34 Nonrheumatic mitral valve disorders ICD-10
0-L I35 Nonrheumatic aortic valve disorders ICD-10
0-L I36 Nonrheumatic tricuspid valve disorders ICD-10
0-L I37 Pulmonary valve disorders ICD-10
0-L I38 Endocarditis, valve unspecified ICD-10
0-L I39 Endocarditis and heart valve disorders in diseases classified elsewhere ICD-10
0-L I40 Acute myocarditis ICD-10
0-L I41 Myocarditis in diseases classified elsewhere ICD-10
0-L I42 Cardiomyopathy ICD-10
0-L I43 Cardiomyopathy in diseases classified elsewhere ICD-10
0-L I44 Atrioventricular and left bundle-branch block ICD-10
0-L I45 Other conduction disorders ICD-10
0-L I46 Cardiac arrest ICD-10
0-L I47 Paroxysmal tachycardia ICD-10
0-L I48 Atrial fibrillation and flutter ICD-10
0-L I49 Other cardiac arrhythmias ICD-10
0-L I49.0 Ventricular fibrillation and flutter ICD-10
0-L I49.1 Atrial premature depolarization ICD-10
0-L I49.2 Junctional premature depolarization ICD-10
0-L I49.3 Ventricular premature depolarization ICD-10
0-L I49.5 Sick sinus syndrome ICD-10
0-L I49.9 Cardiac arrhythmia, unspecified ICD-10
0-L I50 Heart failure ICD-10
0-L I50.0 Congestive heart failure ICD-10
0-L I51 Complications and ill-defined descriptions of heart disease ICD-10
0-L I52 Other heart disorders in diseases classified elsewhere ICD-10
0-L I60 Subarachnoid haemorrhage ICD-10
0-L I61 Intracerebral haemorrhage ICD-10
0-L I62 Other nontraumatic intracranial haemorrhage ICD-10
0-L I63 Cerebral infarction ICD-10
0-L I64 Stroke, not specified as haemorrhage or infarction ICD-10
0-L I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction ICD-10
0-L I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction ICD-10
0-L I67 Other cerebrovascular diseases ICD-10
0-L I68 Cerebrovascular disorders in diseases classified elsewhere ICD-10
0-L I69 Sequelae of cerebrovascular disease ICD-10
0-L I70 Atherosclerosis ICD-10
0-L I71 Aortic aneurysm and dissection ICD-10
0-L I71.4 Abdominal aortic aneurysm, without mention of rupture ICD-10
0-L I72 Other aneurysm ICD-10
0-L I73 Other peripheral vascular diseases ICD-10
0-L I74 Arterial embolism and thrombosis ICD-10
0-L I77 Other disorders of arteries and arterioles ICD-10
0-L I78 Diseases of capillaries ICD-10
0-L I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere ICD-10
0-L I80 Phlebitis and thrombophlebitis ICD-10
0-L I81 Portal vein thrombosis ICD-10
0-L I82 Other venous embolism and thrombosis ICD-10
0-L I83 Varicose veins of lower extremities ICD-10
0-L I84 Haemorrhoids ICD-10
0-L I85 Oesophageal varices ICD-10
0-L I86 Varicose veins of other sites ICD-10
0-L I87 Other disorders of veins ICD-10
0-L I88 Nonspecific lymphadenitis ICD-10
0-L I89 Other noninfective disorders of lymphatic vessels and lymph nodes ICD-10
0-L I95 Hypotension ICD-10
0-L I97 Postprocedural disorders of circulatory system, not elsewhere classified ICD-10
0-L I98 Other disorders of circulatory system in diseases classified elsewhere ICD-10
0-L I99 Other and unspecified disorders of circulatory system ICD-10
0-L J00 Acute nasopharyngitis [common cold] ICD-10
0-L J01 Acute sinusitis ICD-10
0-L J02 Acute pharyngitis ICD-10
0-L J03 Acute tonsillitis ICD-10
0-L J04 Acute laryngitis and tracheitis ICD-10
0-L J05 Acute obstructive laryngitis [croup] and epiglottitis ICD-10
0-L J06 Acute upper respiratory infections of multiple and unspecified sites ICD-10
0-L J09 Influenza due to identified avian influenza virus ICD-10
0-L J10 Influenza due to other identified influenza virus ICD-10
0-L J11 Influenza, virus not identified ICD-10
0-L J12 Viral pneumonia, not elsewhere classified ICD-10
0-L J13 Pneumonia due to Streptococcus pneumoniae ICD-10
0-L J14 Pneumonia due to Haemophilus influenzae ICD-10
0-L J15 Bacterial pneumonia, not elsewhere classified ICD-10
0-L J16 Pneumonia due to other infectious organisms, not elsewhere classified ICD-10
0-L J17 Pneumonia in diseases classified elsewhere ICD-10
0-L J18 Pneumonia, organism unspecified ICD-10
0-L J20 Acute bronchitis ICD-10
0-L J21 Acute bronchiolitis ICD-10
0-L J22 Unspecified acute lower respiratory infection ICD-10
0-L J30 Vasomotor and allergic rhinitis ICD-10
0-L J31 Chronic rhinitis, nasopharyngitis and pharyngitis ICD-10
0-L J32 Chronic sinusitis ICD-10
0-L J33 Nasal polyp ICD-10
0-L J34 Other disorders of nose and nasal sinuses ICD-10
0-L J35 Chronic diseases of tonsils and adenoids ICD-10
0-L J36 Peritonsillar abscess ICD-10
0-L J37 Chronic laryngitis and laryngotracheitis ICD-10
0-L J38 Diseases of vocal cords and larynx, not elsewhere classified ICD-10
0-L J39 Other diseases of upper respiratory tract ICD-10
0-L J40 Bronchitis, not specified as acute or chronic ICD-10
0-L J41 Simple and mucopurulent chronic bronchitis ICD-10
0-L J42 Unspecified chronic bronchitis ICD-10
0-L J43 Emphysema ICD-10
0-L J44 Other chronic obstructive pulmonary disease ICD-10
0-L J45 Asthma ICD-10
0-L J46 Status asthmaticus ICD-10
0-L J47 Bronchiectasis ICD-10
0-L J60 Coalworker's pneumoconiosis ICD-10
0-L J61 Pneumoconiosis due to asbestos and other mineral fibres ICD-10
0-L J62 Pneumoconiosis due to dust containing silica ICD-10
0-L J63 Pneumoconiosis due to other inorganic dusts ICD-10
0-L J64 Unspecified pneumoconiosis ICD-10
0-L J65 Pneumoconiosis associated with tuberculosis ICD-10
0-L J66 Airway disease due to specific organic dust ICD-10
0-L J67 Hypersensitivity pneumonitis due to organic dust ICD-10
0-L J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours ICD-10
0-L J69 Pneumonitis due to solids and liquids ICD-10
0-L J70 Respiratory conditions due to other external agents ICD-10
0-L J80 Adult respiratory distress syndrome ICD-10
0-L J81 Pulmonary oedema ICD-10
0-L J82 Pulmonary eosinophilia, not elsewhere classified ICD-10
0-L J84 Other interstitial pulmonary diseases ICD-10
0-L J85 Abscess of lung and mediastinum ICD-10
0-L J86 Pyothorax ICD-10
0-L J90 Pleural effusion, not elsewhere classified ICD-10
0-L J91 Pleural effusion in conditions classified elsewhere ICD-10
0-L J92 Pleural plaque ICD-10
0-L J93 Pneumothorax ICD-10
0-L J94 Other pleural conditions ICD-10
0-L J95 Postprocedural respiratory disorders, not elsewhere classified ICD-10
0-L J96 Respiratory failure, not elsewhere classified ICD-10
0-L J98 Other respiratory disorders ICD-10
0-L J99 Respiratory disorders in diseases classified elsewhere ICD-10
0-L K00 Disorders of tooth development and eruption ICD-10
0-L K01 Embedded and impacted teeth ICD-10
0-L K02 Dental caries ICD-10
0-L K03 Other diseases of hard tissues of teeth ICD-10
0-L K04 Diseases of pulp and periapical tissues ICD-10
0-L K05 Gingivitis and periodontal diseases ICD-10
0-L K06 Other disorders of gingiva and edentulous alveolar ridge ICD-10
0-L K07 Dentofacial anomalies [including malocclusion] ICD-10
0-L K08 Other disorders of teeth and supporting structures ICD-10
0-L K09 Cysts of oral region, not elsewhere classified ICD-10
0-L K10 Other diseases of jaws ICD-10
0-L K11 Diseases of salivary glands ICD-10
0-L K12 Stomatitis and related lesions ICD-10
0-L K13 Other diseases of lip and oral mucosa ICD-10
0-L K14 Diseases of tongue ICD-10
0-L K20 Oesophagitis ICD-10
0-L K21 Gastro-oesophageal reflux disease ICD-10
0-L K22 Other diseases of oesophagus ICD-10
0-L K23 Disorders of oesophagus in diseases classified elsewhere ICD-10
0-L K25 Gastric ulcer ICD-10
0-L K26 Duodenal ulcer ICD-10
0-L K27 Peptic ulcer, site unspecified ICD-10
0-L K28 Gastrojejunal ulcer ICD-10
0-L K29 Gastritis and duodenitis ICD-10
0-L K30 Dyspepsia ICD-10
0-L K31 Other diseases of stomach and duodenum ICD-10
0-L K35 Acute appendicitis ICD-10
0-L K36 Other appendicitis ICD-10
0-L K37 Unspecified appendicitis ICD-10
0-L K38 Other diseases of appendix ICD-10
0-L K40 Inguinal hernia ICD-10
0-L K41 Femoral hernia ICD-10
0-L K42 Umbilical hernia ICD-10
0-L K43 Ventral hernia ICD-10
0-L K44 Diaphragmatic hernia ICD-10
0-L K45 Other abdominal hernia ICD-10
0-L K46 Unspecified abdominal hernia ICD-10
0-L K50 Crohn's disease [regional enteritis] ICD-10
0-L K51 Ulcerative colitis ICD-10
0-L K52 Other noninfective gastroenteritis and colitis ICD-10
0-L K55 Vascular disorders of intestine ICD-10
0-L K56 Paralytic ileus and intestinal obstruction without hernia ICD-10
0-L K57 Diverticular disease of intestine ICD-10
0-L K58 Irritable bowel syndrome ICD-10
0-L K59 Other functional intestinal disorders ICD-10
0-L K60 Fissure and fistula of anal and rectal regions ICD-10
0-L K61 Abscess of anal and rectal regions ICD-10
0-L K62 Other diseases of anus and rectum ICD-10
0-L K63 Other diseases of intestine ICD-10
0-L K65 Peritonitis ICD-10
0-L K66 Other disorders of peritoneum ICD-10
0-L K67 Disorders of peritoneum in infectious diseases classified elsewhere ICD-10
0-L K70 Alcoholic liver disease ICD-10
0-L K71 Toxic liver disease ICD-10
0-L K72 Hepatic failure, not elsewhere classified ICD-10
0-L K72.1 Chronic hepatic failure ICD-10
0-L K73 Chronic hepatitis, not elsewhere classified ICD-10
0-L K74 Fibrosis and cirrhosis of liver ICD-10
0-L K75 Other inflammatory liver diseases ICD-10
0-L K76 Other diseases of liver ICD-10
0-L K77 Liver disorders in diseases classified elsewhere ICD-10
0-L K80 Cholelithiasis ICD-10
0-L K81 Cholecystitis ICD-10
0-L K82 Other diseases of gallbladder ICD-10
0-L K83 Other diseases of biliary tract ICD-10
0-L K85 Acute pancreatitis ICD-10
0-L K86 Other diseases of pancreas ICD-10
0-L K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere ICD-10
0-L K90 Intestinal malabsorption ICD-10
0-L K91 Postprocedural disorders of digestive system, not elsewhere classified ICD-10
0-L K92 Other diseases of digestive system ICD-10
0-L K93 Disorders of other digestive organs in diseases classified elsewhere ICD-10
0-L L00 Staphylococcal scalded skin syndrome ICD-10
0-L L01 Impetigo ICD-10
0-L L02 Cutaneous abscess, furuncle and carbuncle ICD-10
0-L L03 Cellulitis ICD-10
0-L L04 Acute lymphadenitis ICD-10
0-L L05 Pilonidal cyst ICD-10
0-L L08 Other local infections of skin and subcutaneous tissue ICD-10
0-L L10 Pemphigus ICD-10
0-L L11 Other acantholytic disorders ICD-10
0-L L12 Pemphigoid ICD-10
0-L L13 Other bullous disorders ICD-10
0-L L14 Bullous disorders in diseases classified elsewhere ICD-10
0-L L20 Atopic dermatitis ICD-10
0-L L21 Seborrhoeic dermatitis ICD-10
0-L L22 Diaper [napkin] dermatitis ICD-10
0-L L23 Allergic contact dermatitis ICD-10
0-L L24 Irritant contact dermatitis ICD-10
0-L L25 Unspecified contact dermatitis ICD-10
0-L L26 Exfoliative dermatitis ICD-10
0-L L27 Dermatitis due to substances taken internally ICD-10
0-L L28 Lichen simplex chronicus and prurigo ICD-10
0-L L29 Pruritus ICD-10
0-L L30 Other dermatitis ICD-10
0-L L40 Psoriasis ICD-10
0-L L41 Parapsoriasis ICD-10
0-L L42 Pityriasis rosea ICD-10
0-L L43 Lichen planus ICD-10
0-L L44 Other papulosquamous disorders ICD-10
0-L L45 Papulosquamous disorders in diseases classified elsewhere ICD-10
0-L L50 Urticaria ICD-10
0-L L51 Erythema multiforme ICD-10
0-L L52 Erythema nodosum ICD-10
0-L L53 Other erythematous conditions ICD-10
0-L L54 Erythema in diseases classified elsewhere ICD-10
0-L L55 Sunburn ICD-10
0-L L56 Other acute skin changes due to ultraviolet radiation ICD-10
0-L L57 Skin changes due to chronic exposure to nonionizing radiation ICD-10
0-L L58 Radiodermatitis ICD-10
0-L L59 Other disorders of skin and subcutaneous tissue related to radiation ICD-10
0-L L60 Nail disorders ICD-10
0-L L62 Nail disorders in diseases classified elsewhere ICD-10
0-L L63 Alopecia areata ICD-10
0-L L64 Androgenic alopecia ICD-10
0-L L65 Other nonscarring hair loss ICD-10
0-L L66 Cicatricial alopecia [scarring hair loss] ICD-10
0-L L67 Hair colour and hair shaft abnormalities ICD-10
0-L L68 Hypertrichosis ICD-10
0-L L70 Acne ICD-10
0-L L71 Rosacea ICD-10
0-L L72 Follicular cysts of skin and subcutaneous tissue ICD-10
0-L L73 Other follicular disorders ICD-10
0-L L74 Eccrine sweat disorders ICD-10
0-L L75 Apocrine sweat disorders ICD-10
0-L L80 Vitiligo ICD-10
0-L L81 Other disorders of pigmentation ICD-10
0-L L82 Seborrhoeic keratosis ICD-10
0-L L83 Acanthosis nigricans ICD-10
0-L L84 Corns and callosities ICD-10
0-L L85 Other epidermal thickening ICD-10
0-L L86 Keratoderma in diseases classified elsewhere ICD-10
0-L L87 Transepidermal elimination disorders ICD-10
0-L L88 Pyoderma gangrenosum ICD-10
0-L L89 Decubitus ulcer ICD-10
0-L L90 Atrophic disorders of skin ICD-10
0-L L91 Hypertrophic disorders of skin ICD-10
0-L L92 Granulomatous disorders of skin and subcutaneous tissue ICD-10
0-L L93 Lupus erythematosus ICD-10
0-L L94 Other localized connective tissue disorders ICD-10
0-L L95 Vasculitis limited to skin, not elsewhere classified ICD-10
0-L L97 Ulcer of lower limb, not elsewhere classified ICD-10
0-L L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified ICD-10
0-L L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere ICD-10
0-L M00 Pyogenic arthritis ICD-10
0-L M01 Direct infections of joint in infectious and parasitic diseases classified elsewhere ICD-10
0-L M02 Reactive arthropathies ICD-10
0-L M03 Postinfective and reactive arthropathies in diseases classified elsewhere ICD-10
0-L M05 Seropositive rheumatoid arthritis ICD-10
0-L M06 Other rheumatoid arthritis ICD-10
0-L M07 Psoriatic and enteropathic arthropathies ICD-10
0-L M08 Juvenile arthritis ICD-10
0-L M09 Juvenile arthritis in diseases classified elsewhere ICD-10
0-L M10 Gout ICD-10
0-L M11 Other crystal arthropathies ICD-10
0-L M12 Other specific arthropathies ICD-10
0-L M13 Other arthritis ICD-10
0-L M14 Arthropathies in other diseases classified elsewhere ICD-10
0-L M15 Polyarthrosis ICD-10
0-L M16 Coxarthrosis [arthrosis of hip] ICD-10
0-L M17 Gonarthrosis [arthrosis of knee] ICD-10
0-L M18 Arthrosis of first carpometacarpal joint ICD-10
0-L M19 Other arthrosis ICD-10
0-L M20 Acquired deformities of fingers and toes ICD-10
0-L M21 Other acquired deformities of limbs ICD-10
0-L M22 Disorders of patella ICD-10
0-L M23 Internal derangement of knee ICD-10
0-L M24 Other specific joint derangements ICD-10
0-L M25 Other joint disorders, not elsewhere classified ICD-10
0-L M30 Polyarteritis nodosa and related conditions ICD-10
0-L M31 Other necrotizing vasculopathies ICD-10
0-L M32 Systemic lupus erythematosus ICD-10
0-L M33 Dermatopolymyositis ICD-10
0-L M34 Systemic sclerosis ICD-10
0-L M35 Other systemic involvement of connective tissue ICD-10
0-L M36 Systemic disorders of connective tissue in diseases classified elsewhere ICD-10
0-L M40 Kyphosis and lordosis ICD-10
0-L M41 Scoliosis ICD-10
0-L M42 Spinal osteochondrosis ICD-10
0-L M43 Other deforming dorsopathies ICD-10
0-L M45 Ankylosing spondylitis ICD-10
0-L M46 Other inflammatory spondylopathies ICD-10
0-L M47 Spondylosis ICD-10
0-L M48 Other spondylopathies ICD-10
0-L M49 Spondylopathies in diseases classified elsewhere ICD-10
0-L M50 Cervical disc disorders ICD-10
0-L M51 Other intervertebral disc disorders ICD-10
0-L M53 Other dorsopathies, not elsewhere classified ICD-10
0-L M54 Dorsalgia ICD-10
0-L M60 Myositis ICD-10
0-L M61 Calcification and ossification of muscle ICD-10
0-L M62 Other disorders of muscle ICD-10
0-L M63 Disorders of muscle in diseases classified elsewhere ICD-10
0-L M65 Synovitis and tenosynovitis ICD-10
0-L M66 Spontaneous rupture of synovium and tendon ICD-10
0-L M67 Other disorders of synovium and tendon ICD-10
0-L M68 Disorders of synovium and tendon in diseases classified elsewhere ICD-10
0-L M70 Soft tissue disorders related to use, overuse and pressure ICD-10
0-L M71 Other bursopathies ICD-10
0-L M72 Fibroblastic disorders ICD-10
0-L M73 Soft tissue disorders in diseases classified elsewhere ICD-10
0-L M75 Shoulder lesions ICD-10
0-L M76 Enthesopathies of lower limb, excluding foot ICD-10
0-L M77 Other enthesopathies ICD-10
0-L M79 Other soft tissue disorders, not elsewhere classified ICD-10
0-L M80 Osteoporosis with pathological fracture ICD-10
0-L M81 Osteoporosis without pathological fracture ICD-10
0-L M82 Osteoporosis in diseases classified elsewhere ICD-10
0-L M83 Adult osteomalacia ICD-10
0-L M84 Disorders of continuity of bone ICD-10
0-L M85 Other disorders of bone density and structure ICD-10
0-L M86 Osteomyelitis ICD-10
0-L M87 Osteonecrosis ICD-10
0-L M88 Paget's disease of bone [osteitis deformans] ICD-10
0-L M89 Other disorders of bone ICD-10
0-L M90 Osteopathies in diseases classified elsewhere ICD-10
0-L M91 Juvenile osteochondrosis of hip and pelvis ICD-10
0-L M92 Other juvenile osteochondrosis ICD-10
0-L M93 Other osteochondropathies ICD-10
0-L M94 Other disorders of cartilage ICD-10
0-L M95 Other acquired deformities of musculoskeletal system and connective tissue ICD-10
0-L M96 Postprocedural musculoskeletal disorders, not elsewhere classified ICD-10
0-L M99 Biomechanical lesions, not elsewhere classified ICD-10
0-L N00 Acute nephritic syndrome ICD-10
0-L N01 Rapidly progressive nephritic syndrome ICD-10
0-L N02 Recurrent and persistent haematuria ICD-10
0-L N03 Chronic nephritic syndrome ICD-10
0-L N04 Nephrotic syndrome ICD-10
0-L N05 Unspecified nephritic syndrome ICD-10
0-L N06 Isolated proteinuria with specified morphological lesion ICD-10
0-L N07 Hereditary nephropathy, not elsewhere classified ICD-10
0-L N08 Glomerular disorders in diseases classified elsewhere ICD-10
0-L N10 Acute tubulo-interstitial nephritis ICD-10
0-L N11 Chronic tubulo-interstitial nephritis ICD-10
0-L N12 Tubulo-interstitial nephritis, not specified as acute or chronic ICD-10
0-L N13 Obstructive and reflux uropathy ICD-10
0-L N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions ICD-10
0-L N15 Other renal tubulo-interstitial diseases ICD-10
0-L N16 Renal tubulo-interstitial disorders in diseases classified elsewhere ICD-10
0-L N17 Acute renal failure ICD-10
0-L N18 Chronic renal failure ICD-10
0-L N19 Unspecified renal failure ICD-10
0-L N20 Calculus of kidney and ureter ICD-10
0-L N21 Calculus of lower urinary tract ICD-10
0-L N22 Calculus of urinary tract in diseases classified elsewhere ICD-10
0-L N23 Unspecified renal colic ICD-10
0-L N25 Disorders resulting from impaired renal tubular function ICD-10
0-L N26 Unspecified contracted kidney ICD-10
0-L N27 Small kidney of unknown cause ICD-10
0-L N28 Other disorders of kidney and ureter, not elsewhere classified ICD-10
0-L N29 Other disorders of kidney and ureter in diseases classified elsewhere ICD-10
0-L N30 Cystitis ICD-10
0-L N31 Neuromuscular dysfunction of bladder, not elsewhere classified ICD-10
0-L N32 Other disorders of bladder ICD-10
0-L N33 Bladder disorders in diseases classified elsewhere ICD-10
0-L N34 Urethritis and urethral syndrome ICD-10
0-L N35 Urethral stricture ICD-10
0-L N36 Other disorders of urethra ICD-10
0-L N37 Urethral disorders in diseases classified elsewhere ICD-10
0-L N39 Other disorders of urinary system ICD-10
0-L N40 Hyperplasia of prostate ICD-10
0-L N41 Inflammatory diseases of prostate ICD-10
0-L N42 Other disorders of prostate ICD-10
0-L N43 Hydrocele and spermatocele ICD-10
0-L N44 Torsion of testis ICD-10
0-L N45 Orchitis and epididymitis ICD-10
0-L N46 Male infertility ICD-10
0-L N47 Redundant prepuce, phimosis and paraphimosis ICD-10
0-L N48 Other disorders of penis ICD-10
0-L N49 Inflammatory disorders of male genital organs, not elsewhere classified ICD-10
0-L N50 Other disorders of male genital organs ICD-10
0-L N51 Disorders of male genital organs in diseases classified elsewhere ICD-10
0-L N60 Benign mammary dysplasia ICD-10
0-L N61 Inflammatory disorders of breast ICD-10
0-L N62 Hypertrophy of breast ICD-10
0-L N63 Unspecified lump in breast ICD-10
0-L N64 Other disorders of breast ICD-10
0-L N70 Salpingitis and oophoritis ICD-10
0-L N71 Inflammatory disease of uterus, except cervix ICD-10
0-L N72 Inflammatory disease of cervix uteri ICD-10
0-L N73 Other female pelvic inflammatory diseases ICD-10
0-L N74 Female pelvic inflammatory disorders in diseases classified elsewhere ICD-10
0-L N75 Diseases of Bartholin's gland ICD-10
0-L N76 Other inflammation of vagina and vulva ICD-10
0-L N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere ICD-10
0-L N80 Endometriosis ICD-10
0-L N81 Female genital prolapse ICD-10
0-L N82 Fistulae involving female genital tract ICD-10
0-L N83 Noninflammatory disorders of ovary, fallopian tube and broad ligament ICD-10
0-L N84 Polyp of female genital tract ICD-10
0-L N85 Other noninflammatory disorders of uterus, except cervix ICD-10
0-L N86 Erosion and ectropion of cervix uteri ICD-10
0-L N87 Dysplasia of cervix uteri ICD-10
0-L N88 Other noninflammatory disorders of cervix uteri ICD-10
0-L N89 Other noninflammatory disorders of vagina ICD-10
0-L N90 Other noninflammatory disorders of vulva and perineum ICD-10
0-L N91 Absent, scanty and rare menstruation ICD-10
0-L N92 Excessive, frequent and irregular menstruation ICD-10
0-L N93 Other abnormal uterine and vaginal bleeding ICD-10
0-L N94 Pain and other conditions associated with female genital organs and menstrual cycle ICD-10
0-L N95 Menopausal and other perimenopausal disorders ICD-10
0-L N96 Habitual aborter ICD-10
0-L N97 Female infertility ICD-10
0-L N98 Complications associated with artificial fertilization ICD-10
0-L N99 Postprocedural disorders of genitourinary system, not elsewhere classified ICD-10
0-L O00 Ectopic pregnancy ICD-10
0-L O01 Hydatidiform mole ICD-10
0-L O02 Other abnormal products of conception ICD-10
0-L O03 Spontaneous abortion ICD-10
0-L O04 Medical abortion ICD-10
0-L O05 Other abortion ICD-10
0-L O06 Unspecified abortion ICD-10
0-L O07 Failed attempted abortion ICD-10
0-L O08 Complications following abortion and ectopic and molar pregnancy ICD-10
0-L O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium ICD-10
0-L O11 Pre-existing hypertensive disorder with superimposed proteinuria ICD-10
0-L O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension ICD-10
0-L O13 Gestational [pregnancy-induced] hypertension without significant proteinuria ICD-10
0-L O14 Gestational [pregnancy-induced] hypertension with significant proteinuria ICD-10
0-L O15 Eclampsia ICD-10
0-L O16 Unspecified maternal hypertension ICD-10
0-L O20 Haemorrhage in early pregnancy ICD-10
0-L O21 Excessive vomiting in pregnancy ICD-10
0-L O22 Venous complications in pregnancy ICD-10
0-L O23 Infections of genitourinary tract in pregnancy ICD-10
0-L O24 Diabetes mellitus in pregnancy ICD-10
0-L O25 Malnutrition in pregnancy ICD-10
0-L O26 Maternal care for other conditions predominantly related to pregnancy ICD-10
0-L O28 Abnormal findings on antenatal screening of mother ICD-10
0-L O29 Complications of anaesthesia during pregnancy ICD-10
0-L O30 Multiple gestation ICD-10
0-L O31 Complications specific to multiple gestation ICD-10
0-L O32 Maternal care for known or suspected malpresentation of fetus ICD-10
0-L O33 Maternal care for known or suspected disproportion ICD-10
0-L O34 Maternal care for known or suspected abnormality of pelvic organs ICD-10
0-L O35 Maternal care for known or suspected fetal abnormality and damage ICD-10
0-L O36 Maternal care for other known or suspected fetal problems ICD-10
0-L O40 Polyhydramnios ICD-10
0-L O41 Other disorders of amniotic fluid and membranes ICD-10
0-L O42 Premature rupture of membranes ICD-10
0-L O43 Placental disorders ICD-10
0-L O44 Placenta praevia ICD-10
0-L O45 Premature separation of placenta [abruptio placentae] ICD-10
0-L O46 Antepartum haemorrhage, not elsewhere classified ICD-10
0-L O47 False labour ICD-10
0-L O48 Prolonged pregnancy ICD-10
0-L O60 Preterm labour ICD-10
0-L O61 Failed induction of labour ICD-10
0-L O62 Abnormalities of forces of labour ICD-10
0-L O63 Long labour ICD-10
0-L O64 Obstructed labour due to malposition and malpresentation of fetus ICD-10
0-L O65 Obstructed labour due to maternal pelvic abnormality ICD-10
0-L O66 Other obstructed labour ICD-10
0-L O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified ICD-10
0-L O68 Labour and delivery complicated by fetal stress [distress] ICD-10
0-L O69 Labour and delivery complicated by umbilical cord complications ICD-10
0-L O70 Perineal laceration during delivery ICD-10
0-L O71 Other obstetric trauma ICD-10
0-L O72 Postpartum haemorrhage ICD-10
0-L O73 Retained placenta and membranes, without haemorrhage ICD-10
0-L O74 Complications of anaesthesia during labour and delivery ICD-10
0-L O75 Other complications of labour and delivery, not elsewhere classified ICD-10
0-L O80 Single spontaneous delivery ICD-10
0-L O81 Single delivery by forceps and vacuum extractor ICD-10
0-L O82 Single delivery by caesarean section ICD-10
0-L O83 Other assisted single delivery ICD-10
0-L O84 Multiple delivery ICD-10
0-L O85 Puerperal sepsis ICD-10
0-L O86 Other puerperal infections ICD-10
0-L O87 Venous complications in the puerperium ICD-10
0-L O88 Obstetric embolism ICD-10
0-L O89 Complications of anaesthesia during the puerperium ICD-10
0-L O90 Complications of the puerperium, not elsewhere classified ICD-10
0-L O91 Infections of breast associated with childbirth ICD-10
0-L O92 Other disorders of breast and lactation associated with childbirth ICD-10
0-L O94 Sequelae of complication of pregnancy, childbirth and the puerperium ICD-10
0-L O95 Obstetric death of unspecified cause ICD-10
0-L O96 Death from any obstetric cause occurring more than 42 days but less than one year after delivery ICD-10
0-L O97 Death from sequelae of direct obstetric causes ICD-10
0-L O98 Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium ICD-10
0-L O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium ICD-10
0-L P00 Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy ICD-10
0-L P01 Fetus and newborn affected by maternal complications of pregnancy ICD-10
0-L P02 Fetus and newborn affected by complications of placenta, cord and membranes ICD-10
0-L P03 Fetus and newborn affected by other complications of labour and delivery ICD-10
0-L P04 Fetus and newborn affected by noxious influences transmitted via placenta or breast milk ICD-10
0-L P05 Slow fetal growth and fetal malnutrition ICD-10
0-L P07 Disorders related to short gestation and low birth weight, not elsewhere classified ICD-10
0-L P08 Disorders related to long gestation and high birth weight ICD-10
0-L P10 Intracranial laceration and haemorrhage due to birth injury ICD-10
0-L P11 Other birth injuries to central nervous system ICD-10
0-L P12 Birth injury to scalp ICD-10
0-L P13 Birth injury to skeleton ICD-10
0-L P14 Birth injury to peripheral nervous system ICD-10
0-L P15 Other birth injuries ICD-10
0-L P20 Intrauterine hypoxia ICD-10
0-L P21 Birth asphyxia ICD-10
0-L P22 Respiratory distress of newborn ICD-10
0-L P23 Congenital pneumonia ICD-10
0-L P24 Neonatal aspiration syndromes ICD-10
0-L P25 Interstitial emphysema and related conditions originating in the perinatal period ICD-10
0-L P26 Pulmonary haemorrhage originating in the perinatal period ICD-10
0-L P27 Chronic respiratory disease originating in the perinatal period ICD-10
0-L P28 Other respiratory conditions originating in the perinatal period ICD-10
0-L P29 Cardiovascular disorders originating in the perinatal period ICD-10
0-L P35 Congenital viral diseases ICD-10
0-L P36 Bacterial sepsis of newborn ICD-10
0-L P37 Other congenital infectious and parasitic diseases ICD-10
0-L P38 Omphalitis of newborn with or without mild haemorrhage ICD-10
0-L P39 Other infections specific to the perinatal period ICD-10
0-L P50 Fetal blood loss ICD-10
0-L P51 Umbilical haemorrhage of newborn ICD-10
0-L P52 Intracranial nontraumatic haemorrhage of fetus and newborn ICD-10
0-L P53 Haemorrhagic disease of fetus and newborn ICD-10
0-L P54 Other neonatal haemorrhages ICD-10
0-L P55 Haemolytic disease of fetus and newborn ICD-10
0-L P56 Hydrops fetalis due to haemolytic disease ICD-10
0-L P57 Kernicterus ICD-10
0-L P58 Neonatal jaundice due to other excessive haemolysis ICD-10
0-L P59 Neonatal jaundice from other and unspecified causes ICD-10
0-L P60 Disseminated intravascular coagulation of fetus and newborn ICD-10
0-L P61 Other perinatal haematological disorders ICD-10
0-L P70 Transitory disorders of carbohydrate metabolism specific to fetus and newborn ICD-10
0-L P71 Transitory neonatal disorders of calcium and magnesium metabolism ICD-10
0-L P72 Other transitory neonatal endocrine disorders ICD-10
0-L P74 Other transitory neonatal electrolyte and metabolic disturbances ICD-10
0-L P75 Meconium ileus ICD-10
0-L P76 Other intestinal obstruction of newborn ICD-10
0-L P77 Necrotizing enterocolitis of fetus and newborn ICD-10
0-L P78 Other perinatal digestive system disorders ICD-10
0-L P80 Hypothermia of newborn ICD-10
0-L P81 Other disturbances of temperature regulation of newborn ICD-10
0-L P83 Other conditions of integument specific to fetus and newborn ICD-10
0-L P90 Convulsions of newborn ICD-10
0-L P91 Other disturbances of cerebral status of newborn ICD-10
0-L P92 Feeding problems of newborn ICD-10
0-L P93 Reactions and intoxications due to drugs administered to fetus and newborn ICD-10
0-L P94 Disorders of muscle tone of newborn ICD-10
0-L P95 Fetal death of unspecified cause ICD-10
0-L P96 Other conditions originating in the perinatal period ICD-10
0-L Q00 Anencephaly and similar malformations ICD-10
0-L Q01 Encephalocele ICD-10
0-L Q02 Microcephaly ICD-10
0-L Q03 Congenital hydrocephalus ICD-10
0-L Q04 Other congenital malformations of brain ICD-10
0-L Q05 Spina bifida ICD-10
0-L Q06 Other congenital malformations of spinal cord ICD-10
0-L Q07 Other congenital malformations of nervous system ICD-10
0-L Q10 Congenital malformations of eyelid, lacrimal apparatus and orbit ICD-10
0-L Q11 Anophthalmos, microphthalmos and macrophthalmos ICD-10
0-L Q12 Congenital lens malformations ICD-10
0-L Q13 Congenital malformations of anterior segment of eye ICD-10
0-L Q14 Congenital malformations of posterior segment of eye ICD-10
0-L Q15 Other congenital malformations of eye ICD-10
0-L Q16 Congenital malformations of ear causing impairment of hearing ICD-10
0-L Q17 Other congenital malformations of ear ICD-10
0-L Q18 Other congenital malformations of face and neck ICD-10
0-L Q20 Congenital malformations of cardiac chambers and connections ICD-10
0-L Q21 Congenital malformations of cardiac septa ICD-10
0-L Q22 Congenital malformations of pulmonary and tricuspid valves ICD-10
0-L Q23 Congenital malformations of aortic and mitral valves ICD-10
0-L Q24 Other congenital malformations of heart ICD-10
0-L Q25 Congenital malformations of great arteries ICD-10
0-L Q26 Congenital malformations of great veins ICD-10
0-L Q27 Other congenital malformations of peripheral vascular system ICD-10
0-L Q28 Other congenital malformations of circulatory system ICD-10
0-L Q30 Congenital malformations of nose ICD-10
0-L Q31 Congenital malformations of larynx ICD-10
0-L Q32 Congenital malformations of trachea and bronchus ICD-10
0-L Q33 Congenital malformations of lung ICD-10
0-L Q34 Other congenital malformations of respiratory system ICD-10
0-L Q35 Cleft palate ICD-10
0-L Q36 Cleft lip ICD-10
0-L Q37 Cleft palate with cleft lip ICD-10
0-L Q38 Other congenital malformations of tongue, mouth and pharynx ICD-10
0-L Q39 Congenital malformations of oesophagus ICD-10
0-L Q40 Other congenital malformations of upper alimentary tract ICD-10
0-L Q41 Congenital absence, atresia and stenosis of small intestine ICD-10
0-L Q42 Congenital absence, atresia and stenosis of large intestine ICD-10
0-L Q43 Other congenital malformations of intestine ICD-10
0-L Q44 Congenital malformations of gallbladder, bile ducts and liver ICD-10
0-L Q45 Other congenital malformations of digestive system ICD-10
0-L Q50 Congenital malformations of ovaries, fallopian tubes and broad ligaments ICD-10
0-L Q51 Congenital malformations of uterus and cervix ICD-10
0-L Q52 Other congenital malformations of female genitalia ICD-10
0-L Q53 Undescended testicle ICD-10
0-L Q54 Hypospadias ICD-10
0-L Q55 Other congenital malformations of male genital organs ICD-10
0-L Q56 Indeterminate sex and pseudohermaphroditism ICD-10
0-L Q60 Renal agenesis and other reduction defects of kidney ICD-10
0-L Q61 Cystic kidney disease ICD-10
0-L Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter ICD-10
0-L Q63 Other congenital malformations of kidney ICD-10
0-L Q64 Other congenital malformations of urinary system ICD-10
0-L Q65 Congenital deformities of hip ICD-10
0-L Q66 Congenital deformities of feet ICD-10
0-L Q67 Congenital musculoskeletal deformities of head, face, spine and chest ICD-10
0-L Q68 Other congenital musculoskeletal deformities ICD-10
0-L Q69 Polydactyly ICD-10
0-L Q70 Syndactyly ICD-10
0-L Q71 Reduction defects of upper limb ICD-10
0-L Q72 Reduction defects of lower limb ICD-10
0-L Q73 Reduction defects of unspecified limb ICD-10
0-L Q74 Other congenital malformations of limb(s) ICD-10
0-L Q75 Other congenital malformations of skull and face bones ICD-10
0-L Q76 Congenital malformations of spine and bony thorax ICD-10
0-L Q77 Osteochondrodysplasia with defects of growth of tubular bones and spine ICD-10
0-L Q78 Other osteochondrodysplasias ICD-10
0-L Q79 Congenital malformations of the musculoskeletal system, not elsewhere classified ICD-10
0-L Q80 Congenital ichthyosis ICD-10
0-L Q81 Epidermolysis bullosa ICD-10
0-L Q82 Other congenital malformations of skin ICD-10
0-L Q83 Congenital malformations of breast ICD-10
0-L Q84 Other congenital malformations of integument ICD-10
0-L Q85 Phakomatoses, not elsewhere classified ICD-10
0-L Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified ICD-10
0-L Q87 Other specified congenital malformation syndromes affecting multiple systems ICD-10
0-L Q89 Other congenital malformations, not elsewhere classified ICD-10
0-L Q90 Down's syndrome ICD-10
0-L Q91 Edwards' syndrome and Patau's syndrome ICD-10
0-L Q92 Other trisomies and partial trisomies of the autosomes, not elsewhere classified ICD-10
0-L Q93 Monosomies and deletions from the autosomes, not elsewhere classified ICD-10
0-L Q95 Balanced rearrangements and structural markers, not elsewhere classified ICD-10
0-L Q96 Turner's syndrome ICD-10
0-L Q97 Other sex chromosome abnormalities, female phenotype, not elsewhere classified ICD-10
0-L Q98 Other sex chromosome abnormalities, male phenotype, not elsewhere classified ICD-10
0-L Q99 Other chromosome abnormalities, not elsewhere classified ICD-10
0-L R00 Abnormalities of heart beat ICD-10
0-L R01 Cardiac murmurs and other cardiac sounds ICD-10
0-L R02 Gangrene, not elsewhere classified ICD-10
0-L R03 Abnormal blood-pressure reading, without diagnosis ICD-10
0-L R04 Haemorrhage from respiratory passages ICD-10
0-L R05 Cough ICD-10
0-L R06 Abnormalities of breathing ICD-10
0-L R07 Pain in throat and chest ICD-10
0-L R09 Other symptoms and signs involving the circulatory and respiratory systems ICD-10
0-L R10 Abdominal and pelvic pain ICD-10
0-L R11 Nausea and vomiting ICD-10
0-L R12 Heartburn ICD-10
0-L R13 Dysphagia ICD-10
0-L R14 Flatulence and related conditions ICD-10
0-L R15 Faecal incontinence ICD-10
0-L R16 Hepatomegaly and splenomegaly, not elsewhere classified ICD-10
0-L R17 Unspecified jaundice ICD-10
0-L R18 Ascites ICD-10
0-L R19 Other symptoms and signs involving the digestive system and abdomen ICD-10
0-L R20 Disturbances of skin sensation ICD-10
0-L R21 Rash and other nonspecific skin eruption ICD-10
0-L R22 Localized swelling, mass and lump of skin and subcutaneous tissue ICD-10
0-L R23 Other skin changes ICD-10
0-L R25 Abnormal involuntary movements ICD-10
0-L R26 Abnormalities of gait and mobility ICD-10
0-L R27 Other lack of coordination ICD-10
0-L R29 Other symptoms and signs involving the nervous and musculoskeletal systems ICD-10
0-L R30 Pain associated with micturition ICD-10
0-L R31 Unspecified haematuria ICD-10
0-L R32 Unspecified urinary incontinence ICD-10
0-L R33 Retention of urine ICD-10
0-L R34 Anuria and oliguria ICD-10
0-L R35 Polyuria ICD-10
0-L R36 Urethral discharge ICD-10
0-L R39 Other symptoms and signs involving the urinary system ICD-10
0-L R40 Somnolence, stupor and coma ICD-10
0-L R41 Other symptoms and signs involving cognitive functions and awareness ICD-10
0-L R42 Dizziness and giddiness ICD-10
0-L R43 Disturbances of smell and taste ICD-10
0-L R44 Other symptoms and signs involving general sensations and perceptions ICD-10
0-L R45 Symptoms and signs involving emotional state ICD-10
0-L R46 Symptoms and signs involving appearance and behaviour ICD-10
0-L R47 Speech disturbances, not elsewhere classified ICD-10
0-L R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified ICD-10
0-L R49 Voice disturbances ICD-10
0-L R50 Fever of other and unknown origin ICD-10
0-L R51 Headache ICD-10
0-L R52 Pain, not elsewhere classified ICD-10
0-L R53 Malaise and fatigue ICD-10
0-L R54 Senility ICD-10
0-L R55 Syncope and collapse ICD-10
0-L R56 Convulsions, not elsewhere classified ICD-10
0-L R57 Shock, not elsewhere classified ICD-10
0-L R58 Haemorrhage, not elsewhere classified ICD-10
0-L R59 Enlarged lymph nodes ICD-10
0-L R60 Oedema, not elsewhere classified ICD-10
0-L R61 Hyperhidrosis ICD-10
0-L R62 Lack of expected normal physiological development ICD-10
0-L R63 Symptoms and signs concerning food and fluid intake ICD-10
0-L R64 Cachexia ICD-10
0-L R68 Other general symptoms and signs ICD-10
0-L R69 Unknown and unspecified causes of morbidity ICD-10
0-L R70 Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity ICD-10
0-L R71 Abnormality of red blood cells ICD-10
0-L R72 Abnormality of white blood cells, not elsewhere classified ICD-10
0-L R73 Elevated blood glucose level ICD-10
0-L R74 Abnormal serum enzyme levels ICD-10
0-L R75 Laboratory evidence of human immunodeficiency virus [HIV] ICD-10
0-L R76 Other abnormal immunological findings in serum ICD-10
0-L R77 Other abnormalities of plasma proteins ICD-10
0-L R78 Findings of drugs and other substances, not normally found in blood ICD-10
0-L R79 Other abnormal findings of blood chemistry ICD-10
0-L R80 Isolated proteinuria ICD-10
0-L R81 Glycosuria ICD-10
0-L R82 Other abnormal findings in urine ICD-10
0-L R83 Abnormal findings in cerebrospinal fluid ICD-10
0-L R84 Abnormal findings in specimens from respiratory organs and thorax ICD-10
0-L R85 Abnormal findings in specimens from digestive organs and abdominal cavity ICD-10
0-L R86 Abnormal findings in specimens from male genital organs ICD-10
0-L R87 Abnormal findings in specimens from female genital organs ICD-10
0-L R89 Abnormal findings in specimens from other organs, systems and tissues ICD-10
0-L R90 Abnormal findings on diagnostic imaging of central nervous system ICD-10
0-L R91 Abnormal findings on diagnostic imaging of lung ICD-10
0-L R92 Abnormal findings on diagnostic imaging of breast ICD-10
0-L R93 Abnormal findings on diagnostic imaging of other body structures ICD-10
0-L R94 Abnormal results of function studies ICD-10
0-L R95 Sudden infant death syndrome ICD-10
0-L R96 Other sudden death, cause unknown ICD-10
0-L R98 Unattended death ICD-10
0-L R99 Other ill-defined and unspecified causes of mortality ICD-10
0-L S00 Superficial injury of head ICD-10
0-L S01 Open wound of head ICD-10
0-L S02 Fracture of skull and facial bones ICD-10
0-L S03 Dislocation, sprain and strain of joints and ligaments of head ICD-10
0-L S04 Injury of cranial nerves ICD-10
0-L S05 Injury of eye and orbit ICD-10
0-L S06 Intracranial injury ICD-10
0-L S07 Crushing injury of head ICD-10
0-L S08 Traumatic amputation of part of head ICD-10
0-L S09 Other and unspecified injuries of head ICD-10
0-L S10 Superficial injury of neck ICD-10
0-L S11 Open wound of neck ICD-10
0-L S12 Fracture of neck ICD-10
0-L S13 Dislocation, sprain and strain of joints and ligaments at neck level ICD-10
0-L S14 Injury of nerves and spinal cord at neck level ICD-10
0-L S15 Injury of blood vessels at neck level ICD-10
0-L S16 Injury of muscle and tendon at neck level ICD-10
0-L S17 Crushing injury of neck ICD-10
0-L S18 Traumatic amputation at neck level ICD-10
0-L S19 Other and unspecified injuries of neck ICD-10
0-L S20 Superficial injury of thorax ICD-10
0-L S21 Open wound of thorax ICD-10
0-L S22 Fracture of rib(s), sternum and thoracic spine ICD-10
0-L S23 Dislocation, sprain and strain of joints and ligaments of thorax ICD-10
0-L S24 Injury of nerves and spinal cord at thorax level ICD-10
0-L S25 Injury of blood vessels of thorax ICD-10
0-L S26 Injury of heart ICD-10
0-L S27 Injury of other and unspecified intrathoracic organs ICD-10
0-L S28 Crushing injury of thorax and traumatic amputation of part of thorax ICD-10
0-L S29 Other and unspecified injuries of thorax ICD-10
0-L S30 Superficial injury of abdomen, lower back and pelvis ICD-10
0-L S31 Open wound of abdomen, lower back and pelvis ICD-10
0-L S32 Fracture of lumbar spine and pelvis ICD-10
0-L S33 Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis ICD-10
0-L S34 Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level ICD-10
0-L S35 Injury of blood vessels at abdomen, lower back and pelvis level ICD-10
0-L S36 Injury of intra-abdominal organs ICD-10
0-L S37 Injury of urinary and pelvic organs ICD-10
0-L S38 Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis ICD-10
0-L S39 Other and unspecified injuries of abdomen, lower back and pelvis ICD-10
0-L S40 Superficial injury of shoulder and upper arm ICD-10
0-L S41 Open wound of shoulder and upper arm ICD-10
0-L S42 Fracture of shoulder and upper arm ICD-10
0-L S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle ICD-10
0-L S44 Injury of nerves at shoulder and upper arm level ICD-10
0-L S45 Injury of blood vessels at shoulder and upper arm level ICD-10
0-L S46 Injury of muscle and tendon at shoulder and upper arm level ICD-10
0-L S47 Crushing injury of shoulder and upper arm ICD-10
0-L S48 Traumatic amputation of shoulder and upper arm ICD-10
0-L S49 Other and unspecified injuries of shoulder and upper arm ICD-10
0-L S50 Superficial injury of forearm ICD-10
0-L S51 Open wound of forearm ICD-10
0-L S52 Fracture of forearm ICD-10
0-L S53 Dislocation, sprain and strain of joints and ligaments of elbow ICD-10
0-L S54 Injury of nerves at forearm level ICD-10
0-L S55 Injury of blood vessels at forearm level ICD-10
0-L S56 Injury of muscle and tendon at forearm level ICD-10
0-L S57 Crushing injury of forearm ICD-10
0-L S58 Traumatic amputation of forearm ICD-10
0-L S59 Other and unspecified injuries of forearm ICD-10
0-L S60 Superficial injury of wrist and hand ICD-10
0-L S61 Open wound of wrist and hand ICD-10
0-L S62 Fracture at wrist and hand level ICD-10
0-L S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level ICD-10
0-L S64 Injury of nerves at wrist and hand level ICD-10
0-L S65 Injury of blood vessels at wrist and hand level ICD-10
0-L S66 Injury of muscle and tendon at wrist and hand level ICD-10
0-L S67 Crushing injury of wrist and hand ICD-10
0-L S68 Traumatic amputation of wrist and hand ICD-10
0-L S69 Other and unspecified injuries of wrist and hand ICD-10
0-L S70 Superficial injury of hip and thigh ICD-10
0-L S71 Open wound of hip and thigh ICD-10
0-L S72 Fracture of femur ICD-10
0-L S73 Dislocation, sprain and strain of joint and ligaments of hip ICD-10
0-L S74 Injury of nerves at hip and thigh level ICD-10
0-L S75 Injury of blood vessels at hip and thigh level ICD-10
0-L S76 Injury of muscle and tendon at hip and thigh level ICD-10
0-L S77 Crushing injury of hip and thigh ICD-10
0-L S78 Traumatic amputation of hip and thigh ICD-10
0-L S79 Other and specified injuries of hip and thigh ICD-10
0-L S80 Superficial injury of lower leg ICD-10
0-L S81 Open wound of lower leg ICD-10
0-L S82 Fracture of lower leg, including ankle ICD-10
0-L S83 Dislocation, sprain and strain of joints and ligaments of knee ICD-10
0-L S84 Injury of nerves at lower leg level ICD-10
0-L S85 Injury of blood vessels at lower leg level ICD-10
0-L S86 Injury of muscle and tendon at lower leg level ICD-10
0-L S87 Crushing injury of lower leg ICD-10
0-L S88 Traumatic amputation of lower leg ICD-10
0-L S89 Other and unspecified injuries of lower leg ICD-10
0-L S90 Superficial injury of ankle and foot ICD-10
0-L S91 Open wound of ankle and foot ICD-10
0-L S92 Fracture of foot, except ankle ICD-10
0-L S93 Dislocation, sprain and strain of joints and ligaments at ankle and foot level ICD-10
0-L S94 Injury of nerves at ankle and foot level ICD-10
0-L S95 Injury of blood vessels at ankle and foot level ICD-10
0-L S96 Injury of muscle and tendon at ankle and foot level ICD-10
0-L S97 Crushing injury of ankle and foot ICD-10
0-L S98 Traumatic amputation of ankle and foot ICD-10
0-L S99 Other and unspecified injuries of ankle and foot ICD-10
0-L T00 Superficial injuries involving multiple body regions ICD-10
0-L T01 Open wounds involving multiple body regions ICD-10
0-L T02 Fractures involving multiple body regions ICD-10
0-L T03 Dislocations, sprains and strains involving multiple body regions ICD-10
0-L T04 Crushing injuries involving multiple body regions ICD-10
0-L T05 Traumatic amputations involving multiple body regions ICD-10
0-L T06 Other injuries involving multiple body regions, not elsewhere classified ICD-10
0-L T07 Unspecified multiple injuries ICD-10
0-L T08 Fracture of spine, level unspecified ICD-10
0-L T09 Other injuries of spine and trunk, level unspecified ICD-10
0-L T10 Fracture of upper limb, level unspecified ICD-10
0-L T11 Other injuries of upper limb, level unspecified ICD-10
0-L T12 Fracture of lower limb, level unspecified ICD-10
0-L T13 Other injuries of lower limb, level unspecified ICD-10
0-L T14 Injury of unspecified body region ICD-10
0-L T15 Foreign body on external eye ICD-10
0-L T16 Foreign body in ear ICD-10
0-L T17 Foreign body in respiratory tract ICD-10
0-L T18 Foreign body in alimentary tract ICD-10
0-L T19 Foreign body in genitourinary tract ICD-10
0-L T20 Burn and corrosion of head and neck ICD-10
0-L T21 Burn and corrosion of trunk ICD-10
0-L T22 Burn and corrosion of shoulder and upper limb, except wrist and hand ICD-10
0-L T23 Burn and corrosion of wrist and hand ICD-10
0-L T24 Burn and corrosion of hip and lower limb, except ankle and foot ICD-10
0-L T25 Burn and corrosion of ankle and foot ICD-10
0-L T26 Burn and corrosion confined to eye and adnexa ICD-10
0-L T27 Burn and corrosion of respiratory tract ICD-10
0-L T28 Burn and corrosion of other internal organs ICD-10
0-L T29 Burns and corrosions of multiple body regions ICD-10
0-L T30 Burn and corrosion, body region unspecified ICD-10
0-L T31 Burns classified according to extent of body surface involved ICD-10
0-L T32 Corrosions classified according to extent of body surface involved ICD-10
0-L T33 Superficial frostbite ICD-10
0-L T34 Frostbite with tissue necrosis ICD-10
0-L T35 Frostbite involving multiple body regions and unspecified frostbite ICD-10
0-L T36 Poisoning by systemic antibiotics ICD-10
0-L T37 Poisoning by other systemic anti-infectives and antiparasitics ICD-10
0-L T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified ICD-10
0-L T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics ICD-10
0-L T40 Poisoning by narcotics and psychodysleptics [hallucinogens] ICD-10
0-L T41 Poisoning by anaesthetics and therapeutic gases ICD-10
0-L T42 Poisoning by antiepileptic, sedative-hypnotic and antiparkinsonism drugs ICD-10
0-L T43 Poisoning by psychotropic drugs, not elsewhere classified ICD-10
0-L T44 Poisoning by drugs primarily affecting the autonomic nervous system ICD-10
0-L T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified ICD-10
0-L T46 Poisoning by agents primarily affecting the cardiovascular system ICD-10
0-L T47 Poisoning by agents primarily affecting the gastrointestinal system ICD-10
0-L T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system ICD-10
0-L T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolaryngological and dental drugs ICD-10
0-L T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances ICD-10
0-L T51 Toxic effect of alcohol ICD-10
0-L T52 Toxic effect of organic solvents ICD-10
0-L T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons ICD-10
0-L T54 Toxic effect of corrosive substances ICD-10
0-L T55 Toxic effect of soaps and detergents ICD-10
0-L T56 Toxic effect of metals ICD-10
0-L T57 Toxic effect of other inorganic substances ICD-10
0-L T58 Toxic effect of carbon monoxide ICD-10
0-L T59 Toxic effect of other gases, fumes and vapours ICD-10
0-L T60 Toxic effect of pesticides ICD-10
0-L T61 Toxic effect of noxious substances eaten as seafood ICD-10
0-L T62 Toxic effect of other noxious substances eaten as food ICD-10
0-L T63 Toxic effect of contact with venomous animals ICD-10
0-L T64 Toxic effect of aflatoxin and other mycotoxin food contaminants ICD-10
0-L T65 Toxic effect of other and unspecified substances ICD-10
0-L T66 Unspecified effects of radiation ICD-10
0-L T67 Effects of heat and light ICD-10
0-L T68 Hypothermia ICD-10
0-L T69 Other effects of reduced temperature ICD-10
0-L T70 Effects of air pressure and water pressure ICD-10
0-L T71 Asphyxiation ICD-10
0-L T73 Effects of other deprivation ICD-10
0-L T74 Maltreatment syndromes ICD-10
0-L T75 Effects of other external causes ICD-10
0-L T78 Adverse effects, not elsewhere classified ICD-10
0-L T79 Certain early complications of trauma, not elsewhere classified ICD-10
0-L T80 Complications following infusion, transfusion and therapeutic injection ICD-10
0-L T81 Complications of procedures, not elsewhere classified ICD-10
0-L T82 Complications of cardiac and vascular prosthetic devices, implants and grafts ICD-10
0-L T83 Complications of genitourinary prosthetic devices, implants and grafts ICD-10
0-L T84 Complications of internal orthopaedic prosthetic devices, implants and grafts ICD-10
0-L T85 Complications of other internal prosthetic devices, implants and grafts ICD-10
0-L T86 Failure and rejection of transplanted organs and tissues ICD-10
0-L T87 Complications peculiar to reattachment and amputation ICD-10
0-L T88 Other complications of surgical and medical care, not elsewhere classified ICD-10
0-L T90 Sequelae of injuries of head ICD-10
0-L T91 Sequelae of injuries of neck and trunk ICD-10
0-L T92 Sequelae of injuries of upper limb ICD-10
0-L T93 Sequelae of injuries of lower limb ICD-10
0-L T94 Sequelae of injuries involving multiple and unspecified body regions ICD-10
0-L T95 Sequelae of burns, corrosions and frostbite ICD-10
0-L T96 Sequelae of poisoning by drugs, medicaments and biological substances ICD-10
0-L T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source ICD-10
0-L T98 Sequelae of other and unspecified effects of external causes ICD-10
0-L U04 Severe acute respiratory syndrome [SARS] ICD-10
0-L U80 Agent resistant to penicillin and related antibiotics ICD-10
0-L U81 Agent resistant to vancomycin and related antibiotics ICD-10
0-L U88 Agent resistant to multiple antibiotics ICD-10
0-L U89 Agent resistant to other and unspecified antibiotics ICD-10
0-L Z00 General examination and investigation of persons without complaint and reported diagnosis ICD-10
0-L Z01 Other special examinations and investigations of persons without complaint or reported diagnosis ICD-10
0-L Z02 Examination and encounter for administrative purposes ICD-10
0-L Z03 Medical observation and evaluation for suspected diseases and conditions ICD-10
0-L Z04 Examination and observation for other reasons ICD-10
0-L Z08 Follow-up examination after treatment for malignant neoplasms ICD-10
0-L Z09 Follow-up examination after treatment for conditions other than malignant neoplasms ICD-10
0-L Z10 Routine general health check-up of defined subpopulation ICD-10
0-L Z11 Special screening examination for infectious and parasitic diseases ICD-10
0-L Z12 Special screening examination for neoplasms ICD-10
0-L Z13 Special screening examination for other diseases and disorders ICD-10
0-L Z20 Contact with and exposure to communicable diseases ICD-10
0-L Z21 Asymptomatic human immunodeficiency virus [HIV] infection status ICD-10
0-L Z22 Carrier of infectious disease ICD-10
0-L Z23 Need for immunization against single bacterial diseases ICD-10
0-L Z24 Need for immunization against certain single viral diseases ICD-10
0-L Z25 Need for immunization against other single viral diseases ICD-10
0-L Z26 Need for immunization against other single infectious diseases ICD-10
0-L Z27 Need for immunization against combinations of infectious diseases ICD-10
0-L Z28 Immunization not carried out ICD-10
0-L Z29 Need for other prophylactic measures ICD-10
0-L Z30 Contraceptive management ICD-10
0-L Z31 Procreative management ICD-10
0-L Z32 Pregnancy examination and test ICD-10
0-L Z33 Pregnant state, incidental ICD-10
0-L Z34 Supervision of normal pregnancy ICD-10
0-L Z35 Supervision of high-risk pregnancy ICD-10
0-L Z36 Antenatal screening ICD-10
0-L Z37 Outcome of delivery ICD-10
0-L Z38 Liveborn infants according to place of birth ICD-10
0-L Z39 Postpartum care and examination ICD-10
0-L Z40 Prophylactic surgery ICD-10
0-L Z41 Procedures for purposes other than remedying health state ICD-10
0-L Z42 Follow-up care involving plastic surgery ICD-10
0-L Z43 Attention to artificial openings ICD-10
0-L Z44 Fitting and adjustment of external prosthetic device ICD-10
0-L Z45 Adjustment and management of implanted device ICD-10
0-L Z46 Fitting and adjustment of other devices ICD-10
0-L Z47 Other orthopaedic follow-up care ICD-10
0-L Z48 Other surgical follow-up care ICD-10
0-L Z49 Care involving dialysis ICD-10
0-L Z50 Care involving use of rehabilitation procedures ICD-10
0-L Z51 Other medical care ICD-10
0-L Z52 Donors of organs and tissues ICD-10
0-L Z53 Persons encountering health services for specific procedures, not carried out ICD-10
0-L Z54 Convalescence ICD-10
0-L Z55 Problems related to education and literacy ICD-10
0-L Z56 Problems related to employment and unemployment ICD-10
0-L Z57 Occupational exposure to risk-factors ICD-10
0-L Z58 Problems related to physical environment ICD-10
0-L Z59 Problems related to housing and economic circumstances ICD-10
0-L Z60 Problems related to social environment ICD-10
0-L Z61 Problems related to negative life events in childhood ICD-10
0-L Z62 Other problems related to upbringing ICD-10
0-L Z63 Other problems related to primary support group, including family circumstances ICD-10
0-L Z64 Problems related to certain psychosocial circumstances ICD-10
0-L Z65 Problems related to other psychosocial circumstances ICD-10
0-L Z70 Counselling related to sexual attitude, behaviour and orientation ICD-10
0-L Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified ICD-10
0-L Z72 Problems related to lifestyle ICD-10
0-L Z73 Problems related to life-management difficulty ICD-10
0-L Z74 Problems related to care-provider dependency ICD-10
0-L Z75 Problems related to medical facilities and other health care ICD-10
0-L Z76 Persons encountering health services in other circumstances ICD-10
0-L Z80 Family history of malignant neoplasm ICD-10
0-L Z81 Family history of mental and behavioural disorders ICD-10
0-L Z82 Family history of certain disabilities and chronic diseases leading to disablement ICD-10
0-L Z83 Family history of other specific disorders ICD-10
0-L Z84 Family history of other conditions ICD-10
0-L Z85 Personal history of malignant neoplasm ICD-10
0-L Z86 Personal history of certain other diseases ICD-10
0-L Z87 Personal history of other diseases and conditions ICD-10
0-L Z88 Personal history of allergy to drugs, medicaments and biological substances ICD-10
0-L Z89 Acquired absence of limb ICD-10
0-L Z90 Acquired absence of organs, not elsewhere classified ICD-10
0-L Z91 Personal history of risk-factors, not elsewhere classified ICD-10
0-L Z92 Personal history of medical treatment ICD-10
0-L Z93 Artificial opening status ICD-10
0-L Z94 Transplanted organ and tissue status ICD-10
0-L Z95 Presence of cardiac and vascular implants and grafts ICD-10
0-L Z95.0 Presence of cardiac pacemaker ICD-10
0-L Z96 Presence of other functional implants ICD-10
0-L Z97 Presence of other devices ICD-10
0-L Z98 Other postsurgical states ICD-10
0-L Z99 Dependence on enabling machines and devices, not elsewhere classified ICD-10
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 15:09:31 - status: Closed
  Author Alexander Henket
Description Corrected the binding of Problem Code to epSOSIllnessesandDisorders
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:06:50
  Author assigned by Alexander Henket (id#4)
  Description Need to bind to Problem code (currently mapped to epSOSProcedures for some reason)
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-13) Value set epSOSLanguage without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.13)
Last assignment to Alexander Henket

Issue Value set epSOSLanguage without dataset binding
Id epsos-issue-13
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-6 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSLanguage 1.3.6.1.4.1.12559.11.10.1.3.1.42.6 2001 - 2013‑06‑03 Draft
Source Code System:
  • 1.0.639.1 ISO 639-1
Level/ Type Code Display Name Code System Description
0-L bg Bulgarian ISO 639-1
0-L bs Bosnian ISO 639-1
0-L ca Catalan ISO 639-1
0-L cs Czech ISO 639-1
0-L da Danish ISO 639-1
0-L de German ISO 639-1
0-L el Greek ISO 639-1
0-L en English ISO 639-1
0-L es Spanish; Castilian ISO 639-1
0-L et Estonian ISO 639-1
0-L fi Finnish ISO 639-1
0-L fr French ISO 639-1
0-L he Hebrew ISO 639-1
0-L hr Croatian ISO 639-1
0-L hu Hungarian ISO 639-1
0-L hy Armenian ISO 639-1
0-L is Icelandic ISO 639-1
0-L it Italian ISO 639-1
0-L lb Luxembourgish ISO 639-1
0-L lt Lithuanian ISO 639-1
0-L lv Latvian ISO 639-1
0-L mk Macedonian ISO 639-1
0-L mt Maltese ISO 639-1
0-L nl Dutch; Flemish ISO 639-1
0-L no Norwegian ISO 639-1
0-L pl Polish ISO 639-1
0-L pt Portuguese ISO 639-1
0-L ro Romanian ISO 639-1
0-L ru Russian ISO 639-1
0-L sk Slovak ISO 639-1
0-L sl Slovenian ISO 639-1
0-L sq Albanian ISO 639-1
0-L sr Serbian ISO 639-1
0-L sv Swedish ISO 639-1
0-L tr Turkish ISO 639-1
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 15:13:00 - status: Closed
  Author Alexander Henket
Description This makes it impossible to have a formal mapping. Mapping only works for pre coordinated value sets.

Rather this would lead to a textual explanation on how to use these value sets, and potentially a pattern for the code that results from that, e.g. "[a-z]{2}(-[A-Z]{2})?"
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:10:00
  Author assigned by Alexander Henket (id#4)
  Description Not used as-is, but used in conjunction with country to create nl-NL, nl-BE, or fr-FR, fr-CH
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-14) Value set epSOSSubstitutionCodes without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.14)
Last assignment to Alexander Henket

Issue Value set epSOSSubstitutionCodes without dataset binding
Id epsos-issue-14
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-7 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSSubstitutionCode 1.3.6.1.4.1.12559.11.10.1.3.1.42.7 913-20091020 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.5.1070 SubstanceAdminSubstitution
Level/ Type Code Display Name Code System Description
0-L G Generic SubstanceAdminSubstitution
0-L N none SubstanceAdminSubstitution
0-L TE therapeutic alternative SubstanceAdminSubstitution
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 15:17:39 - status: Closed
  Author Alexander Henket
Description Flipped the datatype of dataset field Substitution from string to code and added the binding to epSOSSubstitutionCodes
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:12:53
  Author assigned by Alexander Henket (id#4)
  Description Need to bind to R4.16 Substitution.
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-15) Value set epSOSMedicalDevices without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.15)
Last assignment to Alexander Henket

Issue Value set epSOSMedicalDevices without dataset binding
Id epsos-issue-15
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-8 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSMedicalDevices 1.3.6.1.4.1.12559.11.10.1.3.1.42.8 July 2009 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 304184000 Ankle joint implant SNOMED-CT
0-L 84683006 Aortic valve prosthesis SNOMED-CT
0-L 360046005 Arterial stent SNOMED-CT
0-L 24073000 Artificial cardiac valve prosthesis SNOMED-CT
0-L 429798007 Artificial vertebral disc SNOMED-CT
0-L 303500007 Auditory implant SNOMED-CT
0-L 360123005 Biliary stent SNOMED-CT
0-L 304070008 Body wall implant SNOMED-CT
0-L 77444004 Bone pin SNOMED-CT
0-L 271003 Bone plate SNOMED-CT
0-L 360145006 Bone prosthesis SNOMED-CT
0-L 68183006 Bone screw SNOMED-CT
0-L 77777004 Bone staple SNOMED-CT
0-L 63112008 Bone wire SNOMED-CT
0-L 2282003 Breast prosthesis SNOMED-CT
0-L 264824009 Cardiac conduit SNOMED-CT
0-L 303619008 Cardiac implant SNOMED-CT
0-L 303490004 Cardiovascular implant SNOMED-CT
0-L 413766009 Carotid stent SNOMED-CT
0-L 43252007 Cochlear prosthesis SNOMED-CT
0-L 360329004 Dacron graft SNOMED-CT
0-L 421168009 Eye sphere implant SNOMED-CT
0-L 303277008 Fallopian tube prosthesis SNOMED-CT
0-L 304121006 Femoral head prosthesis SNOMED-CT
0-L 304185004 Foot joint implant SNOMED-CT
0-L 360117000 Gastric bubble SNOMED-CT
0-L 303499003 Gastrointestinal implant SNOMED-CT
0-L 304186003 Hand joint implant SNOMED-CT
0-L 303533002 Hip joint implant SNOMED-CT
0-L 67270000 Hip prosthesis SNOMED-CT
0-L 72506001 Implantable defibrillator SNOMED-CT
0-L 360041000 Implanted drug delivery system SNOMED-CT
0-L 268460000 Intrauterine contraceptive device SNOMED-CT
0-L 360058005 Intraventricular pump SNOMED-CT
0-L 257366006 JJ-stent SNOMED-CT
0-L 314523008 Joint implant SNOMED-CT
0-L 360070009 Laryngeal implant SNOMED-CT
0-L 414580007 Laryngeal keel SNOMED-CT
0-L 74444006 Limb prosthesis SNOMED-CT
0-L 272245008 Maxillofacial prosthesis/appliance SNOMED-CT
0-L 90134004 Metal periosteal implant SNOMED-CT
0-L 17107009 Mitral valve prosthesis SNOMED-CT
0-L 303503009 Musculoskeletal implant SNOMED-CT
0-L 303618000 Nervous system implant SNOMED-CT
0-L 118382007 Neuropacemaker device SNOMED-CT
0-L 257282009 Non-valved conduit SNOMED-CT
0-L 303608005 Ophthalmological implant SNOMED-CT
0-L 303515008 Orbital implant SNOMED-CT
0-L 424921004 Permanent cardiac pacemaker, device SNOMED-CT
0-L 423449009 Pulmonary valve prosthesis, device SNOMED-CT
0-L 303947005 Rod fixation system SNOMED-CT
0-L 304124003 Shoulder joint implant SNOMED-CT
0-L 303726000 Shoulder joint prosthesis SNOMED-CT
0-L 118374007 Silicone implant SNOMED-CT
0-L 257275005 Spinal cage SNOMED-CT
0-L 63289001 Surgical metal nail, device SNOMED-CT
0-L 304120007 Total hip replacement prosthesis SNOMED-CT
0-L 360100007 Tracheal stent SNOMED-CT
0-L 286558002 Ureteric stent SNOMED-CT
0-L 286576009 Urethral stent SNOMED-CT
0-L 303497001 Urogenital implant SNOMED-CT
0-L 257283004 Valved cardiac conduit SNOMED-CT
0-L 303617005 Vascular implant SNOMED-CT
0-L 102303004 Vascular prosthesis SNOMED-CT
0-L 118425005 Ventricular reservoir SNOMED-CT
0-L 258593008 Ventricular shunt SNOMED-CT
0-L 257343005 Xenograft cardiac valve SNOMED-CT
0-L 102314001 Embolisation coil SNOMED-CT
0-L 31031000 Orthopaedic internal fixation system SNOMED-CT
0-L 45633005 Peritoneal dialyser SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 15:22:16 - status: Closed
  Author Alexander Henket
Description Changed the existing binding from epSOSMedicalEquipment to epSOSMedicalDevices
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:13:47
  Author assigned by Alexander Henket (id#4)
  Description Needs to bind to R12.2 Device Code
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-16) Value set epSOSPregnancyInformation without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.16)
Last assignment to Alexander Henket

Issue Value set epSOSPregnancyInformation without dataset binding
Id epsos-issue-16
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-9 (2013‑06‑03)
Description
The Value Set is used to determine the patient's delivery date estimation
Value Set Name Value Set Id Version / effective date Status
epSOSPregnancyInformation 1.3.6.1.4.1.12559.11.10.1.3.1.42.9 2.34 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.1 LOINC
Level/ Type Code Display Name Code System Description
0-L 11778-8 Delivery date estimated (clinical) LOINC
0-L 11779-6 Delivery date estimated from last menstrual period LOINC
0-L 11780-4 Delivery date estimated from ovulation LOINC
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 15:24:49 - status: Closed
  Author Alexander Henket
Description Conceptually this is not really correct. Each of the codes represents a separate concept, but the bindings have been applied.
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:15:14
  Author assigned by Alexander Henket (id#4)
  Description Need to bind to the expected date of delivery itself rather than the conceptList
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-18) Value set epSOSSeverity without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.18)
Last assignment to Alexander Henket

Issue Value set epSOSSeverity without dataset binding
Id epsos-issue-18
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-13 (2013‑06‑03)
Description
The Value Set is used for all Problems and Allergies in the Patient Summary to indicate the severity of the problem (or Allergy)
Value Set Name Value Set Id Version / effective date Status
epSOSSeverity 1.3.6.1.4.1.12559.11.10.1.3.1.42.13 July 2009 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 442452003 Life threatening severity SNOMED-CT
0-L 349915008 Low grade SNOMED-CT
0-L 255604002 Mild SNOMED-CT
0-L 371923003 Mild to moderate SNOMED-CT
0-L 6736007 Moderate SNOMED-CT
0-L 371924009 Moderate to severe SNOMED-CT
0-L 24484000 Severe SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 16:13:03 - status: Closed
  Author Alexander Henket
Description Problem Severity / Allergy Severity added in the dataset, value set bindings added. Added to scenarios where applicable as 0..1
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:31:43
  Author assigned by Alexander Henket (id#4)
  Description Giorgio: add dataset concepts "Problem Severity" (active and past problems) and "Allergy Severity" to support this
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-19) Value set epSOSStatusCode without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.19)
Last assignment to Alexander Henket

Issue Value set epSOSStatusCode without dataset binding
Id epsos-issue-19
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-15 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSStatusCode 1.3.6.1.4.1.12559.11.10.1.3.1.42.15 July 2009 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 55561003 Active SNOMED-CT
0-L 90734009 Chronic SNOMED-CT
0-L 73425007 Inactive SNOMED-CT
0-L 7087005 Intermittent SNOMED-CT
0-L 410516002 Known absent SNOMED-CT
0-L 413322009 Problem resolved SNOMED-CT
0-L 255227004 Recurrent SNOMED-CT
0-L 415684004 Suspected SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 16:55:41 - status: Closed
  Author Alexander Henket
Description Problem Status added in the dataset, value set bindings added. Added to scenarios where applicable as 0..1
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:34:43
  Author assigned by Alexander Henket (id#4)
  Description Relates to the status of the actual and past problems. Giorgio: add dataset concept for that.
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-20) Value set epSOSUnits without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.20)
Last assignment to Alexander Henket

Issue Value set epSOSUnits without dataset binding
Id epsos-issue-20
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-16 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSUnits 1.3.6.1.4.1.12559.11.10.1.3.1.42.16 July 2009 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.8 UCUM
Level/ Type Code Display Name Code System Description
0-L % Percent UCUM
0-L /d PerDay UCUM
0-L /g PerGram UCUM
0-L /h PerHour UCUM
0-L /kg PerKiloGram UCUM
0-L /kg{body wt} PerKiloGramBodyWeight UCUM
0-L /min PerMinute UCUM
0-L /s PerSecond UCUM
0-L 1 Unit UCUM
0-L [iU] InternationalUnit UCUM
0-L [iU]/g InternationalUnitsPerGram UCUM
0-L [iU]/mL InternationalUnitsPerMilliLiter UCUM
0-L a Year UCUM
0-L bar Bar UCUM
0-L Cal Calorie UCUM
0-L cal/d CaloriesPerDay UCUM
0-L cal/g CaloriesPerGram UCUM
0-L cal/h CaloriesPerHour UCUM
0-L cal/mL CaloriesPerMiliLiter UCUM
0-L Cel DegreeCelsius UCUM
0-L cm CentiMeter UCUM
0-L cm2 SquareCentimeter UCUM
0-L cm3 CubicCentimeter UCUM
0-L d Day UCUM
0-L g Gram UCUM
0-L g/kg GramsPerKiloGram UCUM
0-L g/L GramsPerLiter UCUM
0-L g/mL GramsPerMilliliter UCUM
0-L h Hour UCUM
0-L J Joule UCUM
0-L k[iU] KiloInternationalUnits UCUM
0-L k[iU]/L KiloInternationalUnitsPerLiter UCUM
0-L kat Katal UCUM
0-L kcal KiloCalorie UCUM
0-L kcal/d KiloCaloriesPerDay UCUM
0-L kcal/g KiloCaloriesPerGram UCUM
0-L kcal/h KiloCaloriesPerHour UCUM
0-L kcal/mL KiloCaloriesPerMililiter UCUM
0-L kg KiloGrams UCUM
0-L kg/m2 KilogramPerSquareMeter UCUM
0-L kg/m3 KiloGramsPerCubicMeter UCUM
0-L kJ KiloJoule UCUM
0-L kPa KiloPascal UCUM
0-L L Liter UCUM
0-L L/s LitersPerSecond UCUM
0-L m Meter UCUM
0-L m2 SquareMeter UCUM
0-L m[iU] MilliInternationalUnit UCUM
0-L m[iU]/L MilliInternationalUnitsPerLiter UCUM
0-L mbar MilliBar UCUM
0-L mg MilliGram UCUM
0-L mg/L MilliGramsPerLiter UCUM
0-L min Minute UCUM
0-L mL MilliLiter UCUM
0-L mL/s MilliLitersPerSecond UCUM
0-L mm Millimeter UCUM
0-L mm2 SquareMilliMeter UCUM
0-L mm[Hg] MilliMetersOfMercury UCUM
0-L mmol MilliMole UCUM
0-L mmol/L MilliMolesPerLiter UCUM
0-L mo Month UCUM
0-L mol/L MolePerLiter UCUM
0-L ng NanoGram UCUM
0-L ng/L NanoGramsPerLiter UCUM
0-L nmol/L NanoMolesPerLiter UCUM
0-L pH pH UCUM
0-L s Second UCUM
0-L ug Microgram UCUM
0-L ug/(kg.min) MicroGramsPerKiloGramAndMinute UCUM
0-L ug/L MicroGramsPerLiter UCUM
0-L ukat MicroKatal UCUM
0-L ukat/L MicroKatalsPerLiter UCUM
0-L ukat/mL MicroKatalsPerMilliLiter UCUM
0-L uL MicroLiter UCUM
0-L umol MicroMole UCUM
0-L umol/L MicroMolesPerLiter UCUM
0-L wk Week UCUM
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 16:57:29 - status: Closed
  Author Alexander Henket
Description This can only be done at template level. At dataset level we only say something is a "quantity". You may fix the unit, but it is not possible to attach value sets at that level.
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:37:07
  Author assigned by Alexander Henket (id#4)
  Description Bind to anything that is a Quantity
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-21) Value set epSOSUnknownInformation without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.21)
Last assignment to Alexander Henket

Issue Value set epSOSUnknownInformation without dataset binding
Id epsos-issue-21
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-17 (2013‑06‑03)
Description
The Value Set is used when information about a problem or allergy is unknown or where there are no problems or allergies. This element is actually used to confirm explicitely the absence of information.
Value Set Name Value Set Id Version / effective date Status
epSOSUnknownInformation 1.3.6.1.4.1.12559.11.10.1.3.1.42.17 July 2009 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 407559004 Family history unknown SNOMED-CT
0-L 396782006 Medical history unknown SNOMED-CT
0-L 160245001 No current problems or disability SNOMED-CT
0-L 160244002 No known allergies SNOMED-CT
0-L 409137002 No known drug allergies SNOMED-CT
0-L 160243008 No medical history SNOMED-CT
0-L 64970000 Substance type unknown SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 16:58:43 - status: Closed
  Author Alexander Henket
Description In which it is not actually an issue and it can be closed.
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:42:28
  Author assigned by Alexander Henket (id#4)
  Description This cannot be bound to a singular concept. There are 4 assertions that say "I know something" and 3 assertions that say "I don't know something". The codes maybe used to bind specific document contents, but the value set as-is cannot be used.
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-22) Value set epSOSBloodPressure without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.22)
Last assignment to Alexander Henket

Issue Value set epSOSBloodPressure without dataset binding
Id epsos-issue-22
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-21 (2013‑06‑03)
Description
The Value Set is used for the observations of Blood Pressure recorded in the section for Vital Signs Observations in the Patient Summary. It codes what type of pressure (diastolic, systolic) is measured.
Value Set Name Value Set Id Version / effective date Status
epSOSBloodPressure 1.3.6.1.4.1.12559.11.10.1.3.1.42.21 2.34 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.1 LOINC
Level/ Type Code Display Name Code System Description
0-L 8462-4 Diastolic blood pressure LOINC
0-L 8480-6 Systolic blood pressure LOINC
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:02:52 - status: Closed
  Author Alexander Henket
Description Concepts are bound, value set itself left unbounded
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:44:10
  Author assigned by Alexander Henket (id#4)
  Description Need to bind to the concept. Cannot bind the value set as-is, but need to bind the codes to Diastolic and Systolic
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-23) Value set epSOSCodeNoMedication without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.23)
Last assignment to Alexander Henket

Issue Value set epSOSCodeNoMedication without dataset binding
Id epsos-issue-23
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-22 (2013‑06‑03)
Description
The Value Set is used to indicate, when a patient has no medication, if it is because the treatment is unknown, or if no medication was prescribed, or if the patient doesn't take medication on his own (self-medication)
Value Set Name Value Set Id Version / effective date Status
epSOSCodeNoMedication 1.3.6.1.4.1.12559.11.10.1.3.1.42.22 July 2009 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 182904002 Drug treatment unknown SNOMED-CT
0-L 182849000 No drug therapy prescribed SNOMED-CT
0-L 408350003 Patient not on self-medication SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:04:06 - status: Closed
  Author Alexander Henket
Description This will be conveyed at template level.
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:46:36
  Author assigned by Alexander Henket (id#4)
  Description Similar to epSOSUnknownInformation. See issue#21. If there is no medication prescribed you need use one of these codes to convey why information is absent.
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-25) Value set epSOSSections without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.25)
Last assignment to Alexander Henket

Issue Value set epSOSSections without dataset binding
Id epsos-issue-25
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-26 (2013‑06‑03)
Description
The Value Set is used for naming the sections used by the three CDA-documents.
Value Set Name Value Set Id Version / effective date Status
epSOSSections 1.3.6.1.4.1.12559.11.10.1.3.1.42.26 2.34 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.1 LOINC
Level/ Type Code Display Name Code System Description
0-L 10160-0 History of medication use LOINC The medications section shall contain a description of the relevant medications for the patient, e.g. an ambulatory prescription list. It shall include entries for medications as described in the Entry Content Module. All prescribed medicine whose period of time indicated for the treatment has not yet expired whether it has been dispensed or not.
0-L 10162-6 History of pregnancies  LOINC
0-L 10164-2 History of present illness LOINC The history of present illness section shall contain a description of the sequence of events preceding the patient’s current complaints. Step by step description of ethiopathogenesis of current problem patient is being treated for.
0-L 11348-0 History of past illness LOINC The History of Past Illness section shall contain a description of the conditions the patient suffered in the past. It shall include entries for problems as described in the Entry Content Modules. Illness which set on and resolved in the past.
0-L 11369-6 History of immunization LOINC The immunizations section shall contain a description of the immunizations administered to the patient in the past. It shall include entries for medication administration as described in the Entry Content Modules. Active immunizations received in the past.
0-L 11450-4 Problem list LOINC The active problem section shall contain a description of the conditions currently being monitored for the patient. It shall include entries for patient conditions as described in the Entry Content Module. Chronic, recurring or persistent illnesses, requiring repeated reassessment and/or continuos/periodic therapy.
0-L 18776-5 Plan of treatment LOINC The care plan section shall contain a description of the expectations for care including proposals, goals, and order requests for monitoring, tracking, or improving the condition of the patient. Therapeutic recommendations that do not include drugs
0-L 29554-3 Procedures LOINC The procedure entry is used to record procedures that have occurred, or which are planned for in the future.
0-L 29762-2 Social history LOINC
0-L 30954-2 Relevant diagnostic tests/laboratory data LOINC
0-L 46264-8 History of medical device use LOINC The medical devices section contains text describing the patient history of medical device use. Documented necessity to use a device replacing/supporting completely/partially a body organ/organ system function.
0-L 47420-5 Functional status assessment LOINC The Coded Functional Status Assessment Section provided a machine readable and description of the patient’s status of normal functioning at the time the document was created. Pain Scale Assessment, Braden Score Assessment, and Geriatric Depression Scale are subsections of the Functional Status Assessment Section
0-L 47519-4 History of Procedures LOINC The list of surgeries section shall include entries for procedures and references to procedure reports when known as described in the Entry Content Modules. Surgical or other invasive procedures in the past, on vital organs/body cavities/vascular or central nervous system.
0-L 48765-2 Allergies, adverse reactions, alerts LOINC The adverse and other adverse reactions section shall contain a description of the substance intolerances and the associated adverse reactions suffered by the patient. It shall include entries for intolerances and adverse reactions as described in the Entry Content Modules Presence/absence of potentially life threatening reaction to substances/factors, to which patient can be exposed in the environment, or during treatment, of allergic or other known nature.
0-L 57828-6 Prescriptions LOINC
0-L 60590-7 Medication dispensed LOINC
0-L 8716-3 Physical findings LOINC The vital signs section contains coded measurement results of a patient’s vital signs.
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:08:13 - status: Closed
  Author Alexander Henket
Description Conveyed at template level only. Also the valueSet cannot be used as is, as only applies per context. So the valueSet is probably just for convenience.
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:49:14
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑11‑10 19:49:04 - status: Open
  Author Giorgio Cangioli
Description value set introduced for listing the codes used for the CDA section.code
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping. May be HL7 Template only?

 (epsos-issue-26) Value set epSOSConfidentiality without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.26)
Last assignment to Alexander Henket

Issue Value set epSOSConfidentiality without dataset binding
Id epsos-issue-26
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-31 (2013‑06‑03)
Description
The Value Set is used for encoding the confidentiality level of the entire CDA. This Value Set encodes the level of access with regards to the content of the Value Set – for example N concerns all the medical team, R is restricted for specialist that take care of the patient in certain circumstances, and VIP would be for the persons that need the Privacy Officer present or other special consideration (for example a celebrity hospitalized who needs their records protected)
Value Set Name Value Set Id Version / effective date Status
epSOSConfidentiality 1.3.6.1.4.1.12559.11.10.1.3.1.42.31 913-20091020 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.5.25 Confidentiality
Level/ Type Code Display Name Code System Description
0-L B business Confidentiality
0-L D clinician Confidentiality
0-L I individual Confidentiality
0-L L low Confidentiality
0-L N normal Confidentiality
0-L R restricted Confidentiality
0-L V very restricted Confidentiality
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:10:38 - status: Closed
  Author Alexander Henket
Description Concept added to the dataset and added binding. Conveyed in template too of course
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:50:58
  Author assigned by Giorgio Cangioli (id#5)
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑10 19:50:22
  Author assigned by Giorgio Cangioli (id#5)
  Description value set added due to the required CDA element
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-27) Value set epSOSDocumentCode without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.27)
Last assignment to Alexander Henket

Issue Value set epSOSDocumentCode without dataset binding
Id epsos-issue-27
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-32 (2013‑06‑03)
Description
Defines to which category the document belongs to : summary, prescription, or dispensation.
Value Set Name Value Set Id Version / effective date Status
epSOSDocumentCode 1.3.6.1.4.1.12559.11.10.1.3.1.42.32 2.34 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.1 LOINC
Level/ Type Code Display Name Code System Description
0-L 57016-8 Patient Consent LOINC
0-L 57833-6 ePrescription LOINC
0-L 60591-5 Patient Summary LOINC
0-L 60593-1 eDispensation LOINC
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:13:18 - status: Closed
  Author Alexander Henket
Description Concept added to the dataset and added binding. Conveyed in template too of course
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:52:11
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑11‑10 19:52:01 - status: Open
  Author Giorgio Cangioli
Description this Value set lists the code of the CDA document used in the epSOS services
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping. May be HL7 Template only?

 (epsos-issue-28) Value set epSOSEntityNamePartQualifier without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.28)
Not assigned yet.

Issue Value set epSOSEntityNamePartQualifier without dataset binding
Id epsos-issue-28
Type Clarification needed
Status  Closed
Priority normal
Object(s) Value set epsos-valueset-33 (2013‑06‑03)
Description
Not used in epSOS1, therefore translation is not needed.
Value Set Name Value Set Id Version / effective date Status
epSOSEntityNamePartQualifier 1.3.6.1.4.1.12559.11.10.1.3.1.42.33 913-20091020 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.5.43 EntityNamePartQualifier
Level/ Type Code Display Name Code System Description
0-L AC academic EntityNamePartQualifier
0-L AD adopted EntityNamePartQualifier
0-L BR birth EntityNamePartQualifier
0-L CL callme EntityNamePartQualifier
0-L IN initial EntityNamePartQualifier
0-L LS legal status EntityNamePartQualifier
0-L NB nobility EntityNamePartQualifier
0-L PR professional EntityNamePartQualifier
0-L SP spouse EntityNamePartQualifier
0-L TITLE title EntityNamePartQualifier
0-L VV voorvoegsel EntityNamePartQualifier
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:16:00 - status: Closed
  Author Alexander Henket
Description Conveyed in template only on PN.ENXP.qualifier
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping. May be HL7 Template only?

 (epsos-issue-29) Value set epSOSIHEActCode without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.29)
Last assignment to Alexander Henket

Issue Value set epSOSIHEActCode without dataset binding
Id epsos-issue-29
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-35 (2013‑06‑03)
Description
This is a technical value set which describes what kind of information (immunization, intolerance, instructions) are related to the entry. Describes what the entry is all about. For example describes the purpose of acts, e.g. a comment on another act, to distinguish the act of immunization from the act of treating a patient with a medication
Value Set Name Value Set Id Version / effective date Status
epSOSIHEActCode 1.3.6.1.4.1.12559.11.10.1.3.1.42.35 August 2009 (R5) - 2013‑06‑03 Draft
Source Code System:
  • 1.3.6.1.4.1.19376.1.5.3.2
Level/ Type Code Display Name Code System Description
0-L COMMENT This is the act of commenting on another act. 1.3.6.1.4.1.19376.1.5.3.2
0-L DRUG The act of treating a patient with a particular substance or class of substances identified using a specified vocabulary. Use of this vocabulary term requires the use of either the SUBSTANCE or SUBSTCLASS qualifier described below, along with an identified substance or class of substances. 1.3.6.1.4.1.19376.1.5.3.2
0-L FINSTRUCT This is the act of providing instructions to the supplier regarding the fulfillment of the medication order. 1.3.6.1.4.1.19376.1.5.3.2
0-L IMMUNIZ The act of immunization of a patient using a particular substance or class of substances identified using a specified vocabulary. Use of this vocabulary term requires the use of either the SUBSTANCE or SUBSTCLASS qualifier described below, along with an identified substance or class of substances. 1.3.6.1.4.1.19376.1.5.3.2
0-L INTOL An observation that a patient is somehow intollerant of (e.g., allergic to) a particular substance or class of substances using a specified vocabulary. Use of this vocabulary term requires the use of either the SUBSTANCE or SUBSTCLASS qualifi 1.3.6.1.4.1.19376.1.5.3.2
0-L PINSTRUCT This is the act of providing instructions to a patient regarding the use of medication. 1.3.6.1.4.1.19376.1.5.3.2
0-L SUBSTANCE A qualifier that identifies the substance used to treat a patient in an immunization or drug treatment act. The substance is expected to be identified using a vocabulary such as RxNORM, SNOMED CT or other similar vocabulary and should be specific enough to identify the ingredients of the substance used. 1.3.6.1.4.1.19376.1.5.3.2
0-L SUBSTCLASS A qualifier that identifies the class of substance used to treat a patient in an immunization or drug treatment act. The class of substances is expected to be identified using a vocabulary such as NDF-RT, SNOMED CT or other similar vocabulary, and should be broad enough to classify substances by mechanism of action (e.g., Beta Blocker), intended effect (Dieuretic, antibiotic) or ... 1.3.6.1.4.1.19376.1.5.3.2
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:16:33 - status: Closed
  Author Alexander Henket
Description Conveyed in template only
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:53:15
  Author assigned by Giorgio Cangioli (id#5)
  Description list some codes used in some IHE templates adopted
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-30) Value set epSOSIHERoleCode without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.30)
Last assignment to Alexander Henket

Issue Value set epSOSIHERoleCode without dataset binding
Id epsos-issue-30
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-36 (2013‑06‑03)
Description
It is a set of technical codes defined by IHE to represent certain roles that entities play or are scoped by.
Value Set Name Value Set Id Version / effective date Status
epSOSIHERoleCode 1.3.6.1.4.1.12559.11.10.1.3.1.42.36 August 2009 (R5) - 2013‑06‑03 Draft
Source Code System:
  • 1.3.6.1.4.1.19376.1.5.3.3
Level/ Type Code Display Name Code System Description
0-L AFFILIATED An organization with which a person is affiliated (e.g., a volunteer organization). 1.3.6.1.4.1.19376.1.5.3.3
0-L EMPLOYER The employer of a person. 1.3.6.1.4.1.19376.1.5.3.3
0-L PHARMACY The pharmacy a person uses. 1.3.6.1.4.1.19376.1.5.3.3
0-L SCHOOL The school in which a person is enrolled. 1.3.6.1.4.1.19376.1.5.3.3
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:16:53 - status: Closed
  Author Alexander Henket
Description
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:54:16
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-34) Value set epSOSTmingEvent without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.34)
Not assigned yet.

Issue Value set epSOSTmingEvent without dataset binding
Id epsos-issue-34
Type Clarification needed
Status  Closed
Priority normal
Object(s) Value set epsos-valueset-41 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSTimingEvent 1.3.6.1.4.1.12559.11.10.1.3.1.42.41 20050824 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.5.139 TimingEvent
Level/ Type Code Display Name Code System Description
0-L AC before meal (from lat. ante cibus) TimingEvent
0-L ACD before lunch (from lat. ante cibus diurnus) TimingEvent
0-L ACM before breakfast (from lat. ante cibus matutinus) TimingEvent
0-L ACV before dinner (from lat. ante cibus vespertinus) TimingEvent
0-L HS Prior to beginning a regular period of extended sleep (this would exclude naps). Note that this might occur at different times of day depending on a person's regular sleep schedule. TimingEvent
0-L IC between meals (from lat. inter cibus) TimingEvent
0-L ICD between lunch and dinner TimingEvent
0-L ICM between breakfast and lunch TimingEvent
0-L ICV between dinner and the hour of sleep TimingEvent
0-L PC after meal (from lat. post cibus) TimingEvent
0-L PCD after lunch (from lat. post cibus diurnus) TimingEvent
0-L PCM after breakfast (from lat. post cibus matutinus) TimingEvent
0-L PCV after dinner (from lat. post cibus vespertinus) TimingEvent
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:30:25 - status: Closed
  Author Alexander Henket
Description To be conveyed in template only in dosage instructions.
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-35) Value set epSOSURL without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.35)
Not assigned yet.

Issue Value set epSOSURL without dataset binding
Id epsos-issue-35
Type Clarification needed
Status  Closed
Priority normal
Object(s) Value set epsos-valueset-42 (2013‑06‑03)
Description
The Value Set is used (in this very case) to make the distinction between telephone numbers and e-mails in contact information for all roles involved. Also for coding any other forms of communication
Value Set Name Value Set Id Version / effective date Status
epSOSURL 1.3.6.1.4.1.12559.11.10.1.3.1.42.42 913-20091020 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.5.143 URLScheme
Level/ Type Code Display Name Code System Description
0-L fax Fax URLScheme
0-L file File URLScheme
0-L ftp FTP URLScheme
0-L http HTTP URLScheme
0-L mailto Mailto URLScheme
0-L mllp HL7 Minimal Lower Layer Protocol URLScheme
0-L modem Modem URLScheme
0-L nfs NFS URLScheme
0-L tel Telephone URLScheme
0-L telnet Telnet URLScheme
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:35:48 - status: Closed
  Author Alexander Henket
Description Consider for inspiration only. Can make it a textual reference from places in templates where URLs are needed and as indicated in the specification
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-36) Value set epSOSObservationInterpretation without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.36)
Not assigned yet.

Issue Value set epSOSObservationInterpretation without dataset binding
Id epsos-issue-36
Type Clarification needed
Status  Closed
Priority normal
Object(s) Value set epsos-valueset-43 (2013‑06‑03)
Description
The Value Set is used to classify the result of an observation or a measurement
Value Set Name Value Set Id Version / effective date Status
epSOSObservationInterpretation 1.3.6.1.4.1.12559.11.10.1.3.1.42.43 913-20091020 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.5.83
Level/ Type Code Display Name Code System Description
0-L H High 2.16.840.1.113883.5.83
0-L L Low 2.16.840.1.113883.5.83
0-L N Normal 2.16.840.1.113883.5.83
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑11‑28 17:40:01 - status: Closed
  Author Alexander Henket
Description Found in "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf"
NOTE: The Value set epSOSObservationInterpretation, epSOSActSite and epSOSMedicalEquipment are not expected to be used within epSOS-I.
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

 (epsos-issue-40) Dispenser
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.40)
Last assignment to Alexander Henket

Issue Dispenser
Id epsos-issue-40
Type Change Request
Status  Closed, assigned
Priority normal
Object(s) Data element epsos-dataelement-143 "Dispense" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication
folder  Dispense
Id epsos-dataelement-143
notice There are open issues with this item:
Description Information about dispensed medication
Used in 3 scenarios, inherited 0 times
target This concept is used in transaction Send eD to country A (0..*) in scenario
target This concept is used in transaction Return MRO (0..*) in scenario
target This concept is used in transaction Send HCER to country A (0..*) in scenario
tracking Tracking 2013‑11‑28 17:54:31 - status: Closed
  Author Alexander Henket
Description Dispenser with full properties added to the data set and scenarios.
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:38:37
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑11‑10 19:38:27 - status: Open
  Author Giorgio Cangioli
Description required for dispensation
tracking Tracking 2013‑10‑18 15:51:46 - status: Open
  Author Tessa van Stijn
Description Issue:

- According to the specifications at page 123 of the document

 "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf" the Medication element should include an element Dispenser.

In the document "D1 4 3 Specification of services v1 0 20120911 (2).pdf" the element Dispenser is not present.

Proposal:

- Please clarify if the element Dispenser should be included in Dispensation.

More info:

-

 (epsos-issue-41) Prescriber
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.41)
Last assignment to Alexander Henket

Issue Prescriber
Id epsos-issue-41
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Data element epsos-dataelement-102 "Prescription" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication
folder  Prescription
Id epsos-dataelement-102
Description
Used in 4 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (0..*) in scenario
target This concept is used in transaction Return MRO (0..* Conditional) in scenario
target This concept is used in transaction Send HCER to country A (0..* Conditional) in scenario
target This concept is used in transaction Return PS of country A (0..*) in scenario
tracking Tracking 2013‑11‑28 17:54:55 - status: Closed
  Author Alexander Henket
Description Prescriber with full properties added to the data set and scenarios.
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:31:17
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑10‑24 10:41:14 - status: Open
  Author Giorgio Cangioli
Description The Prescriber shall be present.
tracking Tracking 2013‑10‑18 15:53:04 - status: Open
  Author Tessa van Stijn
Description Issue:

- According to the specifications at page 106 of the document

 "epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf" the Medication element should include an element Prescriber.

In the document "D1 4 3 Specification of services v1 0 20120911 (2).pdf" the element Prescriber is not present.

Proposal:

- Please clarify if the element Prescriber should be included in Prescription

More info:

-

 (epsos-issue-44) Definition "Route of administration"
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.44)
Last assignment to Alexander Henket

Issue Definition "Route of administration"
Id epsos-issue-44
Type Change Request
Status  Closed, assigned
Priority normal
Object(s) Data element epsos-dataelement-140 "Route of administration" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication / Prescription
Route of administration
Id epsos-dataelement-140
Description Indicates the part of the body through or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.NOTE FOR GUIDANCE ON DATA ELEMENTS AND STANDARDS FOR DRUG DICTIONARIES(EMEA/CHMP/ICH/168535/2005)
Value Domain Type code
Choice list
Concept List epsos-dataelement-140.0
Terminology Asscociation: This concept list is represented by Value Set epSOSRouteofAdministration (DYNAMIC)
Used in 4 scenarios, inherited once
target This concept is used in transaction Return eP from country A (0..1 Required) in scenario
target This concept is used in transaction Return MRO (0..1 Required) in scenario
target This concept is used in transaction Send HCER to country A (0..1 Required) in scenario
target This concept is used in transaction Return PS of country A (0..1 Required) in scenario
tracking Tracking 2013‑11‑28 18:11:11 - status: Closed
  Author Alexander Henket
Description Definition added to the dataset
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:55:51
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑11‑10 19:55:37 - status: Open
  Author Giorgio Cangioli
Description definition provided in the D 3.1 were the prescription model is described.

Route of administration:

Indicates the part of the body through or into which, or the way in which, the medicinal product is intended to be introduced. In some cases a medicinal product can be intended for more than one route and/or method of administration.

NOTE FOR GUIDANCE ON DATA ELEMENTS AND STANDARDS FOR DRUG DICTIONARIES

(EMEA/CHMP/ICH/168535/2005)
tracking Tracking 2013‑10‑21 11:55:53 - status: Open
  Author Elze de Groot
Description The definition is missing

 (epsos-issue-45) Definition "Instructions to patient"
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.45)
Last assignment to Alexander Henket

Issue Definition "Instructions to patient"
Id epsos-issue-45
Type Change Request
Status  Closed, assigned
Priority normal
Object(s) Data element epsos-dataelement-141 "Instructions to patient" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication / Prescription
Instructions to patient
Id epsos-dataelement-141
Description The prescriber might give to the patient instructions; They must be presented in the original language.
Value Domain Type text
Used in 4 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (0..1 Required) in scenario
target This concept is used in transaction Return MRO (0..1 Required) in scenario
target This concept is used in transaction Send HCER to country A (0..1 Required) in scenario
target This concept is used in transaction Return PS of country A (0..1 Required) in scenario
tracking Tracking 2013‑11‑28 18:18:50 - status: Closed
  Author Alexander Henket
Description Definition added
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:57:30
  Author assigned by Giorgio Cangioli (id#5)
  Description from D3.1
"Instructions to patient" The prescriber might give to the patient instructions; They must be presented in the original language.
tracking Tracking 2013‑10‑21 11:56:12 - status: Open
  Author Elze de Groot
Description Definition is missing here

 (epsos-issue-46) Definition "Advise to the dispenser"
Change Request (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.46)
Last assignment to Alexander Henket

Issue Definition "Advise to the dispenser"
Id epsos-issue-46
Type Change Request
Status  Closed, assigned
Priority normal
Object(s) Data element epsos-dataelement-142 "Advice to dispenser" from dataset "epSOS Data Set" 2013‑05‑30
Path to element: Clinical Data / Medication / Prescription
Advice to dispenser
Id epsos-dataelement-142
Description The prescriber might give instructions to the dispenser. The information will be in the original language as automatic translation is not secure enough. To avoid legal and ethical issues to the dispenser, it should be wise to implement an option that allows the dispenser to decide, knowing that this data is available, whether he wants to consult it or not.
Value Domain Type string
Used in 4 scenarios, inherited 0 times
target This concept is used in transaction Return eP from country A (0..1) in scenario
target This concept is used in transaction Return MRO (0..1) in scenario
target This concept is used in transaction Send HCER to country A (0..1) in scenario
target This concept is used in transaction Return PS of country A (0..1) in scenario
tracking Tracking 2013‑11‑28 18:19:25 - status: Closed
  Author Alexander Henket
Description
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑10 19:58:27
  Author assigned by Giorgio Cangioli (id#5)
tracking Tracking 2013‑11‑10 19:58:18 - status: Open
  Author Giorgio Cangioli
Description from D3.1
"Advise to the dispenser" The prescriber might give instructions to the dispenser. The information will be in the original language as automatic translation is not secure enough. To avoid legal and ethical issues to the dispenser, it should be wise to implement an option that allows the dispenser to decide, knowing that this data is available, whether he wants to consult it or not.
tracking Tracking 2013‑10‑21 11:56:27 - status: Open
  Author Elze de Groot
Description Definition is missing here

 (epsos-issue-17) Value set epSOSReactionAllergy without dataset binding
Clarification needed (issue id 2.16.840.1.113883.2.4.3.11.60.22.6.17)
Last assignment to Giorgio Cangioli

Issue Value set epSOSReactionAllergy without dataset binding
Id epsos-issue-17
Type Clarification needed
Status  Closed, assigned
Priority normal
Object(s) Value set epsos-valueset-11 (2013‑06‑03)
Description
Value Set Name Value Set Id Version / effective date Status
epSOSReactionAllergy 1.3.6.1.4.1.12559.11.10.1.3.1.42.11 July 2009 - 2013‑06‑03 Draft
Source Code System:
  • 2.16.840.1.113883.6.96 SNOMED-CT
Level/ Type Code Display Name Code System Description
0-L 39579001 Anaphylaxis SNOMED-CT
0-L 200769008 Atopic dermatitis and related conditions SNOMED-CT
0-L 4386001 Bronchospasm SNOMED-CT
0-L 9826008 Conjunctivitis SNOMED-CT
0-L 43116000 Eczema SNOMED-CT
0-L 267804004 Pruritus NOS SNOMED-CT
0-L 70076002 Rhinitis SNOMED-CT
0-L 247472004 Weal SNOMED-CT
0-L 41291007 Angio-oedema SNOMED-CT
Legenda: Type L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors to appear in @nullFlavor attribute instead of @code.
download CSV XML 
tracking Tracking 2013‑12‑03 11:54:52 - status: Closed
  Author Alexander Henket
Description Add the binding as an extra binding to Allergy code (see page 158/159 epSOS_D3.9.1_Appendix_B1_B2_Implementation_v1.4_20110725.pdf)
arrowright Assignment to Giorgio Cangioli (id#5) on 2013‑11‑28 17:34:01
  Author assigned by Alexander Henket (id#4)
  Description I'm still not entirely clear on what exact dataset concept we need to split. Could you be exact in what you would like to have/see?
arrowright Assignment to Alexander Henket (id#4) on 2013‑11‑05 15:27:18
  Author assigned by Alexander Henket (id#4)
  Description There are drug allergies and other allergies. The tow use separate value sets. Consider splitting concepts accordingly in the dataset to simplify mapping into the message/document.
tracking Tracking 2013‑10‑16 13:52:13 - status: Open
  Author Alexander Henket
Description Issue:

This value set does not have a clear binding to anything in the dataset. Advice needed for mapping.

Data sets, codes, OIDs and Rules: this information is used for rendering and validation purposes.